Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AC091959.3 ENSG00000275740 5 146203550-146339251 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 21.6" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 8.9;Club cells: 7.9;granulocytes: 3.5;monocytes: 5.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA035944, HPA036422" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035944: AB_10670672, HPA036422: AB_10669987" "unprognostic (6.42e-2)" "unprognostic (7.72e-4)" "unprognostic (2.05e-2)" "unprognostic (4.95e-2)" "unprognostic (1.51e-2)" "unprognostic (1.13e-2)" "unprognostic (3.24e-2)" "unprognostic (8.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.61e-2)" "unprognostic (1.17e-1)" "unprognostic (3.77e-3)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (1.56e-2)" "unprognostic (2.12e-2)" 3.6 2.8 4.0 5.7 5.4 8.0 3.4 6.5 5.4 4.6 5.1 2.9 3.5 6.0 4.8 2.3 4.9 4.4 2.8 3.6 3.7 3.1 4.1 3.3 5.0 3.6 4.1 5.9 3.3 5.5 4.3 4.1 4.0 4.3 3.4 3.0 3.5 3.4 7.3 2.2 4.6 5.8 3.7 4.3 4.2 21.6 3.8 8.4 5.8 4.0 4.7 5.6 3.9 16.1 12.5 17.6 13.3 11.8 15.0 8.4 6.0 9.9 4.8 4.6 1.5 1.5 4.4 7.7 4.7 9.2 9.5 10.6 4.8 7.0 4.6 4.1 5.7 4.6 7.1 6.7 7.8 13.4 3.9 8.1 4.8 1.1 1.1 9.7 8.1 2.2 0.9 8.6 5.3 1.5 2.7 2.7 10.8 4.7 2.7 2.7 7.8 0.0 4.4 2.6 6.5 8.0 9.2 3.9 0.7 7.8 4.7 3.5 11.1 2.5 3.8 1.7 7.9 1.4 5.4 4.9 5.9 6.0 7.5 5.5 12.2 11.4 5.6 5.8 5.4 17.6 8.8 16.6 13.6 8.7 15.0 12.9 12.5 10.4 9.0 16.1 13.3 12.9 12.8 11.8 13.3 12.5 10.8 8.4 8.9 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.9 1.8 0.0 0.4 1.7 1.6 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ADAMTS4 "ADAMTS-2, ADMP-1, KIAA0688" ENSG00000158859 "ADAM metallopeptidase with thrombospondin type 1 motif 4" O75173 1 161184308-161199056 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 58.0" "Cell type enriched" "Detected in many" 7 "Smooth muscle cells: 356.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in many" 8 "dendritic cells: 8.0" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 10.9;HUVEC TERT2: 13.2;SH-SY5Y: 7.4;TIME: 11.1;U-138 MG: 6.9;U-251 MG: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025876, HPA051296, HPA068374" Uncertain Supported "Nuclear speckles" "Secreted to extracellular matrix" NA NA "Nuclear speckles" "CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978" "unprognostic (2.70e-2)" "unprognostic (8.10e-3)" "unprognostic (3.00e-3)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.19e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.20e-2)" "unprognostic (9.59e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.27e-7)" "unprognostic (1.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.44e-3)" "unprognostic (3.13e-2)" 58.0 9.7 2.6 18.1 20.7 1.8 14.6 1.5 10.7 7.8 6.3 33.4 0.0 1.9 5.8 2.0 7.7 14.2 16.4 19.5 3.4 2.3 3.1 11.0 15.7 2.7 28.6 3.5 35.7 10.6 4.7 4.9 4.4 20.5 5.8 3.4 0.0 1.7 1.7 7.7 1.7 3.0 12.0 15.5 1.9 8.1 1.7 15.7 0.0 7.5 1.2 1.4 8.7 4.0 0.5 8.0 1.0 0.2 0.4 0.6 0.2 0.0 0.0 0.2 0.1 6.1 3.9 0.6 4.9 0.2 0.4 2.8 0.2 0.1 0.2 4.1 1.5 0.0 0.1 0.0 0.0 1.7 0.1 0.3 0.1 0.4 1.2 0.6 0.0 0.1 4.3 0.0 10.9 0.1 0.0 13.2 0.1 0.1 0.3 0.3 0.1 0.0 0.2 4.9 0.0 0.0 0.1 4.8 0.1 0.0 0.1 0.1 7.4 0.0 0.1 0.1 0.3 0.2 0.5 11.1 6.9 0.1 0.3 9.8 0.2 0.1 0.1 2.1 0.1 0.1 0.7 0.2 0.2 0.6 0.1 0.3 0.3 0.3 0.3 0.1 0.5 0.4 0.4 1.0 0.4 0.1 8.0 0.3 0.2 2.6 20.7 1.5 10.0 3.4 2.3 28.6 3.5 20.5 15.7 0.0 5.5 0.0 2.3 27.7 2.2 2.8 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.3 0.0 43.0 0.0 0.0 0.0 0.2 33.3 8.7 0.0 0.8 0.8 3.2 0.0 48.5 1.5 0.0 0.3 6.0 33.7 1.8 0.0 0.3 0.0 0.0 1.1 0.0 1.0 51.8 356.4 2.3 0.6 16.7 0.3 1.5 0.0 4.4 AKAP8L "HAP95, NAKAP95" ENSG00000011243 "A-kinase anchoring protein 8 like" Q9ULX6 19 15380048-15419141 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042485, HPA042546" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA042485: AB_2678019, HPA042546: AB_2678046" "unprognostic (9.52e-3)" "unprognostic (5.23e-2)" "prognostic unfavorable (3.49e-4)" "unprognostic (1.08e-2)" "unprognostic (3.25e-1)" "unprognostic (3.53e-2)" "unprognostic (1.38e-2)" "unprognostic (2.87e-2)" "unprognostic (1.08e-1)" "unprognostic (3.57e-2)" "prognostic favorable (8.04e-4)" "unprognostic (1.01e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (2.77e-1)" "unprognostic (1.07e-1)" "unprognostic (8.80e-2)" "unprognostic (2.34e-3)" 13.9 20.6 25.6 12.1 35.8 55.1 14.3 51.0 30.3 17.9 15.9 20.6 20.0 10.7 15.3 26.8 13.6 18.7 13.4 23.4 24.6 17.9 14.8 16.3 17.0 17.3 25.4 22.3 23.9 10.7 23.6 25.6 18.8 23.9 17.6 13.0 19.7 13.7 17.8 31.9 17.8 12.0 14.6 19.5 16.4 13.7 28.5 30.0 15.5 18.0 13.8 18.7 15.1 16.6 4.2 3.0 5.9 2.7 0.7 3.6 1.3 12.8 13.5 20.3 9.4 17.7 20.7 10.6 11.7 13.2 19.7 17.5 22.9 19.0 11.7 20.0 13.9 17.7 14.7 28.2 16.1 16.1 19.8 23.1 22.6 14.3 17.2 31.7 20.1 14.8 18.3 27.4 16.2 20.3 23.3 14.1 18.6 25.7 23.4 11.8 18.6 20.7 19.1 15.9 17.4 23.8 24.5 11.5 14.0 14.8 9.3 18.6 12.3 14.0 15.7 18.3 24.5 11.4 19.4 17.5 12.2 8.6 18.8 19.0 35.9 21.1 24.3 10.1 21.2 11.8 0.1 2.7 2.2 1.2 1.4 3.4 1.4 1.5 1.9 3.0 4.2 1.7 2.6 5.9 0.7 1.8 1.9 3.6 1.3 25.6 35.8 51.0 30.3 24.6 17.9 25.4 22.3 23.9 30.0 6.0 12.8 20.3 41.3 28.0 58.9 6.3 15.3 40.2 29.6 33.2 72.6 28.4 21.6 27.4 21.7 22.4 12.9 23.3 27.6 22.3 23.6 28.7 12.8 13.1 14.6 74.7 24.5 9.8 11.9 6.8 24.5 27.6 25.3 28.9 12.9 40.5 25.6 14.8 27.6 13.2 80.3 25.8 46.4 66.1 49.6 34.4 52.2 27.5 13.6 36.6 ALYREF "ALY, ALY/REF, BEF, REF, THOC4" ENSG00000183684 "Aly/REF export factor" 17 81887844-81891586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "CAB016281, HPA019799, HPA061282" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB016281: AB_626667, HPA019799: AB_1844788, HPA061282: AB_2684464" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (4.89e-3)" "unprognostic (5.35e-2)" "unprognostic (3.43e-1)" "unprognostic (2.13e-2)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.77e-2)" "unprognostic (2.26e-1)" "unprognostic (2.55e-3)" "unprognostic (6.58e-2)" "unprognostic (8.07e-2)" "unprognostic (1.74e-3)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (8.65e-2)" "unprognostic (7.09e-2)" 17.5 15.7 15.7 29.4 15.4 76.6 17.4 13.4 23.8 17.8 20.1 17.7 14.3 20.2 16.3 15.8 30.4 18.2 17.8 27.2 13.4 13.0 16.7 21.9 19.0 34.7 14.8 13.9 19.7 22.9 10.7 17.0 23.0 12.7 16.1 15.1 15.9 18.2 13.2 27.2 22.2 19.3 16.0 15.8 25.3 16.9 50.5 10.2 61.8 19.8 33.7 36.4 15.5 18.3 3.6 5.5 0.5 2.8 2.1 3.9 1.1 37.9 35.9 25.0 24.5 5.1 7.0 32.0 19.2 10.4 40.0 25.2 40.3 25.2 42.0 15.4 15.3 23.9 22.1 36.2 20.3 17.2 16.0 63.9 30.5 22.7 43.1 10.5 48.7 27.7 6.9 9.3 23.4 9.4 5.7 23.7 31.1 38.6 25.7 14.7 41.2 102.7 82.8 34.2 22.2 38.4 68.8 31.0 21.6 8.3 22.8 34.3 44.8 18.4 43.8 15.5 14.0 33.6 49.6 15.5 41.0 41.2 19.1 64.2 30.9 15.1 53.9 21.7 31.1 34.8 0.3 2.8 0.2 3.9 2.8 2.5 2.7 2.7 2.6 3.0 3.6 0.7 2.0 0.5 2.1 2.5 5.5 1.4 1.1 15.7 15.4 13.4 23.8 13.4 13.0 14.8 13.9 12.7 10.2 0.0 20.2 21.2 16.3 31.0 11.8 11.7 7.6 8.1 10.3 19.2 0.0 8.4 1.7 4.8 1.3 11.9 7.5 0.0 7.2 19.1 13.4 14.7 15.0 14.4 15.7 4.8 12.1 7.4 11.1 3.2 3.1 14.5 13.5 4.6 17.0 20.6 8.1 9.1 3.9 3.4 5.9 0.0 11.3 10.9 8.5 37.6 13.8 8.7 18.3 25.5 API5 "AAC-11, AAC11, API5L1" ENSG00000166181 "Apoptosis inhibitor 5" Q9BZZ5 11 43311963-43344529 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026598 Approved Enhanced "Nuclear speckles" NA NA 7900 "Nuclear speckles" "HPA026598: AB_1844927" "unprognostic (4.05e-2)" "unprognostic (1.57e-1)" "unprognostic (2.58e-3)" "unprognostic (6.08e-2)" "unprognostic (5.88e-2)" "unprognostic (3.46e-2)" "unprognostic (1.24e-2)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (1.45e-3)" "unprognostic (2.87e-2)" "unprognostic (1.35e-1)" "prognostic favorable (1.06e-4)" "unprognostic (5.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (3.05e-2)" 33.4 31.3 31.8 31.1 39.8 21.9 35.4 54.5 45.0 33.3 33.0 32.3 26.7 32.1 39.0 26.1 36.9 30.2 25.4 21.5 33.0 30.1 38.4 51.4 26.4 37.3 31.5 37.4 31.7 35.4 41.9 31.6 32.0 40.3 32.1 36.8 19.9 32.8 33.2 38.3 31.9 39.0 37.3 40.0 38.0 31.1 24.5 31.5 52.3 40.9 26.8 42.1 32.4 29.5 24.8 24.2 19.4 25.2 45.4 31.7 30.8 26.7 29.3 38.6 23.1 26.9 26.7 25.7 26.8 29.2 38.3 36.7 20.6 11.8 32.5 20.9 28.6 27.5 33.2 46.3 31.1 52.6 37.3 42.5 29.5 17.2 17.8 23.6 48.8 27.7 21.6 32.1 19.0 33.9 23.1 31.7 20.1 47.9 28.5 25.6 16.5 40.5 19.8 66.7 33.2 27.6 43.2 39.4 24.9 27.6 31.6 29.9 19.6 32.1 27.7 24.7 29.6 33.9 22.4 27.5 32.5 24.3 43.6 43.5 23.5 33.8 51.1 27.6 28.7 19.4 19.4 18.4 19.4 27.7 25.2 31.7 24.8 27.7 28.7 24.2 23.0 28.5 29.6 4.0 45.4 24.3 15.5 23.5 30.8 31.8 39.8 54.5 45.0 33.0 30.1 31.5 37.4 40.3 31.5 14.9 23.5 17.8 14.2 38.9 22.5 13.7 28.1 18.7 31.8 19.2 9.8 25.7 26.6 19.6 6.8 24.8 19.3 23.3 16.9 25.3 25.1 20.5 31.2 42.2 23.0 27.0 23.1 21.5 34.8 4.5 17.3 23.9 30.4 32.5 28.0 20.3 21.8 14.4 19.1 29.1 16.2 6.5 24.7 25.5 23.0 45.4 32.5 28.7 28.8 15.5 BAZ2A "KIAA0314, TIP5, WALp3" ENSG00000076108 "Bromodomain adjacent to zinc finger domain 2A" Q9UIF9 12 56595596-56636816 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005782, HPA063806" Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA005782: AB_10601089, HPA063806: AB_2685128" "unprognostic (1.70e-1)" "unprognostic (1.75e-2)" "unprognostic (5.76e-2)" "unprognostic (1.73e-2)" "unprognostic (1.91e-1)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (3.72e-2)" "unprognostic (3.10e-1)" "unprognostic (6.45e-2)" "unprognostic (9.64e-2)" "unprognostic (3.00e-2)" "unprognostic (3.77e-2)" "unprognostic (1.73e-1)" "unprognostic (1.15e-1)" "unprognostic (2.25e-2)" "unprognostic (3.43e-1)" 25.5 22.8 18.2 25.5 22.4 45.5 25.5 39.0 26.0 25.6 23.2 24.6 23.2 20.1 25.2 21.8 28.0 21.5 24.1 19.1 18.7 11.6 19.9 19.7 31.5 25.0 23.1 13.5 32.6 26.2 33.8 36.1 29.0 19.4 21.9 22.1 27.6 24.0 34.5 24.7 26.0 27.6 19.4 19.2 32.9 20.9 34.1 24.4 46.1 26.4 19.6 30.3 27.3 30.5 5.1 8.6 20.1 9.0 12.6 3.6 1.7 20.4 20.9 27.0 22.5 15.7 16.0 27.2 14.3 19.6 20.2 14.9 24.5 24.9 30.3 21.1 16.6 17.3 17.8 31.9 18.8 18.7 19.5 17.1 34.3 12.8 12.4 17.4 19.8 25.9 14.1 19.5 17.5 25.6 22.9 20.2 12.5 36.4 36.7 11.6 13.1 16.4 13.2 24.6 14.0 15.9 13.9 20.0 20.6 14.6 20.2 18.3 15.2 23.9 25.1 13.2 31.5 27.6 18.1 27.8 10.3 20.4 13.3 10.0 20.5 19.2 28.2 9.8 14.3 15.3 6.5 5.1 3.7 3.6 4.5 3.0 4.3 2.8 2.7 1.8 5.1 2.4 2.1 20.1 12.6 9.0 8.6 2.5 1.7 18.2 22.4 39.0 26.0 18.7 11.6 23.1 13.5 19.4 24.4 62.5 60.7 48.0 38.2 45.2 69.5 21.4 25.5 20.1 27.3 24.4 129.6 38.6 6.6 27.8 52.5 40.9 47.2 0.0 25.1 27.9 32.9 50.8 40.6 25.1 20.9 30.2 42.9 52.2 50.1 51.1 56.1 40.8 37.1 57.7 40.9 27.3 28.7 38.6 54.1 9.6 68.6 84.1 49.5 82.5 133.9 54.1 80.0 43.6 29.6 49.2 BCLAF1 "BTF, KIAA0164" ENSG00000029363 "BCL2 associated transcription factor 1" Q9NYF8 6 136256627-136289851 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006484, HPA006669, HPA027770" Enhanced Enhanced "Nuclear speckles" NA NA 190000 "Nuclear speckles" "HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484" "prognostic unfavorable (1.64e-4)" "unprognostic (1.60e-1)" "prognostic favorable (3.44e-4)" "unprognostic (1.45e-1)" "unprognostic (9.46e-3)" "unprognostic (2.29e-1)" "unprognostic (2.13e-3)" "unprognostic (1.63e-1)" "unprognostic (5.07e-2)" "unprognostic (1.14e-1)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (7.20e-2)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (7.93e-2)" "unprognostic (4.19e-3)" 22.6 20.9 19.3 20.6 33.6 93.9 26.8 56.9 31.0 27.6 23.2 13.3 18.1 15.2 25.8 21.3 22.7 22.9 12.4 17.0 20.4 19.0 19.3 22.0 19.9 22.7 24.4 19.5 33.5 20.5 34.8 50.2 25.5 27.8 21.4 23.7 14.2 23.5 18.2 26.8 22.2 20.8 23.1 22.4 22.7 22.2 16.7 27.2 38.6 24.7 21.5 25.4 24.0 23.2 22.2 25.2 35.7 20.4 29.1 24.9 13.4 18.4 16.0 38.1 31.7 12.1 10.2 19.3 35.2 21.9 23.7 25.3 22.8 12.5 38.8 21.9 26.9 26.4 17.9 42.5 23.2 29.9 21.3 26.4 48.3 23.1 24.7 14.0 80.7 30.8 14.0 11.6 33.5 21.0 8.7 21.0 17.9 42.8 19.2 24.8 22.0 32.2 9.2 28.0 12.4 16.7 29.3 47.8 17.2 17.8 35.4 32.4 22.4 34.5 16.6 13.5 14.9 15.6 16.4 28.8 18.8 27.7 22.5 34.3 16.3 29.4 53.5 11.2 26.0 21.8 15.4 16.4 24.2 21.1 20.4 21.0 22.2 19.4 17.6 25.2 19.8 24.9 22.3 35.7 29.1 19.7 14.9 14.7 13.4 19.3 33.6 56.9 31.0 20.4 19.0 24.4 19.5 27.8 27.2 190.6 153.2 83.6 108.7 60.7 127.0 77.9 45.9 167.3 142.1 54.1 198.3 96.6 28.2 81.2 9.9 101.1 66.6 23.3 56.7 91.0 71.4 104.6 151.4 53.9 65.0 96.9 114.1 63.8 71.0 10.5 113.1 102.2 65.8 111.0 71.1 93.3 66.1 77.5 102.9 34.9 131.3 109.9 75.2 98.4 119.5 62.2 107.3 105.5 70.0 102.3 BMP2K "BIKe, DKFZp434K0614" ENSG00000138756 "BMP2 inducible kinase" Q9NSY1 4 78776342-78916372 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 124.9;Hofbauer cells: 112.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 38.8;HMC-1: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026436, HPA026451, HPA026501" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341" "unprognostic (7.96e-2)" "unprognostic (3.68e-1)" "prognostic favorable (1.74e-4)" "unprognostic (9.08e-2)" "unprognostic (1.97e-1)" "unprognostic (9.73e-3)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (2.98e-1)" "unprognostic (7.60e-2)" "unprognostic (1.39e-1)" "unprognostic (9.60e-2)" "unprognostic (9.90e-2)" "unprognostic (9.45e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-2)" "unprognostic (3.18e-2)" 11.4 11.1 15.6 18.6 15.0 15.3 12.0 8.2 12.7 11.1 13.9 20.3 2.1 8.0 11.3 9.6 15.7 10.0 12.3 17.0 18.0 9.5 8.3 10.2 14.1 22.9 20.9 12.0 6.5 6.4 7.7 7.8 14.4 14.5 8.4 18.9 11.4 10.2 6.0 7.5 14.5 15.9 10.4 28.3 19.2 7.4 19.6 16.5 19.9 12.5 5.9 24.4 9.7 12.8 2.7 1.7 3.8 2.6 0.4 0.4 0.5 5.5 2.0 3.0 4.0 6.0 5.8 2.4 5.4 8.3 6.0 7.9 3.8 2.9 6.7 2.7 25.8 5.2 1.3 3.6 4.3 11.0 1.9 1.3 38.8 2.4 1.7 6.7 8.1 42.0 8.4 5.6 9.4 8.7 3.2 8.1 4.9 10.4 19.5 7.1 1.2 4.8 3.4 1.4 3.7 1.4 7.0 5.5 1.6 7.3 3.0 4.8 2.6 7.8 4.0 4.7 3.8 1.4 4.2 7.9 5.9 2.3 9.8 5.7 3.6 1.4 2.6 5.2 10.2 4.1 0.4 2.2 1.2 0.1 0.9 0.1 2.7 0.1 0.0 1.7 2.7 0.4 0.2 3.8 0.4 2.6 1.3 0.0 0.5 15.6 15.0 8.2 12.7 18.0 9.5 20.9 12.0 14.5 16.5 26.8 18.1 10.4 3.8 22.1 9.6 5.7 2.5 6.7 6.8 7.0 3.9 4.0 0.0 7.0 11.1 12.4 19.7 46.7 7.6 11.6 12.4 6.3 124.9 16.3 112.6 9.5 6.4 30.7 61.7 7.6 7.5 31.6 27.0 22.6 41.6 46.4 10.6 48.2 6.3 18.1 8.4 6.5 7.4 24.1 9.6 27.5 2.9 3.9 21.8 2.3 BPNT1 ENSG00000162813 "3'(2'), 5'-bisphosphate nucleotidase 1" O95861 1 220057482-220090462 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048461 Approved Approved "Nuclear speckles" NA NA 170000 "Nuclear speckles" "HPA048461: AB_2680404" "unprognostic (6.42e-2)" "unprognostic (4.69e-2)" "unprognostic (2.78e-2)" "unprognostic (1.02e-1)" "unprognostic (5.19e-3)" "unprognostic (7.65e-2)" "unprognostic (2.07e-2)" "unprognostic (3.00e-1)" "unprognostic (2.44e-1)" "unprognostic (1.66e-1)" "unprognostic (6.69e-2)" "unprognostic (2.87e-1)" "prognostic favorable (6.38e-4)" "unprognostic (1.82e-2)" "unprognostic (6.58e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-1)" 11.1 24.1 12.7 22.2 17.2 2.9 13.4 13.7 16.5 12.9 27.9 15.9 14.4 30.5 10.6 8.0 14.9 11.5 16.1 11.6 11.3 10.8 31.0 17.0 11.5 21.5 14.0 10.6 13.5 8.6 14.1 20.2 12.7 11.9 9.6 22.5 11.8 22.2 12.2 7.6 10.6 49.0 12.3 17.6 12.0 12.9 10.4 13.3 15.6 13.8 12.6 28.8 13.5 10.4 18.9 10.9 11.6 8.5 12.1 13.8 7.6 11.8 9.8 7.4 5.9 13.2 10.6 11.0 16.0 7.8 13.8 12.8 12.9 24.1 60.2 21.1 10.4 6.4 8.6 14.9 13.4 11.2 21.6 17.3 10.8 12.7 15.9 7.7 28.8 10.2 9.9 6.4 20.4 7.6 8.6 10.8 17.4 18.8 6.0 13.1 6.7 16.5 7.9 6.3 9.6 12.1 11.9 21.3 17.0 17.1 16.3 13.7 11.3 20.2 24.3 13.2 7.5 19.1 10.0 18.0 8.6 6.7 11.9 19.8 10.6 25.5 28.5 7.7 10.8 19.4 11.6 7.8 5.0 11.0 8.5 8.7 18.9 11.3 11.0 9.0 14.1 13.8 10.2 1.1 12.1 7.8 10.9 11.5 7.6 12.7 17.2 13.7 16.5 11.3 10.8 14.0 10.6 11.9 13.3 26.8 19.2 20.8 9.9 3.0 12.5 11.1 15.3 10.7 17.0 14.0 9.8 11.9 11.6 15.3 1.9 4.2 50.6 0.0 13.9 11.4 7.2 5.8 3.5 11.3 8.6 6.4 18.5 4.9 5.7 2.4 8.9 8.3 10.1 7.2 12.6 10.1 15.8 24.6 12.7 21.7 11.2 12.9 6.6 12.5 12.6 4.4 21.1 7.0 15.5 10.7 BRD1 "BRL, BRPF2" ENSG00000100425 "Bromodomain containing 1" O95696 22 49773283-49827512 "Predicted intracellular proteins" "Erythrocyte maturation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000807, HPA001063" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA000807: AB_1078298, HPA001063: AB_1078297" "unprognostic (1.96e-1)" "unprognostic (2.99e-2)" "unprognostic (1.07e-1)" "unprognostic (5.11e-3)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "unprognostic (2.18e-2)" "unprognostic (9.98e-2)" "unprognostic (2.73e-2)" "unprognostic (3.28e-2)" "unprognostic (2.02e-3)" "unprognostic (1.64e-3)" "unprognostic (5.87e-2)" "unprognostic (7.50e-2)" "unprognostic (1.06e-1)" "unprognostic (1.26e-1)" "unprognostic (3.95e-3)" 12.1 9.3 11.3 11.5 12.8 17.0 17.3 32.4 13.0 15.8 14.5 10.8 11.8 15.3 18.9 9.3 14.6 15.5 14.6 8.9 8.6 7.5 7.4 8.0 11.3 11.2 9.6 11.1 19.3 20.3 10.8 13.5 14.8 11.3 11.9 8.2 13.9 14.0 11.7 16.8 23.7 14.7 14.3 7.6 14.8 14.9 38.9 11.7 23.8 13.4 12.1 16.0 15.3 14.2 2.2 2.3 1.7 6.3 1.9 2.9 1.1 8.5 8.7 16.1 8.9 6.6 5.9 13.6 9.5 6.5 10.0 7.9 13.1 5.7 9.0 5.6 7.8 3.7 12.3 10.2 6.7 4.3 9.0 18.5 8.9 13.2 8.0 12.9 20.4 12.8 8.8 10.6 5.9 7.4 7.3 7.2 11.0 10.1 10.0 5.1 14.0 15.2 10.7 11.0 6.4 7.1 22.7 14.0 9.3 3.9 12.5 10.3 18.2 12.1 15.9 12.4 7.8 7.4 16.9 8.9 9.3 10.1 7.0 8.6 11.9 2.8 12.9 6.6 7.3 8.1 0.8 1.6 1.7 1.5 0.7 2.9 1.2 2.4 2.7 1.1 2.2 2.4 2.7 1.7 1.9 6.3 2.3 0.8 1.1 11.3 12.8 32.4 13.0 8.6 7.5 9.6 11.1 11.3 11.7 20.8 28.8 4.7 4.7 14.1 24.8 6.9 7.6 9.4 15.9 3.5 27.5 5.8 0.0 6.7 6.9 9.2 9.3 0.0 8.0 5.4 11.3 6.0 9.3 10.9 5.9 31.8 15.5 12.9 17.1 5.5 10.9 9.9 11.8 6.4 13.1 18.1 7.4 11.5 13.1 3.1 33.4 0.0 8.2 41.7 18.1 16.2 8.5 8.5 10.6 6.8 BRD2 "BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3" ENSG00000204256 "Bromodomain containing 2" P25440 6 32968660-32981505 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042816 Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA042816: AB_10794766" "unprognostic (2.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.10e-1)" "unprognostic (4.60e-2)" "unprognostic (1.45e-1)" "unprognostic (9.89e-2)" "unprognostic (5.03e-2)" "unprognostic (2.54e-1)" "unprognostic (6.85e-3)" "unprognostic (1.39e-2)" "unprognostic (1.95e-2)" "unprognostic (3.42e-2)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.49e-1)" "unprognostic (1.20e-2)" "unprognostic (1.44e-2)" 26.1 35.1 26.8 30.1 28.9 96.2 26.8 42.2 28.8 34.9 27.4 30.6 46.4 21.2 35.0 28.7 33.2 33.0 27.6 21.7 26.5 20.1 28.9 27.5 28.1 28.2 34.9 19.5 40.6 65.5 28.8 33.7 27.2 29.0 28.5 21.8 29.3 32.6 41.7 28.6 28.7 25.6 27.1 26.4 33.4 32.2 66.9 33.1 38.7 58.5 27.1 33.2 26.8 35.8 12.3 13.0 14.0 11.2 12.9 19.5 12.0 19.1 7.5 18.6 13.6 10.1 9.3 26.1 15.1 18.7 19.1 16.5 8.0 13.3 14.4 16.7 21.4 13.1 10.1 11.8 12.2 16.9 14.1 53.9 13.9 9.4 6.6 14.5 22.8 24.3 9.6 10.6 17.1 15.6 25.9 6.8 11.6 17.5 28.9 7.3 3.8 25.6 4.0 10.4 21.6 7.0 30.3 5.5 20.4 5.1 9.0 28.7 11.4 16.8 21.2 21.2 12.4 14.5 12.9 8.5 26.3 12.5 7.4 18.7 43.0 35.8 36.1 7.4 13.3 15.7 10.2 9.1 14.0 19.5 11.2 17.6 12.3 13.0 13.1 13.0 11.8 9.1 13.5 12.9 12.9 10.9 10.8 16.3 12.0 26.8 28.9 42.2 28.8 26.5 20.1 34.9 19.5 29.0 33.1 71.5 114.1 98.7 188.7 188.4 73.7 146.1 94.3 71.0 75.1 57.6 98.2 75.1 18.3 58.2 233.1 107.9 140.5 23.3 79.1 101.6 100.8 173.4 111.0 77.8 71.2 52.4 248.8 105.0 87.8 140.2 80.6 111.7 118.1 78.5 135.2 56.5 69.4 115.4 72.5 35.3 62.2 38.8 179.1 77.0 117.6 198.4 171.5 138.4 122.8 198.6 C11orf49 "FLJ22210, MGC4707" ENSG00000149179 "Chromosome 11 open reading frame 49" Q9H6J7 11 46936689-47164385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040051, HPA040280" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA040051: AB_10795412, HPA040280: AB_10795363" "unprognostic (3.11e-2)" "unprognostic (3.01e-1)" "unprognostic (2.15e-1)" "unprognostic (1.06e-2)" "unprognostic (6.65e-2)" "unprognostic (7.76e-2)" "prognostic unfavorable (2.18e-5)" "unprognostic (1.27e-1)" "unprognostic (2.76e-1)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.55e-1)" "unprognostic (1.54e-2)" "unprognostic (1.36e-1)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.34e-3)" 5.2 9.4 20.9 6.0 27.6 2.9 10.0 18.3 36.3 15.8 11.5 16.5 7.2 11.3 12.7 14.5 7.6 33.1 9.7 10.3 21.0 26.0 13.1 3.5 11.2 5.9 18.7 20.3 15.2 12.4 21.6 21.0 7.2 23.0 11.0 11.7 12.2 8.9 13.9 4.2 23.9 10.6 12.9 12.7 5.6 14.5 19.0 11.4 11.3 15.1 5.1 7.5 8.2 7.1 15.8 16.4 7.6 8.8 15.6 16.2 11.8 5.5 15.3 19.4 15.6 10.3 15.8 5.3 6.0 14.2 14.2 16.6 3.7 9.6 5.0 6.9 13.4 16.8 7.9 10.3 15.4 11.7 9.4 14.4 7.2 18.4 5.9 17.0 8.1 9.2 9.5 10.7 6.7 9.2 26.7 15.4 11.8 5.5 6.4 10.1 11.8 12.2 7.1 8.2 14.3 7.7 4.4 5.8 5.2 22.3 5.7 14.1 19.8 8.2 8.1 7.5 11.4 14.2 4.5 3.8 7.7 6.1 13.4 9.7 5.8 4.7 4.2 19.5 1.8 9.8 7.6 7.0 5.8 13.6 8.8 16.2 15.8 12.9 15.9 16.4 11.3 13.8 14.5 0.1 15.6 5.9 15.3 12.5 11.8 20.9 27.6 18.3 36.3 21.0 26.0 18.7 20.3 23.0 11.4 8.9 25.3 9.1 14.2 11.6 22.3 7.0 10.2 65.6 23.9 22.7 17.7 16.6 39.7 25.8 35.6 9.2 16.8 0.0 18.0 11.3 13.8 9.3 15.1 1.8 8.7 35.0 18.4 7.4 2.6 25.4 11.8 6.6 11.8 16.2 11.6 43.1 14.5 20.4 19.1 27.0 46.2 6.5 7.3 43.3 9.0 15.7 8.4 9.6 13.0 8.6 C12orf57 "C10, GRCC10" ENSG00000111678 "Chromosome 12 open reading frame 57" Q99622 12 6942978-6946003 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046182, HPA059163, HPA066043" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA046182: AB_2679572, HPA059163: AB_2683937, HPA066043: AB_2685603" "unprognostic (5.89e-2)" "unprognostic (1.56e-2)" "unprognostic (2.36e-2)" "unprognostic (1.80e-2)" "unprognostic (2.24e-2)" "unprognostic (2.56e-1)" "unprognostic (5.20e-3)" "unprognostic (8.27e-2)" "unprognostic (1.11e-1)" "unprognostic (3.48e-2)" "prognostic favorable (8.74e-4)" "unprognostic (4.25e-2)" "prognostic unfavorable (2.32e-7)" "unprognostic (1.47e-2)" "unprognostic (3.26e-1)" "unprognostic (6.81e-2)" "unprognostic (8.39e-3)" 34.1 46.2 40.0 22.3 36.3 32.5 57.5 32.9 47.1 55.1 40.6 17.3 66.1 22.7 63.7 48.5 38.2 55.3 54.2 61.1 30.9 35.3 38.0 43.3 34.2 47.5 35.3 23.2 132.1 116.3 14.1 49.9 26.5 23.1 58.6 20.7 42.5 52.9 73.4 45.5 42.6 22.3 45.3 21.7 22.8 30.9 25.9 16.3 91.6 50.8 29.3 34.1 50.6 78.1 33.4 43.5 11.8 15.8 17.6 52.6 30.8 14.2 42.0 49.2 48.3 34.0 40.8 16.3 18.8 46.7 16.4 26.1 16.6 24.4 4.4 15.0 29.3 21.1 13.8 18.7 23.3 3.9 25.5 38.9 38.1 34.6 23.5 64.7 15.5 37.5 48.8 27.9 12.6 17.3 32.2 27.5 36.1 13.0 38.8 15.1 42.8 32.5 20.1 87.8 23.8 15.4 36.3 43.9 65.2 21.8 36.0 21.9 64.2 30.3 31.0 37.7 24.3 7.8 82.3 28.8 33.0 31.3 13.1 27.9 28.8 23.2 23.6 34.0 0.4 22.0 11.8 3.9 3.6 38.8 6.4 25.6 25.2 43.8 41.0 5.8 33.4 52.6 42.9 1.6 17.6 15.8 43.5 38.1 30.8 40.0 36.3 32.9 47.1 30.9 35.3 35.3 23.2 23.1 16.3 59.6 118.9 155.2 220.4 234.9 85.7 193.7 191.1 83.0 124.0 116.9 23.6 106.7 310.0 168.6 133.9 186.1 158.5 0.0 372.0 184.2 224.0 232.5 145.5 244.6 58.5 35.0 299.7 176.1 78.4 224.0 419.7 91.0 219.4 62.3 387.2 96.5 211.2 244.1 354.7 163.1 67.1 284.6 342.1 44.5 93.2 187.9 129.0 231.0 327.3 202.6 C16orf71 "DKFZp686H2240, FLJ43261" ENSG00000166246 "Chromosome 16 open reading frame 71" Q8IYS4 16 4734272-4749396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "fallopian tube: 14.1;testis: 48.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 18.7;Early spermatids: 20.4;Late spermatids: 45.3;Spermatocytes: 48.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 7.6;U-2197: 8.3" HPA049468 Enhanced Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA049468: AB_2680779" "unprognostic (1.24e-2)" "unprognostic (8.87e-2)" "unprognostic (2.39e-1)" "prognostic favorable (7.49e-4)" "unprognostic (7.06e-2)" "unprognostic (2.17e-2)" "unprognostic (5.36e-3)" "unprognostic (2.21e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-2)" "unprognostic (6.79e-3)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.54e-5)" "unprognostic (1.65e-1)" 0.3 0.5 0.7 0.3 1.9 0.0 0.3 1.0 1.0 0.9 0.3 2.4 0.6 0.2 0.6 2.5 0.4 14.1 0.8 0.3 1.1 1.0 1.0 1.1 1.7 0.1 0.7 0.5 1.2 0.4 0.8 1.7 0.1 3.6 0.5 0.1 0.4 1.3 1.1 0.4 0.2 0.3 0.4 0.5 0.2 0.3 48.9 0.7 0.2 1.1 0.0 0.4 0.3 0.5 1.4 4.1 0.0 1.1 0.0 0.7 0.4 0.6 3.3 0.7 1.9 4.4 1.9 1.4 1.8 1.6 1.5 1.9 1.5 1.4 0.1 1.8 2.7 4.4 1.5 1.7 1.7 0.3 0.7 1.1 0.4 2.4 0.1 1.4 1.4 0.6 0.5 0.4 5.8 1.6 1.1 0.8 1.3 1.1 0.9 1.5 7.6 0.4 1.2 1.0 2.1 1.6 0.5 0.8 2.2 4.0 0.7 4.9 1.8 1.8 1.5 0.6 1.3 6.7 0.4 0.6 1.2 1.4 8.3 0.9 3.3 2.6 0.8 0.7 0.4 1.3 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.7 0.1 0.9 1.4 0.4 0.5 0.0 0.0 1.1 4.1 0.0 0.4 0.7 1.9 1.0 1.0 1.1 1.0 0.7 0.5 3.6 0.7 0.0 0.6 0.0 0.2 0.0 0.8 0.8 0.0 18.7 5.7 0.0 3.9 0.2 0.0 0.5 20.4 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 45.3 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 1.3 1.7 0.0 0.0 48.1 6.6 0.0 0.1 0.0 0.0 0.0 C3orf62 FLJ43654 ENSG00000188315 "Chromosome 3 open reading frame 62" Q6ZUJ4 3 49268602-49277909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "blood: 25.0;testis: 76.9" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 25.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 25.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043328 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA043328: AB_10795613" "prognostic favorable (3.93e-4)" "unprognostic (4.87e-3)" "unprognostic (3.70e-3)" "unprognostic (2.35e-2)" "unprognostic (9.51e-2)" "prognostic favorable (9.72e-4)" "prognostic unfavorable (5.20e-4)" "prognostic favorable (8.88e-4)" "unprognostic (1.28e-1)" "unprognostic (9.40e-3)" "prognostic favorable (8.15e-4)" "unprognostic (7.23e-2)" "unprognostic (3.27e-2)" "prognostic favorable (3.29e-5)" "unprognostic (2.46e-1)" "unprognostic (4.79e-1)" "prognostic favorable (1.62e-5)" 4.2 5.5 3.2 4.4 4.0 7.4 2.7 6.6 4.8 3.8 3.6 2.8 4.4 3.1 3.5 4.9 3.7 4.1 5.0 3.5 3.7 4.3 2.7 2.8 3.9 4.5 3.3 4.0 8.0 4.7 2.4 4.5 2.6 3.6 4.1 2.3 5.7 4.4 2.2 3.7 3.5 2.7 3.6 3.6 7.0 2.6 76.9 3.3 2.2 3.7 2.2 3.3 4.8 7.5 1.2 1.6 25.0 3.2 0.6 1.0 0.7 4.8 2.9 6.9 8.7 5.7 5.2 3.9 2.9 4.9 2.6 3.9 4.1 3.7 9.6 4.6 4.4 5.4 3.8 3.5 3.2 3.0 8.5 4.0 6.3 6.1 4.6 2.0 8.9 11.9 4.0 9.5 3.8 7.1 4.5 3.1 5.6 7.1 7.3 2.2 3.0 6.6 6.4 4.9 3.8 4.2 5.0 3.6 5.0 4.3 11.2 5.3 7.2 8.0 6.1 10.4 5.4 3.1 9.9 3.5 3.6 8.8 6.1 5.3 6.7 10.9 8.3 2.7 8.6 4.9 1.5 3.2 3.4 0.8 1.2 0.9 1.2 0.9 0.8 0.7 0.9 0.9 0.8 25.0 0.6 1.4 1.6 1.0 0.7 3.2 4.0 6.6 4.8 3.7 4.3 3.3 4.0 3.6 3.3 8.9 17.3 3.0 3.1 6.1 11.5 7.8 7.6 9.4 11.4 10.4 21.6 5.2 0.0 4.1 9.1 5.8 4.3 0.0 3.4 3.6 5.3 5.4 2.3 5.7 9.0 4.8 5.2 8.0 17.3 12.8 8.1 9.2 8.5 9.0 8.6 6.5 4.3 3.5 8.1 4.9 13.5 0.0 3.8 64.4 6.5 7.5 3.4 6.4 6.3 2.0 C6orf226 LOC441150 ENSG00000221821 "Chromosome 6 open reading frame 226" Q5I0X4 6 42890265-42890816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA045350 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA045350: AB_10964640" "prognostic favorable (1.93e-5)" "unprognostic (2.21e-3)" "unprognostic (2.91e-1)" "unprognostic (2.77e-3)" "unprognostic (1.71e-1)" "unprognostic (4.17e-2)" "unprognostic (5.40e-2)" "unprognostic (2.00e-3)" "unprognostic (8.82e-2)" "unprognostic (3.50e-3)" "prognostic favorable (5.13e-4)" "unprognostic (2.24e-2)" "prognostic favorable (3.35e-4)" "unprognostic (4.63e-1)" "unprognostic (3.97e-2)" "unprognostic (6.13e-2)" "unprognostic (5.82e-3)" 16.5 21.7 14.4 11.5 15.2 22.6 23.3 11.0 17.0 9.0 11.1 8.2 11.3 16.3 11.7 21.9 11.1 9.6 9.9 15.1 13.3 15.5 12.4 16.2 11.0 25.8 13.1 11.7 10.5 15.5 8.7 16.4 5.8 14.5 13.1 4.1 12.2 11.9 16.4 22.1 17.5 12.3 16.3 13.8 13.8 12.1 12.9 8.2 14.0 9.4 12.6 7.4 11.4 7.2 13.6 20.9 17.3 18.8 18.7 19.5 12.2 6.5 5.1 4.6 9.4 5.1 4.5 5.6 4.1 2.2 5.0 6.5 1.9 2.3 1.4 8.6 1.9 3.2 5.3 1.2 2.6 1.5 6.2 9.6 5.2 4.7 13.0 5.3 1.4 3.8 5.1 3.5 2.5 1.1 1.4 3.9 5.6 0.3 7.7 3.1 13.2 10.5 8.9 1.7 6.5 4.3 4.7 3.3 6.8 2.7 5.2 9.2 11.1 7.8 3.4 10.1 1.7 8.3 4.1 5.1 4.0 11.9 7.4 3.8 18.7 14.1 21.6 2.5 2.8 2.7 6.1 18.7 17.3 15.6 14.2 11.6 13.3 19.5 15.8 20.9 13.6 15.4 18.8 8.3 18.7 18.8 19.7 15.7 12.2 14.4 15.2 11.0 14.4 13.3 15.5 13.1 11.7 14.5 8.2 11.9 7.2 11.5 17.4 12.8 27.5 13.9 20.4 26.8 9.1 21.0 5.9 20.1 56.3 17.3 1.0 15.3 8.8 0.0 28.6 7.4 14.0 14.0 6.9 16.3 19.3 28.6 9.4 8.0 23.1 1.3 13.6 18.6 28.7 16.2 9.8 38.9 17.4 11.9 12.7 30.5 22.4 0.0 13.7 1.4 3.6 14.9 14.0 22.5 8.8 17.3 C8orf46 MGC33510 ENSG00000169085 "Chromosome 8 open reading frame 46" Q8TAG6 8 66460003-66518524 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 51.7" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 1.4;Hepatocytes: 2.4;Leydig cells: 2.6;Peritubular cells: 1.8" "Cancer enriched" "Detected in many" 6 "glioma: 16.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 6.5;LHCN-M2: 4.0;SK-MEL-30: 4.4;T-47d: 5.6;WM-115: 5.6" "Group enriched" "Detected in many" 8 "amygdala: 164.2;basal ganglia: 80.3;cerebral cortex: 305.1;hippocampal formation: 240.3" "Low region specificity" "Detected in all" HPA075134 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA075134: AB_2686736" "unprognostic (6.87e-2)" "unprognostic (7.85e-2)" "unprognostic (2.01e-1)" "unprognostic (8.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (7.53e-4)" "unprognostic (7.87e-3)" "unprognostic (1.45e-1)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "unprognostic (1.82e-1)" "unprognostic (6.36e-3)" "unprognostic (3.53e-4)" "unprognostic (1.86e-1)" "unprognostic (4.98e-2)" "unprognostic (2.91e-2)" 1.2 1.4 14.9 1.2 16.6 1.2 1.2 1.8 51.7 1.6 1.2 16.3 0.0 1.0 1.6 1.3 1.5 1.2 1.7 2.2 39.1 8.3 1.3 1.2 1.4 1.4 13.8 19.4 1.1 1.8 1.1 0.2 1.1 10.9 2.2 1.3 0.0 1.7 5.3 3.1 1.4 1.4 2.0 17.9 1.2 1.1 1.4 10.0 0.0 1.3 0.0 1.1 1.5 0.2 0.0 0.7 0.0 0.0 0.0 0.7 0.1 3.1 0.2 0.4 2.0 0.0 0.1 0.0 0.3 0.3 0.5 0.1 0.0 3.0 0.0 0.3 3.0 6.5 0.1 0.0 0.0 2.2 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 4.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 1.3 0.1 0.5 0.0 0.0 0.0 4.4 0.4 5.6 0.0 0.0 0.4 0.7 0.2 2.7 0.1 1.1 0.0 1.1 0.1 5.6 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.9 16.6 1.8 26.7 39.1 8.3 13.8 19.4 10.9 10.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.4 0.1 0.0 0.0 0.6 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.8 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 CBFA2T2 "MTGR1, ZMYND3" ENSG00000078699 "CBFA2/RUNX1 translocation partner 2" O43439 20 33490075-33650036 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060523, HPA072433" Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA060523: AB_2684305, HPA072433: AB_2686520" "unprognostic (6.51e-3)" "unprognostic (3.29e-1)" "unprognostic (2.16e-2)" "unprognostic (1.91e-3)" "unprognostic (1.21e-1)" "unprognostic (8.37e-3)" "unprognostic (2.85e-3)" "unprognostic (3.90e-2)" "unprognostic (3.08e-1)" "unprognostic (3.89e-2)" "prognostic favorable (6.93e-6)" "unprognostic (7.83e-2)" "unprognostic (1.39e-3)" "unprognostic (9.40e-2)" "unprognostic (1.21e-1)" "unprognostic (2.24e-2)" "unprognostic (3.12e-2)" 8.7 8.5 19.2 15.6 20.8 10.2 11.6 19.2 20.3 12.3 14.7 24.6 8.1 14.8 12.8 10.0 12.7 12.8 10.1 10.5 16.4 13.2 10.9 10.1 11.3 11.6 21.2 17.0 21.0 11.0 19.5 15.9 9.7 17.5 27.9 17.3 15.2 13.9 12.7 16.2 21.7 16.9 13.4 15.9 13.3 13.7 15.4 21.2 15.8 15.6 3.9 14.2 13.4 14.9 5.6 3.1 5.9 2.4 2.7 7.3 1.4 5.2 5.3 6.4 5.2 6.0 4.7 8.3 3.2 3.4 4.6 3.7 11.4 4.5 5.8 7.3 3.9 9.6 6.7 4.3 4.9 3.8 2.5 3.2 8.1 4.5 7.4 3.8 3.2 6.3 4.0 5.8 5.0 5.7 4.6 3.5 5.7 5.3 3.8 3.2 4.4 7.4 4.6 2.2 5.7 6.1 5.8 8.1 6.1 4.1 7.5 22.4 31.9 16.3 5.5 4.6 7.2 5.6 4.3 3.9 10.9 4.7 6.5 3.9 7.9 9.1 3.6 5.4 2.8 2.9 5.9 2.4 2.8 5.3 2.3 5.0 5.3 5.2 7.3 1.0 5.6 2.9 3.9 4.8 2.7 1.4 3.1 4.2 1.4 19.2 20.8 19.2 20.3 16.4 13.2 21.2 17.0 17.5 21.2 11.9 23.7 9.7 13.6 16.9 28.7 9.6 7.6 8.1 10.3 12.2 43.2 9.6 1.7 6.8 5.7 10.6 13.4 0.0 5.5 8.2 14.1 22.5 1.1 6.6 8.2 12.7 86.8 11.6 9.9 11.0 13.0 9.9 16.9 8.2 48.4 12.3 8.8 17.3 12.0 4.2 35.5 12.9 9.8 23.1 16.7 13.4 7.4 19.3 17.8 8.9 CBLL1 "FLJ23109, HAKAI, RNF188" ENSG00000105879 "Cbl proto-oncogene like 1" Q75N03 7 107743697-107761667 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021773, HPA026699" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA021773: AB_1846103, HPA026699: AB_1846104" "unprognostic (1.90e-2)" "unprognostic (2.25e-1)" "unprognostic (8.57e-2)" "unprognostic (3.79e-2)" "unprognostic (8.16e-2)" "unprognostic (7.20e-2)" "unprognostic (1.37e-2)" "unprognostic (3.96e-3)" "unprognostic (4.28e-2)" "unprognostic (2.16e-3)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (2.12e-3)" "unprognostic (9.12e-2)" "unprognostic (2.07e-1)" "unprognostic (1.09e-1)" "unprognostic (8.71e-2)" 15.8 12.0 11.7 13.6 20.0 38.8 16.8 18.7 19.4 15.3 17.2 19.2 11.6 10.8 22.9 9.7 14.4 14.2 10.2 11.5 11.9 10.7 11.6 12.5 12.9 16.5 12.6 14.3 18.2 15.5 14.5 17.2 13.5 16.5 18.7 13.0 14.7 12.8 19.6 32.6 16.6 14.4 16.2 15.1 15.8 14.7 21.1 13.3 29.0 15.8 11.8 19.3 17.6 12.7 17.9 16.7 32.2 15.7 23.4 40.3 20.1 13.7 15.7 12.2 15.5 11.2 9.8 8.3 10.4 10.8 11.6 11.6 10.6 14.0 19.9 15.0 11.6 19.7 9.8 16.8 12.5 16.0 14.2 10.6 16.2 11.6 8.9 13.0 23.9 15.9 10.1 11.7 15.7 17.2 8.8 12.0 14.1 25.5 17.0 11.1 23.5 32.6 16.2 17.5 11.6 10.7 15.2 13.2 20.6 8.8 12.7 13.0 20.3 15.5 22.7 11.3 14.9 7.7 12.2 11.7 18.2 13.1 17.2 15.8 27.6 30.0 32.3 11.2 14.9 15.3 32.2 14.2 23.3 19.0 14.7 28.0 17.9 30.1 21.8 16.7 17.4 20.9 19.6 21.9 23.4 15.7 9.0 40.3 20.1 11.7 20.0 18.7 19.4 11.9 10.7 12.6 14.3 16.5 13.3 17.9 8.3 18.6 13.2 20.9 11.5 14.9 7.6 5.3 10.3 3.5 3.9 9.0 6.6 8.7 7.0 12.0 7.7 0.0 9.4 7.7 8.2 13.2 12.7 9.4 9.1 9.5 16.1 12.9 21.5 3.6 8.6 10.8 18.6 7.2 7.2 6.8 9.1 14.4 11.0 9.2 13.7 19.4 9.9 22.4 13.0 17.3 8.6 19.8 8.4 16.3 CCDC181 "C1orf114, FLJ25846" ENSG00000117477 "Coiled-coil domain containing 181" Q5TID7 1 169394870-169460669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 22.3;testis: 29.2" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 168.6;Early spermatids: 201.9;Rod photoreceptor cells: 81.8;Spermatocytes: 143.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "basophil: 3.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "AF22: 7.2;GAMG: 7.4;NTERA-2: 13.8;SCLC-21H: 8.5;SH-SY5Y: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027189, HPA027275, HPA027281, HPA027312" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349" "unprognostic (2.45e-1)" "unprognostic (2.20e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-3)" "unprognostic (3.00e-1)" "unprognostic (5.97e-2)" "unprognostic (6.87e-2)" "unprognostic (2.15e-3)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (4.89e-4)" "unprognostic (4.03e-2)" "unprognostic (3.06e-2)" "unprognostic (1.18e-2)" "unprognostic (8.41e-2)" 0.8 3.3 6.3 1.0 8.3 0.9 0.9 5.9 8.4 2.6 0.7 1.6 0.4 0.7 4.6 2.7 0.9 14.5 4.6 2.3 6.6 9.9 7.5 0.6 2.4 0.6 5.2 5.0 8.0 3.0 17.3 22.3 0.5 8.7 2.9 0.7 5.3 0.8 2.9 0.7 1.1 0.9 2.7 4.9 0.5 1.2 29.2 4.1 0.0 1.1 0.0 0.5 1.4 0.8 0.1 0.0 3.2 0.1 0.0 0.2 0.0 0.2 0.3 7.2 0.1 0.2 0.2 0.2 0.1 0.0 1.8 3.8 0.1 0.1 0.1 0.1 0.0 7.4 0.1 0.3 0.0 0.3 0.2 1.6 1.7 0.1 0.0 0.0 1.9 0.1 0.7 0.0 0.4 0.0 0.2 0.1 5.7 0.1 0.1 1.3 0.1 4.3 0.0 13.8 0.1 0.0 0.0 5.9 0.1 1.1 0.0 8.5 10.0 0.0 0.3 0.5 4.0 0.0 0.0 0.5 1.4 4.5 0.2 6.1 2.1 1.8 0.0 2.8 0.1 5.5 3.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 6.3 8.3 5.9 8.4 6.6 9.9 5.2 5.0 8.7 4.1 3.0 6.6 0.0 0.1 0.0 68.6 5.8 0.0 168.6 38.7 8.7 62.8 0.0 13.3 0.9 201.9 0.4 0.0 0.0 1.4 0.0 0.0 0.3 1.1 0.0 0.1 23.8 18.5 0.6 0.0 50.5 2.8 0.0 0.0 0.0 0.0 18.7 0.7 0.0 9.9 14.1 81.8 6.5 1.7 143.9 41.9 0.0 0.1 0.0 0.0 0.6 CCNB3 ENSG00000147082 "Cyclin B3" Q8WWL7 X 50202713-50351910 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 6.1;epididymis: 11.6;pituitary gland: 3.7;testis: 14.8" "Cell type enhanced" "Detected in some" 20 "Sertoli cells: 12.9;Spermatocytes: 17.4;Spermatogonia: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;GAMG: 6.1" "Low region specificity" "Detected in all" HPA000496 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA000496: AB_1078605" "unprognostic (1.57e-1)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (9.96e-3)" "unprognostic (8.11e-2)" "unprognostic (1.86e-1)" "unprognostic (1.82e-2)" "unprognostic (1.34e-2)" "unprognostic (1.48e-3)" "unprognostic (6.93e-2)" "unprognostic (2.50e-1)" "unprognostic (1.67e-1)" "unprognostic (4.73e-2)" "unprognostic (1.87e-1)" "unprognostic (4.51e-2)" "unprognostic (2.63e-2)" 0.7 0.7 0.9 0.3 3.5 0.2 0.8 0.4 1.7 0.4 0.4 5.8 0.0 0.4 0.3 11.6 0.4 0.7 0.6 0.6 1.3 1.5 0.7 1.1 0.7 0.4 2.4 2.0 0.4 0.9 0.7 3.7 0.9 4.3 0.5 0.4 0.0 0.5 0.8 1.4 1.0 0.3 0.3 6.1 0.6 1.0 14.8 1.3 0.1 0.9 1.1 0.5 0.4 0.2 0.3 0.3 0.0 0.5 0.0 2.2 0.1 0.3 1.3 0.7 0.4 0.2 0.2 0.0 0.1 0.2 0.2 0.3 1.1 4.3 1.2 0.8 0.3 6.1 0.2 0.6 0.4 0.2 1.1 1.4 0.9 0.0 0.0 1.2 0.9 0.9 0.7 0.2 0.3 0.8 0.1 0.4 3.2 0.1 3.5 1.1 0.0 0.6 0.1 0.6 0.5 0.0 0.0 1.5 0.1 0.2 0.4 0.1 0.8 0.4 0.2 0.9 0.5 3.0 0.2 0.4 1.8 3.1 0.8 0.5 0.9 0.6 1.9 0.5 0.4 0.2 0.0 0.0 0.0 2.2 0.5 0.3 0.3 0.5 0.0 0.3 0.3 0.4 1.0 0.0 0.0 0.3 0.0 0.1 0.1 0.9 3.5 0.4 1.7 1.3 1.5 2.4 2.0 4.3 1.3 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.6 0.6 0.9 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 12.9 0.0 17.4 3.8 0.1 0.0 0.0 0.0 0.0 CCNJL FLJ14166 ENSG00000135083 "Cyclin J like" Q8IV13 5 160249106-160345396 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 48.9" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 25.5;Mucus-secreting cells: 27.9;Paneth cells: 20.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 19 "cerebellum: 48.9" "Group enriched" "Detected in some" 19 "neutrophil: 13.5;NK-cell: 4.1" "Group enriched" "Detected in many" 35 "granulocytes: 13.5;NK-cells: 4.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 26.8;WM-115: 20.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049970 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049970: AB_2680974" "unprognostic (1.09e-2)" "unprognostic (2.36e-2)" "prognostic favorable (7.31e-4)" "unprognostic (1.50e-3)" "unprognostic (1.79e-1)" "unprognostic (4.31e-2)" "unprognostic (1.60e-4)" "unprognostic (1.26e-2)" "unprognostic (6.92e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-1)" "unprognostic (1.75e-2)" "unprognostic (6.27e-3)" "unprognostic (6.63e-3)" "unprognostic (2.62e-1)" "prognostic favorable (7.10e-4)" "prognostic favorable (8.02e-4)" 1.0 3.0 0.9 3.4 1.2 1.3 2.1 48.9 1.5 2.1 9.0 0.9 1.5 1.8 1.1 1.5 0.8 1.0 1.0 4.4 2.5 0.8 2.7 1.2 9.0 2.5 1.5 1.1 5.3 0.2 0.0 17.0 1.7 2.1 2.0 7.9 3.9 7.6 2.0 0.6 0.4 2.7 1.0 0.9 5.8 4.4 10.7 1.2 4.8 8.4 1.7 2.6 4.0 5.4 0.1 0.2 13.5 0.0 4.1 0.0 0.2 3.0 11.3 9.2 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.4 4.9 8.8 0.0 8.7 0.1 7.7 3.8 1.2 26.8 0.7 0.0 0.2 4.8 4.0 3.5 0.1 0.0 1.0 0.0 2.3 1.5 6.7 5.7 6.8 3.1 0.0 0.0 2.9 1.6 0.0 7.9 8.5 0.0 6.3 1.8 3.0 1.0 7.1 14.3 3.1 8.3 1.5 2.3 10.2 3.6 5.1 0.5 8.2 1.6 10.3 0.0 5.6 0.0 0.0 0.0 0.0 0.0 20.3 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 13.5 4.1 0.0 0.2 0.0 0.2 0.9 1.2 48.9 1.5 2.5 0.8 1.5 1.1 2.1 1.2 20.8 25.5 0.0 1.2 0.2 0.6 4.8 0.0 1.4 7.9 3.5 0.0 0.0 5.0 2.6 0.7 0.9 3.6 0.0 0.2 0.0 1.3 0.8 1.1 0.0 0.1 0.0 2.4 1.8 0.0 3.0 2.0 0.1 5.0 1.0 27.9 7.3 1.1 20.1 2.5 0.0 0.0 0.0 1.0 0.5 5.7 0.4 0.0 0.0 2.3 1.6 CDC25C "CDC25, PPP1R60" ENSG00000158402 "Cell division cycle 25C" P30307 5 138285265-138338355 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 23.3;testis: 22.3" "Group enriched" "Detected in some" 4 "Early spermatids: 32.9;Late spermatids: 35.1;Spermatocytes: 36.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.1;T-reg: 2.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB003800, HPA066991" Approved Enhanced "Nuclear speckles" No Yes "Nuclear speckles" "CAB003800: AB_562081, HPA066991: AB_2685760" "unprognostic (2.45e-3)" "unprognostic (5.89e-3)" "prognostic favorable (2.49e-4)" "unprognostic (9.72e-3)" "unprognostic (2.17e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.03e-6)" "prognostic unfavorable (4.38e-4)" "unprognostic (5.56e-2)" "unprognostic (2.08e-1)" "unprognostic (1.70e-3)" "unprognostic (1.00e-1)" "unprognostic (0.00e+0)" "unprognostic (5.04e-2)" "unprognostic (1.43e-1)" "unprognostic (2.59e-1)" "unprognostic (3.06e-1)" 1.1 0.6 0.3 6.7 0.4 5.2 1.1 0.4 0.6 0.6 3.3 0.1 0.7 3.0 0.3 0.6 2.5 0.2 0.4 0.7 0.4 0.4 0.4 0.6 0.7 2.6 0.4 0.3 0.3 0.3 0.0 0.4 1.9 0.3 0.4 4.0 0.0 1.2 0.7 0.2 1.1 3.7 0.5 0.3 1.7 1.2 22.3 0.2 23.3 0.3 1.8 5.0 0.6 0.9 1.0 0.1 0.7 0.0 2.1 2.7 0.5 13.3 5.6 18.8 14.5 0.4 1.9 4.7 8.1 8.7 18.4 25.4 13.5 26.0 6.2 6.8 4.9 20.2 7.3 15.5 12.4 17.8 5.1 10.6 4.7 7.6 10.0 0.1 3.2 4.9 0.4 0.5 10.9 9.0 1.9 11.8 13.5 6.9 12.3 11.2 7.4 8.7 8.1 4.8 10.6 6.1 5.7 17.2 7.3 3.2 4.1 9.5 5.9 18.1 5.5 8.6 17.3 9.2 6.7 3.5 10.2 8.6 7.0 12.9 7.5 6.1 6.1 4.0 6.8 7.7 0.0 0.0 0.1 0.6 0.0 0.0 1.0 0.5 0.3 0.0 0.2 0.0 0.0 0.7 2.1 0.0 0.1 2.7 0.5 0.3 0.4 0.4 0.6 0.4 0.4 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 32.9 0.0 0.3 0.0 0.0 5.7 0.2 0.3 0.0 0.2 2.2 0.0 0.0 0.0 0.3 35.1 1.7 1.2 0.0 1.0 0.6 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 36.3 8.3 0.4 1.1 0.0 1.6 0.1 CDK11B "CDC2L1, CDK11-p110, CDK11-p46, CDK11-p58" ENSG00000248333 "Cyclin dependent kinase 11B" 1 1635227-1659012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 147.7;Spermatogonia: 172.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA025061, HPA073626" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA025061: AB_1846407, HPA073626: AB_2686619" "unprognostic (7.52e-3)" "unprognostic (4.85e-2)" "unprognostic (1.14e-1)" "unprognostic (2.02e-2)" "unprognostic (3.75e-2)" "prognostic favorable (1.14e-4)" "unprognostic (9.75e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (1.48e-1)" "unprognostic (2.18e-1)" "unprognostic (1.14e-2)" "unprognostic (6.04e-2)" "unprognostic (8.45e-2)" "unprognostic (1.27e-1)" "unprognostic (7.19e-2)" "unprognostic (6.52e-3)" 10.5 9.8 10.4 11.7 15.1 24.3 8.6 15.0 14.1 9.0 13.3 11.6 6.7 17.4 11.0 6.1 8.6 7.3 7.5 11.2 12.2 9.3 7.9 8.3 12.8 13.1 11.4 9.7 10.3 11.8 9.1 9.6 8.3 11.0 8.9 7.1 7.0 14.0 9.5 33.7 14.0 18.0 14.0 14.8 12.9 9.6 15.8 13.1 12.2 9.5 8.3 10.3 11.6 11.8 5.2 6.2 16.4 4.2 5.1 8.0 2.1 20.5 16.7 12.8 10.1 12.2 8.1 14.3 20.1 11.1 15.8 13.7 18.7 23.3 19.2 20.0 10.0 10.9 18.8 11.7 11.9 9.3 17.4 20.5 20.2 31.1 16.7 14.2 23.0 24.4 10.0 8.1 14.8 11.7 8.9 12.9 21.1 24.5 13.8 8.2 14.4 22.6 22.3 19.2 8.0 20.6 23.3 21.0 15.3 8.4 8.1 14.5 17.7 19.3 19.9 21.3 7.9 14.9 17.1 17.8 15.5 16.4 10.5 19.3 28.4 25.1 38.8 17.9 27.9 10.7 8.2 4.2 6.3 8.0 3.6 4.1 4.2 5.1 5.4 3.1 5.2 5.9 4.4 16.4 5.1 3.8 6.2 4.1 2.1 10.4 15.1 15.0 14.1 12.2 9.3 11.4 9.7 11.0 13.1 17.9 42.1 36.6 15.2 12.8 30.5 36.0 25.5 42.8 48.9 26.2 19.6 25.0 8.3 26.8 28.9 28.9 89.0 23.3 30.7 26.3 20.4 16.2 52.2 33.4 18.4 14.3 27.6 18.4 25.4 16.7 26.7 23.2 5.0 35.1 53.9 22.7 29.9 56.1 25.1 12.6 42.3 51.8 25.5 147.7 172.1 15.2 37.3 27.7 50.7 12.2 CDYL "CDYL1, DKFZP586C1622" ENSG00000153046 "Chromodomain Y like" Q9Y232 6 4706159-4955551 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Lyase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035578 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA035578: AB_2674685" "unprognostic (1.25e-1)" "unprognostic (8.99e-2)" "unprognostic (6.03e-2)" "unprognostic (2.38e-3)" "prognostic favorable (1.53e-4)" "unprognostic (1.92e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.62e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (2.06e-1)" "unprognostic (2.05e-2)" "unprognostic (2.09e-1)" "unprognostic (5.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" "unprognostic (2.60e-2)" "unprognostic (3.94e-1)" 18.4 9.2 13.3 14.2 14.4 19.3 16.5 8.1 15.8 19.8 16.2 13.3 20.6 8.2 22.2 15.5 19.6 14.7 11.7 14.5 11.0 8.6 9.9 6.9 11.8 12.7 12.5 10.7 13.3 8.5 12.7 8.3 35.4 12.8 12.5 15.8 11.0 12.8 15.3 24.7 23.2 12.2 17.7 8.5 12.6 13.3 10.1 12.9 11.3 11.7 12.5 15.2 17.7 24.8 1.8 11.2 5.1 2.1 2.3 2.4 1.9 11.8 10.4 15.0 12.6 11.8 8.0 17.4 11.4 9.2 10.8 11.4 8.4 8.3 2.5 11.9 8.8 16.5 10.5 12.2 13.8 13.1 8.3 10.9 10.1 10.2 7.6 15.0 13.1 11.7 6.5 24.8 12.3 18.9 6.6 10.5 9.4 18.3 7.6 5.4 10.6 7.5 12.2 15.5 8.4 11.5 9.3 13.4 20.6 7.2 9.7 12.9 7.8 13.9 12.1 18.0 44.7 7.3 13.0 13.9 12.8 11.3 9.3 13.2 17.6 28.3 9.3 4.3 8.6 13.9 5.1 2.1 0.8 2.4 1.1 1.7 1.4 1.7 1.8 2.5 1.8 1.0 1.7 0.6 2.3 1.2 11.2 0.2 1.9 13.3 14.4 8.1 15.8 11.0 8.6 12.5 10.7 12.8 12.9 17.9 6.5 17.1 15.7 33.2 16.2 16.5 15.3 10.7 10.3 14.0 21.6 10.7 13.3 9.8 56.5 19.6 27.4 70.0 8.8 19.3 13.4 20.9 5.7 9.0 9.0 42.9 31.0 18.4 13.2 47.4 5.5 12.7 8.5 21.6 25.3 22.3 13.6 31.7 7.8 6.6 24.9 6.5 19.6 5.9 24.7 36.6 53.3 12.8 21.7 54.5 CHTOP "C1orf77, DKFZP547E1010, FOP, SRAG" ENSG00000160679 "Chromatin target of PRMT1" Q9Y3Y2 1 153633982-153646306 "Plasma proteins, Predicted intracellular proteins" "mRNA transport, Transcription, Transcription regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028647, HPA030540" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA028647: AB_10602699, HPA030540: AB_2673516" "unprognostic (2.72e-1)" "unprognostic (2.41e-1)" "unprognostic (3.41e-2)" "unprognostic (6.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.08e-2)" "prognostic unfavorable (4.85e-4)" "unprognostic (8.65e-2)" "prognostic unfavorable (4.08e-4)" "unprognostic (9.16e-2)" "unprognostic (2.20e-1)" "unprognostic (7.30e-3)" "prognostic unfavorable (2.02e-4)" "unprognostic (1.58e-2)" "unprognostic (4.19e-2)" "unprognostic (2.70e-1)" "prognostic favorable (2.69e-4)" 22.1 26.5 34.6 33.0 41.1 42.5 32.8 40.6 51.0 25.1 22.7 29.1 29.7 23.4 29.9 30.0 28.5 30.0 22.1 35.3 32.3 24.9 26.0 29.9 32.3 33.6 42.6 32.8 34.6 37.9 31.9 29.2 31.0 32.3 27.0 26.5 20.8 25.0 30.5 83.6 31.5 25.4 29.1 47.1 37.7 25.9 35.0 39.8 34.5 32.8 30.6 33.3 21.6 33.1 29.2 34.8 43.0 28.2 20.5 31.9 27.4 26.4 23.4 39.8 24.1 17.3 12.7 31.6 18.7 17.4 26.8 23.2 26.0 26.9 30.0 28.5 17.5 17.6 24.5 38.2 27.4 17.8 35.0 35.2 23.6 35.7 21.5 21.6 36.1 29.7 14.8 31.8 25.8 36.9 22.4 21.4 33.0 28.9 23.2 20.0 33.6 38.7 36.6 46.2 38.7 29.3 24.1 24.3 33.1 26.0 36.7 24.2 28.1 20.0 29.1 31.3 27.6 31.1 50.1 18.3 18.1 26.8 22.7 30.2 32.5 27.1 34.8 19.0 29.6 21.0 43.0 28.0 25.2 31.7 28.2 31.5 29.2 31.2 30.7 34.8 27.4 31.9 28.4 19.8 20.5 25.5 26.8 31.8 27.4 34.6 41.1 40.6 51.0 32.3 24.9 42.6 32.8 32.3 39.8 29.8 31.2 60.7 103.3 55.9 38.3 63.7 43.3 24.1 34.2 50.6 31.4 78.2 43.1 53.9 18.8 54.0 43.4 46.7 56.5 101.7 51.2 66.2 45.1 36.6 60.9 41.3 57.8 47.3 40.7 12.7 41.4 41.9 33.7 72.1 44.9 42.0 50.7 48.0 39.6 37.8 49.7 19.4 59.0 110.0 97.7 54.0 107.6 44.9 46.5 107.5 CIR1 CIR ENSG00000138433 "Corepressor interacting with RBPJ, 1" Q86X95 2 174348022-174395715 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 56.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 56.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015784, HPA061442" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA015784: AB_1846782, HPA061442: AB_2732664" "unprognostic (3.17e-3)" "unprognostic (4.07e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (9.56e-4)" "unprognostic (2.40e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.52e-4)" "unprognostic (1.00e-2)" "unprognostic (4.39e-2)" "prognostic favorable (9.80e-4)" "unprognostic (1.27e-1)" "unprognostic (3.66e-2)" "prognostic unfavorable (1.04e-7)" "unprognostic (2.23e-1)" "unprognostic (1.48e-1)" "unprognostic (8.10e-3)" "prognostic favorable (2.04e-5)" 24.1 20.8 27.0 21.9 38.1 48.4 31.0 41.0 34.8 33.6 22.8 19.8 27.2 21.4 23.9 38.6 23.8 24.7 19.8 23.1 25.1 24.7 28.4 22.3 22.2 23.4 26.2 28.3 30.0 24.4 22.5 54.0 36.9 32.3 31.6 22.8 14.0 21.2 23.5 30.8 27.5 34.3 20.3 27.6 32.4 21.0 26.9 30.7 35.8 35.8 21.4 23.7 37.8 22.2 12.0 11.9 56.9 10.1 13.3 10.9 7.6 10.2 5.8 13.9 11.0 19.4 27.3 20.6 16.9 24.0 17.0 21.0 10.9 15.8 7.1 16.0 16.5 14.9 12.4 11.4 12.0 20.5 13.1 15.1 14.8 9.2 17.5 18.9 17.5 13.7 22.4 22.0 18.6 14.0 29.4 16.8 12.9 15.2 16.0 16.1 9.7 21.8 27.8 12.8 16.8 16.5 12.4 20.0 21.0 20.0 16.3 16.2 19.0 11.6 15.0 25.7 25.2 11.2 26.1 17.2 13.8 10.1 13.0 8.7 18.2 15.5 2.6 19.8 9.2 12.0 17.8 10.1 15.8 9.1 9.2 9.0 12.0 10.3 9.6 6.4 11.8 10.9 10.0 56.9 13.3 9.4 11.9 10.5 7.6 27.0 38.1 41.0 34.8 25.1 24.7 26.2 28.3 32.3 30.7 110.2 65.6 68.2 50.4 25.3 52.0 53.3 79.0 231.6 86.4 40.1 29.5 63.6 101.2 53.5 115.6 59.6 61.4 46.7 68.9 48.3 50.4 36.2 77.6 47.4 56.2 42.9 49.3 70.6 74.2 20.4 99.2 90.2 32.1 71.3 77.3 66.2 52.8 66.2 77.4 70.5 52.0 71.1 42.4 112.8 47.6 28.0 97.0 87.3 52.5 41.4 COPS4 CSN4 ENSG00000138663 "COP9 signalosome subunit 4" Q9BT78 4 83034447-83075818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036894, HPA042828" Uncertain Supported "Nuclear speckles" NA NA 84000 "Nuclear speckles" "HPA036894: AB_10670929, HPA042828: AB_2678191" "unprognostic (1.82e-3)" "unprognostic (1.01e-2)" "prognostic favorable (4.14e-4)" "unprognostic (7.97e-3)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (1.73e-2)" "unprognostic (1.57e-1)" "unprognostic (8.96e-2)" "unprognostic (3.26e-1)" "unprognostic (3.10e-2)" "unprognostic (9.21e-2)" "prognostic favorable (5.21e-6)" "unprognostic (5.84e-2)" "unprognostic (3.07e-1)" "unprognostic (1.72e-1)" "unprognostic (2.80e-1)" 16.3 24.1 22.5 12.5 35.8 21.1 19.4 20.8 33.0 20.5 15.6 13.4 11.5 13.8 19.2 18.0 20.6 16.1 13.5 34.9 22.0 28.9 23.3 18.3 13.1 16.0 24.2 25.4 20.2 14.5 22.3 32.0 21.7 35.7 18.8 15.4 11.6 14.1 19.4 55.1 16.3 12.9 20.1 15.6 17.0 14.3 27.6 14.6 24.8 23.2 23.9 18.6 20.8 14.9 20.3 22.4 34.2 27.7 25.4 28.5 24.1 17.2 10.2 22.5 20.4 20.1 25.9 12.2 22.9 29.8 26.2 23.3 14.7 18.0 29.5 20.2 48.2 14.6 13.1 27.8 23.6 35.6 18.5 19.7 17.1 16.9 14.1 16.7 28.8 48.7 19.5 16.4 19.7 16.8 19.9 34.8 18.2 21.4 16.7 31.7 14.4 34.3 21.2 12.3 27.4 14.0 24.6 17.0 16.2 21.0 16.0 23.7 13.8 15.3 24.2 14.6 15.9 18.2 15.8 22.7 18.5 19.6 13.8 16.2 17.5 10.6 32.4 17.7 18.7 18.1 34.2 18.4 26.0 22.9 24.9 28.5 20.3 25.4 26.2 22.4 18.6 24.3 26.0 4.2 25.4 27.7 14.6 23.1 24.1 22.5 35.8 20.8 33.0 22.0 28.9 24.2 25.4 35.7 14.6 11.9 15.3 29.7 33.9 38.0 40.3 70.0 25.5 34.8 31.8 19.2 29.5 70.9 76.3 33.7 85.1 30.0 14.4 0.0 29.2 51.1 38.3 20.9 33.5 19.5 43.1 25.4 30.0 18.4 27.3 20.9 28.4 27.9 32.1 36.1 19.3 59.6 24.6 22.6 40.3 51.6 32.9 32.3 41.2 64.2 40.9 30.7 79.4 29.8 24.5 33.2 CRIP3 "bA480N24.2, TLP, TLP-A" ENSG00000146215 "Cysteine rich protein 3" Q6Q6R5 6 43299710-43308797 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 25.5;heart muscle: 24.8;liver: 29.0" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 5.1;Distal tubular cells: 8.3;Late spermatids: 6.8;Spermatocytes: 5.9" "Cancer enhanced" "Detected in some" "liver cancer: 3.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 14 "myeloid DC: 25.5" "Lineage enriched" "Detected in many" 14 "dendritic cells: 25.5" "Cell line enhanced" "Detected in some" "HAP1: 4.1;HEK 293: 4.9;HeLa: 5.1;Hep G2: 9.2;NTERA-2: 8.4;RPMI-8226: 6.8;THP-1: 3.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036198 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036198: AB_10670791" "unprognostic (8.35e-3)" "unprognostic (4.14e-3)" "unprognostic (6.37e-2)" "unprognostic (5.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.07e-2)" "unprognostic (1.18e-1)" "unprognostic (2.30e-2)" "unprognostic (4.34e-2)" "unprognostic (1.46e-2)" "unprognostic (8.49e-4)" "unprognostic (1.86e-2)" "unprognostic (7.30e-3)" "unprognostic (5.02e-2)" "unprognostic (4.89e-2)" "unprognostic (4.46e-2)" "unprognostic (2.80e-4)" 0.4 0.5 4.2 5.6 5.8 2.5 2.1 9.4 3.0 0.8 0.8 0.6 3.1 2.2 0.8 2.7 0.9 1.0 4.6 24.8 3.5 3.5 10.4 29.0 0.6 5.3 2.3 2.2 1.0 2.4 0.8 1.1 0.7 2.1 4.1 0.5 1.0 0.7 9.5 0.5 1.8 4.5 1.0 1.7 4.4 0.3 13.5 0.4 0.6 1.1 0.4 6.1 1.8 0.5 1.7 25.5 0.5 1.5 0.2 0.0 0.9 0.0 1.2 0.3 0.1 0.4 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.4 0.0 0.2 0.9 4.1 0.1 0.0 0.0 4.9 0.0 5.1 9.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 0.0 0.0 0.0 6.8 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.6 0.9 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 1.5 0.5 0.0 1.0 0.0 1.4 0.0 0.0 25.5 1.7 0.0 0.0 0.4 0.2 1.3 0.2 0.0 0.9 4.2 5.8 9.4 3.0 3.5 3.5 2.3 2.2 2.1 0.4 0.0 0.0 2.2 0.2 0.6 0.4 1.8 5.1 0.0 0.0 0.0 0.0 0.0 8.3 0.8 3.1 0.0 0.3 0.0 0.2 0.0 0.2 0.1 0.0 2.9 0.2 0.0 0.0 0.0 0.8 6.8 1.1 0.0 0.0 1.0 0.0 0.3 0.4 0.0 0.0 2.4 0.7 0.0 0.0 5.9 0.9 0.0 0.0 0.0 0.1 0.1 CSRNP2 "C12ORF2, C12orf22, FAM130A1, PPP1R72, TAIP-12" ENSG00000110925 "Cysteine and serine rich nuclear protein 2" Q9H175 12 51061205-51083664 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018503, HPA019914" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA018503: AB_1845535, HPA019914: AB_2670315" "unprognostic (8.67e-3)" "unprognostic (1.00e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-1)" "unprognostic (1.83e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.38e-1)" "unprognostic (1.20e-1)" "unprognostic (2.41e-2)" "unprognostic (1.14e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (6.51e-4)" "unprognostic (1.10e-1)" "unprognostic (8.98e-2)" "unprognostic (1.74e-2)" "prognostic favorable (2.78e-4)" 13.7 12.3 14.7 8.0 16.5 3.5 22.2 23.3 26.4 13.3 9.2 11.4 6.0 7.6 16.1 14.2 9.0 9.6 13.3 11.8 14.0 16.2 10.4 7.9 9.7 9.3 12.7 13.5 14.7 10.4 11.2 15.7 12.8 13.3 11.3 8.2 11.7 8.6 12.8 15.8 8.9 7.1 16.7 11.4 9.6 8.3 32.1 12.8 12.1 13.0 8.3 7.7 11.2 9.0 1.2 0.9 2.6 0.9 5.9 2.7 0.4 5.5 6.2 19.0 16.9 14.6 10.4 20.2 10.9 12.3 15.0 10.4 11.9 4.0 4.6 10.8 11.4 10.3 6.7 9.2 5.9 12.0 10.0 7.0 5.4 7.1 3.7 16.0 3.7 8.3 12.6 16.7 17.4 10.0 16.5 14.7 21.1 7.7 8.2 17.3 9.4 12.9 5.2 15.7 2.5 9.8 7.8 12.3 3.6 8.6 7.1 13.5 16.0 15.9 12.5 15.9 14.0 7.9 10.4 13.3 15.0 8.0 10.0 7.4 9.0 9.9 4.3 9.2 5.0 4.8 0.0 0.9 2.3 1.9 0.1 0.7 1.2 2.0 1.1 0.9 0.7 2.0 2.7 2.6 5.9 0.6 0.4 1.3 0.4 14.7 16.5 23.3 23.2 14.0 16.2 12.7 13.5 13.3 12.8 3.0 5.0 4.2 10.0 15.9 6.6 14.6 2.5 4.0 2.3 5.2 23.6 5.5 3.3 6.2 18.8 15.5 9.5 0.0 4.4 6.7 12.2 9.1 11.5 2.4 5.5 6.4 7.9 11.1 5.3 11.7 5.8 5.2 15.1 3.6 5.9 5.8 6.1 5.8 7.4 3.3 7.5 0.0 24.7 30.4 15.1 14.1 12.6 5.0 5.0 4.8 CWC25 "CCDC49, FLJ20291" ENSG00000273559 "CWC25 spliceosome associated protein homolog" Q9NXE8 17 38800434-38825481 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 29.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014874, HPA062997" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB014874: , HPA062997: AB_2684917" "unprognostic (2.21e-1)" "unprognostic (4.30e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (4.75e-2)" "unprognostic (3.69e-2)" "unprognostic (1.01e-2)" "unprognostic (3.24e-2)" "unprognostic (3.43e-3)" "unprognostic (8.79e-3)" "unprognostic (4.17e-3)" "unprognostic (4.98e-2)" "unprognostic (1.32e-1)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (8.68e-3)" 6.0 4.4 5.1 5.5 5.8 29.7 4.6 6.6 6.2 5.5 4.8 4.4 5.4 5.4 6.0 3.6 3.9 3.1 4.5 3.0 4.3 4.6 4.8 4.6 6.5 5.0 3.7 5.0 4.3 4.0 7.8 7.5 4.4 5.1 4.1 4.4 4.5 6.3 7.6 8.6 5.6 4.3 6.5 5.2 4.0 10.4 5.8 7.8 4.6 4.4 6.4 5.4 5.6 4.5 4.8 18.0 5.2 3.4 4.4 2.5 5.9 7.4 5.3 7.4 6.5 5.3 4.6 6.2 4.8 8.8 6.7 6.2 6.2 8.0 4.5 5.9 5.9 13.6 5.9 4.7 9.5 7.0 8.3 5.6 7.5 6.5 6.4 13.8 9.1 5.5 7.5 7.1 6.2 7.6 5.4 8.6 8.7 8.1 5.7 3.9 14.3 14.5 4.7 5.0 4.5 10.5 7.2 6.3 7.7 6.0 5.1 4.7 6.1 4.1 7.4 7.6 6.3 11.0 5.8 6.1 5.3 7.9 10.0 7.3 5.8 10.3 6.6 7.4 6.0 7.6 5.2 5.8 3.9 3.0 3.3 4.2 3.6 3.7 3.6 4.5 4.4 3.3 18.0 3.4 4.1 4.8 3.1 2.5 53.6 65.8 41.0 55.5 56.7 36.2 16.5 20.4 42.8 40.9 22.7 78.5 31.2 24.9 23.9 91.6 38.3 59.9 0.0 20.6 29.6 30.9 43.3 57.7 21.2 25.2 25.4 40.1 33.7 24.5 18.9 34.5 34.1 25.3 34.3 24.6 32.1 24.1 42.1 32.5 21.6 45.5 38.8 31.1 88.3 31.3 67.0 66.1 52.2 22.8 57.6 CXorf57 "FLJ10178, FLJ14191" ENSG00000147231 "Chromosome X open reading frame 57" Q6NSI4 X 106611930-106679442 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;pituitary gland: 32.3" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 26.8;Intestinal endocrine cells: 14.9;Syncytiotrophoblasts: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 3.5;MAIT T-cell: 2.6;memory B-cell: 3.9;memory CD4 T-cell: 3.0;memory CD8 T-cell: 2.4;naive B-cell: 2.9;naive CD4 T-cell: 3.7;naive CD8 T-cell: 3.0;NK-cell: 2.1;T-reg: 1.1" "Group enriched" "Detected in many" 11 "B-cells: 3.9;NK-cells: 2.1;T-cells: 3.7" "Cell line enhanced" "Detected in many" "HEK 293: 22.6;RT4: 23.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA000896, HPA001010, HPA001374" Uncertain Supported "Nuclear speckles" NA No "Nuclear speckles" "HPA000896: AB_1078880, HPA001010: , HPA001374: AB_2666288" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (4.85e-2)" "unprognostic (8.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-1)" "unprognostic (5.49e-2)" "unprognostic (3.81e-3)" "unprognostic (1.17e-1)" "unprognostic (4.20e-3)" "unprognostic (1.63e-1)" "unprognostic (2.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.23e-3)" 1.4 12.0 5.2 2.1 23.0 0.8 2.3 0.9 8.5 2.9 1.3 6.8 1.0 1.8 5.1 3.7 1.3 6.3 1.0 1.5 5.9 25.8 4.2 2.2 3.8 4.8 4.7 5.3 11.3 2.5 0.1 32.3 5.7 6.3 2.3 1.3 2.6 1.1 2.2 2.2 4.0 2.0 1.5 4.5 2.9 4.2 6.0 5.4 1.9 5.2 0.4 3.3 5.9 2.0 3.9 0.2 0.2 0.0 2.1 3.7 1.2 4.2 0.0 4.4 6.1 2.5 2.1 6.6 0.1 0.8 0.0 0.0 0.9 0.9 8.8 0.0 0.5 4.7 1.2 11.2 1.9 0.0 0.0 22.6 2.9 0.0 0.2 0.1 0.0 2.0 1.2 1.3 0.3 0.8 1.2 0.0 7.9 0.1 11.6 1.0 0.0 8.0 0.0 4.0 2.8 0.7 0.0 4.0 0.0 1.9 23.8 7.2 0.0 0.4 0.1 2.5 3.5 1.0 0.1 0.0 1.9 1.6 0.0 2.6 4.2 1.7 10.9 3.4 0.0 3.1 0.0 0.0 0.0 3.5 0.0 2.6 3.9 3.0 2.4 0.0 2.9 3.7 3.0 0.2 2.1 0.0 0.2 1.1 1.2 5.2 23.0 0.9 6.8 5.9 25.8 4.7 5.3 6.3 5.4 8.9 2.6 0.0 0.8 2.3 3.2 0.8 2.5 26.8 7.9 1.8 0.0 10.7 3.3 0.3 1.0 0.0 0.3 0.0 0.5 3.6 0.7 0.2 0.0 1.9 1.1 0.0 14.9 0.0 0.0 0.9 0.6 0.0 5.0 0.0 0.0 2.3 0.3 0.0 0.4 0.8 0.2 6.5 0.6 2.9 11.5 1.4 18.9 2.5 0.1 0.5 CYP4V2 CYP4AH1 ENSG00000145476 "Cytochrome P450 family 4 subfamily V member 2" Q6ZWL3 4 186191520-186213456 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sensory transduction, Vision" "Monooxygenase, Oxidoreductase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 92.7;Muller glia cells: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 13.1;SK-MEL-30: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029122 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA029122: AB_10601806" "unprognostic (1.65e-1)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "prognostic favorable (5.86e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.05e-1)" "unprognostic (6.49e-2)" "unprognostic (9.89e-2)" "prognostic favorable (1.49e-7)" "unprognostic (3.25e-2)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" 6.6 16.6 7.8 5.0 12.4 1.6 5.5 8.9 7.5 6.7 8.0 8.9 4.9 11.4 5.7 4.2 5.2 6.2 13.7 7.4 7.7 4.6 21.6 64.7 7.3 4.1 7.7 9.0 6.3 12.1 30.8 16.1 3.0 6.7 5.6 8.2 19.1 6.2 9.1 3.3 2.8 14.7 6.4 7.0 7.5 5.2 3.2 7.4 4.4 11.9 2.1 3.8 8.0 5.1 2.3 2.5 0.0 6.2 1.3 4.0 1.5 2.6 1.8 0.6 0.0 11.3 4.6 0.1 3.8 8.1 1.4 2.0 0.0 10.9 1.0 0.5 2.5 5.7 1.3 1.3 1.2 0.4 6.5 1.3 4.1 0.4 0.5 3.4 2.2 2.0 4.2 0.5 1.4 0.7 4.7 0.1 4.2 1.6 13.1 4.7 2.3 2.5 0.6 1.4 1.1 0.0 2.1 0.5 1.1 4.6 5.2 2.8 4.1 0.9 0.0 19.4 0.2 1.9 3.5 4.2 3.0 0.7 3.3 1.6 0.0 0.0 0.5 9.0 8.3 3.6 0.0 1.2 0.0 4.0 4.1 2.5 1.0 2.5 3.4 1.5 2.3 2.7 2.3 0.0 1.3 6.2 2.5 2.1 1.5 7.8 12.4 8.9 7.5 7.7 4.6 7.7 9.0 6.7 7.4 6.0 7.8 8.3 3.1 2.3 31.1 15.3 45.9 12.0 10.3 14.0 29.5 1.8 8.3 16.1 2.4 5.5 19.2 0.0 19.5 1.7 8.4 5.5 6.9 92.7 11.5 4.8 16.3 9.2 11.2 1.7 4.6 7.1 3.3 0.0 19.1 64.2 11.0 10.5 6.0 31.8 27.1 0.0 10.2 8.1 5.4 2.8 0.8 10.7 8.9 5.0 DAZAP2 KIAA0058 ENSG00000183283 "DAZ associated protein 2" Q15038 12 51238292-51271362 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045940 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA045940: AB_2679506" "unprognostic (1.00e-2)" "unprognostic (3.13e-2)" "unprognostic (7.35e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-1)" "unprognostic (5.47e-2)" "unprognostic (4.75e-3)" "unprognostic (8.43e-2)" "unprognostic (4.75e-2)" "unprognostic (3.30e-1)" "unprognostic (5.80e-2)" "unprognostic (1.42e-1)" "prognostic favorable (3.94e-9)" "unprognostic (1.79e-1)" "unprognostic (2.40e-1)" "unprognostic (3.04e-1)" "unprognostic (5.84e-3)" 53.5 54.3 45.1 46.0 52.2 152.2 47.8 35.9 67.9 43.5 53.9 88.3 30.4 52.3 56.8 37.5 48.6 59.8 51.1 57.2 43.5 39.2 72.8 64.1 53.3 63.6 68.6 46.0 40.5 38.5 46.0 20.5 30.3 57.0 38.7 60.2 51.3 50.8 53.3 50.7 42.6 63.7 48.0 72.0 63.8 47.7 23.8 57.8 63.6 62.4 30.2 64.1 63.4 37.1 55.4 71.7 186.5 108.9 50.4 70.2 204.7 29.7 43.3 17.7 16.4 39.0 33.9 9.8 19.8 44.1 40.3 32.3 28.5 41.9 26.0 55.5 44.3 26.0 25.9 28.7 37.3 34.6 35.4 35.4 44.8 25.6 13.3 45.3 43.9 61.7 47.1 43.7 39.6 32.0 39.0 51.1 22.8 24.7 59.4 27.6 46.0 44.8 18.4 3.2 20.4 13.4 23.5 25.8 28.5 37.2 41.3 20.3 18.5 33.3 22.6 21.0 10.4 33.8 58.5 38.1 19.5 19.6 24.2 25.6 45.3 48.0 32.6 31.2 29.5 13.2 84.8 108.9 170.2 60.0 88.0 54.2 55.4 53.3 56.3 71.7 51.9 60.8 51.1 186.5 50.4 80.9 46.6 70.2 204.7 45.1 52.2 35.9 67.9 43.5 39.2 68.6 46.0 57.0 57.8 134.0 215.8 198.7 161.3 101.1 50.1 104.4 152.8 117.8 91.0 223.3 55.0 43.5 225.5 137.2 21.6 128.9 230.9 70.0 170.0 44.1 85.9 166.6 174.7 152.9 184.1 63.5 121.3 159.0 414.8 59.5 108.7 219.6 128.2 151.5 210.8 86.0 155.8 224.5 89.8 234.0 46.9 45.3 88.6 26.1 31.1 116.6 104.5 188.6 152.8 202.4 DDX17 P72 ENSG00000100201 "DEAD-box helicase 17" Q92841 22 38483440-38507660 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024908, HPA063142" Supported Supported "Nuclear speckles" "Intracellular and membrane" NA NA 90000 "Nuclear speckles" "CAB024908: , HPA063142: AB_2684949" "unprognostic (1.46e-2)" "unprognostic (5.99e-3)" "unprognostic (4.24e-3)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-2)" "unprognostic (1.36e-2)" "prognostic favorable (6.06e-4)" "unprognostic (1.17e-1)" "unprognostic (5.51e-1)" "unprognostic (2.52e-2)" "unprognostic (2.73e-2)" "unprognostic (1.89e-2)" "unprognostic (2.19e-2)" "unprognostic (1.76e-1)" "unprognostic (4.31e-2)" "unprognostic (3.19e-3)" 49.7 43.1 46.3 49.2 54.5 19.8 50.8 69.7 52.0 47.7 53.3 56.5 54.4 33.1 58.5 82.9 37.5 52.2 46.1 39.9 47.0 31.2 34.3 41.9 41.5 52.6 64.0 37.7 67.8 41.5 68.5 83.7 49.4 46.0 46.2 36.8 51.4 43.9 51.8 89.2 60.3 38.7 52.7 47.1 54.1 39.7 24.6 63.1 69.3 59.8 29.2 47.7 54.5 52.9 10.3 12.4 23.7 9.5 4.0 9.9 6.1 29.7 28.9 59.0 35.4 39.1 45.1 30.8 25.4 25.4 37.1 36.1 27.6 24.9 57.8 17.5 33.2 23.6 33.0 64.5 36.0 41.5 56.9 36.8 35.9 48.4 33.0 42.0 45.8 42.8 31.4 47.3 24.2 41.8 53.1 42.3 27.9 37.1 65.5 29.4 19.4 32.2 39.1 38.0 43.3 14.1 58.5 32.9 35.4 35.3 39.8 34.1 20.1 39.8 31.5 42.0 47.3 27.2 35.5 34.3 31.7 19.8 20.2 19.1 50.6 35.0 49.8 41.0 29.7 39.0 8.5 9.5 11.0 9.9 7.3 9.4 9.0 8.0 7.1 6.8 10.3 5.8 7.5 23.7 4.0 6.8 12.4 7.9 6.1 46.3 54.5 69.7 52.0 47.0 31.2 64.0 37.7 46.0 63.1 199.5 293.3 141.2 174.3 198.5 453.4 121.4 180.9 248.9 260.5 268.7 331.8 105.4 28.2 86.0 34.1 224.8 142.5 23.3 77.8 81.8 163.6 205.3 193.1 180.6 98.1 303.5 226.7 240.6 191.5 27.7 299.7 152.5 146.8 97.4 162.3 302.5 92.9 133.3 262.0 57.6 548.6 284.6 173.1 96.3 66.0 244.7 116.6 128.3 119.9 237.1 DDX39A "BAT1L, DDX39, DDXL, URH49" ENSG00000123136 "DExD-box helicase 39A" O00148 19 14408819-14419383 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 238.8;Late spermatids: 232.5;Spermatocytes: 336.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055334 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA055334: AB_2682787" "unprognostic (1.31e-1)" "prognostic favorable (6.86e-4)" "unprognostic (2.41e-1)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (5.20e-2)" "unprognostic (2.55e-3)" "unprognostic (1.92e-1)" "unprognostic (1.87e-1)" "unprognostic (8.81e-2)" "unprognostic (1.64e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (1.50e-10)" "unprognostic (1.55e-3)" "unprognostic (8.57e-2)" "unprognostic (3.92e-1)" "unprognostic (7.38e-3)" 10.9 8.5 7.2 20.6 11.4 41.4 10.5 9.1 7.9 8.2 10.9 11.0 4.4 13.0 9.4 7.2 15.9 7.0 8.1 7.8 6.6 6.1 9.7 12.1 10.3 31.2 12.6 5.0 7.4 8.8 3.0 7.4 10.5 10.0 7.3 8.9 5.2 7.9 4.4 7.9 10.6 12.8 6.8 9.4 23.4 10.4 60.7 10.3 39.9 8.4 16.3 26.1 10.3 8.8 36.7 36.6 7.7 28.5 21.5 39.7 33.6 32.9 27.1 13.9 26.9 5.7 4.2 13.6 14.7 8.1 30.6 18.9 27.5 17.9 63.7 15.6 12.1 16.4 20.4 34.2 23.8 12.5 22.3 17.9 68.4 31.6 19.7 10.1 37.2 30.6 5.8 5.4 19.8 8.1 4.5 16.0 23.4 42.0 28.1 17.0 39.9 63.7 55.2 26.6 32.2 41.5 44.2 24.6 37.3 10.9 27.1 32.4 17.9 10.9 22.8 16.5 9.5 25.2 36.3 14.9 27.1 16.9 44.5 32.8 29.2 51.2 65.6 30.4 40.6 27.0 6.8 25.9 7.7 35.6 28.5 30.5 36.7 28.4 28.2 36.6 33.2 24.9 26.7 7.7 21.5 23.4 22.6 39.7 33.6 7.2 11.4 9.1 7.9 6.6 6.1 12.6 5.0 10.0 10.3 14.9 27.9 70.7 37.1 67.5 10.3 9.4 17.8 21.4 18.2 5.2 0.0 37.6 31.5 37.9 238.8 33.8 44.6 23.3 57.3 97.5 36.2 30.0 89.1 10.6 78.7 11.1 24.6 27.6 51.6 232.5 24.5 64.4 47.2 70.3 24.3 13.8 42.5 28.1 17.7 22.6 3.9 19.4 54.6 336.3 94.8 62.0 50.1 65.4 35.5 32.5 DDX39B "BAT1, D6S81E, UAP56" ENSG00000198563 "DExD-box helicase 39B" Q13838 6 31530219-31542448 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 40.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034012, HPA055334, HPA058450" Enhanced Enhanced "Nuclear speckles" NA NA 120000 "Nuclear speckles" "CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721" "unprognostic (2.78e-2)" "unprognostic (1.30e-2)" "unprognostic (6.86e-3)" "unprognostic (3.44e-2)" "unprognostic (3.22e-2)" "unprognostic (5.13e-3)" "unprognostic (2.89e-2)" "unprognostic (1.19e-2)" "unprognostic (4.89e-3)" "unprognostic (1.25e-1)" "unprognostic (2.81e-2)" "unprognostic (3.53e-3)" "prognostic unfavorable (1.11e-6)" "unprognostic (2.85e-1)" "unprognostic (1.72e-1)" "unprognostic (1.90e-2)" "prognostic favorable (1.43e-5)" 27.1 31.0 16.1 33.3 20.6 11.3 29.1 37.3 22.7 34.9 35.4 31.8 25.6 8.2 53.4 75.4 40.2 43.5 23.8 28.3 16.3 12.8 25.3 28.6 29.1 26.5 19.2 15.6 49.8 36.8 17.6 50.6 25.9 19.7 35.3 19.3 35.3 26.4 34.4 39.0 24.7 33.2 25.8 30.8 39.9 27.7 21.3 17.8 45.5 31.2 30.5 37.1 32.9 27.7 5.1 8.5 3.8 6.2 3.4 7.4 5.5 3.0 16.3 13.5 6.6 13.7 11.8 7.8 3.5 3.9 10.1 9.1 4.1 4.0 3.1 11.8 16.9 14.1 5.6 15.3 26.0 9.6 2.7 40.9 5.5 4.8 9.7 4.5 7.5 6.1 18.2 15.6 10.2 32.1 18.0 6.3 18.0 24.1 2.5 8.4 2.1 6.6 27.4 5.7 6.0 2.9 5.6 6.0 3.7 20.4 4.0 6.2 17.2 6.9 3.1 4.0 13.2 2.3 6.5 3.5 1.3 4.9 1.3 9.0 10.3 12.8 25.3 0.8 10.5 5.4 3.5 6.1 3.8 5.4 6.2 6.7 4.5 6.8 6.5 8.5 5.1 7.4 6.8 3.4 3.4 5.6 6.5 7.3 5.5 16.1 20.6 37.3 22.7 16.3 12.8 19.2 15.6 19.7 17.8 20.8 37.5 38.9 22.5 12.8 19.8 3.5 7.6 48.2 27.3 3.5 21.6 11.5 5.0 7.9 0.9 17.1 14.7 0.0 7.0 10.1 12.1 18.4 34.8 5.8 8.7 14.3 16.6 10.4 8.9 2.2 15.0 21.5 8.5 8.2 7.4 10.4 7.8 9.3 11.0 4.1 27.3 25.8 12.7 6.0 5.9 11.8 14.2 27.4 8.6 20.7 DDX42 "RHELP, RNAHP, SF3b125, SF3B8" ENSG00000198231 "DEAD-box helicase 42" Q86XP3 17 63773603-63819317 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023447, HPA023571, HPA025941" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562" "unprognostic (3.46e-1)" "unprognostic (7.11e-2)" "unprognostic (8.44e-2)" "unprognostic (1.29e-1)" "unprognostic (2.49e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (1.06e-1)" "unprognostic (4.73e-2)" "unprognostic (1.90e-1)" "unprognostic (2.54e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (9.26e-4)" "unprognostic (3.02e-1)" "unprognostic (2.42e-1)" "unprognostic (7.35e-2)" "unprognostic (1.55e-2)" 32.4 28.2 27.1 26.3 39.4 24.2 32.5 34.1 40.7 39.1 31.2 33.7 20.9 23.0 39.2 30.7 26.1 34.4 35.1 25.6 25.6 26.7 23.0 25.7 26.4 27.5 29.6 35.8 43.5 41.8 36.8 26.2 30.7 34.1 39.0 28.0 28.8 34.0 35.6 44.7 29.2 26.7 37.7 27.3 26.9 30.5 28.6 21.5 33.2 26.1 21.8 33.7 42.6 25.4 7.6 5.0 8.4 4.4 6.7 6.6 2.8 30.9 32.6 29.3 30.1 29.8 24.1 31.7 30.5 27.5 28.0 27.5 30.6 20.5 43.4 12.0 34.1 23.2 24.9 33.1 27.1 37.1 12.7 21.7 32.6 31.6 37.1 29.4 37.7 22.4 30.7 25.9 25.3 30.8 23.8 27.7 22.5 36.2 18.4 28.3 25.3 36.0 21.1 28.0 24.9 17.5 31.5 50.5 22.2 25.5 36.6 18.5 35.1 23.0 41.6 26.0 43.3 28.5 31.2 29.4 41.4 25.3 16.7 35.8 20.6 16.5 40.0 21.3 20.9 21.7 2.6 3.9 8.4 6.2 3.2 6.6 4.1 5.2 6.1 5.0 7.6 6.6 6.4 2.9 6.7 4.4 3.0 3.1 2.8 27.1 39.4 34.1 40.7 25.6 26.7 29.6 35.8 34.1 21.5 74.5 54.3 18.8 21.3 27.7 38.2 41.5 22.9 75.0 64.8 34.9 35.3 28.4 11.6 24.6 7.1 33.8 21.4 0.0 23.3 19.4 28.9 33.4 29.0 26.8 20.2 47.7 39.1 29.4 29.5 9.8 45.1 26.6 13.5 54.1 34.3 42.7 31.2 24.6 47.4 18.9 43.5 38.8 36.0 46.6 53.5 26.0 22.9 19.5 33.8 26.7 DGKZ "DAGK5, DAGK6, DGK-ZETA, hDGKzeta" ENSG00000149091 "Diacylglycerol kinase zeta" Q13574 11 46332905-46380554 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.7" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 84.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051336 Enhanced Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA051336: AB_2681448" "unprognostic (2.85e-2)" "unprognostic (3.90e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.40e-1)" "unprognostic (4.12e-2)" "unprognostic (3.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (2.49e-2)" "unprognostic (3.66e-3)" "unprognostic (8.18e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (1.48e-3)" "unprognostic (7.75e-2)" "unprognostic (3.61e-2)" "unprognostic (7.84e-3)" 8.6 6.7 34.5 11.8 27.4 28.0 6.8 22.6 50.7 7.5 7.4 8.5 2.5 21.0 6.1 4.3 7.1 6.3 6.7 16.0 48.0 9.2 5.3 3.3 8.3 20.7 9.4 26.7 5.0 17.3 7.0 18.6 8.4 7.5 5.9 4.2 4.8 24.1 7.0 42.8 8.3 23.2 5.6 7.2 15.6 9.9 5.0 7.5 14.2 4.1 9.1 9.9 7.6 5.0 0.9 12.3 11.2 11.8 7.7 7.5 8.1 11.9 10.7 7.2 10.8 3.8 4.3 33.7 9.3 7.0 9.9 8.7 12.7 5.5 15.4 6.8 9.7 10.9 14.0 8.7 13.5 3.5 15.4 20.3 10.0 7.8 9.3 6.9 18.9 20.3 5.8 6.4 5.4 7.4 5.1 10.9 12.8 14.0 9.5 7.0 31.5 18.2 29.7 21.1 17.3 16.4 21.8 12.6 6.5 3.0 11.7 49.8 8.5 10.7 35.9 7.3 4.8 25.8 23.9 12.2 13.1 14.2 20.6 16.8 6.3 7.1 12.6 17.9 17.2 12.1 11.2 11.8 5.8 7.5 6.1 4.5 0.4 4.7 6.3 12.3 0.9 4.9 5.0 9.8 7.7 5.9 5.9 4.5 8.1 34.5 27.4 22.6 50.7 48.0 9.2 9.4 26.7 7.5 7.5 3.0 10.0 17.1 20.8 11.7 19.2 20.9 10.2 1.4 4.5 8.7 19.6 12.7 8.3 11.4 5.4 22.4 36.9 0.0 41.8 84.0 10.8 14.0 20.7 7.8 43.9 15.9 49.4 57.1 44.7 5.4 12.0 18.5 11.8 19.8 18.9 5.8 26.8 45.6 7.8 15.4 9.2 32.3 11.3 7.0 13.2 8.2 22.9 57.3 18.0 14.7 DHX15 "DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p" ENSG00000109606 "DEAH-box helicase 15" O43143 4 24517441-24584550 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047047 Approved Enhanced "Nuclear speckles" NA NA 30000 "Nuclear speckles" "HPA047047: AB_2679916" "unprognostic (4.46e-3)" "unprognostic (2.47e-2)" "prognostic favorable (5.74e-4)" "unprognostic (3.35e-1)" "unprognostic (5.30e-2)" "unprognostic (5.74e-2)" "unprognostic (2.06e-3)" "unprognostic (5.53e-3)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (3.60e-2)" "unprognostic (8.68e-3)" "unprognostic (7.77e-3)" "unprognostic (2.51e-3)" "unprognostic (2.19e-1)" "unprognostic (1.59e-1)" "unprognostic (5.41e-3)" 34.3 29.6 23.2 32.1 27.5 42.5 33.0 38.0 27.6 31.1 31.9 29.5 24.1 22.8 37.5 23.4 40.8 30.6 22.9 32.6 22.8 18.8 30.0 29.5 31.2 34.7 29.4 17.7 36.5 35.9 42.5 32.8 39.2 27.4 28.2 37.7 22.4 34.1 24.9 36.5 36.0 30.7 30.7 22.8 32.4 32.4 21.0 27.9 58.3 33.5 31.6 43.0 35.4 35.7 20.3 26.7 31.4 24.1 24.5 28.8 17.7 30.1 29.6 49.1 24.3 24.2 23.6 29.3 35.2 31.0 37.2 37.0 30.0 36.7 55.5 21.7 28.8 43.4 25.3 63.1 42.4 58.0 20.3 29.9 48.1 32.4 24.2 14.2 49.5 33.2 19.7 25.5 36.2 24.5 23.9 31.0 26.2 45.0 22.4 42.1 22.8 64.9 33.2 53.4 30.2 26.9 42.8 57.6 25.9 44.3 43.5 42.2 26.4 27.3 26.3 24.7 36.8 28.8 25.7 28.3 31.6 20.8 23.8 41.0 17.0 28.6 66.4 21.1 40.5 37.5 31.4 20.2 18.8 21.1 20.6 28.8 19.9 23.6 24.5 26.7 20.3 24.9 23.7 9.7 24.5 24.1 17.8 25.8 17.7 23.2 27.5 38.0 27.6 22.8 18.8 29.4 17.7 27.4 27.9 71.5 53.1 27.6 56.7 87.6 28.3 26.0 28.1 49.5 71.7 26.2 21.6 64.7 31.5 51.9 23.9 49.1 52.6 0.0 36.1 61.0 55.6 53.7 55.4 42.4 39.4 25.4 58.2 47.3 49.9 11.8 36.5 48.1 45.5 36.1 59.4 22.6 47.7 37.4 37.8 26.9 28.3 25.8 58.7 54.9 45.5 87.4 73.8 35.5 57.5 79.7 DLX2 TES-1 ENSG00000115844 "Distal-less homeobox 2" Q07687 2 172099439-172102900 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.9" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 1.5;Early spermatids: 4.3;Melanocytes: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "AN3-CA: 39.6;HEK 293: 25.2" "Group enriched" "Detected in many" 4 "basal ganglia: 13.8;olfactory region: 36.1" "Region enriched" "Detected in many" 5 "olfactory region: 43.5" HPA056965 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA056965: AB_2683291" "unprognostic (8.12e-2)" "unprognostic (3.56e-1)" "unprognostic (2.48e-2)" "unprognostic (1.28e-2)" "unprognostic (4.07e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (3.03e-2)" "unprognostic (2.41e-1)" "unprognostic (8.74e-2)" "unprognostic (3.53e-2)" "unprognostic (3.01e-1)" "unprognostic (6.69e-10)" "unprognostic (9.38e-2)" "unprognostic (2.47e-1)" "unprognostic (2.41e-1)" "unprognostic (7.95e-3)" 0.7 3.2 4.5 0.7 5.4 1.2 1.2 0.1 10.9 0.4 0.7 1.1 0.0 0.6 0.5 0.4 0.4 0.5 0.7 0.7 4.3 7.5 0.5 0.6 0.5 0.4 0.4 4.1 0.4 0.4 0.4 0.2 0.6 0.0 1.0 0.6 0.0 1.7 0.7 0.4 1.9 1.2 0.5 0.1 0.4 0.5 2.5 3.4 1.4 1.5 1.5 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.6 0.2 0.2 1.1 2.1 0.5 0.3 0.1 0.2 0.1 0.0 1.2 0.9 1.9 2.0 1.3 0.1 0.1 0.0 25.2 0.6 4.1 0.9 0.1 0.2 0.1 0.0 1.8 0.0 0.2 0.1 0.0 1.0 0.2 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.6 2.3 0.6 0.3 0.1 0.1 2.8 0.0 1.5 0.2 0.0 0.0 0.2 2.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 5.4 0.1 10.9 4.3 7.5 0.4 4.1 0.0 3.4 0.0 0.0 0.0 0.1 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.7 0.0 0.3 0.0 0.2 0.0 DNMT3L MGC1090 ENSG00000142182 "DNA methyltransferase 3 like" Q9UJW3 21 44246339-44262216 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "kidney: 7.8;liver: 20.5" "Group enriched" "Detected in some" 4 "Hepatocytes: 17.3;Proximal tubular cells: 13.5" "Cancer enriched" "Detected in some" 90 "testis cancer: 46.3" "Region enriched" "Detected in single" 13 "cerebellum: 2.5" "Group enriched" "Detected in some" 16 "memory B-cell: 3.2;naive B-cell: 1.1;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 19 "B-cells: 3.2;dendritic cells: 1.1" "Cell line enriched" "Detected in some" 7 "BEWO: 31.2" "HPA055234, HPA066780" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA055234: AB_2682750, HPA066780: AB_2685719" "unprognostic (1.05e-4)" "unprognostic (1.91e-1)" "unprognostic (2.73e-9)" "unprognostic (2.77e-1)" "unprognostic (5.28e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 2.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 7.8 20.5 0.1 1.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.6 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.2 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.2 0.0 0.0 0.0 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 4.1 0.0 0.0 4.6 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.1 2.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DPCD "DKFZP566F084, RP11-529I10.4" ENSG00000166171 "Deleted in primary ciliary dyskinesia homolog (mouse)" Q9BVM2 10 101570560-101609668 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 56.2" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 438.7;Late spermatids: 828.3;Spermatocytes: 210.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 11.9;intermediate monocyte: 13.2;myeloid DC: 17.4;non-classical monocyte: 5.3" "Group enriched" "Detected in many" 13 "dendritic cells: 17.4;monocytes: 13.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036603, HPA036604" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036603: AB_2675212, HPA036604: AB_10673503" "unprognostic (1.22e-2)" "unprognostic (1.73e-3)" "unprognostic (4.66e-1)" "prognostic favorable (6.57e-4)" "unprognostic (1.90e-1)" "unprognostic (9.13e-2)" "unprognostic (4.00e-3)" "unprognostic (1.71e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (1.64e-1)" "unprognostic (4.55e-2)" "unprognostic (2.70e-1)" "unprognostic (5.04e-2)" "unprognostic (3.83e-2)" "unprognostic (7.54e-2)" 4.6 8.1 21.9 4.0 19.9 4.4 9.3 3.4 14.0 10.7 7.1 6.0 4.6 3.1 8.4 20.6 8.3 35.0 7.2 13.0 15.6 16.6 14.7 4.9 6.7 3.8 16.1 18.6 10.8 9.0 17.9 23.6 4.8 16.0 7.9 6.5 9.6 10.0 10.2 9.5 5.8 2.8 8.5 8.1 1.7 6.1 56.2 7.5 1.1 15.5 5.1 3.6 5.2 5.5 0.8 17.4 0.6 13.2 0.9 1.2 4.6 29.4 16.4 11.9 24.4 11.2 18.8 5.1 14.0 15.8 17.7 16.9 11.6 16.0 2.7 23.5 12.5 7.3 16.8 16.5 19.5 18.9 6.9 16.3 3.4 16.1 17.3 6.0 18.0 2.6 13.4 16.8 21.7 17.4 46.7 15.2 3.8 9.2 3.8 13.4 36.7 0.0 14.2 8.8 7.9 12.6 0.0 16.3 6.2 28.6 8.0 11.8 20.3 11.3 7.5 9.3 11.0 22.6 7.2 11.0 8.6 8.1 17.6 18.5 11.0 12.7 5.0 30.5 4.1 3.7 0.0 11.9 0.5 1.1 13.2 1.0 0.8 0.9 0.9 17.4 0.5 1.0 1.2 0.6 0.9 5.3 2.4 0.3 4.6 21.9 19.9 3.4 14.0 15.6 16.6 16.1 18.6 16.0 7.5 32.8 7.7 2.2 25.6 8.7 11.8 24.6 35.7 158.0 35.2 47.1 17.7 19.9 81.2 52.5 438.7 13.1 5.2 0.0 23.9 15.9 26.0 24.1 1.1 10.2 20.8 11.1 23.0 11.6 6.2 828.3 21.9 11.0 15.1 4.6 10.7 17.5 29.9 10.5 26.2 91.2 37.4 0.0 27.0 210.7 59.6 12.4 8.9 2.2 21.5 16.5 E2F7 ENSG00000165891 "E2F transcription factor 7" Q96AV8 12 77021247-77065580 "Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 42.0" "Group enriched" "Detected in some" 7 "Early spermatids: 38.5;Late spermatids: 53.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 5.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 5.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "midbrain: 7.6;pons and medulla: 7.4;thalamus: 12.1" HPA064866 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA064866: AB_2685374" "unprognostic (1.21e-1)" "unprognostic (8.92e-2)" "unprognostic (7.39e-2)" "unprognostic (7.27e-2)" "unprognostic (1.54e-1)" "unprognostic (3.80e-2)" "unprognostic (6.14e-5)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (3.57e-2)" "unprognostic (5.67e-5)" "unprognostic (1.42e-1)" "unprognostic (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (1.57e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-1)" 1.3 0.4 0.6 4.7 0.7 8.4 0.4 0.5 0.8 1.1 1.7 1.2 0.5 1.3 1.2 1.4 5.0 1.2 1.3 0.8 0.7 0.6 0.5 0.5 1.4 2.7 0.5 0.0 0.7 0.7 0.5 1.8 2.1 0.6 0.7 3.0 0.4 0.9 1.0 0.3 2.1 2.3 0.9 0.6 2.4 1.2 6.1 0.2 42.0 0.4 2.3 6.3 1.4 1.7 0.6 5.0 1.2 0.0 0.2 1.0 0.0 9.6 4.6 13.0 5.0 0.4 1.3 15.7 13.6 14.8 7.2 8.7 6.2 3.3 5.4 2.7 2.7 15.0 7.5 7.7 14.7 13.8 2.1 5.1 4.7 13.3 3.5 3.1 4.0 4.4 0.4 3.9 18.9 11.7 4.2 7.0 9.4 4.9 4.4 14.7 4.9 15.2 0.0 9.1 3.2 11.0 11.1 11.2 3.0 1.8 8.2 8.2 5.4 11.3 3.9 3.2 5.7 6.3 4.2 19.4 27.3 13.7 11.6 17.8 4.8 2.7 3.5 9.8 1.8 17.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.2 0.0 5.0 1.0 0.0 0.6 0.7 0.5 0.8 0.7 0.6 0.5 0.0 0.6 0.2 0.0 0.3 0.0 1.0 0.2 0.0 1.6 0.0 1.4 3.4 0.0 0.0 0.4 0.0 0.4 38.5 0.0 0.0 0.0 0.9 2.6 0.2 0.3 4.6 0.0 0.8 0.0 0.0 0.0 0.3 53.3 0.3 0.3 0.0 0.0 0.5 1.5 7.0 0.0 0.7 0.0 0.0 0.0 0.3 1.0 1.9 0.5 0.2 0.7 0.4 4.4 EPC2 DKFZP566F2124 ENSG00000135999 "Enhancer of polycomb homolog 2" Q52LR7 2 148644440-148787568 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036759 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036759: AB_10672365" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "unprognostic (2.83e-3)" "unprognostic (2.59e-2)" "unprognostic (1.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.47e-2)" "unprognostic (3.86e-2)" "unprognostic (2.29e-1)" "unprognostic (6.21e-2)" "unprognostic (5.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.54e-2)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" 19.5 16.3 16.1 16.2 15.6 41.0 18.6 32.9 18.3 23.9 17.2 13.6 19.3 9.7 26.0 15.2 13.2 17.1 15.8 16.2 14.1 14.0 13.6 12.8 14.7 16.4 14.5 16.6 33.4 12.0 15.4 30.6 22.7 13.7 20.1 14.6 13.1 14.8 19.0 19.1 14.6 16.5 19.8 14.8 18.1 12.0 13.8 15.8 27.7 20.0 12.9 15.6 18.8 22.7 1.9 2.0 8.6 3.7 0.8 3.3 1.0 5.9 4.7 16.4 10.1 11.0 13.9 12.3 10.7 14.6 17.4 14.8 9.4 8.2 13.2 5.4 12.5 7.6 8.2 14.1 8.6 21.6 11.4 10.4 25.4 7.5 13.1 11.2 19.1 15.6 14.5 15.4 17.7 17.5 10.9 10.8 10.7 13.4 22.6 10.9 9.7 13.1 13.1 16.5 5.8 9.3 13.5 15.0 11.9 8.8 17.2 22.6 16.3 13.2 8.2 19.8 11.9 5.3 17.2 12.8 13.9 12.3 9.4 8.9 13.8 10.7 16.8 11.0 11.5 14.9 0.3 1.9 2.2 2.1 1.4 2.7 1.9 3.0 1.8 1.8 1.9 3.3 2.3 8.6 0.8 3.7 2.0 2.6 1.0 16.1 15.6 32.9 18.3 14.1 14.0 14.5 16.6 13.7 15.8 23.8 9.9 2.9 22.8 12.5 17.3 18.1 7.6 13.4 23.9 8.7 5.9 9.1 3.3 8.2 15.4 11.5 7.3 23.3 7.8 9.1 16.7 17.7 5.8 3.8 7.4 7.9 17.3 7.4 12.6 2.7 22.2 12.8 11.8 9.0 8.1 13.3 7.4 7.0 21.5 5.8 14.8 12.9 17.6 14.1 14.7 13.7 16.8 12.1 6.8 23.6 EPG5 "hEPG5, KIAA1632" ENSG00000152223 "Ectopic P-granules autophagy protein 5 homolog" Q9HCE0 18 45847609-45967274 "Disease related genes, Predicted intracellular proteins" Autophagy "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031689 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA031689: AB_10609997" "unprognostic (3.43e-1)" "unprognostic (1.20e-1)" "unprognostic (8.11e-2)" "unprognostic (6.84e-2)" "unprognostic (2.20e-2)" "unprognostic (4.59e-2)" "unprognostic (5.58e-2)" "unprognostic (1.02e-1)" "unprognostic (4.66e-1)" "unprognostic (4.87e-1)" "unprognostic (1.15e-2)" "unprognostic (7.50e-2)" "prognostic favorable (4.04e-5)" "unprognostic (5.71e-2)" "unprognostic (1.35e-1)" "unprognostic (4.05e-1)" "unprognostic (1.18e-1)" 11.1 12.5 15.4 11.3 16.1 26.8 16.3 20.1 21.1 10.3 9.3 11.2 11.6 7.8 13.1 14.5 12.2 10.4 8.1 14.5 14.1 10.1 13.5 10.0 14.7 14.0 11.5 12.3 16.7 11.1 18.6 18.1 14.8 12.7 10.4 10.1 13.0 10.7 10.1 23.8 22.7 10.2 10.2 15.6 16.9 9.5 8.6 12.4 20.2 17.0 8.7 13.8 9.1 14.4 1.7 1.9 2.4 2.2 1.1 4.8 0.9 2.8 2.2 2.3 1.6 7.9 9.6 2.3 18.2 7.6 10.5 11.0 0.6 2.1 2.9 1.1 13.6 12.7 2.7 3.0 3.6 13.5 2.3 1.3 2.2 2.6 2.2 7.5 3.8 5.9 6.4 3.4 11.6 8.0 9.3 5.2 2.6 1.9 1.6 30.9 2.0 1.6 3.7 1.1 1.0 1.4 1.6 2.8 2.0 4.9 4.0 2.4 1.9 3.2 1.3 3.7 3.4 1.9 2.7 12.5 13.1 2.7 1.9 5.0 3.2 2.2 1.6 5.6 3.4 4.3 1.2 2.2 2.0 4.8 2.1 4.6 1.2 2.9 2.8 1.6 1.7 2.6 3.1 2.4 1.1 2.0 1.9 1.6 0.9 15.4 16.1 20.1 21.1 14.1 10.1 11.5 12.3 12.7 12.4 17.9 8.0 10.9 4.0 9.2 15.3 13.9 7.6 5.3 3.4 10.4 23.6 5.9 1.7 6.2 2.0 8.7 5.4 0.0 3.2 3.4 6.8 6.6 6.9 8.5 10.6 12.7 7.9 13.5 12.6 1.8 11.5 6.5 13.5 6.4 7.0 8.7 6.0 5.8 11.0 7.3 18.6 12.9 6.8 7.5 6.6 11.5 7.6 8.9 6.4 5.9 EPHB6 HEP ENSG00000106123 "EPH receptor B6" 7 142855061-142871094 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1" "Cell type enhanced" "Detected in many" 16 "Muller glia cells: 270.3;Sertoli cells: 103.5;Suprabasal keratinocytes: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "MOLT-4: 18.2;RT4: 34.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035784 Uncertain "Nuclear speckles" "Intracellular and membrane" NA NA "Nuclear speckles" "HPA035784: AB_2674781" "unprognostic (1.90e-2)" "prognostic favorable (1.80e-4)" "unprognostic (7.08e-3)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (2.53e-3)" "unprognostic (3.15e-2)" "unprognostic (4.39e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.06e-3)" "unprognostic (3.18e-1)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.16e-1)" "prognostic favorable (4.68e-5)" 3.3 1.7 7.4 3.0 30.1 3.3 2.6 3.1 29.3 9.0 1.5 0.8 3.4 0.9 3.0 4.5 7.5 6.4 2.8 1.4 5.4 4.2 1.7 1.3 2.4 3.6 3.3 14.4 3.9 7.8 0.8 1.1 2.9 1.7 6.8 0.9 1.5 4.7 8.1 1.8 32.1 1.6 2.0 1.4 2.6 3.3 3.8 3.6 26.7 6.6 2.5 3.3 5.1 6.5 4.1 0.9 1.0 1.3 0.0 3.1 1.4 0.1 0.0 0.0 0.4 2.0 1.0 0.0 0.2 0.4 0.1 0.0 0.6 1.3 0.0 0.0 0.1 0.0 4.5 0.2 0.0 0.0 1.0 0.1 0.3 0.0 0.2 0.6 4.3 0.2 0.3 0.0 1.2 0.0 0.0 0.2 3.0 0.6 0.0 0.0 0.0 18.2 3.3 3.1 0.7 1.3 0.4 0.0 0.0 0.0 34.6 0.0 0.0 1.2 0.9 0.0 0.4 2.9 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 1.3 0.5 0.1 1.0 0.6 4.1 2.5 1.4 0.9 1.0 3.1 1.5 1.0 0.0 0.4 0.1 1.9 1.4 7.4 30.1 3.1 29.3 5.4 4.2 3.3 14.4 1.7 3.6 3.0 1.7 4.5 25.1 48.3 4.3 2.0 38.2 6.7 10.3 7.0 2.0 0.2 5.0 25.0 0.7 1.4 0.0 0.0 5.7 0.0 12.3 11.7 0.0 1.8 4.3 0.0 1.7 1.3 11.5 4.0 27.9 5.3 11.8 0.0 0.0 270.3 19.6 0.0 9.2 0.4 5.0 103.5 18.4 0.2 8.3 103.5 0.2 8.3 0.0 23.4 ERCC8 "CKN1, CSA" ENSG00000049167 "ERCC excision repair 8, CSA ubiquitin ligase complex subunit" Q13216 5 60873831-60945073 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Cockayne syndrome, Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029328 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA029328: AB_2673000" "unprognostic (5.45e-2)" "unprognostic (1.90e-1)" "unprognostic (2.56e-2)" "unprognostic (6.59e-2)" "unprognostic (1.68e-2)" "unprognostic (4.96e-2)" "unprognostic (2.10e-3)" "unprognostic (9.68e-2)" "unprognostic (3.85e-2)" "unprognostic (3.23e-1)" "unprognostic (7.49e-2)" "unprognostic (1.09e-1)" "unprognostic (4.75e-3)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (7.19e-2)" 13.6 10.4 11.5 7.1 12.4 4.2 13.9 10.2 16.5 9.8 9.9 11.8 8.6 8.5 9.8 10.0 10.0 8.4 8.0 11.6 10.3 10.6 13.2 10.6 8.0 9.2 11.4 8.9 9.1 8.5 6.6 18.7 12.6 14.7 7.7 12.2 10.6 8.4 10.3 8.7 7.2 7.7 12.9 12.5 11.5 7.6 14.1 11.7 14.0 10.2 8.9 11.6 11.2 7.8 4.3 12.1 1.4 6.5 3.6 6.3 3.9 6.0 8.8 12.2 13.3 7.6 10.2 7.0 8.9 10.4 12.7 14.9 10.1 9.5 8.1 13.2 10.5 13.1 6.0 9.9 13.3 16.2 13.4 5.9 5.7 3.6 12.6 10.4 6.3 5.3 9.1 12.0 10.8 6.1 5.6 11.7 10.4 7.7 4.6 12.3 9.2 9.0 6.8 6.5 2.6 5.4 14.9 13.4 8.0 6.4 7.8 8.4 11.3 9.5 5.6 9.4 9.6 10.0 7.6 7.0 5.1 7.8 8.4 14.3 6.2 12.3 9.9 7.3 12.4 13.6 0.0 6.5 1.4 5.1 5.9 5.6 4.3 4.3 6.2 12.1 2.4 5.9 5.9 0.2 3.6 1.7 5.5 6.3 3.9 11.5 12.4 10.2 16.5 10.3 10.6 11.4 8.9 14.7 11.7 3.0 2.9 3.0 2.5 2.6 0.0 3.4 2.5 8.1 2.3 15.7 0.0 7.1 13.3 5.2 35.4 2.5 1.3 0.0 4.5 8.4 3.9 3.2 5.7 4.3 5.6 0.0 0.0 3.7 4.7 6.2 4.4 3.7 6.8 7.2 3.7 0.0 4.2 2.6 2.8 5.4 0.0 0.0 3.1 14.4 9.1 3.8 2.9 5.1 4.3 2.8 ESX1 "ESX1L, ESXR1" ENSG00000123576 "ESX homeobox 1" Q8N693 X 104250038-104254933 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 99 "testis: 25.4" "Cell type enriched" "Detected in some" 37 "Spermatogonia: 71.7" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "TIME: 23.7" HPA051992 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA051992: AB_2681684" "unprognostic (1.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 71.7 0.0 0.0 0.0 0.0 0.0 EXOSC7 "EAP1, hRrp42p, KIAA0116, p8, RRP42, Rrp42p" ENSG00000075914 "Exosome component 7" Q15024 3 44975241-45036066 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036182, HPA057980" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA036182: AB_10673346, HPA057980: AB_2683571" "unprognostic (1.69e-2)" "unprognostic (3.92e-3)" "unprognostic (1.84e-3)" "unprognostic (4.97e-2)" "unprognostic (3.00e-3)" "unprognostic (2.16e-1)" "unprognostic (2.34e-3)" "unprognostic (2.21e-2)" "unprognostic (2.96e-1)" "unprognostic (7.85e-2)" "unprognostic (1.20e-1)" "unprognostic (7.67e-3)" "prognostic favorable (2.69e-4)" "unprognostic (4.33e-1)" "unprognostic (7.30e-2)" "unprognostic (2.94e-1)" "unprognostic (1.20e-1)" 13.2 37.1 11.2 14.2 18.8 13.0 17.2 16.5 17.6 17.7 11.9 15.8 14.2 10.5 17.7 17.8 21.1 14.8 12.5 23.4 17.4 12.9 17.0 18.8 12.1 15.6 13.3 15.5 16.1 18.6 11.3 17.6 13.9 15.8 14.7 10.0 16.2 14.4 17.8 30.3 33.2 10.8 15.7 9.3 12.9 15.6 26.0 11.9 14.8 18.2 19.6 18.3 16.5 17.1 27.4 27.6 3.0 17.7 22.7 23.6 17.8 18.8 17.6 14.3 11.6 15.0 16.6 13.0 8.1 13.4 18.1 18.8 29.2 15.1 24.0 13.0 14.2 13.8 10.7 17.6 22.8 14.8 16.0 15.6 20.7 20.1 28.1 29.4 28.9 8.5 14.5 14.6 19.7 40.4 11.8 17.3 26.9 32.4 11.8 12.7 19.5 20.6 51.7 17.2 17.1 25.0 10.4 13.4 36.3 16.1 26.8 6.6 10.1 11.6 10.0 12.1 12.8 14.8 24.0 12.3 9.3 13.9 15.2 22.2 15.2 14.1 28.4 13.7 40.9 8.1 2.0 17.7 3.0 17.2 17.1 19.1 27.4 20.0 17.8 27.6 20.9 23.6 18.9 0.9 22.7 12.0 16.7 18.9 17.8 11.2 18.8 16.5 17.6 17.4 12.9 13.3 15.5 15.8 11.9 32.8 29.6 22.6 61.8 55.0 26.2 29.3 17.8 25.4 25.0 33.2 17.7 56.9 114.4 37.6 3.1 21.2 9.6 0.0 40.6 51.6 36.1 28.6 14.0 23.2 40.7 19.1 12.6 16.0 12.4 5.8 44.3 19.1 25.3 19.8 17.3 35.5 33.7 10.5 38.5 38.2 20.0 12.9 28.8 53.5 60.5 64.7 52.7 25.5 23.7 47.4 FAM107A "DRR1, TU3A" ENSG00000168309 "Family with sequence similarity 107 member A" O95990 3 58564117-58627610 "Predicted intracellular proteins" "Cell cycle, Growth regulation, Stress response" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 149.7" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 151.7;Ito cells: 84.7;Muller glia cells: 82.8" "Cancer enriched" "Detected in many" 6 "glioma: 110.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "ASC diff: 11.7;HUVEC TERT2: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055888 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA055888: AB_2682957" "unprognostic (1.20e-2)" "unprognostic (1.19e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.11e-1)" "unprognostic (7.80e-3)" "prognostic favorable (3.38e-4)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (5.73e-2)" "unprognostic (7.82e-3)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (1.33e-2)" "unprognostic (2.82e-1)" "unprognostic (1.92e-1)" "unprognostic (7.95e-3)" 22.4 4.6 119.4 4.7 86.5 1.3 8.4 32.4 149.7 17.0 7.6 68.6 1.7 3.6 9.4 25.1 13.9 39.6 8.4 15.8 91.5 52.0 12.4 3.5 18.1 2.4 66.6 44.3 4.3 11.1 4.1 12.0 13.8 33.5 16.3 8.4 10.7 17.5 19.4 7.5 3.5 5.8 19.8 77.5 12.0 5.8 2.5 87.2 1.2 9.9 1.4 4.8 6.5 10.2 0.3 0.3 1.3 0.9 0.7 0.6 0.1 0.0 0.0 0.5 0.0 11.7 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 1.9 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 1.3 0.4 0.5 0.3 0.4 0.6 0.2 0.3 0.2 0.2 0.3 0.2 0.3 0.6 0.7 0.9 0.3 0.3 0.1 119.4 86.5 32.4 80.7 91.5 52.0 66.6 44.3 33.5 87.2 6.0 8.5 0.0 39.0 1.9 4.2 23.8 5.1 4.0 5.7 36.6 49.1 0.0 8.3 0.9 13.1 151.7 0.0 0.0 0.2 0.0 9.4 6.0 1.1 0.8 0.0 3.2 3.5 84.7 1.3 25.6 30.5 1.9 5.0 0.0 0.0 82.8 0.5 0.0 11.0 1.9 41.9 6.5 14.4 0.7 0.2 2.4 0.0 0.0 0.0 0.9 FAM120C "CXorf17, FLJ20506, ORF34" ENSG00000184083 "Family with sequence similarity 120C" Q9NX05 X 54068324-54183281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047677 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA047677: AB_2680118" "unprognostic (4.70e-2)" "unprognostic (2.58e-3)" "unprognostic (3.72e-2)" "unprognostic (2.20e-2)" "unprognostic (3.21e-2)" "prognostic favorable (4.48e-4)" "unprognostic (1.86e-2)" "unprognostic (3.53e-3)" "unprognostic (2.74e-2)" "unprognostic (4.90e-2)" "unprognostic (2.71e-3)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (1.76e-3)" "unprognostic (5.21e-2)" "unprognostic (5.28e-2)" "unprognostic (3.28e-2)" 8.7 10.5 15.3 8.1 15.8 9.4 9.3 15.5 18.3 11.9 6.2 16.9 6.2 4.6 10.5 16.3 8.1 9.9 6.9 6.8 14.0 11.6 9.9 8.3 6.2 8.4 16.8 11.5 14.9 9.0 16.0 15.8 7.1 12.5 9.0 5.9 7.9 7.3 10.6 12.4 8.3 5.6 9.2 12.1 8.6 5.6 8.3 16.2 10.9 10.8 5.5 9.4 7.8 7.8 4.9 6.0 0.3 2.7 1.7 3.1 1.6 4.0 7.2 3.8 8.5 8.7 6.3 6.9 3.8 6.4 5.9 6.3 3.4 4.3 5.6 2.6 3.3 8.8 10.8 10.7 2.8 5.2 4.3 11.7 2.9 10.5 5.5 4.0 2.7 3.2 4.4 3.6 5.2 6.1 6.9 3.6 5.9 3.1 4.6 4.6 10.8 4.3 10.7 7.0 2.3 16.2 5.2 6.0 5.8 4.8 2.2 5.1 5.1 10.0 7.7 2.6 9.6 9.0 2.4 6.5 5.3 6.8 6.9 3.1 5.7 5.4 4.2 5.9 8.2 6.3 0.0 2.7 0.3 2.6 1.4 2.3 4.4 2.5 2.1 4.8 4.9 2.9 3.1 0.0 1.7 0.6 6.0 0.9 1.6 15.3 15.8 15.5 13.6 14.0 11.6 16.8 11.5 12.5 16.2 3.0 1.6 4.2 4.9 5.3 9.9 5.6 5.1 1.4 0.0 0.0 3.9 7.6 8.3 2.4 0.1 5.7 0.7 0.0 2.4 4.3 4.1 3.6 2.3 3.2 3.6 6.4 4.6 3.7 1.3 0.4 6.1 4.4 1.7 1.8 0.2 4.8 1.6 0.9 4.6 5.3 8.6 0.0 4.2 1.4 9.1 4.1 2.1 2.2 2.2 2.6 FAM227B "C15orf33, FLJ32800" ENSG00000166262 "Family with sequence similarity 227 member B" Q96M60 15 49326962-49620931 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 25.4;Early spermatids: 25.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA049774, HPA061695" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049774: AB_2680873, HPA061695: AB_2684588" "unprognostic (1.19e-2)" "unprognostic (2.57e-1)" "unprognostic (1.89e-2)" "unprognostic (4.74e-3)" "unprognostic (1.17e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-4)" "unprognostic (3.32e-2)" "unprognostic (9.21e-2)" "unprognostic (6.57e-3)" "unprognostic (6.32e-3)" "unprognostic (6.41e-2)" "unprognostic (7.48e-5)" "unprognostic (2.70e-1)" "unprognostic (9.01e-2)" "unprognostic (7.47e-2)" "unprognostic (1.76e-1)" 1.9 7.6 8.0 6.4 8.4 1.8 9.1 2.4 6.7 10.5 6.5 11.6 10.6 3.8 9.0 10.5 4.8 11.0 5.3 11.5 7.8 7.2 10.9 9.7 4.9 7.6 9.8 7.1 13.9 8.6 9.0 28.4 1.8 6.6 8.1 3.9 6.7 7.2 8.7 10.8 5.2 4.0 11.3 9.5 3.7 4.5 19.0 8.1 12.1 10.1 5.2 5.6 8.6 4.0 5.5 4.7 7.8 0.9 3.3 8.2 2.6 0.9 0.9 5.9 3.2 1.8 3.5 0.7 2.4 3.4 3.7 6.0 0.8 2.8 1.7 5.7 3.9 4.3 0.9 2.1 3.5 4.4 3.9 1.7 3.7 1.5 1.8 5.0 1.6 1.6 3.7 4.7 2.2 2.3 7.2 3.4 8.6 5.8 2.7 8.1 3.8 3.4 1.4 2.6 1.3 1.5 3.0 5.0 8.8 5.5 1.1 4.5 6.1 2.2 2.9 6.7 4.9 3.5 1.3 2.4 2.5 2.1 3.4 1.4 14.0 11.4 5.3 2.9 4.4 2.7 7.8 0.3 2.4 4.9 0.7 6.4 4.0 4.9 6.4 0.5 5.5 8.2 7.8 0.6 3.3 0.9 4.7 4.2 2.6 8.0 8.4 2.4 6.7 7.8 7.2 9.8 7.1 6.6 8.1 8.9 4.5 2.0 4.7 2.5 4.5 9.1 2.5 25.4 13.6 3.5 0.0 1.6 21.6 3.2 25.3 1.6 1.2 0.0 2.9 1.1 3.2 4.0 3.5 4.3 0.5 4.8 8.1 0.6 0.3 19.0 3.7 1.1 3.3 0.0 2.2 10.5 2.7 0.9 2.8 9.1 5.9 0.0 1.9 18.5 12.9 3.8 0.3 4.3 2.3 2.0 FAM71A FLJ32796 ENSG00000162771 "Family with sequence similarity 71 member A" Q8IYT1 1 212624474-212626778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 149 "testis: 57.1" "Group enriched" "Detected in many" 135 "Early spermatids: 1249.7;Late spermatids: 344.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.2;SK-BR-3: 1.6;U-266/70: 1.0" "Not detected" "Not detected" "HPA028462, HPA060344" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA028462: AB_10601904, HPA060344: " 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.8 0.5 0.0 0.0 2.5 0.0 3.4 0.0 0.0 2.0 0.0 0.4 1249.7 0.1 0.5 0.0 1.1 1.5 0.4 2.9 1.1 0.0 1.2 0.0 1.2 3.1 0.0 344.8 4.9 1.0 0.0 0.0 2.6 0.3 1.0 0.9 2.5 0.0 0.0 0.0 0.9 3.6 1.8 0.1 2.4 0.0 1.7 0.6 FBXL4 "FBL4, FBL5" ENSG00000112234 "F-box and leucine rich repeat protein 4" Q9UKA2 6 98868538-98948006 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029140, CAB033362" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "CAB033362: AB_2103974, HPA029140: AB_10611967" "unprognostic (1.24e-1)" "unprognostic (5.10e-2)" "unprognostic (1.10e-2)" "unprognostic (1.42e-1)" "unprognostic (3.34e-2)" "unprognostic (1.66e-1)" "unprognostic (2.03e-1)" "unprognostic (3.10e-1)" "unprognostic (2.79e-1)" "unprognostic (2.68e-1)" "unprognostic (4.53e-2)" "unprognostic (1.14e-1)" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.65e-1)" "unprognostic (2.62e-1)" 13.7 18.9 9.2 11.2 13.1 7.9 18.4 10.7 14.2 12.7 10.9 14.2 14.4 9.9 12.9 19.2 11.9 13.2 11.6 13.5 10.1 11.1 22.3 24.9 13.2 16.4 15.2 8.4 14.4 21.7 26.8 17.4 11.3 13.8 13.9 11.8 11.5 14.9 14.8 21.2 11.9 12.2 15.2 20.1 10.5 12.5 6.9 13.2 19.9 20.3 7.5 12.2 12.6 12.6 6.8 3.9 16.5 5.7 4.1 6.7 3.9 4.6 7.4 6.3 8.5 10.7 19.7 6.8 10.4 8.8 6.1 8.7 3.3 8.8 10.5 9.7 8.6 10.8 6.7 7.3 7.5 9.3 17.1 6.0 7.4 5.2 7.5 8.3 9.1 7.5 11.2 13.7 5.5 15.5 17.2 7.8 8.4 9.9 8.4 11.0 4.5 3.3 4.4 3.3 6.0 4.6 11.7 4.3 8.5 11.7 6.6 8.0 6.4 5.5 7.4 9.7 8.0 5.4 6.6 10.8 7.1 3.1 9.9 7.4 2.8 2.6 4.4 8.8 8.4 8.4 16.5 4.8 12.6 5.1 4.5 6.7 6.8 5.1 5.0 3.9 6.7 6.6 6.0 6.1 4.1 5.7 2.5 6.1 3.9 9.2 13.1 10.7 14.2 10.1 11.1 15.2 8.4 13.8 13.2 17.9 11.0 6.9 6.8 8.7 12.9 14.3 7.6 10.7 7.9 34.9 21.6 8.5 16.6 8.5 3.5 10.8 8.4 0.0 9.6 9.1 9.3 12.8 9.2 18.7 7.6 9.5 6.9 11.1 14.6 1.5 17.5 6.2 5.0 12.6 12.5 10.2 7.1 8.6 12.0 10.3 13.4 12.9 7.1 3.0 5.8 7.4 8.2 4.9 9.3 7.1 FBXO34 "Fbx34, FLJ20725" ENSG00000178974 "F-box protein 34" Q9NWN3 14 55271303-55361918 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 134.7;Late spermatids: 158.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052592 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA052592: AB_2681877" "unprognostic (6.19e-2)" "unprognostic (1.73e-1)" "unprognostic (5.47e-2)" "unprognostic (6.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (9.87e-3)" "unprognostic (3.07e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.20e-13)" "unprognostic (4.49e-2)" "unprognostic (3.14e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" 9.7 8.2 17.7 15.0 21.1 12.6 20.1 13.5 29.3 11.6 23.9 5.6 9.5 12.6 10.0 14.5 31.3 13.9 11.6 11.4 25.9 10.6 16.4 10.5 15.6 11.3 8.8 18.5 11.9 16.0 10.8 7.9 8.7 9.4 11.9 24.9 10.8 19.5 11.3 36.3 12.7 13.6 11.2 9.1 11.6 15.5 24.1 6.4 12.4 30.6 12.0 13.5 13.6 17.1 8.2 11.8 10.5 13.5 13.6 14.9 9.7 18.7 11.4 8.7 8.1 11.4 9.5 9.5 9.5 16.6 14.7 17.1 9.7 24.4 15.1 8.0 8.5 9.7 18.7 11.3 10.0 19.1 9.5 7.5 16.2 7.0 6.0 8.7 18.5 15.8 8.0 14.5 10.3 10.6 11.2 11.2 16.7 12.3 12.4 9.6 12.3 14.8 12.9 5.1 16.4 9.1 15.9 21.6 8.3 13.2 21.9 10.1 10.5 11.5 11.4 9.0 11.4 13.8 12.0 8.1 12.6 16.8 6.7 7.3 5.7 5.0 17.2 9.1 10.2 7.1 10.5 12.0 2.8 13.1 7.6 14.9 8.2 12.6 12.9 11.8 8.2 11.3 10.7 6.9 13.6 13.5 5.3 7.8 9.7 17.7 21.1 13.5 29.3 25.9 10.6 8.8 18.5 9.4 6.4 20.8 24.0 7.8 28.6 18.7 30.5 20.4 2.5 38.8 30.7 17.4 21.6 10.6 14.9 19.3 134.7 24.8 42.0 0.0 27.0 3.8 13.4 29.3 17.3 6.8 8.6 35.0 25.3 7.4 12.9 158.7 21.3 16.7 11.8 6.4 25.4 14.1 15.5 31.6 15.6 14.3 31.4 6.5 17.0 39.4 14.6 21.2 22.5 27.4 24.8 54.5 FEV Pet-1 ENSG00000163497 "FEV, ETS transcription factor" Q99581 2 218981087-218985657 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.9;intestine: 7.0;pituitary gland: 5.4;stomach 1: 6.1" "Cell type enriched" "Detected in some" 123 "Intestinal endocrine cells: 716.0" "Group enriched" "Detected in some" 10 "pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4" "Region enhanced" "Detected in many" "pons and medulla: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HMC-1: 19.1;SH-SY5Y: 24.5" "Group enriched" "Detected in some" 13 "midbrain: 2.3;pons and medulla: 0.9" "Group enriched" "Detected in some" 35 "midbrain: 7.3;pons and medulla: 3.9" HPA067679 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA067679: AB_2685884" "unprognostic (4.58e-1)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "prognostic favorable (4.85e-4)" "unprognostic (2.87e-1)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.15e-1)" 0.1 4.1 0.0 1.2 3.5 0.0 0.0 0.0 2.6 0.0 2.0 0.7 0.0 7.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.2 0.0 5.4 0.0 6.9 4.0 3.2 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.1 0.0 6.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 2.6 1.1 0.2 0.2 0.0 6.9 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 716.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 5.8 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.1 FIBP FGFIBP ENSG00000172500 "FGF1 intracellular binding protein" O43427 11 65883741-65888539 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 477.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011729 Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA011729: AB_1848579" "unprognostic (1.70e-1)" "unprognostic (6.06e-2)" "unprognostic (1.06e-1)" "unprognostic (3.35e-1)" "unprognostic (1.37e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (2.23e-1)" "unprognostic (2.95e-1)" "unprognostic (3.10e-3)" "unprognostic (2.13e-1)" "unprognostic (1.29e-1)" "unprognostic (5.50e-2)" "unprognostic (2.39e-1)" "unprognostic (3.18e-1)" "unprognostic (1.83e-2)" "unprognostic (4.89e-2)" 17.9 27.8 33.8 20.0 33.4 21.4 18.8 27.2 53.7 21.6 20.6 22.4 16.4 23.2 21.1 23.7 19.9 29.5 17.9 34.5 31.5 31.3 26.1 29.7 17.7 29.8 29.9 27.8 19.7 23.9 28.4 18.4 22.7 36.8 17.2 21.6 20.0 15.7 20.5 30.8 24.2 27.1 23.9 22.2 25.2 20.0 40.7 17.4 35.2 25.0 28.5 31.3 21.0 15.3 33.3 56.7 34.7 46.0 31.6 32.4 33.9 18.1 25.8 15.0 36.1 22.8 28.7 11.3 16.8 34.0 22.7 19.2 10.7 25.0 23.7 30.2 36.9 11.1 19.9 14.6 36.2 15.0 27.5 19.6 23.6 26.8 15.7 31.5 30.0 20.7 23.3 21.0 16.5 35.9 18.8 28.5 19.1 8.0 42.7 29.7 56.2 24.8 25.7 14.7 18.2 40.9 31.0 14.5 57.6 26.9 23.5 27.0 24.9 18.4 34.2 33.1 10.6 34.7 17.1 25.2 24.9 21.3 40.2 11.8 23.8 25.7 14.4 31.8 22.0 9.2 34.7 41.8 32.1 26.3 44.7 26.4 33.3 24.7 23.7 56.7 28.4 19.8 21.2 7.3 31.6 46.0 29.1 32.4 33.9 33.8 33.4 27.2 53.7 31.5 31.3 29.9 27.8 36.8 17.4 11.9 31.3 82.4 37.7 42.0 44.5 38.5 38.2 41.5 34.2 41.8 29.5 73.3 79.6 85.8 142.3 40.3 70.9 0.0 131.2 106.9 55.6 45.9 65.8 31.8 102.7 39.7 89.8 43.0 69.8 477.4 33.4 68.2 49.0 129.8 39.6 28.6 82.6 63.1 37.1 104.0 35.5 19.4 45.7 101.5 77.4 45.7 60.1 55.4 56.2 40.5 FNBP4 KIAA1014 ENSG00000109920 "Formin binding protein 4" Q8N3X1 11 47716517-47767443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039485, HPA040029" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA039485: AB_2676536, HPA040029: AB_2676808" "unprognostic (2.49e-2)" "unprognostic (3.95e-1)" "unprognostic (5.50e-2)" "unprognostic (2.78e-1)" "unprognostic (1.19e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (7.33e-5)" "unprognostic (5.58e-3)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.60e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (6.35e-4)" "prognostic unfavorable (1.91e-8)" "unprognostic (3.54e-1)" "unprognostic (1.60e-1)" "unprognostic (3.58e-1)" "prognostic favorable (7.23e-5)" 21.7 19.0 14.0 33.0 16.7 31.9 25.3 33.8 18.4 29.6 21.1 19.7 21.5 17.2 32.2 23.8 20.2 21.5 19.3 15.7 12.6 9.8 16.1 17.7 22.5 26.8 18.0 14.6 31.1 23.4 21.8 25.9 20.2 18.3 21.8 17.4 20.7 21.9 28.2 29.4 28.0 24.5 21.8 19.6 30.7 18.3 10.9 18.4 29.6 26.6 16.7 31.5 26.0 23.2 9.0 9.1 5.4 3.7 2.8 6.6 1.4 7.8 6.2 13.2 9.3 7.7 9.1 9.3 9.3 9.4 8.4 9.8 6.1 10.3 17.1 4.7 10.2 7.0 16.5 11.7 7.4 12.4 14.5 22.1 13.4 18.8 10.3 10.8 13.9 12.7 10.9 12.3 7.3 16.7 12.2 9.7 10.9 14.3 14.5 8.0 6.9 22.2 16.6 12.4 6.7 6.8 15.9 13.0 9.9 8.2 9.4 5.9 10.3 13.8 11.5 7.3 10.4 9.3 6.6 11.6 9.9 11.0 14.2 12.8 14.8 10.4 19.4 7.4 9.0 6.8 5.1 3.7 5.4 6.6 2.5 5.1 7.6 4.6 4.6 2.2 9.0 4.8 5.1 3.5 2.8 3.5 9.1 6.2 1.4 14.0 16.7 33.8 18.4 12.6 9.8 18.0 14.6 18.3 18.4 47.6 67.9 57.0 102.1 63.0 93.6 30.8 25.5 48.2 70.5 24.4 102.1 39.8 5.0 31.6 4.3 46.6 34.9 0.0 32.9 33.2 52.1 94.9 55.5 24.1 25.2 63.5 35.1 49.7 27.9 3.9 82.8 50.8 37.1 45.9 30.4 40.9 40.0 32.5 58.4 7.8 107.9 45.3 38.2 37.4 27.7 61.1 69.3 66.6 34.2 123.1 FNDC1 "bA243O10.1, dJ322A24.1, FNDC2, KIAA1866" ENSG00000164694 "Fibronectin type III domain containing 1" Q4ZHG4 6 159169397-159272109 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell type enriched" "Detected in some" 5 "Fibroblasts: 15.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.5" "Region enriched" "Detected in single" 6 "hippocampal formation: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.4;fHDF/TERT166: 6.6;SuSa: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA030962, HPA030963" Approved Approved "Nuclear speckles" "Secreted to extracellular matrix" NA NA "Nuclear speckles" "HPA030962: AB_10696212, HPA030963: AB_2673676" "unprognostic (4.59e-2)" "unprognostic (9.17e-3)" "unprognostic (7.62e-2)" "prognostic favorable (6.10e-5)" "unprognostic (4.57e-1)" "unprognostic (2.11e-1)" "unprognostic (5.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "unprognostic (4.18e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.93e-6)" "unprognostic (6.49e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.76e-3)" 5.2 0.6 0.5 7.6 0.7 0.0 2.5 0.3 0.7 9.7 12.9 3.2 0.0 2.1 4.8 2.2 2.2 0.9 13.1 3.5 4.8 0.5 1.0 1.5 1.2 2.1 0.7 0.0 4.8 1.2 0.0 0.4 0.7 0.5 0.7 1.6 1.0 2.5 0.6 6.2 1.2 7.0 10.2 1.5 0.7 0.7 2.1 0.1 1.0 36.6 11.8 3.6 1.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.1 2.4 6.6 0.3 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.2 0.0 0.0 0.9 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 7.4 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.7 4.8 0.5 0.7 0.0 0.5 0.1 0.0 1.1 0.0 0.0 2.9 0.0 1.4 0.0 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 15.5 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.4 0.3 1.3 0.1 0.0 0.0 0.0 FYTTD1 "DKFZp761B1514, UIF" ENSG00000122068 "Forty-two-three domain containing 1" Q96QD9 3 197737179-197787596 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054474, HPA074880" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA054474: , HPA074880: " "unprognostic (3.61e-2)" "unprognostic (6.01e-2)" "unprognostic (4.88e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (2.33e-2)" "unprognostic (3.80e-1)" "unprognostic (3.69e-2)" "unprognostic (9.57e-3)" "unprognostic (4.44e-2)" "unprognostic (1.66e-1)" "unprognostic (5.04e-3)" "unprognostic (8.74e-2)" "unprognostic (8.49e-3)" "unprognostic (3.40e-2)" "unprognostic (3.36e-1)" "unprognostic (3.29e-1)" "unprognostic (3.15e-1)" 12.0 10.2 12.8 13.6 13.1 14.5 24.5 20.5 13.9 11.3 11.9 6.9 13.3 6.6 13.2 10.2 19.0 13.2 10.3 19.4 11.0 12.5 11.1 12.0 11.8 13.5 11.1 10.9 13.3 17.0 13.8 13.2 13.9 13.4 11.0 9.2 6.0 10.0 13.9 82.6 11.6 10.1 21.8 17.1 11.4 10.3 16.7 10.7 10.5 12.6 15.8 15.3 15.7 21.8 11.2 15.9 23.7 16.6 32.5 22.7 21.5 30.1 6.7 13.2 12.6 15.6 17.3 4.1 14.8 15.2 23.0 18.9 10.4 10.4 19.4 54.5 17.5 12.2 10.9 16.6 15.2 24.5 4.2 7.6 29.1 10.2 4.7 15.2 21.6 14.2 12.4 19.7 12.4 17.9 15.9 18.1 11.0 13.1 41.9 20.3 25.3 23.4 5.1 2.9 13.2 12.3 21.8 16.2 13.6 16.7 19.9 25.2 10.9 22.8 18.1 16.8 10.1 42.5 11.5 15.9 11.8 11.8 14.9 15.6 25.4 38.6 23.3 12.5 31.3 12.1 23.7 14.2 13.6 18.3 16.6 22.7 11.2 17.6 20.1 15.9 9.9 19.4 18.7 4.6 32.5 15.2 8.9 15.5 21.5 12.8 13.1 20.5 13.9 11.0 12.5 11.1 10.9 13.4 10.7 32.8 25.6 37.5 37.5 73.2 33.7 111.7 22.9 56.2 30.7 45.4 29.5 21.1 76.3 32.4 14.6 54.0 13.7 0.0 31.3 24.4 46.8 54.4 65.7 45.5 33.4 42.9 54.2 37.4 46.8 12.1 29.7 54.4 49.0 141.5 21.6 36.9 28.5 18.4 35.0 39.2 39.7 38.8 66.5 84.2 83.9 79.5 41.9 50.3 18.0 59.3 GADD45A "DDIT1, GADD45" ENSG00000116717 "Growth arrest and DNA damage inducible alpha" P24522 1 67685061-67688338 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, Growth arrest" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 86.7;skeletal muscle: 102.1" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 2362.0;Urothelial cells: 1859.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.9" "Group enriched" "Detected in all" 5 "granulocytes: 24.9;T-cells: 9.3" "Cell line enhanced" "Detected in many" "HHSteC: 60.1;hTERT-HME1: 92.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053420 Supported "Nuclear speckles" NA Yes "Nuclear speckles" "HPA053420: AB_2682144" "unprognostic (1.36e-2)" "unprognostic (3.29e-2)" "unprognostic (9.58e-2)" "unprognostic (3.76e-3)" "unprognostic (5.81e-2)" "unprognostic (1.36e-2)" "unprognostic (1.57e-3)" "unprognostic (2.80e-3)" "unprognostic (1.42e-1)" "unprognostic (6.26e-2)" "unprognostic (3.43e-2)" "unprognostic (5.21e-2)" "prognostic favorable (8.06e-6)" "unprognostic (6.11e-2)" "unprognostic (2.89e-1)" "unprognostic (3.43e-3)" "unprognostic (1.93e-1)" 29.6 6.8 10.7 8.2 20.9 46.2 20.9 1.7 15.8 11.7 10.8 5.8 18.8 10.1 23.3 13.8 12.2 8.8 16.7 12.9 18.1 9.8 86.7 66.9 17.1 4.9 11.4 4.1 13.8 8.3 4.1 5.1 10.8 21.2 16.5 9.0 9.4 9.5 15.6 102.1 14.8 20.4 16.1 15.5 7.4 14.1 9.2 7.5 9.2 26.2 10.1 10.9 23.9 11.1 1.1 2.2 24.9 3.2 3.1 9.3 4.8 22.2 1.4 3.8 1.1 6.8 7.1 35.9 39.6 18.5 13.2 14.4 7.8 3.8 9.6 12.1 6.4 33.1 13.4 0.4 33.9 24.9 7.0 3.8 12.0 3.5 7.8 60.1 3.5 1.1 12.0 17.2 16.7 92.9 6.6 9.4 2.3 25.6 17.1 15.5 0.7 1.0 4.2 4.8 2.9 15.7 2.6 29.5 9.8 6.8 16.8 16.4 2.9 8.3 2.3 23.7 13.5 0.4 3.7 9.7 13.8 18.6 14.5 27.7 43.8 8.5 17.5 6.1 1.7 13.4 7.2 3.2 24.9 3.7 1.5 3.0 1.1 2.5 3.0 1.4 0.7 0.7 1.2 4.1 3.1 1.0 2.2 9.3 4.8 10.7 20.9 1.7 15.8 18.1 9.8 11.4 4.1 21.2 7.5 59.6 21.3 30.0 2362.0 763.0 34.8 176.4 48.4 136.5 91.0 97.7 9.8 17.5 200.6 253.6 0.6 85.9 120.7 93.5 224.9 94.3 192.2 631.8 44.9 99.0 16.2 25.4 126.2 49.1 19.7 2.2 35.4 33.2 150.1 467.1 44.4 25.0 252.2 49.1 60.8 290.2 70.0 51.8 190.0 2.7 12.4 341.6 14.8 38.8 37.5 1859.7 GAS1 ENSG00000180447 "Growth arrest specific 1" P54826 9 86944363-86947189 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Growth arrest" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 61.8" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 57.5;Muller glia cells: 106.0;Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 19.7;ASC diff: 13.5;BJ hTERT+: 26.7;HSkMC: 19.1;RH-30: 40.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB024164, HPA036085, HPA066902" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: AB_2685746" "unprognostic (2.78e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.97e-2)" "unprognostic (6.15e-2)" "unprognostic (2.84e-2)" "unprognostic (6.46e-2)" "unprognostic (6.91e-2)" "unprognostic (3.32e-1)" "unprognostic (1.28e-3)" "unprognostic (2.25e-3)" "unprognostic (4.30e-2)" "prognostic unfavorable (1.96e-5)" "prognostic unfavorable (8.26e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.13e-5)" "unprognostic (3.59e-2)" 26.5 2.9 0.9 8.3 1.1 0.0 14.0 1.3 1.3 26.4 9.1 2.1 15.0 0.9 61.8 37.1 10.0 20.9 11.8 9.9 1.0 0.5 4.5 0.8 4.1 5.7 1.8 0.8 31.5 4.3 0.8 3.2 50.1 2.0 18.1 1.0 8.7 4.8 8.9 8.1 10.1 3.4 24.5 0.9 1.2 6.3 18.9 0.5 3.6 6.0 3.8 1.6 11.3 15.6 0.0 0.8 0.0 0.0 0.1 0.6 0.0 0.0 0.0 3.3 19.7 13.5 5.1 0.3 3.7 26.7 1.3 1.1 0.0 0.0 0.0 0.2 6.9 0.1 0.2 0.0 0.1 0.5 2.2 7.6 0.0 11.1 0.0 6.9 0.0 0.3 19.1 2.9 0.4 2.4 0.0 0.0 0.4 0.0 0.0 5.6 0.0 0.0 0.1 4.1 0.1 0.0 3.9 40.7 0.0 0.2 0.0 0.4 1.7 5.5 0.0 5.8 2.3 0.0 0.1 0.0 5.8 1.6 0.4 1.3 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.9 1.1 1.3 1.2 1.0 0.5 1.8 0.8 2.0 0.5 0.0 1.1 0.0 8.0 23.0 6.5 5.8 0.0 0.0 1.2 14.0 9.8 17.4 8.3 0.6 0.0 6.1 0.0 0.0 0.3 3.8 57.5 1.9 0.0 0.0 5.2 4.8 0.0 23.4 0.6 0.0 30.0 1.0 16.9 0.0 0.0 106.0 0.3 0.0 11.7 2.2 2.8 38.8 10.3 0.1 0.7 10.9 3.8 0.0 0.0 0.3 GCNT1 "C2GNT, NACGT2, NAGCT2" ENSG00000187210 "Glucosaminyl (N-acetyl) transferase 1, core 2" Q02742 9 76419850-76507416 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.0;parathyroid gland: 57.8" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 26.5;Kupffer cells: 29.1;Undifferentiated cells: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 16.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 26.3;HSkMC: 22.3;U-2197: 18.7" "Group enriched" "Detected in some" 6 "cerebellum: 8.2;olfactory region: 30.1" "Low region specificity" "Detected in all" "HPA003522, HPA003523, HPA031151" Uncertain Supported "Nuclear speckles" NA NA 72000 "Nuclear speckles" "HPA003522: , HPA003523: , HPA031151: AB_10602904" "unprognostic (3.14e-1)" "unprognostic (2.01e-1)" "unprognostic (2.19e-1)" "prognostic favorable (8.44e-4)" "unprognostic (5.53e-2)" "unprognostic (2.41e-1)" "unprognostic (1.65e-2)" "unprognostic (3.37e-2)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "unprognostic (1.90e-1)" "unprognostic (3.06e-1)" "unprognostic (3.02e-3)" "unprognostic (4.21e-1)" "unprognostic (2.00e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (4.96e-4)" 5.6 1.1 1.6 7.9 3.9 2.2 8.2 10.9 2.7 5.3 24.5 0.7 3.0 23.2 5.2 1.2 2.1 1.8 4.1 3.1 2.1 1.4 1.4 1.0 4.5 9.2 1.6 2.1 0.9 2.0 57.8 1.9 3.9 1.0 4.9 4.6 0.5 9.1 1.8 0.8 1.5 32.0 2.5 1.2 7.6 18.6 1.4 0.6 2.8 16.9 1.2 6.4 2.4 3.3 9.4 4.7 16.8 6.4 4.7 1.9 1.6 2.4 0.2 0.1 0.0 3.1 15.2 3.7 10.2 4.6 8.3 5.9 2.5 0.6 1.7 1.0 7.6 1.6 2.2 5.2 4.2 9.3 1.2 0.8 4.3 0.2 0.4 26.3 3.1 1.5 22.3 1.1 8.0 8.7 6.8 7.6 2.2 0.0 1.8 8.2 3.8 1.7 5.1 4.8 6.4 0.6 2.8 5.1 0.8 9.7 4.5 1.1 0.0 1.2 1.4 0.0 3.8 0.0 2.2 3.1 5.2 3.4 18.7 4.4 2.6 0.5 0.0 10.5 5.4 1.3 4.3 2.7 16.8 1.3 6.4 0.4 1.3 1.5 1.3 4.7 9.4 0.2 1.0 0.9 4.7 5.7 2.3 1.9 1.6 1.6 3.9 10.9 2.7 2.1 1.4 1.6 2.1 1.0 0.6 0.0 1.7 2.2 3.5 0.8 0.0 0.8 0.0 9.4 9.1 3.5 0.0 1.6 0.0 1.3 19.4 4.2 16.9 0.0 22.1 17.9 4.1 9.1 10.4 0.0 7.4 0.0 26.5 6.2 29.1 9.7 0.0 11.2 1.7 1.0 12.5 0.0 8.5 15.6 1.1 1.3 0.1 0.0 1.0 1.8 2.4 0.3 15.9 4.3 26.5 0.9 GPATCH2 "CT110, FLJ10252, GPATC2, Pfa1, PPP1R30" ENSG00000092978 "G-patch domain containing 2" Q9NW75 1 217426992-217631082 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cone photoreceptor cells: 161.0;Rod photoreceptor cells: 125.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027181, HPA027322" Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA027181: AB_10602601, HPA027322: AB_1848645" "unprognostic (3.27e-1)" "unprognostic (2.66e-1)" "unprognostic (1.29e-1)" "unprognostic (2.04e-1)" "unprognostic (3.27e-2)" "unprognostic (5.13e-2)" "unprognostic (6.50e-2)" "unprognostic (1.28e-1)" "unprognostic (6.24e-3)" "unprognostic (2.46e-2)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (9.99e-6)" "unprognostic (3.52e-1)" "unprognostic (2.50e-2)" "unprognostic (1.53e-2)" "unprognostic (5.41e-2)" 11.0 10.4 14.6 13.7 19.0 6.7 17.1 12.2 19.9 15.1 12.4 10.6 19.4 11.4 15.9 19.2 13.4 12.2 14.8 11.6 12.9 13.7 12.7 11.4 10.4 11.0 11.0 13.4 13.6 12.5 18.2 27.7 14.6 12.8 17.0 11.2 8.5 12.2 19.5 13.0 12.0 13.8 12.3 11.5 11.7 11.2 16.6 12.2 20.6 16.5 11.7 12.7 12.2 13.3 5.2 9.0 6.6 6.0 4.8 6.0 2.7 6.9 8.0 8.6 6.7 7.6 7.8 7.1 6.5 8.1 9.2 8.7 7.0 9.1 7.5 6.7 5.6 5.7 8.3 9.6 7.7 10.8 5.5 5.5 4.9 6.6 4.4 9.5 7.4 5.9 6.8 11.4 10.7 17.6 8.0 6.3 8.4 12.0 0.1 6.6 6.6 9.9 5.3 15.6 5.6 8.8 4.9 19.8 8.9 6.5 15.2 10.2 14.4 11.7 10.8 8.6 14.2 10.1 7.3 6.4 8.6 6.0 12.1 6.1 7.9 5.6 7.2 6.6 5.0 6.1 6.6 6.0 1.9 5.1 3.4 3.5 4.6 6.0 3.5 6.1 5.2 5.3 4.8 0.9 4.8 4.9 9.0 5.1 2.7 14.6 19.0 12.2 19.9 12.9 13.7 11.0 13.4 12.8 12.2 11.9 12.8 16.6 15.6 13.9 49.4 13.0 28.1 17.4 17.0 17.4 161.0 17.3 11.6 17.9 30.7 18.0 16.5 23.3 15.6 17.4 18.3 19.4 9.2 11.5 13.4 47.7 20.0 16.0 6.1 20.2 18.4 13.8 5.0 12.6 12.7 34.2 12.7 14.0 21.5 12.7 125.4 19.4 13.3 55.3 22.5 16.9 18.1 12.5 18.3 15.9 GTF2H2 "BTF2, BTF2P44, p44, T-BTF2P44, TFIIH" ENSG00000145736 "General transcription factor IIH subunit 2" Q13888 5 71032670-71067689 "Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 15.3" HPA047001 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA047001: AB_2679899" "unprognostic (7.40e-3)" "unprognostic (4.71e-1)" "unprognostic (6.31e-2)" "unprognostic (2.99e-1)" "unprognostic (1.62e-1)" "unprognostic (3.07e-1)" "unprognostic (1.29e-2)" "unprognostic (4.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.22e-3)" "unprognostic (3.74e-1)" "unprognostic (3.06e-1)" "unprognostic (3.67e-2)" "unprognostic (3.93e-2)" "unprognostic (2.43e-1)" "unprognostic (1.87e-3)" "unprognostic (1.62e-1)" 3.9 3.0 1.5 1.3 1.6 1.4 2.0 1.3 2.2 5.0 3.1 0.1 3.3 3.0 3.7 2.8 1.5 1.8 1.4 1.8 4.4 2.8 2.1 6.4 1.4 4.0 4.2 2.1 1.6 0.9 3.1 1.3 2.2 0.7 3.2 2.2 2.2 7.4 1.4 3.6 2.2 3.9 4.6 0.1 2.4 2.0 2.9 1.8 6.2 1.8 1.2 2.1 0.6 3.4 0.0 3.3 0.0 8.1 9.7 10.7 0.4 0.1 0.2 0.5 8.7 0.3 13.3 6.4 7.1 4.6 2.3 0.4 0.1 0.2 10.6 10.3 8.1 0.2 0.7 9.2 0.5 0.0 0.0 2.0 0.3 0.0 2.0 0.0 0.2 0.2 2.5 0.0 5.0 5.1 4.3 0.2 0.0 0.1 4.7 2.4 8.6 15.3 0.0 0.3 3.5 8.2 1.0 8.7 0.3 5.9 5.8 3.3 4.0 1.0 0.6 6.6 0.2 0.5 3.9 0.3 0.8 7.9 1.1 1.8 0.7 1.9 1.0 0.7 1.5 2.0 1.9 0.9 2.9 2.1 1.7 6.2 1.2 1.1 1.8 0.3 0.6 14.9 24.8 17.1 15.1 14.7 22.4 13.8 20.4 30.8 22.7 12.2 37.3 25.4 39.7 11.2 3.4 11.1 7.8 23.3 17.8 12.2 12.7 14.7 5.8 11.5 12.6 23.8 11.5 9.8 13.3 4.1 22.5 12.8 13.5 7.2 3.9 10.1 12.0 5.8 12.4 13.2 37.8 25.8 10.0 27.1 40.1 10.9 8.0 21.0 7.7 17.6 GTF2H2C ENSG00000183474 "GTF2H2 family member C" Q6P1K8 5 69560208-69594723 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA047001 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA047001: AB_2679899" "unprognostic (3.70e-1)" "unprognostic (3.46e-2)" "unprognostic (2.11e-2)" "unprognostic (1.95e-1)" "unprognostic (5.97e-2)" "unprognostic (4.33e-2)" "unprognostic (8.59e-3)" "unprognostic (5.34e-2)" "unprognostic (7.12e-2)" "unprognostic (6.03e-2)" "unprognostic (6.08e-2)" "unprognostic (1.56e-1)" "unprognostic (1.86e-1)" "unprognostic (7.52e-2)" "unprognostic (2.68e-1)" "unprognostic (2.40e-3)" "unprognostic (2.55e-1)" 3.0 3.4 2.3 6.8 2.3 2.0 3.4 2.8 3.2 4.1 2.9 1.1 4.8 1.2 2.6 4.1 1.9 3.2 2.5 2.5 5.0 5.5 4.0 5.9 2.5 7.2 5.4 6.1 3.0 1.9 3.9 3.6 3.6 4.1 3.0 2.4 3.8 7.7 2.7 3.8 3.5 4.2 8.4 1.1 3.3 3.2 4.5 3.2 8.2 2.9 3.4 4.6 3.0 4.5 2.4 3.0 3.4 1.4 2.1 7.4 10.4 5.0 7.8 9.5 3.8 3.2 8.7 16.2 1.9 2.8 1.7 4.0 2.5 13.2 11.4 4.1 13.7 1.7 2.9 1.8 7.9 4.1 1.5 0.8 2.9 1.9 1.6 2.8 4.6 8.9 5.6 0.3 6.5 8.1 0.5 4.1 0.4 1.6 2.9 9.4 13.5 12.1 5.4 3.0 7.6 14.3 1.8 1.7 3.3 3.7 7.1 6.2 6.3 5.3 3.2 15.5 2.9 21.0 7.0 3.4 8.0 13.3 6.0 2.9 3.5 2.4 2.9 3.4 3.2 1.9 3.6 3.2 4.5 2.7 4.6 8.2 3.4 2.1 2.6 3.3 3.0 8.9 7.5 13.8 4.7 3.2 10.2 6.9 12.7 10.7 13.6 14.0 11.8 3.9 8.3 6.4 14.7 5.2 5.4 0.0 5.0 2.2 5.1 5.1 0.0 5.6 3.7 17.5 2.4 9.2 7.3 14.7 8.3 9.0 3.3 1.8 2.7 7.6 5.0 4.2 11.0 7.7 14.8 0.0 6.6 17.6 14.5 3.6 1.1 5.4 4.7 6.4 GTF2H4 "P52, TFB2, TFIIH" ENSG00000213780 "General transcription factor IIH subunit 4" Q92759 6 30908184-30914106 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "granulocytes: 6.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074336 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA074336: AB_2686679" "unprognostic (7.05e-2)" "unprognostic (1.79e-1)" "unprognostic (3.07e-1)" "unprognostic (4.79e-4)" "unprognostic (7.42e-2)" "unprognostic (1.11e-1)" "unprognostic (5.54e-2)" "unprognostic (1.58e-1)" "unprognostic (1.84e-1)" "unprognostic (2.36e-2)" "unprognostic (5.66e-4)" "unprognostic (7.74e-3)" "prognostic unfavorable (4.08e-4)" "unprognostic (1.22e-1)" "unprognostic (9.53e-2)" "unprognostic (6.06e-2)" "unprognostic (2.07e-2)" 11.2 13.8 13.4 16.1 13.3 10.5 17.8 27.3 17.7 12.2 9.8 9.7 9.1 7.1 12.4 12.8 13.0 11.8 11.2 8.4 12.6 8.4 13.3 18.6 10.2 11.6 10.3 14.8 14.6 9.9 8.5 12.9 9.8 11.2 9.6 10.0 7.5 13.4 16.8 10.9 12.1 12.9 10.4 13.4 11.3 10.7 9.9 12.4 13.1 12.7 8.9 9.5 9.5 10.4 2.3 3.4 5.5 2.2 1.3 3.0 1.7 7.5 3.8 6.6 7.4 5.9 4.1 6.2 2.0 1.9 4.2 3.5 6.0 3.9 7.1 3.4 5.7 5.0 6.3 8.0 10.1 2.7 6.4 6.5 5.7 5.1 3.9 3.5 0.0 5.4 5.4 7.0 5.9 0.0 6.5 3.7 4.7 15.0 2.9 4.5 7.0 5.8 8.4 5.2 4.7 1.5 10.0 4.9 3.7 10.6 3.3 2.7 1.9 3.8 2.8 2.7 3.6 7.5 4.0 3.2 5.7 7.1 5.0 9.7 4.5 6.3 7.7 2.8 8.9 3.5 5.5 2.2 1.4 2.1 1.7 1.7 2.3 2.1 2.1 3.4 2.2 2.5 3.0 0.0 1.3 1.3 2.8 2.5 1.7 13.4 13.3 27.3 17.7 12.6 8.4 10.3 14.8 11.2 12.4 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 1.4 0.0 0.0 2.0 0.4 1.7 0.5 0.0 0.7 0.0 0.0 0.6 0.3 0.2 0.1 6.9 0.5 0.3 0.0 0.0 0.6 1.2 0.0 0.9 0.2 1.7 0.0 0.0 0.2 0.0 0.2 0.7 0.8 0.1 0.0 0.5 1.6 0.4 0.9 0.2 0.5 0.2 0.0 HAS2 ENSG00000170961 "Hyaluronan synthase 2" Q92819 8 121612116-121641390 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 22.8" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 44.7;Fibroblasts: 34.9;Melanocytes: 28.7;Urothelial cells: 95.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HBF TERT88: 34.7;hTEC/SVTERT24-B: 33.4;LHCN-M2: 44.3;U-138 MG: 87.1;U-251 MG: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052060 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA052060: AB_2681712" "unprognostic (7.01e-2)" "unprognostic (1.34e-2)" "unprognostic (4.07e-2)" "unprognostic (4.65e-2)" "unprognostic (1.17e-1)" "unprognostic (2.91e-2)" "unprognostic (5.33e-2)" "unprognostic (2.57e-3)" "unprognostic (3.44e-2)" "unprognostic (1.34e-1)" "unprognostic (8.19e-3)" "unprognostic (1.24e-1)" "unprognostic (1.66e-7)" "unprognostic (1.47e-3)" "unprognostic (3.67e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-3)" 22.8 0.9 1.6 9.1 2.4 0.0 5.5 0.8 1.7 4.0 8.5 2.0 0.0 2.6 1.5 2.5 4.8 3.9 7.7 8.3 1.7 1.7 1.2 2.7 6.5 4.5 1.8 0.6 1.2 1.8 0.3 0.7 2.1 5.7 4.3 5.6 2.7 1.9 0.1 2.7 3.8 9.5 3.7 4.2 0.3 2.3 3.2 2.6 0.4 1.7 5.5 2.1 5.7 1.4 0.0 0.2 0.7 0.2 0.3 0.1 0.0 0.0 0.6 0.0 0.0 1.0 2.6 0.0 4.9 3.7 6.5 11.2 0.0 0.0 0.0 0.0 4.4 0.0 0.8 0.0 0.0 34.7 0.0 0.1 0.0 0.1 0.0 4.4 0.0 0.0 6.8 0.0 33.4 3.0 0.1 0.0 0.0 0.0 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.7 0.0 0.0 0.4 0.0 0.1 2.1 0.0 1.1 2.0 0.0 0.0 0.0 87.1 0.3 8.1 25.8 0.0 0.0 0.0 1.8 0.0 1.7 0.5 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.7 0.3 0.2 0.2 0.1 0.0 1.6 2.4 0.8 1.7 1.7 1.7 1.8 0.6 5.7 2.6 0.0 0.0 0.0 44.7 14.4 0.0 1.2 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.7 12.7 2.2 0.0 0.0 0.0 0.0 34.9 5.5 13.8 0.0 0.2 0.0 1.2 0.0 0.0 1.6 1.7 1.6 28.7 0.0 1.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 10.8 0.2 0.0 10.5 0.1 0.0 3.3 95.7 HBP1 ENSG00000105856 "HMG-box transcription factor 1" O60381 7 107168961-107202529 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 228.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020225, CAB032824" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "CAB032824: AB_2114615, HPA020225: " "unprognostic (9.00e-2)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (4.43e-1)" "unprognostic (4.79e-2)" "unprognostic (7.49e-3)" "unprognostic (1.99e-1)" "unprognostic (2.25e-2)" "unprognostic (3.47e-2)" "unprognostic (2.07e-2)" "unprognostic (2.99e-3)" "unprognostic (1.50e-1)" "prognostic favorable (7.70e-5)" "unprognostic (7.39e-2)" "unprognostic (2.31e-1)" "unprognostic (7.69e-2)" "unprognostic (5.26e-2)" 28.7 26.2 17.5 14.2 19.2 33.7 27.9 33.6 20.7 27.0 21.1 17.3 23.9 13.1 36.5 16.9 28.8 18.8 16.7 23.8 16.3 8.9 21.0 27.4 25.8 13.8 29.4 12.3 27.8 18.0 18.5 14.4 37.1 19.8 26.4 14.6 14.5 23.7 19.4 40.8 34.3 17.6 21.5 23.5 17.9 18.5 25.9 27.5 24.5 33.5 19.0 17.8 30.9 32.5 11.6 12.9 47.2 19.5 16.6 17.2 24.7 5.1 5.8 10.4 6.6 21.5 20.2 5.2 8.4 18.8 6.1 10.8 2.3 12.4 4.6 11.1 11.5 13.2 6.1 4.1 5.1 7.6 3.8 3.9 3.1 9.7 4.2 12.3 2.4 9.3 23.5 15.4 5.9 7.3 21.4 19.7 4.9 5.8 11.7 7.7 8.4 3.9 7.9 6.5 6.8 6.4 3.5 7.5 11.4 10.8 6.2 4.0 12.5 9.7 14.3 13.1 15.1 4.6 6.9 19.0 8.3 6.4 12.1 2.7 13.4 15.8 4.5 7.9 5.3 7.6 41.3 19.1 24.7 13.0 19.5 12.2 11.6 13.7 12.4 12.9 11.2 16.0 13.4 47.2 16.6 18.9 6.6 17.2 24.7 17.5 19.2 33.6 20.7 16.3 8.9 29.4 12.3 19.8 27.5 20.8 32.0 48.0 76.4 96.2 28.2 19.3 15.3 29.4 26.1 31.4 7.9 37.4 38.1 37.9 140.0 39.8 44.5 23.3 28.2 22.1 49.4 82.2 49.7 31.6 26.0 39.7 51.9 31.3 49.0 228.9 50.0 34.0 70.9 32.5 34.8 29.1 32.4 35.1 54.5 32.3 27.8 45.3 56.7 41.7 31.1 116.2 176.0 45.3 22.0 82.3 HIST1H1E "H1.4, H1e, H1F4, H1s-4" ENSG00000168298 "Histone cluster 1 H1 family member e" P10412 6 26156354-26157107 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 56.4;bone marrow: 102.3;lymphoid tissue: 123.9" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 46.7;Muller glia cells: 63.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 9.8;U-266/70: 12.1;U-266/84: 13.5;U-87 MG: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB011506, HPA055907" Supported Supported "Nuclear speckles" NA Yes "Nuclear speckles" "CAB011506: AB_470256, HPA055907: AB_2682966" "unprognostic (6.96e-2)" "unprognostic (1.25e-1)" "unprognostic (3.06e-2)" "unprognostic (1.86e-1)" "unprognostic (9.62e-2)" "unprognostic (1.04e-2)" "unprognostic (5.78e-3)" "unprognostic (2.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (7.72e-13)" "unprognostic (4.54e-3)" "unprognostic (3.46e-2)" "unprognostic (1.30e-3)" "unprognostic (2.18e-2)" 6.7 3.6 3.1 14.3 3.5 102.3 10.3 8.1 9.0 10.7 7.7 4.7 4.2 4.1 6.8 7.5 13.7 4.0 11.3 7.4 4.0 3.5 6.6 6.7 13.1 18.4 3.4 2.4 19.3 17.1 3.7 9.0 7.3 3.5 10.2 4.4 9.8 10.0 4.0 4.1 14.4 9.0 7.4 6.8 14.6 5.3 5.9 0.7 123.9 4.6 10.0 18.4 14.3 10.7 39.6 14.6 56.4 12.9 19.2 24.4 9.4 2.4 0.3 0.5 5.3 0.1 0.0 6.4 0.0 0.4 1.2 0.8 0.1 1.5 1.2 0.7 0.1 0.5 1.2 0.3 0.7 0.5 1.7 1.5 0.8 0.5 0.4 0.1 0.7 1.1 0.1 0.3 0.3 0.5 0.1 0.5 1.4 3.9 6.8 0.1 0.5 7.9 7.2 1.9 0.7 0.8 3.6 1.2 9.8 0.3 0.0 3.9 0.9 3.1 0.8 1.1 0.6 1.0 2.6 0.4 2.4 3.7 1.5 2.4 12.1 13.5 5.4 12.3 2.1 1.1 56.4 12.7 30.0 21.1 12.9 24.4 21.4 16.7 19.2 14.3 39.6 12.7 11.6 18.6 19.2 10.9 14.6 16.4 9.4 3.1 3.5 8.1 9.0 4.0 3.5 3.4 2.4 3.5 0.7 32.8 16.3 10.4 23.8 0.6 26.5 9.8 5.1 34.8 45.5 1.8 7.9 5.2 3.3 11.4 0.5 6.7 5.1 46.7 7.4 9.1 1.9 6.7 4.7 8.7 6.9 15.9 0.0 10.4 10.0 1.1 4.4 14.0 1.7 8.2 2.5 63.4 7.0 3.5 1.8 4.1 26.6 6.5 6.4 2.8 6.3 0.0 6.1 26.1 2.5 10.2 HP1BP3 HP1-BP74 ENSG00000127483 "Heterochromatin protein 1 binding protein 3" Q5SSJ5 1 20742661-20787323 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028215, HPA054295" Supported Supported "Nuclear speckles" NA Yes 50000 "Nuclear speckles" "HPA028215: AB_10601021, HPA054295: AB_2682440" "unprognostic (3.90e-3)" "unprognostic (6.83e-2)" "unprognostic (7.69e-2)" "unprognostic (3.66e-2)" "unprognostic (1.31e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.97e-1)" "unprognostic (3.26e-2)" "unprognostic (1.68e-1)" "unprognostic (1.94e-2)" "unprognostic (9.50e-2)" "unprognostic (6.86e-2)" "unprognostic (1.65e-1)" "unprognostic (6.30e-2)" "unprognostic (1.27e-1)" "unprognostic (2.43e-2)" 40.1 41.4 52.6 41.2 59.0 62.2 39.0 53.3 60.0 52.8 46.8 45.8 41.2 34.1 65.7 32.2 46.9 38.6 36.9 35.9 49.1 33.7 42.4 31.7 39.7 41.4 47.6 41.2 70.8 36.5 54.6 46.7 55.1 46.7 41.6 44.2 32.5 39.5 44.5 48.7 41.7 43.9 49.7 50.1 41.9 39.6 27.9 58.6 58.1 52.7 30.9 42.9 48.0 62.9 21.9 18.9 60.5 17.0 18.3 27.3 14.0 43.8 23.3 59.0 35.5 35.4 42.7 35.3 49.7 41.8 36.7 38.8 21.1 51.0 45.5 25.3 39.7 24.3 37.7 30.7 29.1 47.6 65.5 28.2 64.0 45.6 18.8 23.3 44.0 41.2 32.1 21.6 35.8 48.9 44.6 36.9 55.0 35.5 56.1 41.7 14.0 67.6 20.3 15.5 33.8 28.5 53.7 57.2 47.3 26.1 14.2 39.7 40.9 61.3 25.4 40.4 31.5 26.1 31.1 42.7 40.1 37.1 40.4 30.2 32.1 38.7 51.2 34.4 47.8 45.3 25.5 17.0 60.5 19.4 13.9 20.0 21.9 20.9 20.7 15.5 19.0 27.3 18.6 21.8 18.3 15.8 18.9 21.3 14.0 52.6 59.0 53.3 60.0 49.1 33.7 47.6 41.2 46.7 58.6 140.0 127.5 85.8 101.0 115.9 110.2 129.3 96.8 72.3 125.1 99.5 51.1 70.6 131.0 73.7 29.3 134.9 81.9 186.9 81.3 56.0 120.8 105.9 129.9 89.8 62.7 76.3 99.6 116.0 95.2 11.5 159.9 90.0 108.0 91.0 98.8 111.4 88.9 84.5 152.8 77.4 93.1 155.2 104.6 110.6 94.1 117.6 77.7 103.3 91.3 95.2 HPD "4-HPPD, 4HPPD, GLOD3, PPD" ENSG00000158104 "4-hydroxyphenylpyruvate dioxygenase" P32754 12 121839527-121863596 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 267.5" "Group enriched" "Detected in some" 9 "Hepatocytes: 1077.2;Proximal tubular cells: 1892.6" "Cancer enriched" "Detected in many" 100 "liver cancer: 540.9" "Region enriched" "Detected in single" 29 "pons and medulla: 13.7" "Group enriched" "Detected in many" 4 "eosinophil: 9.8;neutrophil: 4.8;plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 5.0;granulocytes: 9.8" "Cell line enriched" "Detected in some" 30 "Hep G2: 107.2" "Region enriched" "Detected in single" 8 "amygdala: 0.4" "Not detected" "Not detected" "HPA038321, HPA038322" Enhanced Uncertain "Nuclear speckles" NA NA 23000000 "Nuclear speckles" "HPA038321: AB_2675957, HPA038322: AB_10670778" "unprognostic (3.01e-2)" "unprognostic (2.30e-1)" "unprognostic (4.81e-3)" "unprognostic (1.42e-3)" "unprognostic (1.10e-2)" "unprognostic (9.08e-2)" "unprognostic (1.13e-2)" "unprognostic (8.84e-2)" "unprognostic (5.58e-2)" "unprognostic (6.14e-3)" "unprognostic (9.72e-3)" "unprognostic (8.61e-3)" "unprognostic (7.16e-2)" "unprognostic (1.97e-1)" "unprognostic (4.12e-1)" "unprognostic (3.06e-2)" "unprognostic (2.34e-1)" 0.1 0.5 0.0 0.1 0.1 0.0 0.4 0.1 0.3 0.2 0.1 2.1 0.3 0.0 0.3 0.4 0.1 0.7 0.2 0.3 0.4 0.0 51.3 267.5 0.2 0.4 0.1 0.0 0.7 0.7 0.0 0.1 0.0 13.7 0.5 0.0 3.8 0.0 0.8 0.2 0.0 0.1 0.4 0.2 0.2 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.6 0.2 0.1 5.0 9.8 1.4 0.0 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 107.2 2.5 0.3 3.5 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 2.1 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 1.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.8 9.8 0.0 1.0 0.1 0.1 0.1 0.1 1.3 0.1 0.3 0.2 4.8 0.0 1.4 5.0 0.0 0.3 0.0 0.1 0.1 0.3 0.4 0.0 0.1 0.0 13.7 0.1 0.0 0.0 18.3 0.0 0.0 0.0 0.3 48.4 0.0 0.0 87.2 0.0 0.6 164.2 0.3 33.1 0.0 0.0 0.0 14.8 0.2 0.0 0.0 0.0 1077.2 0.3 0.0 0.0 33.2 23.4 97.3 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.9 1892.6 0.0 0.0 0.0 1.7 1.1 0.0 0.9 0.0 0.0 0.0 HSF4 CTM ENSG00000102878 "Heat shock transcription factor 4" Q9ULV5 16 67164681-67169945 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 41.3;Leydig cells: 30.5;Peritubular cells: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 14.9;T-47d: 11.2;U-266/70: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA048584 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA048584: AB_2680452" "unprognostic (1.90e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (8.24e-5)" "unprognostic (9.20e-3)" "unprognostic (2.61e-1)" "unprognostic (1.43e-1)" "unprognostic (8.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.06e-2)" "unprognostic (2.45e-1)" "unprognostic (2.85e-2)" "unprognostic (4.26e-3)" "prognostic unfavorable (2.19e-6)" "unprognostic (1.20e-1)" "unprognostic (1.33e-1)" "unprognostic (4.48e-2)" "unprognostic (8.74e-3)" 6.9 16.8 11.8 2.5 14.7 2.6 5.5 16.4 20.2 7.1 4.6 2.6 16.0 6.4 6.5 13.7 7.5 7.9 5.3 8.7 11.6 5.5 6.4 8.3 6.0 2.6 19.3 16.9 7.1 17.4 10.2 12.3 5.0 11.5 12.2 3.4 19.1 16.4 4.3 36.8 13.2 6.3 26.8 11.7 3.4 16.1 3.4 15.1 0.3 7.4 10.6 1.9 10.9 8.4 0.0 0.5 0.0 0.9 0.0 0.4 0.2 1.4 0.9 0.0 1.0 0.5 2.7 4.9 0.6 0.5 0.2 0.0 2.0 2.5 0.0 2.2 0.9 0.6 4.8 0.4 0.6 0.2 1.6 1.9 0.7 1.9 2.9 2.0 0.3 3.5 1.5 4.1 0.3 2.2 14.9 0.7 2.3 1.4 4.7 1.9 1.2 0.6 1.3 0.1 2.8 1.7 2.3 1.7 5.7 3.7 2.1 2.7 5.7 4.0 2.6 6.0 2.3 11.2 3.9 1.2 1.4 1.6 5.4 1.5 20.4 2.9 1.3 3.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 11.8 14.7 16.4 20.2 11.6 5.5 19.3 16.9 11.5 15.1 3.0 7.7 0.0 3.3 2.7 7.9 5.5 2.5 2.7 2.3 3.5 2.0 0.8 0.0 0.5 0.4 1.0 0.5 0.0 1.2 0.5 4.4 4.1 1.1 4.7 16.6 41.3 1.2 3.1 1.5 0.0 30.5 1.3 10.1 1.8 2.0 6.9 1.6 3.2 20.8 2.1 11.6 0.0 2.1 0.2 1.0 3.0 0.6 0.0 2.6 1.1 HSPB3 HSPL27 ENSG00000169271 "Heat shock protein family B (small) member 3" Q12988 5 54455601-54456384 "Disease related genes, Predicted intracellular proteins" "Stress response" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 106.0;skeletal muscle: 46.1;tongue: 22.3" "Cell type enriched" "Detected in some" 55 "Cardiomyocytes: 353.4" "Cancer enriched" "Detected in many" 6 "head and neck cancer: 7.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 37.9;fHDF/TERT166: 17.0;HSkMC: 7.4;LHCN-M2: 5.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA062124 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA062124: AB_2684690" "unprognostic (1.44e-1)" "unprognostic (2.21e-1)" "unprognostic (1.78e-3)" "unprognostic (3.06e-1)" "unprognostic (2.25e-3)" "unprognostic (1.13e-1)" "unprognostic (4.41e-3)" "unprognostic (6.42e-2)" "unprognostic (1.85e-1)" "unprognostic (2.70e-2)" "unprognostic (2.73e-1)" "unprognostic (2.82e-2)" "unprognostic (7.15e-2)" 0.7 0.1 1.1 0.1 1.0 0.0 0.5 0.0 2.7 0.2 1.0 0.0 0.1 0.1 1.8 4.3 3.7 0.7 0.1 106.0 0.5 0.4 0.0 0.0 0.5 0.0 0.1 1.1 0.3 0.0 0.0 0.9 0.0 0.2 2.0 0.5 0.1 2.1 0.2 46.1 0.5 0.2 2.4 0.0 0.2 0.2 0.3 0.0 0.0 0.1 22.3 0.9 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 37.9 0.0 0.0 0.1 0.0 0.0 0.1 17.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 7.4 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 1.0 0.0 2.7 0.5 0.4 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.2 5.7 0.0 353.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.5 5.7 0.5 0.0 4.5 0.1 0.0 0.0 0.3 IK "RED, RER" ENSG00000113141 "IK cytokine" Q13123 5 140647058-140662479 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Ciliated cells: 931.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048798 Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA048798: AB_2680525" "unprognostic (9.90e-2)" "prognostic favorable (1.29e-4)" "unprognostic (6.99e-2)" "unprognostic (1.49e-2)" "unprognostic (3.23e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (2.32e-7)" "unprognostic (1.19e-1)" "unprognostic (4.87e-2)" "unprognostic (4.37e-2)" "unprognostic (8.45e-2)" "unprognostic (2.81e-1)" "unprognostic (2.53e-3)" "unprognostic (3.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.26e-2)" "unprognostic (2.83e-1)" 42.0 37.7 35.6 35.3 45.6 61.3 36.9 56.3 41.6 40.2 38.8 44.1 31.3 29.7 44.3 41.0 45.8 79.4 28.9 40.1 36.6 35.6 40.7 36.7 37.0 43.3 34.2 39.2 48.3 27.4 42.3 47.8 39.6 41.6 43.8 38.9 31.0 37.2 41.6 71.4 39.6 40.0 48.3 39.4 45.6 34.1 54.4 45.4 69.5 42.0 37.8 49.4 55.4 37.4 54.3 39.2 76.6 50.0 53.9 76.4 60.5 32.6 35.4 31.7 46.1 35.4 31.1 38.1 38.8 41.2 43.2 43.6 49.6 37.4 38.1 50.0 40.2 47.8 33.8 47.2 53.0 50.3 55.9 37.4 37.8 59.7 31.5 37.7 60.0 39.1 34.0 34.8 43.1 38.7 31.1 36.5 31.6 38.6 35.8 38.3 28.8 52.3 59.0 21.1 26.6 37.8 39.6 47.7 38.0 32.6 30.8 29.6 32.8 47.8 44.8 45.8 29.0 51.2 46.4 39.3 36.4 25.1 30.6 46.4 51.9 78.5 53.5 41.5 45.5 27.6 76.6 39.2 65.6 57.0 44.0 50.3 54.3 61.8 58.0 39.2 50.1 65.7 61.1 66.1 53.9 50.0 37.3 76.4 60.5 35.6 45.6 56.3 41.6 36.6 35.6 34.2 39.2 41.6 45.4 151.8 106.3 83.8 77.6 41.0 68.2 107.3 76.5 931.5 209.3 82.0 27.5 103.6 102.8 88.8 302.0 80.4 62.6 46.7 87.0 83.7 71.3 48.7 126.2 63.8 63.2 50.9 32.7 46.1 49.8 12.7 90.9 69.4 54.0 101.8 46.7 96.1 88.8 53.5 78.8 76.3 74.9 71.1 90.4 282.4 138.0 39.6 111.1 103.8 53.4 64.7 ISY1 "fSAP33, KIAA1160" ENSG00000240682 "ISY1 splicing factor homolog" Q9ULR0 3 129127415-129161293 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006312, HPA016995" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA006312: AB_1079734, HPA016995: AB_1852387" "unprognostic (2.20e-2)" "prognostic favorable (2.46e-5)" "unprognostic (1.46e-2)" "unprognostic (1.84e-3)" "unprognostic (2.19e-1)" "unprognostic (5.52e-2)" "prognostic unfavorable (7.25e-4)" "unprognostic (4.08e-1)" "unprognostic (5.94e-2)" "unprognostic (7.38e-2)" "unprognostic (1.71e-1)" "unprognostic (7.34e-2)" "unprognostic (2.23e-3)" "unprognostic (2.49e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" 20.7 17.1 16.4 21.8 18.1 43.4 22.2 21.8 19.5 18.8 22.5 13.9 15.9 15.2 25.0 20.0 25.2 16.9 17.7 20.9 16.0 13.2 15.6 13.6 16.8 28.3 14.8 15.9 22.5 24.1 12.3 15.3 21.6 12.6 15.6 17.4 14.4 17.4 18.1 31.6 22.8 17.6 22.1 13.7 21.8 17.5 15.4 16.7 25.5 17.0 20.4 28.2 20.7 31.3 28.7 32.3 46.9 30.0 41.6 36.1 26.7 18.9 7.3 10.9 15.2 13.3 13.9 12.7 14.2 12.9 17.2 16.6 14.5 14.3 23.9 15.4 11.7 14.9 16.3 20.5 11.5 24.3 22.9 9.4 27.7 12.5 11.6 12.3 42.4 19.8 8.7 8.1 15.0 23.3 10.7 13.6 15.7 19.8 12.3 9.2 19.1 25.7 23.7 11.9 20.0 11.4 22.8 24.8 16.8 6.4 12.1 17.4 13.1 26.2 5.8 14.9 6.2 11.1 35.3 16.3 12.5 12.5 18.4 14.8 15.0 8.9 47.3 11.5 24.6 14.2 35.7 30.0 46.8 30.3 28.5 33.7 28.7 30.9 32.0 32.3 26.8 34.3 30.8 46.9 41.6 24.3 28.1 36.1 26.7 16.4 18.1 21.8 19.5 16.0 13.2 14.8 15.9 12.6 16.7 23.8 16.0 20.8 15.0 24.4 17.9 16.6 15.3 14.7 22.7 8.7 21.6 38.3 19.9 22.1 1.5 22.6 14.7 0.0 24.6 33.6 22.0 14.5 43.9 11.1 30.7 19.1 8.6 22.7 21.5 1.1 15.0 25.9 10.1 56.9 15.9 19.9 19.9 14.0 15.2 18.3 17.0 19.4 16.8 24.6 30.6 31.2 38.3 35.2 18.4 14.9 ISY1-RAB43 ENSG00000261796 "ISY1-RAB43 readthrough" 3 129087575-129161036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 17 "Ciliated cells: 1.4;Club cells: 1.2;granulocytes: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA006312, HPA016995" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA006312: AB_1079734, HPA016995: AB_1852387" "unprognostic (1.09e-1)" "unprognostic (5.42e-2)" "unprognostic (1.52e-1)" "unprognostic (9.05e-3)" "unprognostic (2.81e-1)" "unprognostic (3.15e-1)" "unprognostic (1.63e-1)" "unprognostic (2.52e-1)" "unprognostic (1.51e-3)" "unprognostic (1.89e-1)" "unprognostic (1.40e-1)" "unprognostic (5.67e-2)" "unprognostic (1.87e-1)" 14.4 15.8 11.8 17.9 13.1 11.9 16.2 15.9 14.2 15.0 14.7 9.9 11.5 7.9 17.8 14.6 11.7 12.9 12.8 11.5 11.6 7.7 15.9 22.5 19.1 17.0 10.6 11.5 19.1 17.6 17.7 13.3 13.0 9.0 15.3 14.4 10.3 13.7 17.2 18.2 10.6 13.3 16.1 9.2 20.4 13.1 11.1 12.0 18.6 17.1 14.8 16.8 12.6 23.0 0.6 0.7 2.3 1.8 2.1 3.3 1.9 15.5 3.5 8.0 7.4 10.2 6.0 3.6 7.5 17.6 12.1 15.0 1.8 8.1 0.5 11.0 13.5 13.9 6.0 3.1 12.6 7.6 5.9 1.1 1.4 1.5 6.2 17.6 6.4 8.0 13.9 6.8 7.6 4.9 12.2 15.7 14.7 2.5 6.1 10.5 6.5 9.6 4.7 5.5 16.8 4.2 8.2 3.5 5.4 13.2 6.0 0.6 3.6 3.5 8.1 11.2 7.0 4.0 6.1 12.7 6.0 5.0 8.4 3.4 8.9 4.1 2.7 6.8 0.7 8.2 0.4 1.8 0.5 2.4 0.9 2.6 0.2 2.2 3.0 0.7 0.6 3.3 2.5 2.3 2.1 1.6 0.6 1.8 1.9 11.8 13.1 15.9 14.2 11.6 7.7 10.6 11.5 9.0 12.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ITPKC "IP3-3KC, IP3KC" ENSG00000086544 "Inositol-trisphosphate 3-kinase C" Q96DU7 19 40717103-40740860 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 80.4;Basal glandular cells: 76.3;Glandular cells: 89.9;Urothelial cells: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050760, HPA053003" Approved Supported "Nuclear speckles" No No "Nuclear speckles" "HPA050760: AB_2681227, HPA053003: AB_2682011" "unprognostic (4.27e-2)" "unprognostic (3.73e-2)" "unprognostic (8.31e-2)" "unprognostic (9.12e-3)" "unprognostic (1.10e-2)" "unprognostic (9.81e-2)" "unprognostic (6.06e-2)" "prognostic unfavorable (4.91e-4)" "unprognostic (1.48e-1)" "unprognostic (1.54e-3)" "unprognostic (1.84e-3)" "unprognostic (2.63e-1)" "unprognostic (2.59e-1)" "unprognostic (1.70e-1)" "unprognostic (2.86e-2)" "unprognostic (3.45e-2)" "unprognostic (3.32e-1)" 26.0 8.2 6.6 9.8 10.9 2.4 13.4 4.4 7.7 14.2 9.3 3.7 7.6 8.5 8.8 5.2 46.8 11.0 17.1 10.8 13.2 3.7 7.3 7.7 18.4 6.9 4.4 2.7 6.8 16.4 6.4 9.9 10.8 23.8 12.1 5.2 6.0 15.4 8.4 8.1 21.6 9.8 11.9 17.8 6.5 11.4 3.8 5.2 3.2 7.8 31.4 28.0 10.6 17.1 3.3 2.3 3.9 3.2 0.9 3.5 1.7 6.6 6.3 3.9 6.1 17.7 15.4 6.2 3.9 8.3 4.1 3.6 8.9 6.9 1.8 4.6 5.0 3.1 7.0 3.8 17.1 1.7 3.4 4.0 1.4 2.2 6.3 17.5 1.5 1.9 21.3 24.9 3.8 14.3 5.5 10.0 2.6 5.3 3.2 4.0 8.1 2.2 2.3 2.0 15.2 2.9 2.4 1.9 2.5 6.4 11.2 2.8 3.4 4.0 16.3 3.7 4.7 7.5 3.9 6.4 2.6 4.0 1.8 2.6 1.8 0.4 1.9 4.1 1.6 2.8 3.9 3.2 1.7 3.5 1.6 1.4 1.4 2.7 1.9 1.5 3.3 1.9 2.2 1.6 0.9 2.2 2.3 2.6 1.7 6.6 10.9 4.4 7.7 13.2 3.7 4.4 2.7 23.8 5.2 80.4 35.7 2.2 76.3 53.7 8.9 3.8 10.2 16.0 28.4 3.5 0.0 6.0 1.7 12.8 2.0 14.2 35.9 0.0 10.8 4.4 10.8 89.9 3.5 4.9 2.4 4.8 16.0 26.4 7.5 1.9 10.9 7.0 18.6 3.6 9.4 3.1 18.0 17.5 7.1 3.3 4.4 0.0 9.4 1.2 1.7 46.7 14.1 5.4 8.0 88.5 KCTD16 KIAA1317 ENSG00000183775 "Potassium channel tetramerization domain containing 16" Q68DU8 5 144170832-144485686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 25.1" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 12.9;Early spermatids: 7.6;Horizontal cells: 19.1" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Group enriched" "Detected in many" 5 "amygdala: 11.4;basal ganglia: 14.5;cerebral cortex: 25.1;hippocampal formation: 14.5;olfactory region: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 7.1;TIME: 13.4;U-87 MG: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044590, HPA050154" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA044590: AB_2679008, HPA050154: AB_2681034" "unprognostic (7.22e-2)" "unprognostic (3.63e-1)" "unprognostic (2.54e-2)" "unprognostic (6.81e-5)" "unprognostic (9.88e-2)" "unprognostic (1.21e-1)" "unprognostic (7.74e-3)" "unprognostic (3.23e-2)" "unprognostic (1.94e-2)" "unprognostic (9.57e-2)" "unprognostic (9.38e-3)" "unprognostic (6.20e-3)" "unprognostic (2.52e-8)" "unprognostic (1.55e-3)" "unprognostic (2.34e-1)" "unprognostic (5.80e-3)" "unprognostic (1.22e-2)" 1.0 2.0 11.4 0.7 14.5 0.6 0.9 0.7 25.1 1.5 0.8 0.4 0.0 1.0 0.9 1.5 0.8 1.2 1.4 0.9 14.5 3.2 2.9 0.8 2.4 0.7 1.7 12.0 1.0 5.2 0.8 1.7 0.9 1.3 0.8 0.7 0.0 0.7 1.1 0.6 0.7 1.2 0.9 1.6 0.7 0.8 4.4 2.4 0.0 2.2 0.0 0.7 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.1 0.7 0.0 1.9 1.6 0.6 0.8 0.4 0.0 0.0 0.6 0.5 0.1 0.0 0.0 0.3 0.9 0.2 0.1 0.0 0.5 0.1 0.2 0.1 0.0 0.4 0.1 1.2 0.1 1.5 0.0 0.3 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 7.1 0.3 0.1 0.0 0.1 0.3 0.0 0.0 13.4 1.1 0.7 0.2 0.0 0.2 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 14.5 0.7 25.1 14.5 3.2 1.7 12.0 1.3 2.4 0.0 0.0 0.0 0.0 0.0 12.9 0.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 2.7 7.6 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 19.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.7 2.4 0.0 0.8 3.8 1.9 0.0 0.0 0.0 0.0 0.0 KDM6B "JMJD3, KIAA0346" ENSG00000132510 "Lysine demethylase 6B" O15054 17 7839904-7854796 "Predicted intracellular proteins" "Inflammatory response" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 190.4;granulocytes: 180.6;Suprabasal keratinocytes: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 3.7;neutrophil: 11.6" "Lineage enriched" "Detected in single" 12 "granulocytes: 11.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037988 Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA037988: AB_10672502" "unprognostic (3.43e-1)" "unprognostic (3.43e-1)" "unprognostic (1.09e-1)" "unprognostic (2.13e-3)" "unprognostic (1.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.21e-1)" "unprognostic (2.43e-1)" "unprognostic (9.89e-2)" "unprognostic (8.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.42e-2)" "prognostic favorable (6.07e-4)" "unprognostic (5.73e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.85e-1)" 10.7 6.7 3.1 10.6 5.3 17.5 4.4 9.0 7.6 3.9 5.0 6.7 3.1 7.5 6.3 6.1 4.8 6.7 10.4 6.9 3.1 2.5 6.0 6.2 9.8 12.2 5.6 3.1 12.3 9.6 4.0 8.7 6.6 6.6 5.4 1.7 10.2 4.2 3.3 4.7 5.5 8.0 7.6 8.0 8.4 6.1 7.2 3.1 5.9 6.1 7.1 3.1 5.2 4.3 0.7 0.9 11.6 0.8 0.1 0.6 0.4 4.0 5.7 10.9 16.0 4.0 3.0 13.7 3.2 4.8 2.3 2.5 8.2 3.0 9.4 3.9 2.6 3.3 10.1 5.2 4.5 1.4 3.7 3.9 4.4 5.4 5.2 11.5 5.7 13.6 4.6 6.9 5.6 4.6 6.2 4.1 10.1 7.2 4.0 1.0 6.7 8.7 5.2 5.5 3.9 3.3 9.8 2.4 2.5 4.2 7.0 5.8 18.3 4.1 9.6 8.3 6.3 5.4 7.3 2.0 3.4 6.3 6.1 4.5 4.9 0.9 3.2 4.8 3.4 6.7 3.7 0.8 1.3 0.4 0.5 0.4 0.4 0.3 0.2 0.5 0.7 0.4 0.6 11.6 0.1 0.3 0.9 0.1 0.4 3.1 5.3 9.0 7.6 3.1 2.5 5.6 3.1 6.6 3.1 23.8 34.8 16.9 105.1 190.4 43.9 9.9 28.1 6.7 28.4 7.0 29.5 13.0 1.7 24.3 25.9 38.3 46.3 0.0 21.8 12.3 68.9 86.7 180.6 19.5 22.0 36.5 76.6 28.3 40.4 6.5 15.3 69.4 54.0 9.0 35.8 8.9 40.4 43.5 13.1 7.7 16.8 19.4 94.7 18.6 17.3 164.4 43.5 15.2 34.6 91.6 KIF22 "Kid, KNSL4, OBP-1, OBP-2" ENSG00000079616 "Kinesin family member 22" Q14807 16 29790719-29805385 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 78.2" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 228.4;Hepatocytes: 445.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048213, HPA075670" Enhanced Supported "Nuclear speckles" NA Yes "Nuclear speckles" "HPA048213: AB_2680316, HPA075670: " "unprognostic (3.71e-2)" "prognostic favorable (3.87e-8)" "unprognostic (1.86e-1)" "unprognostic (2.21e-3)" "unprognostic (1.25e-1)" "unprognostic (6.06e-3)" "unprognostic (5.06e-3)" "unprognostic (2.70e-1)" "unprognostic (2.70e-1)" "unprognostic (4.73e-2)" "unprognostic (7.84e-2)" "unprognostic (2.10e-2)" "unprognostic (2.21e-2)" "unprognostic (3.67e-2)" "unprognostic (2.62e-1)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" 5.6 4.3 8.5 21.7 11.2 38.9 7.0 6.4 10.9 5.1 12.5 8.8 3.0 8.4 5.1 10.1 13.6 6.5 6.0 5.6 6.2 5.9 7.2 4.5 5.8 16.1 6.3 6.2 5.8 3.9 18.6 5.7 22.1 5.8 13.2 10.7 8.9 6.3 9.6 4.0 16.7 9.6 4.1 5.8 11.6 5.9 17.9 5.9 78.2 16.8 13.1 19.0 6.5 7.6 13.6 6.6 19.7 9.1 13.3 25.0 17.1 21.5 23.2 30.6 22.1 2.1 3.1 26.9 16.4 13.2 31.4 29.4 22.2 25.9 31.5 15.4 8.5 15.6 22.5 29.8 16.8 14.8 20.5 23.9 17.4 25.2 28.1 0.7 19.0 19.4 1.7 4.5 17.4 13.2 4.4 16.9 36.5 25.5 26.3 16.4 43.9 41.3 47.7 25.7 16.1 14.3 57.9 27.2 30.0 11.3 10.1 25.5 16.5 11.9 23.9 8.3 10.5 21.4 25.7 7.4 16.4 17.3 14.5 17.6 24.7 24.4 34.0 10.7 31.3 20.9 19.7 6.4 17.0 23.6 9.1 17.6 13.6 23.7 25.0 6.6 11.3 19.5 18.5 2.8 13.3 7.7 4.2 24.0 17.1 8.5 11.2 6.4 10.9 6.2 5.9 6.3 6.2 5.8 5.9 29.8 104.5 22.9 29.2 27.4 27.2 228.4 58.6 28.1 38.7 66.3 23.6 50.7 53.0 13.7 7.8 21.8 20.4 46.7 43.2 72.5 31.0 20.0 40.6 445.7 42.2 6.4 39.7 38.6 48.9 6.4 14.4 41.1 33.7 20.8 36.3 35.5 16.6 42.1 12.0 77.3 19.7 12.9 32.6 52.8 47.7 24.1 64.3 26.6 38.5 11.1 KLHDC7A FLJ38753 ENSG00000179023 "Kelch domain containing 7A" Q5VTJ3 1 18480982-18486126 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 36.4" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 7.6;Ciliated cells: 6.7;Collecting duct cells: 8.7;Hepatocytes: 5.7;Proximal tubular cells: 8.4" "Cancer enhanced" "Detected in many" "renal cancer: 10.9" "Region enriched" "Detected in single" 4 "pons and medulla: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.3;CAPAN-2: 10.4;EFO-21: 5.4;NTERA-2: 5.8;RPTEC TERT1: 11.9;RT4: 9.4;T-47d: 10.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA056616 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA056616: AB_2683193" "unprognostic (4.63e-1)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (5.25e-2)" "unprognostic (1.68e-3)" "unprognostic (2.02e-1)" "unprognostic (1.31e-2)" "unprognostic (1.80e-3)" "unprognostic (2.94e-2)" "unprognostic (1.91e-1)" "unprognostic (9.01e-2)" "unprognostic (2.79e-1)" "prognostic favorable (7.81e-9)" "unprognostic (4.64e-3)" "unprognostic (1.37e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.88e-4)" 0.6 0.0 0.0 0.3 0.2 0.0 5.0 0.5 0.5 2.5 0.6 0.7 2.6 0.3 0.0 2.6 1.8 0.8 7.4 0.3 0.0 0.0 36.4 6.9 1.4 0.0 0.1 0.6 0.2 5.7 0.0 0.3 0.3 2.9 0.5 0.7 2.8 2.2 1.2 0.0 0.1 0.4 1.0 0.1 0.0 4.8 0.2 0.0 0.0 1.6 0.3 0.8 5.5 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 5.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.1 10.4 0.0 5.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 1.1 0.0 0.2 0.0 0.0 11.9 9.4 2.9 0.0 0.0 0.8 0.0 1.1 10.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.5 0.5 0.0 0.0 0.1 0.6 2.9 0.0 0.0 2.7 0.0 0.1 0.1 0.0 1.2 7.6 6.7 1.2 8.7 0.0 0.0 1.7 2.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.9 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 LHX4 Gsh4 ENSG00000121454 "LIM homeobox 4" Q969G2 1 180230286-180278982 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 21.0" "Group enriched" "Detected in some" 9 "Bipolar cells: 48.5;Cone photoreceptor cells: 49.1;Early spermatids: 42.7;Late spermatids: 55.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 6.1;BEWO: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA055705 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA055705: AB_2682892" "unprognostic (2.83e-2)" "unprognostic (3.23e-2)" "unprognostic (1.94e-1)" "unprognostic (2.86e-2)" "unprognostic (9.38e-2)" "unprognostic (5.76e-5)" "unprognostic (9.39e-4)" "unprognostic (1.47e-1)" "unprognostic (2.39e-3)" "unprognostic (2.95e-1)" "unprognostic (3.77e-3)" "unprognostic (2.72e-3)" "unprognostic (4.07e-8)" "unprognostic (3.63e-1)" "unprognostic (1.43e-1)" "unprognostic (6.44e-3)" "unprognostic (7.83e-3)" 0.8 1.4 0.8 2.3 0.8 1.5 0.9 4.3 1.4 0.9 1.2 0.8 0.8 2.5 1.3 0.8 1.2 1.3 1.2 0.8 0.8 0.4 4.6 0.8 1.0 2.2 0.8 0.8 2.2 2.5 0.0 2.4 2.8 2.1 1.2 1.1 21.0 1.4 0.8 1.3 3.4 2.4 0.8 1.4 2.2 1.4 3.6 0.8 0.8 1.9 0.8 0.8 1.3 1.5 0.6 0.1 0.6 0.7 0.2 0.7 0.0 1.4 6.1 1.6 3.3 0.0 0.0 14.7 1.6 0.4 0.4 0.1 1.2 2.7 1.5 0.4 0.0 0.6 2.6 2.9 0.0 0.7 0.8 2.4 1.0 5.8 0.6 0.0 1.7 1.8 0.0 0.0 0.0 0.0 0.6 0.0 1.6 1.7 0.6 0.0 3.1 0.9 3.0 1.3 0.5 0.3 1.0 3.9 0.6 0.0 1.2 1.5 1.3 1.7 1.3 0.5 1.4 3.4 0.3 1.9 1.4 2.6 1.5 1.0 1.1 0.4 1.4 0.5 1.3 1.5 0.0 0.7 0.0 0.6 0.2 0.4 0.6 0.3 0.4 0.0 0.5 0.6 0.3 0.6 0.2 0.5 0.1 0.7 0.0 0.8 0.8 4.3 0.8 0.8 0.4 0.8 0.8 2.1 0.8 0.0 0.0 0.0 0.0 0.1 48.5 0.3 0.0 0.0 0.0 0.0 49.1 0.1 0.0 0.0 42.7 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 55.3 0.6 0.0 0.0 0.0 0.5 2.4 0.0 0.0 0.0 0.8 5.3 0.0 0.0 0.3 0.7 0.0 0.1 0.0 0.2 0.0 LIN52 C14orf46 ENSG00000205659 "Lin-52 DREAM MuvB core complex component" Q52LA3 14 74084796-74201235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000900, HPA001777" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA000900: AB_2135058, HPA001777: AB_2666431" "unprognostic (2.34e-2)" "unprognostic (6.51e-3)" "unprognostic (1.86e-1)" "unprognostic (1.94e-1)" "unprognostic (7.90e-3)" "prognostic favorable (6.60e-4)" "prognostic unfavorable (6.08e-5)" "unprognostic (2.48e-3)" "unprognostic (9.34e-2)" "unprognostic (8.65e-2)" "unprognostic (1.39e-3)" "unprognostic (3.18e-1)" "unprognostic (1.74e-3)" "unprognostic (1.20e-2)" "unprognostic (8.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.04e-1)" 10.8 11.7 12.8 7.3 13.9 4.8 9.1 19.5 17.8 8.8 12.0 12.2 5.6 8.4 10.6 9.6 6.8 7.5 7.0 13.4 11.3 16.8 26.0 9.9 6.9 8.0 13.3 10.3 12.5 10.6 7.5 15.3 7.1 16.5 9.7 8.0 14.2 6.6 8.6 7.7 5.9 14.2 9.0 8.7 7.0 6.9 10.8 7.9 9.3 7.2 5.1 9.3 8.7 6.1 7.4 6.8 16.1 5.3 8.3 13.8 8.2 5.9 4.4 15.1 7.6 9.6 4.2 6.1 9.1 8.3 12.0 13.5 7.7 5.2 3.3 3.2 4.5 5.1 5.1 11.3 3.9 18.5 26.9 4.9 4.4 5.4 11.7 9.6 4.8 6.6 4.4 4.4 7.1 9.0 3.6 5.8 10.6 5.1 16.0 6.5 8.4 7.8 7.7 4.6 8.1 6.5 10.1 13.1 5.9 3.5 3.8 10.9 8.9 8.5 7.1 7.6 5.8 9.8 7.5 3.4 6.5 11.9 6.5 8.0 10.0 21.5 6.8 7.0 6.0 10.6 4.8 5.1 16.1 9.2 5.3 13.8 7.1 8.1 9.0 6.8 7.4 11.9 11.2 3.0 8.3 3.5 6.3 11.5 8.2 12.8 13.9 19.5 17.8 11.3 16.8 13.3 10.3 16.5 7.9 8.9 7.0 4.5 2.8 4.2 5.7 8.1 7.6 8.1 9.1 5.2 7.9 5.0 6.6 2.2 0.7 6.3 4.2 23.3 2.1 4.6 4.9 3.5 2.3 11.3 5.2 15.9 2.9 6.2 3.5 1.3 4.9 3.7 0.0 7.2 5.4 8.2 1.8 3.2 9.2 14.2 7.6 6.5 3.1 13.7 11.8 4.8 7.3 6.9 4.7 1.3 LRRC8B "KIAA0231, TA-LRRP" ENSG00000197147 "Leucine rich repeat containing 8 VRAC subunit B" Q6P9F7 1 89524836-89597864 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 81.5;Late spermatids: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017950 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA017950: AB_1853346" "unprognostic (2.50e-2)" "unprognostic (3.93e-2)" "prognostic favorable (7.15e-4)" "prognostic unfavorable (9.99e-4)" "unprognostic (1.22e-1)" "unprognostic (5.24e-2)" "unprognostic (3.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-2)" "unprognostic (1.72e-1)" "unprognostic (8.80e-3)" "unprognostic (2.30e-2)" "unprognostic (1.85e-1)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" 8.1 18.0 13.0 4.4 19.3 3.0 6.6 2.5 27.8 3.8 5.6 15.4 0.5 7.4 2.6 6.9 5.0 4.3 6.2 3.3 15.3 6.5 4.9 4.8 5.8 4.9 8.8 17.1 2.6 8.5 12.4 5.1 2.4 8.3 5.6 6.8 4.4 5.0 1.6 5.9 6.9 4.9 3.6 16.2 4.3 6.4 17.4 8.2 3.1 6.1 2.7 5.9 3.3 3.3 3.0 2.4 1.5 2.2 0.9 3.7 1.6 8.5 3.3 2.4 8.4 12.2 7.3 9.7 0.2 2.5 1.1 1.6 5.2 5.2 0.7 3.5 1.2 3.3 4.5 22.3 1.9 1.4 4.1 4.5 16.6 2.2 4.5 1.2 7.9 11.8 4.0 7.1 0.9 3.7 0.4 11.9 6.7 18.5 5.7 1.3 4.6 3.9 3.8 13.8 3.5 4.8 8.8 1.1 3.0 2.7 10.7 7.0 11.2 4.7 11.4 8.1 3.0 6.9 3.8 3.9 1.0 5.7 2.6 2.7 4.2 3.4 4.2 1.4 2.0 2.0 1.4 2.2 1.5 1.1 1.1 1.7 3.0 2.1 1.7 2.4 2.3 3.7 2.9 0.7 0.9 1.2 2.1 3.4 1.6 13.0 19.3 2.5 27.5 15.3 6.5 8.8 17.1 8.3 8.2 14.9 11.5 5.6 11.4 29.3 34.9 3.4 12.7 20.1 14.8 7.0 45.2 2.6 1.7 12.0 81.5 8.4 5.1 0.0 16.2 9.6 1.5 17.3 2.3 6.7 6.1 0.0 25.8 19.6 13.2 55.3 2.3 7.7 1.7 3.6 13.0 5.5 12.8 3.5 2.5 4.5 21.5 6.5 14.7 6.9 4.1 24.1 2.1 2.5 11.0 8.9 LUC7L3 "CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18" ENSG00000108848 "LUC7 like 3 pre-mRNA splicing factor" O95232 17 50719544-50756213 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018475, HPA018484, HPA020017" Enhanced Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249" "unprognostic (3.90e-1)" "unprognostic (4.71e-2)" "unprognostic (2.15e-1)" "unprognostic (1.05e-1)" "unprognostic (8.47e-2)" "unprognostic (2.99e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (1.39e-2)" "unprognostic (1.24e-2)" "unprognostic (1.18e-2)" "prognostic favorable (6.07e-4)" "unprognostic (1.16e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (7.23e-2)" "unprognostic (1.49e-1)" "unprognostic (1.67e-1)" "prognostic favorable (5.35e-5)" 24.1 42.2 57.2 39.6 66.9 24.0 28.7 137.4 62.6 37.6 36.7 22.3 36.4 37.0 55.0 35.0 23.7 31.5 24.3 27.5 54.5 31.3 25.4 20.4 27.8 45.9 72.2 51.8 60.1 27.3 34.1 71.9 29.3 51.3 34.7 29.1 21.6 32.8 35.2 50.6 39.1 35.9 38.2 78.4 41.8 30.5 20.7 70.9 29.1 37.2 27.5 32.1 30.2 39.2 28.8 30.6 22.7 15.9 10.3 18.8 5.2 36.3 23.6 48.1 30.8 20.3 19.6 22.8 34.2 13.3 16.6 20.0 45.1 28.2 44.4 37.1 13.7 18.9 31.7 31.7 14.3 29.0 45.9 50.1 52.6 82.4 35.9 11.1 45.9 29.4 18.5 20.3 18.0 10.6 42.4 17.0 34.5 40.7 40.6 21.2 20.2 45.1 44.8 31.4 26.1 17.9 49.0 45.2 46.1 22.8 23.2 34.1 35.7 20.4 26.2 35.4 43.8 42.2 34.1 24.0 37.5 31.8 15.7 35.1 35.8 38.3 54.5 23.3 31.7 26.1 18.3 15.9 14.5 16.3 11.3 14.3 27.5 17.6 13.5 9.9 28.8 18.8 15.4 22.7 10.3 8.8 30.6 13.3 5.2 57.2 66.9 137.4 62.6 54.5 31.3 72.2 51.8 51.3 70.9 140.0 185.5 122.4 190.4 192.1 526.4 100.3 56.0 161.9 194.5 89.0 216.0 91.5 63.0 86.8 13.9 136.5 125.0 70.0 73.3 92.9 119.5 130.2 141.2 71.6 66.6 359.1 199.5 83.4 88.5 25.8 365.3 114.4 91.1 95.6 120.6 279.8 78.4 140.3 333.8 46.4 433.6 232.8 173.3 126.5 149.4 154.7 83.5 132.1 115.8 167.3 MAML3 "CAGH3, GDN, KIAA1816, MAM2, TNRC3" ENSG00000196782 "Mastermind like transcriptional coactivator 3" Q96JK9 4 139716753-140154184 "Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 29.1" "Cell type enhanced" "Detected in many" "basophil: 11.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 11.5;SCLC-21H: 12.1;SH-SY5Y: 18.5;WM-115: 15.4" "Low region specificity" "Detected in many" HPA037717 Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA037717: AB_10794323" "unprognostic (1.83e-1)" "unprognostic (1.28e-1)" "unprognostic (1.17e-1)" "unprognostic (7.83e-3)" "unprognostic (4.73e-2)" "unprognostic (2.63e-1)" "unprognostic (3.36e-2)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (3.89e-1)" "unprognostic (5.52e-3)" "unprognostic (1.73e-1)" "prognostic favorable (7.60e-5)" "unprognostic (3.38e-1)" "unprognostic (1.20e-1)" "unprognostic (7.22e-2)" "unprognostic (2.88e-1)" 5.9 5.5 6.0 10.3 4.2 3.9 6.4 29.1 4.1 10.0 6.3 5.4 8.3 6.8 19.4 11.5 10.5 8.4 11.2 3.7 3.2 3.6 4.2 4.8 6.8 6.0 4.9 2.8 13.3 11.3 7.4 16.7 7.2 5.8 8.4 5.7 5.5 15.3 16.2 2.5 12.9 6.2 9.2 7.8 4.9 6.0 6.5 5.1 13.5 6.2 5.9 6.8 8.9 8.9 0.6 1.8 11.0 1.9 3.9 0.6 1.3 0.4 6.1 4.2 2.1 1.7 3.5 3.8 0.7 3.4 0.3 0.2 2.4 1.7 1.3 0.4 0.6 0.2 0.1 1.6 1.4 0.2 0.0 0.9 4.3 1.4 0.2 0.3 2.0 6.8 3.4 1.2 0.1 0.7 2.6 11.5 0.1 1.1 0.0 0.2 0.6 0.4 0.9 1.0 2.7 2.7 2.6 0.4 2.6 1.9 8.4 12.1 18.5 0.0 3.2 4.1 3.4 1.8 0.6 9.8 0.5 1.1 0.0 1.4 2.3 2.5 0.0 0.6 6.9 15.4 11.0 1.9 3.5 0.0 1.3 0.2 0.0 0.0 0.0 1.8 0.6 0.6 0.5 4.5 3.9 1.2 1.5 0.0 1.3 6.0 4.2 29.1 4.1 3.2 3.6 4.9 2.8 5.8 5.1 3.0 8.6 1.7 7.0 7.1 5.7 2.8 15.3 9.4 12.5 5.2 17.7 4.4 5.0 4.4 3.5 8.8 9.2 0.0 4.5 6.2 4.2 9.2 18.5 16.3 6.9 11.1 14.3 8.6 21.2 7.2 3.7 15.8 3.3 2.8 12.8 2.8 2.5 11.8 3.5 4.3 3.3 0.0 6.2 0.5 1.7 11.8 6.9 1.3 11.0 5.8 MAMSTR "FLJ36070, MASTR" ENSG00000176909 "MEF2 activating motif and SAP domain containing transcriptional regulator" Q6ZN01 19 48712742-48719721 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 53.9" "Cell type enhanced" "Detected in many" 5 "Melanocytes: 6.8;Peritubular cells: 5.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 7.6;RH-30: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049765 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049765: AB_2680870" "unprognostic (6.00e-2)" "unprognostic (3.20e-2)" "unprognostic (5.98e-2)" "unprognostic (6.07e-2)" "unprognostic (1.65e-1)" "unprognostic (6.50e-3)" "unprognostic (4.34e-4)" "unprognostic (2.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (4.65e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-2)" "unprognostic (2.79e-1)" "unprognostic (4.84e-2)" "unprognostic (1.39e-2)" 2.4 14.7 1.8 1.0 1.9 0.5 0.9 8.0 4.3 7.9 1.0 2.2 1.1 0.7 13.5 3.5 2.7 4.8 1.0 2.7 1.6 1.0 0.7 0.4 0.9 0.7 1.0 4.3 9.5 1.0 2.7 2.7 1.4 0.7 4.7 0.8 3.3 1.5 1.7 53.9 1.7 0.9 3.6 0.8 2.9 0.7 7.7 1.1 0.0 0.9 9.2 1.1 1.4 2.4 4.1 2.9 1.1 0.9 0.7 4.0 0.6 0.6 1.4 1.5 3.8 3.0 5.2 1.5 5.1 4.1 2.5 4.0 1.5 1.0 0.7 0.3 4.8 1.5 1.1 0.2 0.9 1.0 0.5 1.7 0.3 0.5 7.6 1.6 0.1 1.1 3.1 1.0 3.5 0.5 3.5 0.9 1.5 0.3 1.0 1.6 0.7 1.2 0.6 0.1 1.2 1.1 1.4 18.3 0.4 0.3 0.3 1.7 3.1 0.8 0.4 0.3 0.4 0.6 0.0 0.3 5.2 0.9 4.2 0.7 1.1 0.7 0.5 1.9 0.6 1.0 0.0 0.5 1.1 3.9 0.9 2.5 3.1 4.0 3.8 1.0 4.1 4.0 3.5 0.4 0.7 0.9 2.9 1.7 0.6 1.8 1.9 8.0 4.3 1.6 1.0 1.0 4.3 0.7 1.1 0.0 0.0 0.0 1.5 0.8 1.7 2.8 0.0 0.0 2.3 1.8 2.0 0.8 5.0 1.4 0.4 1.6 0.4 0.0 0.9 2.4 2.5 0.5 0.0 0.0 1.0 0.0 0.0 2.5 0.0 1.4 5.2 1.6 6.8 1.8 0.3 4.8 0.5 0.0 5.6 0.6 2.5 0.0 2.2 0.5 1.7 0.6 0.8 0.9 0.6 1.0 MAST3 KIAA0561 ENSG00000099308 "Microtubule associated serine/threonine kinase 3" O60307 19 18097793-18151692 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.5" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 21.5;Late spermatids: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035061, HPA035062" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035061: AB_10670585, HPA035062: AB_10671508" "unprognostic (5.94e-3)" "unprognostic (4.75e-2)" "unprognostic (1.70e-1)" "unprognostic (1.02e-1)" "unprognostic (3.38e-1)" "prognostic favorable (2.97e-4)" "unprognostic (1.93e-1)" "unprognostic (4.63e-2)" "unprognostic (1.43e-1)" "unprognostic (3.21e-1)" "prognostic favorable (7.01e-4)" "unprognostic (2.58e-1)" "unprognostic (1.64e-3)" "unprognostic (1.02e-2)" "unprognostic (3.61e-1)" "unprognostic (1.58e-3)" "unprognostic (1.26e-3)" 4.6 3.5 20.7 8.3 36.1 12.3 1.8 1.1 72.5 3.8 5.3 19.0 0.2 9.1 3.6 4.9 2.2 4.9 3.1 2.1 19.7 9.3 3.6 6.4 4.6 9.9 13.0 33.6 4.6 14.3 7.1 7.7 2.6 13.0 2.7 4.4 0.7 4.6 4.2 2.6 6.9 8.8 3.0 7.9 11.4 3.9 2.1 12.5 1.8 2.4 0.3 9.4 3.3 2.4 4.4 10.3 23.2 9.7 5.8 8.4 3.1 3.3 5.0 2.3 10.1 6.8 5.5 5.5 3.4 2.2 2.4 3.5 5.0 4.7 8.7 5.2 3.4 2.6 1.8 3.3 1.9 1.7 7.4 4.1 4.0 5.2 7.9 5.8 2.1 13.3 6.3 5.7 3.6 1.4 3.3 1.1 6.0 4.0 5.7 2.7 6.0 4.4 7.0 2.4 7.4 6.2 12.1 2.0 6.4 1.8 1.5 3.8 6.2 4.8 2.8 2.0 1.7 3.2 4.9 4.0 3.1 3.3 13.0 1.4 6.2 8.4 8.0 6.8 11.2 2.8 0.1 4.5 9.4 8.4 5.6 6.2 4.1 4.7 3.3 2.1 4.4 3.7 6.4 23.2 5.8 9.7 10.3 5.0 3.1 20.7 36.1 1.1 72.5 19.7 9.3 13.0 33.6 13.0 12.5 6.0 10.3 7.8 0.7 0.5 3.2 1.1 7.6 0.0 3.4 8.7 2.0 0.5 3.3 2.8 9.1 1.6 20.0 0.0 9.2 1.2 2.2 0.8 2.3 12.5 6.9 0.0 2.4 7.4 21.5 24.6 3.7 7.9 5.0 6.4 6.9 0.8 6.1 8.6 6.3 8.7 0.6 0.0 1.8 0.6 2.8 1.9 0.3 9.6 8.6 0.6 MBD4 MED1 ENSG00000129071 "Methyl-CpG binding domain 4, DNA glycosylase" O95243 3 129430944-129440179 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002031 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA002031: AB_1079319" "unprognostic (2.70e-2)" "unprognostic (3.48e-3)" "unprognostic (1.18e-2)" "unprognostic (6.37e-2)" "unprognostic (4.31e-2)" "unprognostic (7.11e-2)" "unprognostic (4.70e-2)" "unprognostic (3.25e-2)" "unprognostic (2.02e-2)" "unprognostic (5.73e-2)" "prognostic unfavorable (2.18e-4)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (2.73e-6)" "unprognostic (9.27e-2)" "unprognostic (1.59e-2)" "unprognostic (8.58e-2)" "unprognostic (3.35e-2)" 18.1 14.5 14.9 41.9 19.0 26.2 22.8 22.1 16.3 24.0 17.2 14.2 11.2 16.0 16.6 17.8 14.1 15.3 17.4 22.0 15.3 12.8 24.1 30.1 19.0 41.6 17.6 13.7 26.5 18.9 14.8 23.8 17.4 13.6 14.7 16.2 8.4 16.2 16.2 18.2 16.0 21.9 14.7 15.9 34.2 18.7 11.3 15.4 30.4 16.0 14.7 47.8 18.3 18.0 40.3 8.7 19.6 9.5 9.3 15.1 8.7 19.8 12.0 14.7 16.4 16.9 15.2 17.0 17.2 16.3 16.5 19.7 14.7 13.4 28.0 14.1 10.7 15.3 18.0 11.2 10.6 20.2 15.8 7.4 16.7 13.8 10.6 27.0 30.5 22.3 18.0 15.3 14.1 12.5 16.6 15.6 16.4 18.6 21.2 12.2 18.4 17.6 21.5 12.9 16.8 10.4 16.6 8.6 19.2 18.4 9.9 16.5 9.2 21.7 11.4 18.1 13.3 14.4 27.1 10.3 15.7 12.1 16.8 11.3 14.5 8.7 49.1 13.4 17.4 12.9 19.6 8.7 11.6 11.5 7.8 8.7 40.3 12.3 11.3 7.3 36.0 15.1 12.6 15.4 9.3 9.5 8.7 10.5 8.7 14.9 19.0 22.1 16.3 15.3 12.8 17.6 13.7 13.6 15.4 17.9 51.1 69.0 27.1 15.3 31.5 31.3 12.7 30.8 33.0 41.8 17.7 40.7 38.1 28.3 15.4 28.5 22.2 0.0 61.2 41.7 32.4 24.5 56.7 29.7 66.1 20.6 32.3 25.8 40.5 5.3 30.5 34.9 20.3 36.9 23.5 18.6 35.8 24.3 34.3 52.3 41.2 38.8 29.2 38.6 68.7 17.1 31.0 39.9 24.4 28.8 MECOM "EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3" ENSG00000085276 "MDS1 and EVI1 complex locus" Q03112 3 169083499-169663618 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 169.5;Club cells: 93.3;Collecting duct cells: 118.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 15.6;HUVEC TERT2: 22.0;RPTEC TERT1: 28.2;RT4: 44.4;TIME: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA046537 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA046537: AB_2679689" "unprognostic (4.09e-2)" "unprognostic (1.96e-1)" "unprognostic (3.24e-3)" "unprognostic (7.29e-2)" "unprognostic (2.87e-2)" "unprognostic (2.53e-1)" "unprognostic (1.83e-2)" "unprognostic (4.77e-3)" "unprognostic (1.53e-2)" "unprognostic (3.27e-3)" "prognostic unfavorable (2.59e-4)" "unprognostic (1.87e-1)" "unprognostic (2.60e-3)" "unprognostic (6.54e-2)" "unprognostic (1.03e-1)" "unprognostic (2.81e-2)" "unprognostic (3.37e-3)" 25.9 0.7 3.3 5.7 5.6 0.3 9.1 3.4 5.3 13.5 13.9 1.6 22.1 11.2 15.4 5.7 10.4 14.3 8.1 8.2 3.3 2.9 32.2 2.6 30.0 1.5 4.6 1.4 6.2 27.8 1.1 5.3 10.0 4.7 9.3 17.5 4.2 5.9 25.3 16.0 2.3 5.9 5.6 5.8 6.4 39.4 2.7 3.5 0.2 4.7 3.3 3.5 18.1 18.5 0.3 0.0 0.6 1.5 1.8 1.0 0.0 9.8 0.1 0.2 0.0 1.3 1.0 0.1 1.3 1.6 0.5 0.9 3.9 10.1 0.0 15.6 0.2 2.2 5.2 4.1 6.1 1.1 0.5 6.4 6.2 1.7 0.1 0.1 0.0 1.9 2.1 0.8 0.3 4.6 4.8 22.0 0.5 4.7 0.7 3.9 1.0 0.0 0.0 0.2 5.1 2.5 3.7 5.1 0.2 28.2 44.4 0.3 1.2 0.4 2.6 0.1 0.3 3.0 0.0 20.9 3.9 2.5 1.0 6.5 0.5 0.1 0.3 1.9 0.0 0.6 0.3 0.0 0.6 0.4 0.2 1.0 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.3 1.8 1.5 0.0 0.1 0.0 3.3 5.6 3.4 5.3 3.3 2.9 4.6 1.4 4.7 3.5 56.6 169.5 0.0 27.4 1.9 0.0 6.7 5.1 64.3 93.3 118.7 0.0 0.9 44.7 0.8 4.6 40.2 10.5 0.0 65.4 0.1 1.5 9.9 9.2 0.0 0.0 0.0 19.1 34.4 0.6 1.7 0.3 1.0 1.7 1.8 23.3 0.0 42.3 3.5 0.0 0.3 0.0 0.0 0.7 2.1 0.4 1.3 0.3 0.5 49.4 38.8 MFSD11 "FLJ20226, FLJ22196" ENSG00000092931 "Major facilitator superfamily domain containing 11" O43934 17 76735865-76781449 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 231.7;Early spermatids: 185.4;Late spermatids: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022001 Uncertain Approved "Nuclear speckles" Yes No "Nuclear speckles" "HPA022001: AB_2297599" "unprognostic (2.84e-2)" "unprognostic (1.22e-1)" "unprognostic (2.43e-2)" "prognostic unfavorable (7.69e-4)" "unprognostic (4.87e-2)" "unprognostic (1.17e-1)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-3)" "unprognostic (1.68e-2)" "unprognostic (2.06e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-1)" "unprognostic (1.18e-2)" "unprognostic (6.98e-2)" "prognostic unfavorable (7.90e-4)" 17.2 20.7 13.9 14.3 21.3 15.6 18.7 20.4 25.0 18.0 20.9 19.6 16.9 17.4 18.8 18.8 24.1 13.4 14.3 23.5 13.3 14.8 13.3 19.2 17.4 22.0 20.1 16.1 14.4 17.4 24.6 27.9 27.4 18.1 14.8 22.8 32.8 21.3 17.3 26.8 20.8 17.7 16.8 17.9 19.0 21.7 28.6 19.7 15.6 18.0 16.8 18.6 16.8 21.6 8.0 14.9 16.7 16.1 6.3 18.3 8.2 13.8 7.9 9.3 8.8 20.0 12.2 10.9 12.3 11.5 11.9 10.6 15.8 25.4 11.2 10.5 12.5 13.1 13.6 6.5 6.4 12.4 5.1 13.1 11.3 14.9 10.9 9.6 6.0 11.2 14.4 10.5 15.2 6.9 17.3 22.6 15.1 13.5 16.8 15.1 10.6 13.5 9.8 3.9 15.8 4.6 10.7 12.1 23.3 9.2 10.3 9.0 15.2 11.8 16.8 10.5 14.3 29.5 9.2 15.9 21.7 10.7 13.6 10.2 18.7 7.4 17.0 16.8 5.3 14.3 11.2 14.1 11.3 15.2 16.1 6.4 7.5 13.6 15.3 14.9 8.0 8.5 10.6 16.7 6.3 12.5 10.7 18.3 8.2 13.9 21.3 20.4 25.0 13.3 14.8 20.1 16.1 18.1 19.7 11.9 12.3 7.5 17.8 14.9 36.0 15.1 10.2 4.0 14.8 14.0 231.7 33.6 5.0 13.3 185.4 14.8 23.9 0.0 15.9 60.6 17.0 13.3 26.5 15.6 29.3 38.1 16.1 17.2 21.9 141.7 17.0 18.6 18.6 21.6 14.2 18.8 16.6 10.5 13.1 8.7 96.6 6.5 12.8 33.4 10.4 15.1 34.6 17.5 14.3 12.5 MKL2 "FLJ31823, MRTF-B" ENSG00000186260 "MKL1/myocardin like 2" Q9ULH7 16 14071321-14266773 "Disease related genes, Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Endothelial cells: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011286 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA011286: AB_1853973" "unprognostic (2.00e-1)" "unprognostic (5.28e-1)" "unprognostic (1.30e-2)" "unprognostic (3.62e-1)" "unprognostic (7.16e-2)" "unprognostic (7.14e-3)" "unprognostic (1.21e-1)" "unprognostic (1.37e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-1)" "unprognostic (3.19e-1)" "unprognostic (2.32e-1)" "prognostic favorable (6.20e-4)" "unprognostic (5.22e-2)" "unprognostic (3.55e-1)" "unprognostic (2.47e-2)" "unprognostic (5.96e-2)" 25.2 9.8 32.5 7.7 44.9 5.5 22.0 7.4 47.8 19.0 9.1 5.1 9.2 8.9 18.1 8.8 13.7 13.5 12.4 13.2 18.3 9.0 8.2 8.0 16.2 7.0 7.7 26.8 8.2 10.9 28.2 16.4 19.6 8.5 15.2 10.5 8.3 15.0 15.4 11.1 15.9 9.6 14.7 9.9 4.7 10.3 15.4 12.1 2.6 16.3 6.8 7.4 14.0 15.1 7.1 3.7 0.9 1.5 2.3 5.0 1.2 13.0 13.5 14.3 10.3 4.6 8.8 6.5 3.7 10.5 5.8 8.8 6.0 12.8 7.2 9.7 6.3 7.3 10.8 9.9 11.0 10.6 17.1 5.4 4.9 10.8 9.9 6.5 3.2 4.3 7.1 11.7 9.9 6.7 6.3 11.2 9.4 5.8 8.8 4.5 11.2 9.8 2.4 4.6 3.6 4.0 15.5 10.7 6.6 5.8 13.6 5.0 8.6 18.1 7.8 3.8 6.8 14.0 2.6 7.6 12.1 11.8 3.4 4.8 6.0 6.3 6.8 13.0 5.5 9.0 0.4 1.0 0.3 2.7 1.4 3.6 7.1 4.0 2.0 1.5 3.9 5.0 3.0 0.9 2.3 1.5 3.7 1.8 1.2 32.5 44.9 7.4 47.8 18.3 9.0 7.7 26.8 8.5 12.1 11.9 25.6 1.5 10.8 12.9 14.8 24.8 15.3 18.7 22.7 8.7 21.6 8.0 0.0 9.4 17.6 54.1 6.5 0.0 7.9 8.3 11.6 13.1 1.1 16.8 4.0 30.2 18.5 11.6 5.6 14.0 10.0 8.6 11.8 5.4 12.2 29.8 10.8 8.6 13.8 4.9 18.1 25.8 23.0 14.2 9.8 17.2 8.7 6.2 11.8 8.7 MORF4L1 "Eaf3, HsT17725, MEAF3, MORFRG15, MRG15" ENSG00000185787 "Mortality factor 4 like 1" Q9UBU8 15 78810487-78898133 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042360, HPA062010" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA042360: AB_10794275, HPA062010: AB_2684655" "unprognostic (5.36e-2)" "unprognostic (4.30e-1)" "unprognostic (3.68e-1)" "unprognostic (9.69e-2)" "unprognostic (1.27e-1)" "unprognostic (1.83e-3)" "unprognostic (3.61e-3)" "unprognostic (8.61e-3)" "unprognostic (3.15e-1)" "unprognostic (3.58e-2)" "unprognostic (6.96e-2)" "unprognostic (3.69e-1)" "unprognostic (5.77e-2)" "unprognostic (1.17e-1)" "unprognostic (2.12e-1)" "unprognostic (3.92e-2)" "unprognostic (2.60e-3)" 49.3 57.8 59.9 40.8 60.9 66.9 44.2 76.6 70.6 55.5 50.1 32.5 37.5 29.8 58.8 41.7 45.3 48.1 46.5 85.0 54.8 75.3 60.9 46.0 43.3 40.5 71.1 52.6 68.2 32.2 44.5 60.1 60.1 60.1 45.7 41.8 41.5 41.6 54.6 89.5 28.2 46.2 63.6 58.8 37.2 40.3 215.8 40.7 23.0 65.0 38.3 48.0 57.0 92.6 45.9 61.3 51.6 53.8 37.5 72.5 73.3 46.0 62.7 114.2 47.4 82.4 85.7 60.6 84.4 82.5 75.1 72.9 56.4 70.2 56.1 69.5 84.4 50.7 58.2 138.8 56.6 71.3 56.6 55.6 62.3 67.5 52.1 84.7 51.7 57.1 59.7 64.6 42.9 60.5 74.1 90.3 40.6 64.9 53.1 87.1 43.0 49.3 38.3 124.2 61.1 27.6 55.3 89.3 54.7 61.6 63.3 59.4 61.8 75.0 48.5 106.0 122.0 58.4 69.1 69.8 90.9 64.6 48.1 70.6 34.6 94.7 63.3 56.0 83.2 66.2 25.9 53.8 51.6 36.2 50.6 43.2 45.9 52.4 40.8 61.3 43.6 72.5 52.0 43.2 37.5 39.8 58.7 56.1 73.3 59.9 60.9 76.6 70.6 54.8 75.3 71.1 52.6 60.1 40.7 279.9 231.2 245.5 501.1 371.3 98.4 338.0 259.9 528.6 353.8 275.7 58.9 536.2 581.9 469.0 550.4 393.3 137.8 46.7 275.1 678.5 597.1 398.9 447.7 277.2 339.1 189.1 264.2 340.7 271.9 377.0 360.7 374.0 475.8 519.4 181.7 260.3 322.5 172.9 437.0 539.2 84.0 310.4 508.2 1152.9 415.8 323.7 554.4 274.5 152.8 513.1 MSX2 "CRS2, FPP, HOX8, MSH, PFM, PFM1" ENSG00000120149 "Msh homeobox 2" P35548 5 174724533-174730893 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Osteogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.7;urinary bladder: 18.2" "Group enriched" "Detected in many" 16 "Cytotrophoblasts: 123.2;Syncytiotrophoblasts: 195.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "BEWO: 84.9" "Region enriched" "Detected in single" 7 "cerebellum: 6.9" "Low region specificity" "Detected in some" HPA005652 Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA005652: AB_1079418" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "prognostic favorable (8.43e-5)" "unprognostic (2.50e-2)" "unprognostic (1.22e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.08e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-2)" "unprognostic (7.26e-2)" "unprognostic (1.36e-4)" "unprognostic (7.64e-3)" "unprognostic (5.06e-2)" "unprognostic (2.12e-6)" "unprognostic (1.43e-2)" 2.0 0.4 0.3 0.4 0.5 0.0 7.6 6.3 1.6 2.6 0.9 2.0 0.0 0.3 6.2 0.2 0.9 1.1 1.5 1.7 2.5 0.5 0.3 0.1 0.9 0.1 1.5 1.2 0.4 0.6 9.4 0.5 44.7 7.2 6.3 0.1 6.6 0.9 0.8 2.1 6.4 0.9 10.4 6.6 1.1 2.6 5.2 1.3 0.0 0.8 0.2 0.3 18.2 2.4 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.1 1.0 0.3 0.8 0.0 0.0 84.9 0.5 0.9 0.2 0.0 14.4 5.9 0.0 2.2 0.0 5.2 1.6 4.5 1.6 0.0 0.0 2.8 0.0 0.3 0.0 0.6 0.0 0.8 1.0 1.2 0.8 0.9 0.0 0.0 0.0 0.0 0.0 1.2 6.9 0.0 0.1 0.6 9.6 2.2 0.0 2.3 0.0 1.0 9.0 0.0 0.6 0.0 11.2 0.7 19.3 6.7 0.0 0.0 0.2 1.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.5 6.3 1.6 2.5 0.5 1.5 1.2 7.2 1.3 0.0 0.0 0.0 2.4 8.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 123.2 0.0 0.6 0.1 0.5 0.5 0.0 0.0 7.6 5.0 2.6 4.6 0.0 9.9 0.0 0.0 0.6 0.6 0.2 0.0 0.0 1.7 0.0 1.0 1.2 0.8 0.0 0.0 0.0 0.0 0.0 3.1 1.1 4.9 9.9 195.5 0.0 0.4 8.3 MYADM ENSG00000179820 "Myeloid associated differentiation marker" Q96S97 19 53866223-53876437 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 336.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 52.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056301 Approved "Nuclear speckles" NA NA 34000 "Nuclear speckles" "HPA056301: " "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (2.94e-1)" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (8.21e-3)" "prognostic unfavorable (8.15e-4)" "unprognostic (3.97e-2)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (4.11e-1)" "prognostic unfavorable (7.71e-7)" "unprognostic (2.28e-3)" "unprognostic (1.29e-1)" "unprognostic (2.37e-2)" "unprognostic (6.14e-3)" 58.2 9.5 9.2 26.4 13.9 53.5 39.2 7.4 17.1 67.9 58.9 18.8 25.1 15.8 105.6 33.0 44.6 66.1 40.8 39.9 9.3 11.7 13.0 15.6 42.4 22.3 8.2 11.4 51.7 31.8 8.7 8.9 46.5 13.3 41.9 13.4 22.2 21.1 45.4 13.2 19.5 26.8 76.8 9.6 22.6 37.6 28.7 9.4 20.3 20.5 32.6 15.3 81.6 30.5 2.0 14.3 52.2 11.6 4.1 5.4 3.9 6.5 55.1 7.0 5.7 24.1 16.6 11.3 35.1 25.2 13.9 14.2 22.6 20.4 0.6 12.5 44.6 15.1 13.5 3.5 13.3 12.1 8.2 8.3 9.0 9.1 17.2 55.1 18.4 32.5 18.1 3.1 17.8 2.5 23.0 12.5 3.5 9.4 16.9 8.8 7.9 4.9 14.4 6.7 24.7 15.7 19.4 7.6 3.3 15.6 0.7 0.1 10.9 0.3 11.0 3.4 15.0 10.7 15.8 25.5 31.3 11.2 4.1 15.7 11.0 6.9 0.1 19.2 9.0 0.5 14.1 11.6 38.3 5.4 6.7 5.1 1.4 3.5 3.9 14.3 2.0 3.4 2.8 52.2 4.1 5.4 5.5 1.3 3.9 9.2 13.9 7.4 17.1 9.3 11.7 8.2 11.4 13.3 9.4 151.8 58.6 29.9 149.5 91.5 3.9 57.6 43.3 57.6 119.4 19.2 3.9 32.7 0.0 107.8 2.1 93.1 5.4 0.0 45.1 208.7 179.0 42.1 336.4 16.3 69.9 9.5 194.1 115.4 66.4 2.0 83.4 144.1 57.3 15.4 91.5 1.7 54.2 52.6 109.6 0.3 0.9 148.8 157.7 22.0 7.7 52.2 41.4 54.3 65.7 78.1 NCBP3 "C17orf85, ELG, HSA277841" ENSG00000074356 "Nuclear cap binding subunit 3" Q53F19 17 3802165-3846251 "Predicted intracellular proteins" "Antiviral defense, mRNA capping, mRNA processing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008959, HPA013195" Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA008959: AB_2668184, HPA013195: AB_2668800" "unprognostic (1.39e-1)" "unprognostic (1.42e-1)" "unprognostic (2.11e-1)" "unprognostic (3.49e-3)" "unprognostic (1.97e-2)" "unprognostic (5.47e-2)" "unprognostic (2.53e-1)" "unprognostic (2.06e-2)" "prognostic unfavorable (4.68e-4)" "unprognostic (1.23e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (4.90e-4)" "unprognostic (2.00e-1)" "unprognostic (1.32e-1)" "unprognostic (3.64e-1)" "unprognostic (5.68e-2)" "unprognostic (5.36e-2)" 14.4 12.8 11.9 20.8 18.4 36.3 14.2 14.3 14.8 17.1 17.8 26.1 17.4 20.5 20.5 18.2 16.9 16.6 15.7 15.9 14.4 11.0 12.3 11.3 13.5 15.1 15.0 13.3 20.5 18.2 17.5 16.4 17.3 15.2 13.8 15.1 12.4 14.4 17.8 20.7 19.6 17.6 16.2 18.9 16.7 15.2 25.4 17.1 29.3 14.7 9.0 17.7 16.6 17.9 3.4 4.4 6.1 3.9 2.9 6.6 2.1 9.2 12.0 11.1 8.2 5.8 4.3 5.5 6.4 4.4 9.0 5.7 4.8 3.7 8.2 5.8 6.7 4.3 17.0 8.3 8.4 11.5 10.2 11.5 6.7 5.5 5.3 4.9 4.0 9.9 6.6 3.6 8.6 9.1 7.2 7.4 12.3 8.2 8.7 6.6 3.1 14.5 7.3 10.2 4.2 4.6 25.3 8.8 5.3 4.6 4.8 4.1 8.8 13.3 4.6 8.4 9.5 7.0 8.5 7.5 5.2 7.1 8.0 13.7 4.7 4.2 6.6 6.6 7.3 8.0 1.5 3.9 4.8 4.7 2.6 4.1 3.4 4.0 6.6 2.6 2.4 6.5 5.4 6.1 2.9 1.6 4.4 6.0 2.1 11.9 18.4 14.3 14.4 14.4 11.0 15.0 13.3 15.2 17.1 47.6 32.1 6.7 21.1 0.0 42.8 0.0 25.5 64.3 44.3 24.4 33.4 77.5 11.6 20.6 9.2 23.3 9.7 0.0 20.4 16.0 21.3 25.1 22.1 19.5 20.3 31.8 10.5 29.4 24.7 12.4 23.0 21.5 0.0 28.9 22.5 20.1 20.7 21.0 17.7 15.4 46.1 32.3 0.0 45.3 45.3 0.0 83.1 26.1 24.7 24.5 NR4A2 "HZF-3, NOT, NURR1, RNR1, TINUR" ENSG00000153234 "Nuclear receptor subfamily 4 group A member 2" P43354 2 156324432-156342348 "Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 102.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 342.7;Melanocytes: 229.5;Smooth muscle cells: 233.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 14.4;HMC-1: 10.7;U-266/70: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000543, CAB010481" Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "CAB010481: AB_2298676, HPA000543: AB_1854631" "unprognostic (4.26e-2)" "unprognostic (2.14e-1)" "unprognostic (3.42e-2)" "unprognostic (4.10e-2)" "unprognostic (3.04e-2)" "unprognostic (5.26e-2)" "unprognostic (2.30e-1)" "unprognostic (6.14e-2)" "unprognostic (8.63e-2)" "unprognostic (3.88e-2)" "unprognostic (1.60e-2)" "unprognostic (2.89e-1)" "unprognostic (2.39e-2)" "unprognostic (3.58e-2)" "unprognostic (3.43e-1)" "unprognostic (9.29e-3)" "unprognostic (1.11e-1)" 15.0 58.5 3.1 10.2 5.7 49.1 7.5 15.2 14.4 9.1 4.2 7.3 11.0 1.4 6.4 7.5 5.7 13.6 21.3 15.8 5.2 2.6 5.9 7.6 12.5 2.8 4.8 4.2 60.0 4.2 8.7 23.7 2.3 5.1 11.7 8.5 5.3 18.0 102.1 6.1 5.3 6.0 8.4 5.9 2.1 8.3 3.8 3.7 2.1 6.8 8.0 5.3 17.8 7.5 0.7 2.8 10.1 2.3 0.0 1.6 0.6 0.8 1.2 0.5 1.8 3.2 0.7 0.9 1.0 5.3 0.4 1.3 0.0 3.7 0.0 1.2 0.4 0.4 1.5 2.5 0.7 0.4 1.2 1.3 1.0 14.4 0.0 0.6 0.8 10.7 0.6 1.1 0.4 0.4 2.1 0.3 0.0 1.4 1.0 1.1 1.8 0.0 0.9 2.2 1.4 1.0 0.2 0.7 3.0 0.6 0.8 2.6 0.1 2.5 4.0 7.1 0.3 0.2 0.9 0.7 2.8 0.8 0.7 0.4 14.5 1.5 0.0 5.3 0.9 6.7 3.0 2.3 3.4 1.6 0.5 0.9 0.7 0.5 0.8 2.8 0.5 0.9 0.4 10.1 0.0 0.9 0.0 0.5 0.6 3.1 5.7 15.2 14.4 5.2 2.6 4.8 4.2 5.1 3.7 23.8 129.3 22.9 17.5 194.2 9.3 10.4 7.6 40.2 34.2 68.0 47.1 4.2 0.0 11.1 31.2 31.6 24.7 0.0 8.2 5.0 68.9 34.7 342.7 4.0 110.1 0.0 198.2 24.5 106.2 25.4 3.7 192.8 229.5 8.2 78.3 0.6 8.9 45.3 0.7 0.2 26.4 12.9 233.9 1.7 2.8 186.8 8.2 117.1 49.4 27.5 NR5A2 "B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1" ENSG00000116833 "Nuclear receptor subfamily 5 group A member 2" O00482 1 200027602-200177424 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "intestine: 38.7;liver: 36.1;pancreas: 100.4" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 35.9;Exocrine glandular cells: 46.6;Hepatocytes: 34.2;Ito cells: 46.1;Pancreatic endocrine cells: 31.2;Undifferentiated cells: 29.8" "Cancer enhanced" "Detected in many" "liver cancer: 6.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "A549: 19.7;HAP1: 12.0;HMC-1: 5.2;HUVEC TERT2: 16.5" "Region enhanced" "Detected in single" "hypothalamus: 1.5" "HPA005455, HPA017067" Approved Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA005455: AB_1078140, HPA017067: AB_1844767" "unprognostic (7.47e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-2)" "unprognostic (1.56e-2)" "unprognostic (1.19e-2)" "unprognostic (6.63e-3)" "unprognostic (4.46e-2)" "unprognostic (3.78e-2)" "unprognostic (3.34e-1)" "unprognostic (8.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.44e-1)" "unprognostic (1.00e-7)" "unprognostic (5.48e-2)" "unprognostic (5.07e-2)" "unprognostic (9.23e-2)" "unprognostic (1.37e-1)" 2.9 0.2 0.2 4.5 0.3 0.0 2.6 0.2 0.2 2.3 23.8 0.2 0.6 8.1 3.5 1.3 0.7 1.3 5.7 0.5 0.2 0.4 0.4 36.1 1.6 0.7 0.3 0.3 1.0 100.4 0.0 0.3 0.3 0.3 1.1 6.3 0.3 0.5 1.3 1.0 0.7 38.7 1.8 0.4 0.3 0.6 0.6 0.2 0.2 0.8 0.3 0.4 0.8 1.1 1.3 1.4 5.5 1.2 1.5 1.1 0.3 0.0 19.7 0.0 0.1 0.0 0.2 0.5 0.0 0.3 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.6 0.5 12.0 0.0 0.0 2.5 0.8 0.0 0.2 2.0 0.4 0.0 5.2 0.1 0.0 0.0 0.1 0.0 16.5 0.1 0.0 0.3 0.0 0.5 0.0 0.3 0.8 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.6 3.8 0.3 0.1 0.8 0.2 0.1 0.1 2.8 1.8 2.0 0.3 0.1 0.1 5.5 1.2 1.1 0.6 0.7 0.7 0.7 1.0 0.8 0.4 1.3 1.1 1.0 4.2 1.5 0.5 1.4 0.9 0.3 0.2 0.3 0.2 0.2 0.2 0.4 0.3 0.3 0.3 0.2 0.0 1.7 0.0 0.1 1.6 0.1 6.2 22.9 1.4 0.0 0.0 0.0 0.0 0.0 25.4 0.2 16.3 35.9 0.0 46.6 0.0 0.6 0.2 12.7 34.2 0.1 0.0 4.7 46.1 6.5 0.0 0.6 0.0 0.0 5.4 9.8 0.0 31.2 24.6 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.3 0.0 0.0 29.8 0.2 NSL1 "C1orf48, DC8, DKFZP566O1646, MIS14" ENSG00000117697 "NSL1, MIS12 kinetochore complex component" Q96IY1 1 212726153-212791782 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA045761, HPA053721" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA045761: AB_2679444, HPA053721: AB_2682240" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "unprognostic (8.08e-2)" "unprognostic (2.67e-2)" "unprognostic (2.58e-2)" "unprognostic (1.78e-2)" "unprognostic (8.22e-3)" "unprognostic (3.55e-1)" "unprognostic (4.78e-2)" "unprognostic (6.09e-3)" "unprognostic (3.44e-3)" "unprognostic (1.58e-1)" "unprognostic (3.10e-3)" "unprognostic (2.59e-1)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (6.66e-2)" 15.1 14.6 23.1 16.5 26.3 16.1 19.7 22.9 20.6 14.5 12.9 27.2 9.9 15.4 14.9 12.3 14.2 13.8 13.2 21.5 23.9 21.5 17.4 20.6 12.5 22.0 25.6 15.0 17.1 10.9 12.0 19.2 17.2 20.7 13.9 11.8 12.8 12.4 11.3 19.4 8.3 17.1 13.3 36.0 18.9 11.5 12.4 25.0 24.4 14.9 8.8 16.2 16.3 11.4 33.1 32.4 35.3 35.6 24.4 29.9 31.2 14.7 17.5 18.8 17.2 9.6 9.3 23.4 12.5 10.1 16.8 14.9 14.8 16.6 21.7 11.6 7.9 8.7 11.2 17.8 13.1 14.6 39.7 13.5 14.3 14.7 23.6 9.2 23.6 14.0 8.8 7.7 16.8 9.2 8.2 12.7 25.6 31.5 18.8 12.7 8.9 30.3 11.9 33.7 8.2 13.1 26.4 27.7 24.4 16.4 7.6 16.3 23.0 18.0 8.8 21.2 18.0 25.4 17.5 12.7 16.0 13.6 14.4 20.6 10.5 28.2 27.7 13.9 16.6 19.6 12.7 29.1 35.3 22.7 35.6 26.6 33.1 24.6 24.3 32.4 26.9 29.9 26.6 29.4 24.4 35.1 31.4 28.5 31.2 23.1 26.3 22.9 18.9 23.9 21.5 25.6 15.0 20.7 25.0 14.9 16.5 22.6 20.5 13.2 33.6 19.4 17.8 26.8 20.5 17.4 13.7 53.8 36.5 27.2 18.5 24.0 12.3 0.0 18.5 55.3 28.6 9.1 14.0 23.8 53.2 31.8 20.8 26.4 61.2 12.5 32.2 35.8 18.6 55.1 11.7 30.6 22.2 13.5 30.8 44.4 31.0 58.2 28.2 49.2 58.4 14.2 17.5 29.9 18.2 8.2 PARN DAN ENSG00000140694 "Poly(A)-specific ribonuclease" O95453 16 14435701-14632728 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006314, CAB011673, HPA012010" Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976" "unprognostic (2.54e-1)" "unprognostic (3.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.99e-3)" "unprognostic (5.07e-2)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.52e-1)" "unprognostic (3.25e-2)" "unprognostic (2.46e-1)" "unprognostic (3.10e-3)" "unprognostic (1.09e-2)" 19.4 25.9 14.9 23.5 19.1 12.5 19.8 16.8 23.5 21.3 21.0 22.7 23.3 14.4 24.6 29.0 19.0 19.4 22.5 18.4 15.4 19.0 17.9 18.9 26.7 31.6 22.2 17.9 21.8 22.7 37.4 26.0 21.9 21.0 21.4 21.8 21.0 18.9 31.0 19.2 21.0 18.8 28.7 18.3 20.1 19.6 25.4 19.6 29.4 27.8 14.0 26.8 25.6 19.3 16.1 15.6 13.3 14.8 15.0 17.8 11.0 11.9 14.1 7.4 9.4 12.4 14.3 8.6 10.2 14.3 12.7 12.2 7.8 11.1 21.4 25.9 11.7 9.6 13.0 17.1 11.5 17.6 18.1 10.1 14.7 9.8 17.4 13.0 17.4 14.6 12.9 14.4 11.4 16.3 9.6 8.5 11.9 12.5 12.1 12.3 14.8 17.5 11.3 10.1 9.4 8.5 23.2 16.8 21.5 8.6 8.4 9.3 6.7 20.8 11.3 14.1 10.8 11.9 10.1 7.8 12.4 6.5 6.7 10.4 12.3 13.1 26.1 13.6 12.8 13.6 11.9 11.1 13.3 13.5 14.8 13.9 16.1 13.1 15.5 15.6 13.9 17.8 17.8 7.2 15.0 14.3 10.8 14.7 11.0 14.9 19.1 16.8 23.5 15.4 19.0 22.2 17.9 21.0 19.6 29.8 30.8 16.1 7.2 6.4 12.1 17.3 10.2 29.4 14.8 10.4 7.9 25.3 10.0 12.5 8.9 13.5 10.5 0.0 11.2 19.3 10.4 6.8 2.3 9.9 12.9 7.9 14.3 12.3 13.1 5.8 19.5 11.7 10.1 28.9 14.8 10.0 12.3 12.2 16.6 8.4 9.1 19.4 9.2 30.7 62.8 7.2 18.8 11.3 12.5 3.9 PASD1 CT63 ENSG00000166049 "PAS domain containing repressor 1" Q8IV76 X 151563622-151676739 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 301 "testis: 30.0" "Cell type enriched" "Detected in some" 8 "Spermatogonia: 63.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 20.0;HMC-1: 31.8;U-266/84: 14.8" "HPA011122, HPA011152" Enhanced Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA011122: AB_1854990, HPA011152: AB_1854991" "unprognostic (3.34e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 8.0 63.0 0.0 0.0 0.0 0.0 0.0 PHYHD1 MGC16638 ENSG00000175287 "Phytanoyl-CoA dioxygenase domain containing 1" Q5SRE7 9 128920895-128942041 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 101.2;Muller glia cells: 104.5;Proximal tubular cells: 114.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 21.4;ASC TERT1: 15.3;BEWO: 23.4;HSkMC: 13.1;RPTEC TERT1: 35.3" "Low region specificity" "Detected in many" HPA012115 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA012115: AB_1859448" "unprognostic (1.18e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-3)" "unprognostic (2.16e-1)" "unprognostic (1.17e-2)" "unprognostic (4.49e-2)" "unprognostic (5.37e-3)" "unprognostic (1.35e-1)" "unprognostic (3.18e-1)" "unprognostic (1.86e-2)" "unprognostic (3.70e-2)" "prognostic favorable (6.38e-10)" "unprognostic (1.10e-2)" "unprognostic (3.09e-1)" "unprognostic (2.14e-1)" "unprognostic (9.83e-3)" 14.4 11.4 20.3 3.9 15.7 5.9 20.0 8.5 14.0 31.1 8.3 16.3 31.9 2.3 14.2 29.7 16.3 18.5 12.7 14.9 18.4 13.6 25.0 35.9 14.4 5.6 16.9 11.2 24.3 29.9 12.4 6.3 7.3 16.4 16.9 3.2 29.4 29.4 30.2 17.5 25.4 4.3 13.7 25.8 5.5 11.9 9.0 17.7 3.1 30.2 6.6 8.1 9.9 9.8 3.5 13.9 1.1 0.7 2.6 2.5 0.6 0.1 0.2 0.1 0.4 21.4 15.3 23.4 1.6 0.0 1.5 2.7 0.8 0.2 0.3 0.2 1.3 0.1 0.3 0.1 0.1 1.4 0.2 2.4 0.0 3.1 7.7 7.0 0.3 0.3 13.1 0.5 0.2 0.1 0.0 0.1 0.1 0.2 0.5 10.9 0.5 0.2 1.0 7.6 0.1 0.2 9.0 4.3 0.2 35.3 0.3 0.5 0.2 0.2 0.1 0.1 5.4 2.1 0.7 0.5 0.3 1.0 0.3 0.2 0.2 0.4 8.9 0.2 0.2 0.3 1.1 0.6 0.5 1.6 0.7 0.6 3.5 0.8 0.7 1.8 1.2 2.3 2.5 1.1 2.6 0.6 13.9 0.4 0.6 20.3 15.7 8.5 14.0 18.4 13.6 16.9 11.2 16.4 17.7 29.8 26.4 3.6 47.1 19.6 7.5 18.2 10.2 14.7 40.9 31.4 27.5 46.7 101.2 7.6 0.3 4.3 0.0 0.0 13.8 24.1 20.5 15.1 0.0 70.6 8.7 3.2 1.2 38.1 2.2 1.3 63.6 2.5 11.8 0.0 2.6 104.5 17.8 0.0 62.2 114.6 61.9 51.8 14.1 0.9 2.8 21.2 25.9 2.5 1.1 26.5 PLEKHN1 DKFZP434H2010 ENSG00000187583 "Pleckstrin homology domain containing N1" Q494U1 1 966497-975865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.5;lymphoid tissue: 21.2;skin 1: 31.3;tongue: 20.2" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 17.5;Glandular cells: 28.7;Pancreatic endocrine cells: 24.5;Suprabasal keratinocytes: 15.2;Urothelial cells: 37.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 11.3;HaCaT: 19.9;SK-BR-3: 13.6" "Not detected" "Not detected" HPA031742 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA031742: AB_10670704" "unprognostic (2.72e-3)" "unprognostic (8.05e-3)" "unprognostic (9.03e-2)" "unprognostic (4.47e-2)" "unprognostic (7.50e-4)" "unprognostic (2.93e-2)" "unprognostic (1.38e-2)" "unprognostic (1.78e-1)" "unprognostic (3.24e-1)" "unprognostic (1.01e-2)" "unprognostic (2.58e-3)" "unprognostic (2.08e-2)" "prognostic unfavorable (4.97e-5)" "unprognostic (9.98e-2)" "unprognostic (1.96e-1)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" 0.4 0.6 0.0 1.8 0.2 0.4 1.4 0.0 0.1 7.7 0.9 0.0 0.0 0.8 1.1 2.7 31.5 0.3 5.0 0.5 0.3 0.0 2.3 0.8 1.1 0.3 0.0 0.0 0.1 0.5 0.3 0.0 1.5 0.0 3.7 0.2 0.3 5.3 1.2 1.5 31.3 0.7 0.6 0.6 0.5 1.7 0.8 0.0 0.2 0.7 20.2 21.2 6.0 10.6 0.0 0.3 2.0 0.9 2.3 1.1 0.2 11.3 1.2 0.0 0.8 0.0 0.6 1.9 5.3 1.3 3.4 0.8 1.5 8.8 0.0 2.5 2.1 4.5 19.9 0.2 3.3 0.5 3.9 0.8 0.0 3.5 2.3 0.5 0.2 0.1 0.1 2.8 2.2 1.2 2.9 0.3 0.0 0.2 3.2 0.2 6.6 0.0 0.2 0.4 1.6 9.1 0.0 0.0 4.2 3.7 3.4 0.1 0.1 5.9 13.6 0.8 0.3 2.6 0.0 2.4 4.3 1.9 0.4 3.5 2.6 0.1 0.1 5.2 1.9 2.4 0.0 0.9 2.0 0.3 0.3 0.0 0.0 0.5 1.1 0.3 0.0 0.2 0.0 0.0 2.3 0.1 0.0 0.8 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.9 17.5 4.0 0.1 0.8 0.0 1.4 1.2 0.0 0.0 5.9 0.0 11.4 0.0 0.6 0.0 0.0 12.2 1.5 0.6 28.7 0.0 0.0 1.0 3.2 0.0 0.0 0.8 0.0 0.0 1.4 1.7 1.8 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 15.2 8.2 2.5 0.0 37.9 PNN memA ENSG00000100941 "Pinin, desmosome associated protein" Q9H307 14 39175183-39183218 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001378 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA001378: AB_1079648" "unprognostic (9.28e-3)" "unprognostic (5.07e-2)" "unprognostic (5.46e-2)" "unprognostic (3.91e-1)" "unprognostic (7.38e-3)" "unprognostic (7.40e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (1.65e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.51e-3)" "unprognostic (1.25e-1)" "unprognostic (1.53e-1)" "unprognostic (1.00e-1)" "unprognostic (4.30e-2)" 21.7 25.3 38.9 38.4 50.8 57.5 26.1 54.3 39.3 31.0 30.0 26.4 34.6 27.9 40.4 66.6 29.5 29.6 21.6 19.1 40.1 18.4 27.3 45.7 24.2 40.7 43.9 31.2 36.6 31.3 31.3 61.3 26.7 44.8 33.9 32.0 18.7 26.7 24.5 37.7 27.0 36.0 34.7 49.1 42.6 26.9 21.7 50.4 32.7 37.1 25.9 32.8 28.4 39.9 20.8 15.8 20.4 10.5 10.6 13.5 3.9 32.7 15.7 42.9 21.1 10.0 8.8 31.6 26.2 7.3 18.1 17.4 25.0 51.5 50.6 16.7 11.4 14.3 34.5 32.5 17.8 31.4 22.8 23.1 33.6 47.4 55.1 8.3 43.5 24.6 12.0 15.6 16.4 13.7 24.9 11.5 23.7 31.8 28.5 14.8 26.9 30.7 37.2 28.5 15.5 23.1 40.8 32.1 13.6 14.8 50.0 21.4 12.0 27.0 20.7 15.1 30.6 25.5 25.1 21.2 26.4 20.9 12.2 30.7 23.4 18.6 43.6 13.2 36.1 15.6 5.1 10.2 15.1 13.2 8.0 12.2 14.8 9.0 8.0 8.3 20.8 13.5 12.3 20.4 10.6 10.5 15.8 9.7 3.9 38.9 50.8 54.3 39.3 40.1 18.4 43.9 31.2 44.8 50.4 178.6 96.5 96.3 183.3 112.1 191.9 51.8 48.4 160.6 229.7 57.6 53.0 93.2 29.9 72.1 36.1 84.5 90.7 23.3 50.2 81.5 78.0 127.1 138.6 57.2 54.3 144.6 130.6 65.1 58.9 40.6 144.7 95.9 47.2 56.9 56.4 137.8 66.8 81.6 142.5 18.8 174.1 148.8 92.4 180.7 144.8 97.9 83.3 132.0 84.8 194.6 POLR3B "FLJ10388, RPC2" ENSG00000013503 "RNA polymerase III subunit B" Q9NW08 12 106357658-106510198 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Nucleotidyltransferase, Transferase" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036466 Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036466: AB_10671842" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (4.80e-2)" "unprognostic (1.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.73e-1)" "unprognostic (4.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.33e-1)" "unprognostic (3.36e-2)" "unprognostic (6.11e-2)" "unprognostic (5.09e-2)" "prognostic favorable (1.21e-4)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" 6.4 14.0 7.1 7.9 14.6 6.5 6.9 8.6 13.6 8.6 7.2 8.2 5.7 6.0 10.1 7.2 14.8 7.7 5.8 8.2 8.9 7.1 9.9 17.5 7.1 11.4 6.2 10.4 11.3 11.9 22.5 17.0 22.9 12.3 8.0 8.3 6.2 8.6 9.9 12.1 15.3 5.7 7.8 6.0 6.4 7.5 9.9 4.7 10.3 8.5 10.2 10.0 7.3 10.1 4.3 4.9 9.8 4.1 3.7 6.3 3.1 11.2 5.3 11.9 5.7 10.6 9.7 16.6 15.9 9.5 11.0 8.5 9.8 3.1 14.4 5.7 9.8 4.1 10.5 13.8 13.5 13.7 11.6 9.2 11.5 7.1 8.3 6.8 18.1 12.4 8.6 9.7 11.0 12.8 7.8 8.1 7.0 16.8 4.7 8.4 8.3 13.1 6.0 12.9 8.2 20.1 8.0 7.1 9.4 6.2 15.4 12.9 7.0 9.7 13.0 9.3 8.3 12.2 5.4 7.8 6.1 7.1 9.8 9.1 5.9 15.0 21.4 3.0 11.2 6.5 9.8 3.9 2.6 4.1 4.1 5.5 4.3 4.5 4.3 4.9 2.6 6.3 3.9 2.6 3.7 4.0 1.8 4.7 3.1 7.1 14.6 8.6 13.6 8.9 7.1 6.2 10.4 12.3 4.7 0.0 8.6 0.0 1.6 1.5 5.6 8.7 2.5 9.4 9.1 5.2 5.9 8.2 1.7 4.3 5.3 2.9 2.7 0.0 4.0 7.9 3.1 1.0 4.7 10.2 2.7 3.2 4.1 3.1 1.2 3.1 3.4 1.7 3.3 0.0 5.7 2.5 3.6 0.0 4.6 2.7 6.8 6.5 2.1 6.7 9.8 2.6 6.2 1.7 4.9 0.8 POMP "C13orf12, HSPC014, UMP1" ENSG00000132963 "Proteasome maturation protein" Q9Y244 13 28659104-28678925 "Disease related genes, Predicted intracellular proteins" Chaperone "Ichthyosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026995 Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA026995: AB_1845546" "unprognostic (2.00e-1)" "unprognostic (3.56e-2)" "unprognostic (2.26e-1)" "unprognostic (3.15e-1)" "unprognostic (8.58e-2)" "prognostic unfavorable (2.05e-5)" "unprognostic (2.71e-3)" "unprognostic (2.50e-2)" "unprognostic (9.90e-2)" "unprognostic (4.35e-2)" "unprognostic (4.83e-2)" "unprognostic (4.93e-1)" "unprognostic (1.39e-3)" "unprognostic (1.70e-2)" "unprognostic (9.41e-2)" "unprognostic (1.03e-2)" "unprognostic (9.81e-2)" 35.4 31.5 44.5 29.3 37.7 27.4 28.8 21.1 38.2 24.2 32.2 17.7 19.6 27.5 21.1 41.4 30.1 20.3 22.9 52.7 38.4 36.3 38.6 58.4 27.8 28.4 48.2 32.1 18.5 22.9 11.7 21.9 48.4 38.1 23.5 33.9 18.0 20.4 26.7 68.2 20.6 35.0 28.3 40.4 31.5 24.1 32.5 29.2 31.3 30.9 44.7 33.0 29.3 19.9 36.7 62.7 38.5 57.3 24.9 35.9 41.6 22.6 28.0 29.9 34.8 34.6 38.9 27.9 52.2 46.6 52.7 42.2 54.8 51.9 40.2 31.9 40.4 56.4 34.0 39.2 40.7 72.0 30.3 30.1 37.8 30.4 41.9 48.0 45.6 31.5 31.2 42.5 37.9 35.3 28.5 41.5 31.7 48.0 16.5 67.2 40.1 38.4 65.3 51.6 71.7 33.3 37.2 45.7 27.0 59.3 35.9 35.2 27.1 23.4 33.7 35.2 39.2 23.4 53.4 37.3 25.2 25.7 39.7 43.2 14.1 25.3 56.8 30.0 31.0 55.0 31.8 45.5 27.3 30.2 57.3 26.3 36.5 31.1 33.6 53.9 36.7 22.1 31.5 38.5 24.9 56.1 62.7 35.9 41.6 44.5 37.7 21.1 38.2 38.4 36.3 48.2 32.1 38.1 29.2 122.1 115.5 270.4 282.6 363.9 101.9 740.4 226.7 153.9 125.1 226.8 51.1 560.5 509.0 542.7 892.7 432.2 372.1 163.5 606.8 753.5 389.5 266.1 203.1 510.9 696.1 92.2 219.6 444.4 419.3 306.8 186.1 393.6 285.1 776.3 226.2 178.3 612.1 277.0 219.6 724.0 93.7 316.9 484.0 392.4 243.8 363.9 813.2 219.9 266.1 411.3 PPIE "CyP-33, MGC111222, MGC3736" ENSG00000084072 "Peptidylprolyl isomerase E" Q9UNP9 1 39692182-39763914 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Isomerase, RNA-binding, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019357, HPA020131" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA019357: AB_2670131, HPA020131: AB_1847405" "unprognostic (2.94e-1)" "unprognostic (4.32e-2)" "unprognostic (6.34e-2)" "unprognostic (6.97e-2)" "unprognostic (5.99e-2)" "unprognostic (8.41e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.52e-2)" "unprognostic (2.69e-1)" "unprognostic (3.88e-3)" "unprognostic (1.25e-1)" "unprognostic (9.29e-2)" "prognostic unfavorable (5.05e-5)" "unprognostic (5.86e-2)" "unprognostic (3.95e-1)" "unprognostic (9.06e-2)" "unprognostic (1.00e-1)" 19.3 23.8 23.7 24.3 22.5 18.6 25.7 25.9 36.1 25.5 28.1 35.6 22.2 19.7 30.6 26.5 26.0 34.7 21.1 27.1 22.3 22.1 25.2 29.8 20.6 25.9 26.3 20.5 35.5 42.1 27.4 23.6 21.9 24.9 26.1 22.7 26.9 30.7 28.9 29.6 21.7 23.2 34.2 25.6 25.7 23.9 38.8 20.2 22.8 33.7 21.9 33.9 31.5 22.6 43.3 31.6 14.1 27.2 49.0 46.9 44.2 9.8 17.1 15.7 12.6 17.5 15.6 8.3 17.0 17.1 26.0 24.5 21.3 29.2 28.0 24.1 19.0 16.7 15.1 21.5 25.2 24.8 18.1 23.2 30.9 19.8 6.4 24.0 27.8 16.9 14.1 23.1 24.4 9.0 18.9 23.3 25.0 31.3 19.6 18.9 17.7 12.8 22.6 18.8 23.3 19.1 19.0 11.8 15.9 19.6 18.4 22.4 17.9 17.8 14.5 12.3 19.4 18.2 73.1 15.1 16.3 18.1 20.2 26.0 26.9 26.9 19.4 11.3 35.9 25.6 11.6 27.1 14.1 38.3 27.0 37.0 43.3 39.7 38.2 31.6 39.8 46.9 38.9 2.2 49.0 27.2 28.5 40.0 44.2 23.7 22.5 25.9 36.1 22.3 22.1 26.3 20.5 24.9 20.2 29.8 27.1 41.2 35.7 22.0 24.9 29.6 17.8 64.3 56.9 31.4 13.7 54.2 56.3 49.6 25.8 24.5 23.9 0.0 42.1 51.6 34.0 28.9 54.3 27.6 48.7 22.3 27.6 25.8 36.1 47.7 27.6 34.0 37.1 53.3 28.0 35.4 38.6 28.1 42.5 54.9 25.9 58.2 41.0 62.7 44.8 23.1 29.1 40.6 33.0 29.5 PQBP1 "MRX2, MRX55, MRXS3, MRXS8, RENS1, SHS" ENSG00000102103 "Polyglutamine binding protein 1" O60828 X 48897912-48903143 "Disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001880 Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA001880: AB_1079671" "unprognostic (7.25e-2)" "prognostic favorable (1.48e-4)" "unprognostic (5.98e-2)" "unprognostic (2.09e-2)" "unprognostic (2.73e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.09e-2)" "unprognostic (1.10e-1)" "unprognostic (7.48e-2)" "unprognostic (4.33e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.68e-7)" "unprognostic (2.68e-1)" "unprognostic (2.52e-3)" "unprognostic (3.97e-2)" "unprognostic (5.70e-3)" 24.8 35.3 29.2 22.4 28.5 34.8 28.3 30.3 35.0 27.4 31.9 25.9 23.9 35.6 34.9 22.6 26.9 29.0 25.3 23.5 25.8 30.8 24.8 34.7 20.5 24.7 27.9 25.6 38.8 37.1 21.3 30.2 19.5 26.5 26.0 18.9 27.2 33.6 27.3 43.3 31.9 31.7 29.6 25.3 25.6 27.4 13.6 25.8 31.7 33.8 23.1 27.7 26.6 32.5 32.3 36.7 20.5 30.6 27.7 41.3 27.6 28.7 35.4 19.0 18.4 16.7 11.8 14.4 16.9 19.8 34.1 21.3 42.3 12.8 26.4 14.2 11.3 26.0 22.5 32.0 12.6 13.2 23.1 27.6 22.9 27.7 30.3 16.7 26.9 20.6 15.4 23.6 28.1 28.5 13.8 18.7 10.2 21.5 50.1 14.7 46.7 11.5 27.0 17.7 19.7 38.8 19.2 19.1 59.9 21.1 19.0 28.4 15.2 22.1 24.6 18.6 14.9 30.4 20.7 17.2 15.5 27.3 19.2 22.3 29.5 29.9 19.8 8.8 25.4 16.0 14.5 30.6 20.5 23.2 29.6 30.3 32.3 32.1 23.1 36.7 26.3 32.5 30.1 8.4 27.7 26.3 31.6 41.3 27.6 29.2 28.5 30.3 35.0 25.8 30.8 27.9 25.6 26.5 25.8 38.7 63.6 71.5 66.1 99.4 35.7 35.0 40.8 44.2 46.6 29.6 11.8 49.7 41.4 56.1 4.9 56.2 114.2 46.7 82.8 48.6 67.9 49.5 70.3 38.4 61.3 17.5 67.3 31.3 75.5 3.4 64.7 71.8 84.4 117.2 55.4 32.9 62.7 136.8 41.1 89.1 22.4 38.8 85.5 2.3 13.8 102.6 45.7 50.4 57.2 58.3 PRCC RCCP1 ENSG00000143294 "Papillary renal cell carcinoma (translocation-associated)" Q92733 1 156750610-156800817 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017151, HPA019463, HPA019481" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673" "unprognostic (6.12e-2)" "unprognostic (2.68e-1)" "unprognostic (2.68e-3)" "prognostic unfavorable (5.55e-4)" "unprognostic (3.19e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (8.63e-4)" "unprognostic (3.03e-1)" "unprognostic (9.16e-2)" "unprognostic (3.27e-3)" "unprognostic (1.14e-1)" "unprognostic (6.80e-2)" "prognostic unfavorable (8.99e-15)" "unprognostic (1.72e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.02e-2)" 31.3 24.9 28.5 25.8 29.7 33.7 23.7 33.2 43.5 29.8 30.0 35.9 21.8 24.6 35.1 22.8 30.3 25.6 28.7 23.8 28.0 24.5 26.1 33.1 22.0 30.1 22.1 25.2 30.1 23.7 31.0 22.7 38.8 22.6 25.6 21.5 25.6 37.2 24.0 47.4 33.6 30.1 25.7 20.4 29.7 24.1 26.2 19.2 51.9 27.5 29.8 30.7 25.4 23.8 21.4 27.1 36.9 23.1 19.3 22.1 16.9 20.1 17.4 13.8 15.8 11.6 9.2 24.0 14.1 13.8 15.7 13.6 27.3 17.0 20.7 24.4 11.1 9.1 21.0 19.6 14.8 12.3 25.8 25.6 15.1 12.9 17.6 14.3 20.8 17.9 13.0 17.2 13.7 12.5 12.3 14.4 13.7 24.9 19.3 11.0 35.9 23.7 24.4 33.3 28.1 21.7 20.8 12.2 27.8 16.5 19.4 24.5 43.8 14.9 37.6 23.3 23.7 27.0 33.5 13.2 16.0 16.8 17.6 23.1 49.7 74.3 32.0 15.8 13.5 14.8 26.9 20.0 36.9 20.5 20.6 19.6 18.0 18.5 22.1 22.4 21.4 18.4 18.9 19.3 19.3 23.1 27.1 18.5 16.9 28.5 29.7 33.2 43.5 28.0 24.5 22.1 25.2 22.6 19.2 8.9 16.0 27.9 32.9 46.5 17.3 10.6 20.4 12.0 15.9 19.2 21.6 54.4 18.3 35.7 5.8 27.0 25.1 0.0 28.1 52.6 29.2 25.0 16.2 15.3 37.9 27.0 33.0 23.4 18.7 7.1 28.1 25.4 20.3 51.3 23.1 16.5 29.8 27.4 26.9 23.7 16.8 32.3 32.5 33.6 48.1 44.8 84.6 34.1 27.7 31.8 PRDM7 ZNF910 ENSG00000126856 "PR/SET domain 7" Q9NQW5 16 90056566-90092072 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 4.8" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 1.4;Cardiomyocytes: 5.0;Ciliated cells: 2.7" "Cancer enriched" "Detected in single" 30 "melanoma: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "REH: 9.1;SK-MEL-30: 6.7" HPA059944 Approved Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA059944: AB_2684174" "unprognostic (3.98e-1)" "unprognostic (8.89e-2)" "unprognostic (8.02e-3)" "unprognostic (8.26e-2)" "unprognostic (9.01e-2)" "unprognostic (5.61e-3)" "unprognostic (1.05e-2)" "unprognostic (1.46e-1)" "unprognostic (5.73e-1)" "unprognostic (5.52e-4)" "unprognostic (1.36e-1)" "unprognostic (1.61e-1)" "unprognostic (4.03e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 PRPF19 "hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4" ENSG00000110107 "Pre-mRNA processing factor 19" Q9UMS4 11 60890730-60906588 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012448, HPA038051, HPA059070" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896" "unprognostic (5.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-1)" "unprognostic (2.68e-1)" "unprognostic (4.51e-2)" "unprognostic (1.18e-2)" "prognostic unfavorable (4.11e-8)" "unprognostic (1.03e-1)" "unprognostic (2.13e-1)" "unprognostic (9.37e-3)" "unprognostic (9.53e-2)" "unprognostic (1.54e-1)" "unprognostic (6.70e-2)" "unprognostic (9.62e-2)" "unprognostic (7.12e-2)" "unprognostic (9.04e-2)" "unprognostic (3.41e-3)" 20.5 32.2 33.6 27.0 37.9 32.0 28.9 49.6 61.8 30.4 30.6 21.3 24.5 24.2 27.1 21.4 36.7 34.9 20.1 18.0 32.8 46.3 21.5 39.4 18.0 33.1 35.0 50.0 41.3 31.3 45.7 37.6 24.9 46.2 37.7 31.5 21.5 28.8 30.9 31.9 39.0 24.6 28.8 23.7 28.3 23.7 15.2 24.4 46.3 25.3 24.4 41.7 24.8 24.8 3.1 5.3 4.4 11.8 2.4 3.3 1.2 43.7 34.2 38.4 27.4 22.6 19.8 34.9 23.8 32.4 47.9 36.0 37.5 33.0 63.4 32.1 22.8 28.7 40.1 54.0 42.9 37.3 43.2 34.5 52.7 27.1 40.3 32.7 69.6 37.6 21.0 32.7 36.8 41.5 14.0 37.1 38.9 52.3 36.7 23.4 61.6 70.3 52.4 67.9 34.5 46.1 62.5 39.3 49.6 24.2 28.7 32.8 39.5 29.5 49.1 39.7 18.3 51.3 38.6 23.2 21.2 34.2 36.9 38.4 32.8 45.9 63.8 26.4 47.8 31.9 4.4 11.8 2.6 3.2 5.4 2.6 1.3 2.6 2.3 4.8 3.1 3.3 3.0 0.7 2.4 2.9 5.3 2.2 1.2 33.6 37.9 49.6 61.8 32.8 46.3 35.0 50.0 46.2 24.4 17.9 21.3 32.2 30.9 37.4 31.5 14.9 17.8 18.7 26.1 26.2 9.8 75.0 23.2 33.3 15.9 20.3 20.2 23.3 44.7 70.4 22.6 29.5 22.0 40.0 40.5 58.8 37.5 16.5 27.1 2.7 34.2 21.5 25.3 47.7 32.9 24.1 30.9 24.6 36.4 22.4 22.1 45.3 22.3 18.4 35.8 36.4 34.0 23.8 47.8 26.8 PRPF4 "HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60" ENSG00000136875 "Pre-mRNA processing factor 4" O43172 9 113275343-113292905 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021794, HPA022248" Enhanced Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA021794: AB_1855772, HPA022248: AB_1855773" "unprognostic (1.70e-2)" "unprognostic (6.51e-2)" "unprognostic (3.60e-2)" "unprognostic (1.36e-1)" "unprognostic (1.69e-1)" "unprognostic (3.70e-3)" "prognostic unfavorable (9.35e-4)" "unprognostic (1.95e-2)" "unprognostic (6.57e-2)" "unprognostic (3.14e-2)" "unprognostic (5.00e-2)" "unprognostic (6.76e-3)" "unprognostic (2.18e-3)" "unprognostic (4.43e-2)" "unprognostic (1.29e-1)" "unprognostic (1.42e-1)" "unprognostic (1.57e-2)" 16.4 20.9 13.8 23.8 17.4 18.4 21.7 19.4 23.2 15.2 15.7 14.4 20.0 13.4 18.9 28.6 22.9 17.8 17.6 16.8 15.3 13.9 21.5 24.3 15.2 19.6 12.4 19.2 24.3 22.7 19.1 19.6 17.2 19.0 20.6 17.6 13.9 16.8 19.7 26.1 21.8 14.7 21.1 14.4 18.7 15.9 16.6 12.6 21.8 16.5 18.2 23.1 18.0 24.6 16.5 19.9 18.1 21.7 17.0 17.9 13.7 12.8 22.0 14.7 16.1 10.4 10.7 14.9 20.1 10.1 22.2 16.4 21.4 12.0 26.7 11.9 10.9 22.9 29.6 30.7 17.7 25.1 18.9 11.5 13.6 19.2 15.7 9.5 23.8 12.5 7.7 12.1 23.2 22.5 8.3 10.6 15.0 23.2 14.9 18.9 20.0 22.3 17.1 23.3 33.6 24.3 20.8 35.2 18.4 9.7 10.5 19.3 13.1 29.5 16.0 9.3 12.4 24.9 12.4 10.4 18.1 13.7 23.3 25.6 19.1 51.7 26.3 14.0 15.4 23.2 18.1 15.8 15.1 15.2 19.3 17.9 16.5 15.2 13.8 19.9 16.4 15.5 15.3 5.3 17.0 21.7 13.1 13.6 13.7 13.8 17.4 19.4 23.2 15.3 13.9 12.4 19.2 19.0 12.6 8.9 17.3 24.5 12.9 14.0 20.0 12.5 7.6 18.7 18.2 17.4 17.7 21.3 21.6 13.9 13.3 9.0 4.7 0.0 14.7 27.7 14.9 9.8 18.5 8.1 16.2 27.0 16.8 6.2 10.2 10.2 10.6 17.5 5.0 31.5 12.7 22.1 12.2 10.5 10.3 13.2 22.1 0.0 15.6 28.3 21.0 16.4 18.0 11.4 12.0 12.5 PRPF40A "FBP-11, FBP11, FLAF1, FLJ20585, FNBP3, HIP10, HYPA, NY-REN-6, Prp40" ENSG00000196504 "Pre-mRNA processing factor 40 homolog A" O75400 2 152651593-152717997 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038272, HPA038273" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA038272: AB_2675923, HPA038273: AB_10671526" "unprognostic (1.81e-1)" "unprognostic (2.91e-1)" "unprognostic (4.31e-3)" "unprognostic (4.49e-3)" "unprognostic (1.55e-3)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (4.62e-2)" "unprognostic (3.61e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.58e-5)" "unprognostic (1.03e-1)" "prognostic unfavorable (5.89e-4)" "unprognostic (1.80e-2)" "unprognostic (2.32e-1)" "unprognostic (3.24e-2)" "unprognostic (2.05e-2)" 22.8 21.5 18.8 25.6 21.7 36.6 22.3 30.0 21.3 23.2 24.8 13.0 19.0 22.2 25.1 20.6 28.8 20.3 17.1 16.8 21.1 14.3 26.0 31.1 21.8 27.0 25.2 15.6 24.5 21.1 25.3 30.8 28.4 21.4 23.0 20.7 11.5 23.4 23.3 32.7 25.4 27.0 18.6 24.4 30.5 21.3 25.7 28.7 48.6 24.7 25.7 26.0 24.6 22.8 41.3 50.9 53.3 55.6 39.5 43.4 40.5 21.1 21.2 23.8 24.3 13.9 18.7 33.3 21.0 18.7 29.8 27.6 39.5 20.0 44.4 31.1 21.2 17.1 21.7 31.1 25.2 32.3 24.4 26.2 40.6 19.6 26.4 18.0 44.7 28.5 14.8 21.6 39.7 45.3 18.6 23.0 20.7 43.3 20.9 18.3 12.7 18.9 20.4 35.7 14.0 25.4 36.7 25.3 28.9 15.2 34.1 29.7 19.8 25.1 18.5 23.1 18.5 16.3 28.1 27.0 31.9 19.9 18.0 27.0 13.7 21.8 44.8 20.2 26.3 19.2 45.0 42.2 53.3 43.1 51.7 39.5 39.9 40.1 38.6 47.7 41.3 43.4 38.5 37.8 39.5 55.6 50.9 34.4 40.5 18.8 21.7 30.0 21.3 21.1 14.3 25.2 15.6 21.4 28.7 104.2 99.8 88.1 94.9 125.2 58.8 55.1 58.6 190.1 119.4 50.6 68.7 107.5 41.4 89.9 82.8 82.9 56.4 0.0 97.3 130.2 70.2 81.3 119.1 61.8 96.5 57.2 75.1 47.3 85.8 22.4 64.2 103.4 52.3 193.8 67.9 60.9 100.1 84.3 75.0 58.5 66.2 97.0 82.4 214.0 123.3 132.6 110.5 92.4 83.7 122.9 PRPF4B "KIAA0536, PR4H, Prp4" ENSG00000112739 "Pre-mRNA processing factor 4B" Q13523 6 4021267-4064983 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020638 Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA020638: AB_1855774" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (4.95e-2)" "unprognostic (2.20e-1)" "unprognostic (3.59e-3)" "unprognostic (1.21e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (8.68e-3)" "unprognostic (3.41e-2)" "unprognostic (4.45e-3)" "unprognostic (2.17e-1)" "unprognostic (1.07e-1)" "unprognostic (9.50e-3)" "unprognostic (8.90e-2)" "unprognostic (2.34e-1)" "unprognostic (7.63e-3)" "prognostic favorable (6.82e-5)" 23.2 21.6 19.6 24.0 20.5 8.5 21.4 35.6 26.8 18.3 19.3 6.0 14.7 12.0 22.2 14.2 23.6 14.7 13.6 16.3 16.5 11.7 15.0 14.5 13.0 15.4 14.5 14.1 19.1 14.4 20.9 30.9 17.1 21.0 14.9 15.7 5.3 22.7 20.4 45.7 16.3 16.4 14.9 23.7 19.0 13.6 11.6 20.2 21.8 21.1 11.3 17.4 21.4 22.2 9.7 13.6 7.5 11.9 11.8 9.1 3.9 14.7 12.8 20.2 13.8 11.5 10.7 9.8 14.3 15.7 15.6 15.8 12.2 7.5 24.1 18.0 16.1 12.8 13.2 25.4 12.4 22.5 11.3 18.6 27.1 14.7 10.9 8.8 29.9 14.8 9.7 8.2 11.1 6.9 7.6 15.5 11.8 37.1 8.9 15.3 8.6 21.9 10.0 12.1 12.9 11.9 24.9 19.5 23.4 10.0 16.6 15.7 10.3 16.6 10.4 12.6 16.8 16.2 15.0 16.6 15.4 8.9 10.1 13.8 10.1 15.8 28.1 8.4 13.7 18.7 7.5 11.9 3.6 7.6 9.9 9.1 9.7 8.6 9.0 10.2 9.3 8.0 8.0 6.1 11.8 8.7 13.6 6.3 3.9 19.6 20.5 35.6 26.8 16.5 11.7 14.5 14.1 21.0 20.2 101.3 91.8 89.2 53.8 74.1 81.8 69.0 61.1 89.7 101.2 92.5 84.4 51.4 61.3 56.7 8.7 82.4 58.2 46.7 49.5 40.6 50.2 53.8 86.8 76.7 36.1 100.1 72.3 68.2 59.0 11.9 91.5 57.7 33.7 71.3 57.5 80.9 52.5 57.5 83.8 50.1 181.0 58.2 43.9 67.7 79.4 79.8 53.2 69.3 57.5 63.7 PRPF6 "ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, RP60, SNRNP102, TOM, U5-102K" ENSG00000101161 "Pre-mRNA processing factor 6" O94906 20 63981135-64033100 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047106 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA047106: AB_10963084" "unprognostic (1.29e-1)" "unprognostic (9.96e-3)" "unprognostic (7.02e-2)" "unprognostic (9.36e-3)" "unprognostic (1.80e-1)" "unprognostic (2.34e-1)" "unprognostic (1.66e-3)" "unprognostic (3.37e-2)" "unprognostic (1.44e-2)" "unprognostic (1.14e-1)" "unprognostic (5.76e-3)" "unprognostic (2.18e-1)" "unprognostic (3.16e-3)" "unprognostic (6.16e-2)" "unprognostic (8.04e-2)" "unprognostic (7.19e-2)" "unprognostic (5.39e-3)" 31.5 26.3 28.3 25.0 35.2 25.0 31.4 66.3 46.7 30.1 26.9 43.7 20.8 25.9 37.0 28.9 29.3 44.6 30.3 28.8 26.8 27.6 25.7 25.8 27.9 31.6 28.7 31.0 46.5 33.7 40.5 30.8 29.8 30.1 29.5 23.3 32.3 33.0 34.5 49.3 49.1 27.7 34.2 31.4 32.7 27.6 41.5 30.5 43.8 31.2 28.4 34.4 31.6 27.1 30.1 25.0 31.9 30.4 51.7 44.3 33.8 20.3 24.8 18.2 19.3 20.9 14.7 23.9 16.1 18.2 49.5 22.2 66.3 24.9 25.7 39.4 21.3 31.6 31.7 29.3 33.4 26.4 12.3 17.0 21.6 33.1 59.8 23.1 29.3 30.2 16.6 23.8 22.7 26.5 17.7 18.3 24.2 21.0 22.3 16.4 25.0 29.5 36.7 16.2 32.3 31.0 32.6 15.5 24.5 18.8 20.5 18.2 21.3 31.2 32.1 20.5 13.3 31.4 38.2 25.8 28.6 16.4 22.6 29.5 18.7 18.2 27.2 20.8 17.7 22.0 31.9 25.3 30.1 30.1 26.7 42.1 30.1 37.3 32.4 25.0 26.3 44.3 36.9 21.5 51.7 30.4 23.2 32.7 33.8 28.3 35.2 66.3 46.7 26.8 27.6 28.7 31.0 30.1 30.5 56.6 60.0 45.4 39.6 34.1 76.2 59.7 30.6 108.4 84.2 59.3 35.3 62.7 69.6 45.6 30.3 53.9 45.5 23.3 49.2 40.2 40.3 24.2 87.9 44.7 41.5 39.7 50.6 49.1 39.5 18.5 53.8 46.3 45.5 71.3 52.7 85.0 52.9 37.6 49.5 47.7 97.6 58.2 48.1 92.8 103.3 40.5 79.1 42.6 40.2 32.0 PYROXD1 "DKFZp762G094, FLJ22028" ENSG00000121350 "Pyridine nucleotide-disulphide oxidoreductase domain 1" Q8WU10 12 21437615-21471252 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 137.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038319, HPA038320" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA038319: AB_10669522, HPA038320: AB_2675956" "unprognostic (1.48e-1)" "unprognostic (1.68e-1)" "unprognostic (1.15e-2)" "unprognostic (9.89e-2)" "unprognostic (1.51e-1)" "unprognostic (2.64e-3)" "unprognostic (1.50e-1)" "unprognostic (9.31e-2)" "unprognostic (8.94e-3)" "unprognostic (1.17e-2)" "unprognostic (1.57e-1)" "unprognostic (3.32e-2)" "unprognostic (1.06e-2)" "unprognostic (3.78e-2)" "unprognostic (2.30e-2)" "unprognostic (2.00e-1)" "prognostic favorable (1.70e-4)" 12.7 10.8 6.2 8.5 7.6 7.5 10.4 9.4 10.1 12.2 22.2 5.1 11.7 13.6 9.3 11.2 18.1 8.2 9.2 10.3 6.2 7.6 22.7 32.3 8.3 11.2 8.9 7.5 11.2 15.7 8.8 7.9 9.0 10.6 10.2 11.4 7.6 14.3 13.0 18.9 9.7 26.1 17.2 11.5 9.1 12.3 7.5 6.5 6.8 15.8 12.7 8.1 10.2 8.1 3.0 2.6 2.1 5.8 3.8 5.2 2.1 6.6 2.5 3.8 4.2 2.8 5.2 8.9 10.3 4.9 3.9 3.0 3.2 6.3 7.2 4.4 7.8 3.3 8.3 4.2 8.2 4.4 8.5 3.6 8.5 6.9 4.0 13.1 12.5 8.9 8.5 10.0 2.4 10.7 5.0 5.7 7.8 3.9 3.1 7.8 4.1 5.8 17.3 6.5 5.7 4.7 1.0 8.3 8.0 12.1 6.7 1.2 9.6 4.9 9.0 18.9 5.7 10.7 15.0 7.5 4.7 4.5 9.7 9.5 4.6 3.2 9.1 18.9 9.4 5.5 2.1 2.0 1.3 4.5 3.3 4.8 3.0 5.0 5.2 1.9 2.5 4.2 4.3 0.9 3.8 5.8 2.6 3.8 2.1 6.2 7.6 9.4 10.1 6.2 7.6 8.9 7.5 10.6 6.5 11.9 27.9 6.5 9.0 6.0 20.9 10.1 33.1 36.1 13.6 26.2 23.6 13.5 19.9 20.0 137.0 7.4 34.4 0.0 29.0 10.4 7.3 9.6 24.3 20.2 14.5 7.9 19.7 5.5 19.0 22.8 9.8 17.9 5.0 6.4 19.5 13.3 36.1 23.0 6.0 31.1 27.2 12.9 9.2 26.7 19.0 6.8 16.2 18.3 19.9 11.1 RAF1 "c-Raf, CRAF, Raf-1" ENSG00000132155 "Raf-1 proto-oncogene, serine/threonine kinase" P04049 3 12583601-12664226 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 53.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 53.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002640, CAB019291" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "CAB019291: , HPA002640: AB_1856047" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (5.92e-2)" "unprognostic (2.17e-3)" "unprognostic (6.51e-3)" "unprognostic (7.66e-3)" "unprognostic (2.66e-3)" "unprognostic (1.53e-2)" "unprognostic (2.72e-1)" "unprognostic (7.66e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-2)" "unprognostic (2.79e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (2.36e-2)" 19.5 15.6 15.1 14.7 17.1 32.2 17.5 35.2 18.9 19.9 20.3 21.1 19.6 18.4 24.9 15.7 24.6 18.6 20.2 39.3 15.3 11.0 21.7 36.2 19.7 15.7 16.0 13.4 24.9 31.3 30.7 16.9 24.8 14.3 18.8 19.2 25.0 18.3 18.4 79.7 23.9 29.6 23.7 13.8 22.1 23.7 16.7 17.8 27.7 26.9 27.9 26.1 20.5 20.4 6.6 9.3 53.9 9.9 8.5 8.6 7.7 15.4 17.8 27.1 21.0 23.6 19.1 54.6 23.6 40.0 31.3 35.5 13.9 12.8 16.2 11.3 36.5 16.9 9.9 28.5 20.9 32.6 28.3 22.4 21.8 21.4 12.9 23.9 21.2 20.7 17.6 21.2 32.2 26.1 21.6 22.4 24.9 15.8 42.6 30.1 26.4 27.2 15.7 27.6 19.3 24.2 22.0 23.8 20.4 18.7 23.4 8.5 17.8 19.3 18.7 12.5 22.0 31.0 28.1 16.0 21.5 20.5 18.0 26.2 33.2 52.9 34.9 18.5 24.8 22.8 11.3 9.7 18.4 7.4 9.9 7.5 6.6 7.3 7.2 9.3 6.3 7.5 7.6 53.9 8.5 9.6 4.2 8.6 7.7 15.1 17.1 35.2 18.9 15.3 11.0 16.0 13.4 14.3 17.8 20.8 36.5 39.7 31.1 30.6 51.6 25.8 28.1 25.4 21.6 26.2 62.8 34.3 11.6 22.9 7.1 29.1 32.5 0.0 32.0 39.8 32.9 38.2 33.5 36.5 25.2 41.3 28.2 31.3 36.8 3.4 36.2 34.2 25.3 29.7 29.6 32.1 28.8 34.8 38.9 15.7 84.2 32.3 33.0 17.7 27.4 38.0 52.1 38.3 29.5 36.9 RALGAPB "DKFZp781M2411, KIAA1219, RalGAPbeta" ENSG00000170471 "Ral GTPase activating protein non-catalytic beta subunit" Q86X10 20 38472816-38578861 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051454 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA051454: AB_2681490" "unprognostic (1.06e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-2)" "unprognostic (3.42e-3)" "unprognostic (1.34e-1)" "unprognostic (1.06e-1)" "unprognostic (2.72e-3)" "unprognostic (7.28e-2)" "unprognostic (2.33e-1)" "unprognostic (8.93e-3)" "unprognostic (2.71e-1)" "unprognostic (9.51e-2)" "prognostic favorable (7.25e-4)" "unprognostic (3.03e-1)" "unprognostic (3.95e-1)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" 18.0 19.4 13.9 16.9 22.2 14.3 21.6 28.1 25.4 17.5 16.6 21.2 14.9 15.6 25.3 17.6 18.7 15.3 14.3 15.3 14.3 15.2 19.7 11.6 15.6 14.6 15.5 13.5 17.4 15.5 39.2 34.9 21.5 19.9 19.7 17.8 18.6 17.1 17.9 21.3 19.7 22.3 17.2 13.6 18.5 16.5 25.4 16.2 32.1 24.0 12.3 22.9 22.4 15.5 3.3 3.6 6.1 3.4 5.6 4.8 1.5 13.2 12.5 13.1 9.6 12.6 14.7 13.9 10.9 12.8 13.7 13.5 22.5 10.1 12.5 10.5 12.7 20.2 15.8 12.2 16.6 19.4 7.1 5.2 19.1 11.3 12.8 12.0 15.4 10.2 10.4 21.6 16.1 17.8 10.9 17.8 10.8 13.9 12.5 13.1 8.7 17.6 6.5 9.6 13.2 16.4 10.2 18.7 8.3 9.1 24.9 13.8 15.2 24.1 32.7 20.3 15.7 18.9 8.0 21.0 27.8 11.1 15.6 11.0 14.6 17.9 11.4 20.1 7.6 12.2 3.1 2.3 6.1 3.3 1.8 4.6 3.3 4.8 4.3 3.6 3.0 4.1 3.5 4.6 5.6 3.4 2.4 1.9 1.5 13.9 22.2 28.1 25.4 14.3 15.2 15.5 13.5 19.9 16.2 20.8 17.9 1.4 6.7 12.4 22.8 17.3 15.3 13.4 15.9 29.6 25.5 8.5 3.3 8.5 8.7 14.7 22.3 0.0 8.0 6.5 11.4 16.1 16.1 9.7 8.5 19.1 12.1 18.4 17.0 6.3 15.5 11.0 10.1 6.4 16.1 12.6 12.6 17.8 17.7 7.9 14.9 12.9 10.8 20.7 20.2 15.7 12.7 11.7 13.7 12.4 RBBP6 "P2P-R, PACT, SNAMA" ENSG00000122257 "RB binding protein 6, ubiquitin ligase" Q7Z6E9 16 24537693-24572863 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA replication, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032866, HPA041725, HPA043544" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB032866: AB_2177791, HPA041725: AB_2677639, HPA043544: AB_2678543" "unprognostic (1.04e-1)" "unprognostic (5.08e-2)" "unprognostic (3.35e-1)" "unprognostic (3.85e-2)" "unprognostic (1.97e-2)" "unprognostic (2.15e-2)" "unprognostic (1.08e-2)" "unprognostic (6.60e-2)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.77e-1)" "unprognostic (2.01e-2)" "unprognostic (1.21e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.22e-1)" "unprognostic (2.83e-2)" 15.1 17.6 17.2 14.0 16.4 81.4 17.9 33.0 15.7 17.8 18.8 16.3 19.8 10.2 23.2 18.7 15.3 21.2 17.6 14.7 15.0 13.2 13.1 15.8 15.7 18.1 18.7 12.2 27.2 14.4 20.7 23.1 73.9 15.4 18.2 14.4 18.4 13.7 14.7 19.2 19.2 16.4 18.4 19.2 18.6 16.4 25.1 18.7 24.3 18.6 11.8 15.5 17.9 17.9 3.8 6.9 8.5 3.7 6.5 4.2 1.0 17.7 9.3 21.9 22.8 16.8 17.6 23.8 14.4 13.3 13.2 14.3 10.3 14.4 24.7 10.9 12.2 15.1 17.2 23.5 12.5 21.9 13.5 18.2 21.3 26.7 29.3 13.1 28.2 12.7 15.2 17.5 17.2 20.3 14.9 18.9 21.7 26.7 22.6 15.2 18.3 22.7 25.5 25.2 12.0 8.8 31.4 22.3 21.7 12.7 15.9 17.6 15.4 20.3 18.2 25.5 25.5 14.2 25.1 16.3 16.4 12.1 14.1 15.4 20.1 20.0 31.2 13.2 18.8 13.5 8.5 2.3 3.7 4.0 3.7 4.2 3.8 4.1 2.8 1.6 3.8 3.5 4.0 5.0 6.5 2.1 6.9 3.1 1.0 17.2 16.4 33.0 15.7 15.0 13.2 18.7 12.2 15.4 18.7 80.4 103.7 61.9 93.7 89.4 65.1 127.0 28.1 61.6 67.1 26.2 94.2 37.6 21.6 42.4 225.8 76.4 57.3 46.7 41.4 46.4 91.5 72.4 49.7 50.4 33.6 58.8 78.7 66.3 46.7 20.2 67.0 54.3 59.1 55.1 59.4 50.8 43.9 28.1 55.2 17.7 56.2 51.8 113.1 66.6 47.7 89.0 84.9 56.5 56.8 89.7 RBM10 "DXS8237E, GPATC9, GPATCH9, KIAA0122, ZRANB5" ENSG00000182872 "RNA binding motif protein 10" P98175 X 47144869-47186813 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034972, HPA057372" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA034972: AB_10602919, HPA057372: AB_2683421" "unprognostic (9.07e-2)" "prognostic favorable (6.71e-4)" "unprognostic (7.83e-2)" "unprognostic (1.61e-2)" "unprognostic (1.86e-1)" "unprognostic (3.04e-2)" "unprognostic (4.47e-3)" "unprognostic (8.11e-2)" "unprognostic (9.86e-3)" "unprognostic (1.76e-1)" "prognostic favorable (2.86e-6)" "unprognostic (1.18e-1)" "unprognostic (6.23e-3)" "unprognostic (3.33e-2)" "unprognostic (1.09e-1)" "unprognostic (4.40e-2)" "unprognostic (1.20e-3)" 18.1 22.2 19.8 38.0 21.9 34.0 17.1 41.2 22.9 19.9 20.5 25.7 22.7 21.8 22.1 17.3 23.7 26.2 29.1 21.7 19.8 18.3 18.4 21.6 17.1 27.2 20.1 19.2 36.4 27.4 20.1 28.3 24.9 17.9 23.5 14.2 18.5 25.1 28.8 20.6 23.8 23.7 18.9 17.2 24.7 20.5 8.7 21.4 32.9 26.8 18.0 22.7 17.6 20.9 15.9 14.6 14.4 19.2 12.3 18.3 11.5 20.9 22.7 21.8 25.8 11.7 9.6 25.3 16.0 9.4 16.5 16.1 19.8 17.2 25.6 9.8 11.0 21.1 20.5 28.4 20.1 9.1 26.0 25.7 19.1 27.6 20.7 17.1 19.3 23.1 12.6 9.7 27.3 22.2 11.9 17.7 24.8 15.9 20.6 10.0 32.0 35.4 32.8 35.9 15.8 25.5 31.3 18.2 26.4 12.2 18.6 25.9 19.7 24.1 18.1 15.3 13.5 22.2 19.3 15.4 19.5 24.8 21.0 16.7 21.7 17.5 21.1 17.3 14.0 27.2 14.0 10.8 14.4 18.3 14.5 17.0 15.9 14.7 15.3 12.3 15.6 14.8 14.1 10.1 12.3 19.2 14.6 16.6 11.5 19.8 21.9 41.2 21.9 19.8 18.3 20.1 19.2 17.9 21.4 38.7 44.1 14.3 20.3 9.8 26.5 30.9 25.5 30.8 36.4 8.7 13.7 27.7 10.0 17.2 0.6 18.8 24.8 0.0 15.2 23.9 18.1 14.5 23.1 19.8 16.9 20.6 34.3 14.7 12.9 1.6 16.7 11.8 15.1 18.0 24.9 14.0 16.8 18.6 24.1 11.5 25.3 0.0 16.9 5.7 6.1 9.3 38.6 17.5 23.4 16.5 RBM14 "COAA, DKFZp779J0927, SIP, SYTIP1" ENSG00000239306 "RNA binding motif protein 14" Q96PK6 11 66616582-66627347 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006628 Supported Supported "Nuclear speckles" NA NA 13000 "Nuclear speckles" "HPA006628: AB_1078546" "unprognostic (6.96e-2)" "unprognostic (4.79e-2)" "unprognostic (4.34e-3)" "unprognostic (4.45e-2)" "unprognostic (2.15e-1)" "unprognostic (9.56e-3)" "prognostic unfavorable (2.02e-7)" "unprognostic (4.21e-2)" "unprognostic (1.54e-3)" "unprognostic (1.08e-2)" "prognostic favorable (1.04e-4)" "unprognostic (9.38e-3)" "unprognostic (8.59e-3)" "unprognostic (1.29e-2)" "unprognostic (3.32e-1)" "unprognostic (1.02e-1)" "unprognostic (1.94e-1)" 23.5 23.2 22.6 28.4 27.3 35.2 20.8 44.3 31.0 24.1 20.8 26.9 28.6 18.7 30.8 24.6 25.7 28.9 25.3 22.0 22.3 19.4 26.6 29.1 21.0 34.7 32.1 20.4 37.7 26.6 24.8 34.0 24.5 22.4 27.8 22.9 28.8 27.6 22.3 24.3 34.8 24.7 28.0 21.7 32.1 22.5 42.9 25.6 47.2 27.7 20.2 34.1 18.5 23.0 18.3 24.7 20.1 19.6 15.7 22.6 20.8 23.0 25.9 16.7 14.3 8.8 6.3 31.7 12.2 6.9 18.0 10.6 26.5 20.2 36.8 13.8 7.9 13.7 20.6 22.5 15.8 14.8 16.4 20.0 21.9 20.4 21.1 5.6 20.4 21.7 4.3 5.6 16.6 7.7 7.7 13.3 13.5 26.6 26.9 14.3 22.6 37.9 25.8 33.8 20.4 25.6 35.2 18.8 20.2 12.0 21.4 20.3 17.9 22.6 17.8 9.9 15.5 26.2 19.4 14.7 17.7 30.3 12.9 20.9 14.1 19.8 32.1 14.0 22.2 39.5 12.9 16.9 20.1 22.3 19.6 21.7 17.0 19.6 21.5 24.7 18.3 20.5 22.6 7.6 15.7 19.5 16.2 16.6 20.8 22.6 27.3 44.3 31.0 22.3 19.4 32.1 20.4 22.4 25.6 8.9 14.2 30.3 35.0 33.9 22.8 14.9 22.9 14.7 13.6 14.0 27.5 48.8 14.9 22.7 30.5 22.2 17.1 23.3 15.9 45.0 26.8 23.6 19.6 21.2 25.0 11.1 20.7 20.9 11.6 20.8 15.8 20.2 11.8 22.6 16.1 17.8 17.7 17.3 15.2 7.8 49.1 6.5 30.9 45.6 36.3 27.1 57.9 30.9 20.4 26.1 RBM25 "fSAP94, NET52, RNPC7, S164, Snu71" ENSG00000119707 "RNA binding motif protein 25" P49756 14 73058436-73123898 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003025, HPA070713" Supported Enhanced "Nuclear speckles" NA NA 250000 "Nuclear speckles" "HPA003025: AB_1079748, HPA070713: AB_2686302" "unprognostic (1.15e-2)" "unprognostic (3.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.28e-1)" "unprognostic (4.85e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.22e-2)" "unprognostic (3.32e-2)" "unprognostic (1.93e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (8.09e-4)" "prognostic unfavorable (4.26e-4)" "unprognostic (6.98e-2)" "unprognostic (2.58e-1)" "unprognostic (2.75e-1)" "unprognostic (1.73e-1)" 29.1 25.3 24.2 49.2 36.9 66.0 31.3 48.9 36.4 29.1 25.9 26.4 34.2 24.6 33.7 37.7 27.1 32.4 29.7 22.3 28.2 22.3 21.6 23.5 28.6 38.9 26.5 35.4 36.3 35.6 32.7 45.1 28.1 33.5 26.1 26.5 24.1 29.3 40.5 35.4 29.0 28.9 30.3 30.0 30.4 27.6 29.4 29.7 34.6 33.8 28.4 34.3 26.3 29.4 21.5 24.7 17.4 17.0 23.2 18.4 9.0 32.9 19.1 30.8 23.4 13.8 16.3 27.0 27.2 19.1 21.1 23.4 25.5 21.3 39.8 14.4 18.6 16.1 25.1 35.4 16.4 36.5 24.9 18.6 33.5 15.1 19.5 8.7 29.4 21.3 11.7 11.8 24.7 20.3 18.2 21.0 14.7 34.3 16.7 22.9 24.6 38.2 17.2 26.1 20.3 21.1 33.0 33.6 19.5 17.4 23.1 20.8 19.8 34.1 22.7 12.0 19.4 32.5 12.9 26.5 31.3 30.6 16.7 27.1 17.8 31.5 49.8 14.0 21.0 21.4 11.2 14.8 13.5 18.4 17.0 17.3 18.6 14.5 15.4 15.5 21.5 15.4 16.1 17.4 23.2 13.7 24.7 15.9 9.0 24.2 36.9 48.9 36.4 28.2 22.3 26.5 35.4 33.5 29.7 214.4 331.5 163.2 170.4 201.9 245.3 123.1 86.6 165.9 260.5 87.2 253.3 130.8 14.9 80.3 47.9 128.9 92.3 46.7 106.8 156.4 139.0 166.8 234.1 80.0 100.2 170.0 148.9 90.2 100.2 18.9 146.2 140.8 77.6 124.4 93.3 156.4 103.0 89.7 129.4 32.3 258.3 71.1 142.8 189.6 180.1 206.9 155.0 146.0 97.8 216.1 RBM26 "ARRS2, C13orf10, FLJ20957, PPP1R132, PRO1777, SE70-2, ZC3H17" ENSG00000139746 "RNA binding motif protein 26" Q5T8P6 13 79311824-79406477 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040252 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA040252: AB_10672895" "unprognostic (5.55e-2)" "unprognostic (4.55e-1)" "unprognostic (2.65e-1)" "unprognostic (3.09e-2)" "unprognostic (3.03e-1)" "unprognostic (2.57e-1)" "unprognostic (3.05e-3)" "unprognostic (2.18e-1)" "unprognostic (8.80e-2)" "unprognostic (1.81e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (3.46e-4)" "prognostic unfavorable (5.87e-6)" "unprognostic (8.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.47e-2)" "prognostic favorable (8.20e-4)" 18.0 23.7 25.1 23.2 35.2 28.0 22.9 47.3 30.2 22.1 16.4 21.9 18.4 16.0 25.2 25.8 18.2 21.4 15.5 15.6 23.7 17.7 14.7 17.4 18.7 32.4 24.7 18.5 30.5 24.8 20.3 34.4 20.9 25.5 19.5 19.8 16.2 20.0 17.7 20.9 27.9 23.5 18.6 23.4 29.1 20.4 25.1 27.8 37.0 22.9 15.2 28.9 17.6 18.2 9.4 4.3 6.0 3.3 3.7 7.5 1.6 20.6 11.1 27.4 13.9 12.3 13.1 15.0 14.2 12.0 14.8 15.4 14.8 17.7 31.1 11.7 10.5 9.7 19.8 20.5 14.0 21.6 18.7 21.9 24.0 24.7 13.4 9.7 44.6 19.1 8.8 11.7 15.1 21.3 13.6 15.5 19.4 18.1 10.4 16.5 6.9 27.0 23.6 17.0 18.6 6.6 27.3 22.8 16.4 13.7 11.9 20.9 14.1 12.2 14.8 8.7 17.4 13.3 37.2 14.6 12.7 12.6 10.1 14.4 15.1 13.2 38.7 20.5 25.0 15.0 6.0 2.4 4.4 5.0 3.3 5.2 6.2 5.0 4.7 1.4 9.4 7.5 6.6 3.3 3.7 2.4 4.3 5.2 1.6 25.1 35.2 47.3 30.2 23.7 17.7 24.7 18.5 25.5 27.8 53.6 68.6 40.2 32.3 30.8 65.0 37.4 33.1 34.8 39.8 24.4 68.7 27.9 8.3 21.3 39.0 42.9 27.1 0.0 22.4 26.3 29.4 32.5 54.3 37.2 27.8 54.0 47.1 55.9 55.1 20.7 60.1 36.7 15.1 22.6 36.8 44.7 23.5 31.6 44.6 15.7 67.1 51.8 20.6 81.3 79.1 31.0 19.2 40.7 37.5 30.2 RBM27 "ARRS1, KIAA1311, Psc1, ZC3H20" ENSG00000091009 "RNA binding motif protein 27" Q9P2N5 5 146203600-146289132 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA035944, HPA036422" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035944: AB_10670672, HPA036422: AB_10669987" "unprognostic (8.18e-2)" "unprognostic (3.17e-1)" "unprognostic (6.04e-2)" "unprognostic (7.03e-2)" "unprognostic (2.75e-2)" "unprognostic (2.04e-3)" "prognostic unfavorable (8.58e-4)" "unprognostic (4.73e-2)" "unprognostic (4.59e-2)" "unprognostic (1.65e-2)" "unprognostic (1.19e-2)" "unprognostic (2.90e-2)" "unprognostic (1.16e-2)" "unprognostic (4.49e-2)" "unprognostic (5.51e-2)" "unprognostic (6.67e-3)" "unprognostic (4.09e-3)" 17.1 11.7 14.4 19.0 18.1 28.8 16.3 21.2 18.3 16.0 17.4 11.3 13.0 12.7 18.0 14.4 15.8 14.8 11.1 14.4 13.6 11.3 14.1 17.8 13.5 18.2 13.2 14.6 20.1 12.7 18.7 15.3 15.5 14.4 15.1 14.6 11.6 15.5 12.1 23.4 15.1 15.9 19.2 13.7 15.1 14.4 16.4 13.9 26.4 18.9 14.3 18.6 18.6 16.3 5.2 4.3 5.1 4.7 6.0 6.6 2.4 10.2 8.4 10.9 17.5 9.5 9.1 12.6 7.6 8.7 11.2 12.4 14.7 13.3 21.8 6.0 8.6 15.5 10.7 16.2 17.6 20.0 16.6 7.2 15.0 9.5 10.1 10.4 23.3 17.4 8.5 9.2 12.1 21.5 8.6 10.0 10.4 16.3 13.2 10.6 9.3 16.8 11.7 15.0 11.3 9.6 15.2 17.0 14.9 11.3 11.5 13.7 9.4 15.7 15.3 12.1 11.6 18.0 12.8 9.5 12.1 12.8 8.9 12.3 12.7 12.0 25.8 9.0 17.1 11.2 4.9 2.8 5.1 5.0 4.3 5.7 4.5 5.0 5.7 3.6 5.2 6.6 5.2 4.2 6.0 4.7 4.3 4.9 2.4 14.4 18.1 21.2 18.3 13.6 11.3 13.2 14.6 14.4 13.9 14.9 14.5 12.7 7.9 58.7 10.4 15.9 5.1 26.8 21.6 14.0 9.8 7.8 1.7 6.8 23.3 15.1 7.5 0.0 5.9 6.5 22.2 13.0 20.9 11.3 9.6 14.3 10.4 10.4 22.7 3.6 10.6 18.7 18.6 4.6 15.7 6.6 9.0 7.0 13.8 5.3 8.5 0.0 26.4 27.3 11.1 54.3 8.1 12.5 12.6 19.6 RBM8A "BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP" ENSG00000265241 "RNA binding motif protein 8A" Q9Y5S9 1 145917714-145927678 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 120.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018403 Supported Supported "Nuclear speckles" NA NA 120000 "Nuclear speckles" "HPA018403: AB_1858908" "unprognostic (3.81e-1)" "unprognostic (3.99e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-2)" "unprognostic (1.12e-1)" "unprognostic (3.16e-1)" "unprognostic (4.62e-3)" "unprognostic (1.91e-1)" "unprognostic (1.38e-1)" "unprognostic (8.79e-3)" "unprognostic (7.27e-3)" "prognostic unfavorable (1.55e-4)" "unprognostic (3.30e-3)" "unprognostic (2.18e-1)" "unprognostic (3.77e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-3)" 6.2 6.5 9.1 9.5 9.8 18.7 6.1 6.3 9.8 8.3 6.2 9.6 9.8 6.2 7.4 5.0 15.1 5.7 5.0 6.4 7.3 6.4 6.5 5.5 11.2 7.0 7.1 7.6 5.1 6.9 5.5 7.9 13.5 5.7 5.0 5.7 6.2 6.3 24.6 7.2 6.0 6.8 13.2 6.5 5.8 8.5 9.5 6.8 6.3 4.8 11.7 7.1 3.5 101.9 120.1 118.0 85.5 85.3 89.3 115.9 51.9 42.6 38.9 31.0 14.0 13.8 47.9 31.8 21.6 45.9 33.8 56.2 39.6 47.8 50.4 21.9 24.2 35.8 41.4 34.8 37.7 42.3 39.4 36.8 32.3 41.5 19.8 61.4 32.3 15.1 26.3 41.0 44.0 20.1 34.0 41.6 55.3 45.3 35.2 143.7 61.7 48.7 66.9 45.3 74.3 54.7 34.0 47.5 29.3 50.2 40.0 49.0 47.5 24.4 43.2 35.2 45.7 74.8 35.0 37.0 47.2 36.3 87.0 51.2 80.8 70.1 33.2 37.0 31.9 89.7 77.6 118.0 86.5 85.5 82.1 101.9 82.5 87.8 76.5 90.1 77.7 86.3 89.3 85.3 79.9 120.1 89.3 115.9 65.5 127.4 197.4 354.6 295.8 63.8 60.9 81.5 131.2 154.7 83.7 51.1 325.5 159.2 190.8 135.1 157.7 103.0 116.8 192.9 427.5 170.0 170.0 239.0 101.1 184.0 33.4 152.5 103.2 99.7 35.5 94.6 186.8 197.4 240.7 91.6 97.7 203.4 129.8 80.2 155.5 75.0 97.0 213.9 194.7 163.6 277.9 615.1 199.5 104.0 335.7 RFXAP ENSG00000133111 "Regulatory factor X associated protein" O00287 13 36819224-36829104 "Disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding SCID "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032035 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA032035: AB_2674120" "unprognostic (2.03e-1)" "unprognostic (9.69e-2)" "unprognostic (7.40e-2)" "unprognostic (3.13e-1)" "unprognostic (5.14e-3)" "unprognostic (4.45e-3)" "unprognostic (1.15e-2)" "prognostic favorable (2.26e-5)" "unprognostic (1.45e-1)" "unprognostic (2.94e-1)" "prognostic favorable (4.18e-4)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "prognostic favorable (4.91e-4)" "unprognostic (2.81e-2)" "unprognostic (4.09e-1)" "unprognostic (5.99e-3)" 8.5 6.7 15.0 8.8 14.4 9.2 9.0 31.8 15.6 12.7 9.5 12.3 8.4 5.7 13.1 10.2 5.8 10.9 7.7 6.4 13.0 9.1 6.2 5.0 8.1 11.5 13.3 10.8 13.9 9.3 11.9 14.2 7.0 11.3 10.3 8.1 9.8 8.8 11.3 8.1 6.5 8.7 11.1 10.5 9.1 7.9 11.7 14.5 19.7 11.2 4.6 9.8 8.0 8.1 1.4 1.9 2.4 0.6 0.7 1.3 0.0 4.5 1.1 6.6 9.3 2.5 3.4 4.3 3.7 3.9 7.0 4.3 3.2 3.7 19.9 3.1 3.3 6.2 4.2 6.8 2.2 7.9 14.8 11.3 9.5 5.0 6.2 4.5 17.4 7.0 3.1 4.1 3.4 2.6 2.0 5.2 15.3 5.4 4.0 2.1 2.2 17.3 12.5 7.1 3.9 2.0 15.2 12.3 6.0 3.0 2.8 5.4 6.8 3.6 2.4 2.8 4.2 2.4 10.4 4.0 1.8 3.9 6.3 3.3 3.8 3.1 15.0 5.1 12.1 2.8 0.0 0.1 2.4 1.0 0.0 0.8 1.4 0.6 1.1 0.1 0.5 0.7 1.3 0.0 0.7 0.6 1.9 1.1 0.0 15.0 14.4 31.8 15.6 13.0 9.1 13.3 10.8 11.3 14.5 3.0 3.8 3.9 2.8 3.2 14.7 2.4 2.5 1.4 2.3 3.5 2.0 5.2 13.3 2.8 3.1 4.5 2.0 0.0 4.7 2.8 9.3 1.5 10.3 2.4 2.7 22.3 6.9 8.6 1.6 2.9 10.3 5.0 6.8 2.8 2.4 21.6 2.7 2.9 10.3 1.2 16.3 6.5 6.4 14.6 23.3 1.8 1.0 12.8 4.0 0.7 RNF112 "BFP, ZNF179" ENSG00000128482 "Ring finger protein 112" Q9ULX5 17 19411125-19417276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 3.2;Fibroblasts: 3.0;Muller glia cells: 7.7;Peritubular cells: 3.5;Sertoli cells: 6.5" "Cancer enriched" "Detected in some" 8 "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;fHDF/TERT166: 4.8;SCLC-21H: 4.8;SH-SY5Y: 8.4;U-87 MG: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015970 Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA015970: AB_1859103" "unprognostic (1.16e-1)" "unprognostic (3.74e-1)" "unprognostic (8.43e-5)" "unprognostic (3.65e-2)" "unprognostic (2.96e-2)" "unprognostic (6.02e-2)" "unprognostic (1.27e-1)" "unprognostic (2.88e-1)" "unprognostic (4.26e-1)" "unprognostic (5.02e-2)" "unprognostic (3.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.31e-9)" "unprognostic (1.32e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" "unprognostic (4.24e-1)" 2.5 8.1 11.3 2.3 15.9 0.6 1.8 47.5 29.1 1.2 3.6 1.4 0.0 2.9 2.0 6.9 1.1 1.5 4.4 2.3 12.4 8.2 1.2 0.7 1.7 1.4 3.9 14.1 1.3 0.8 0.5 1.9 1.1 3.1 10.2 4.4 1.6 1.3 3.5 2.1 1.9 3.6 3.5 2.9 1.7 2.1 2.0 3.7 0.0 0.9 0.0 0.8 2.8 1.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.2 4.2 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 4.8 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 3.4 0.0 0.0 1.7 0.2 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.0 4.8 8.4 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 27.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 15.9 47.5 15.9 12.4 8.2 3.9 14.1 3.1 3.7 0.0 0.0 0.0 0.0 0.9 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.3 3.5 0.0 0.4 6.5 1.5 1.1 0.7 0.9 0.2 0.0 0.1 0.1 RPL3L ENSG00000140986 "Ribosomal protein L3 like" Q92901 16 1943974-1957606 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 49.0;skeletal muscle: 148.3;tongue: 36.7" "Cell type enriched" "Detected in some" 18 "Cardiomyocytes: 115.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 7.8;Karpas-707: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA049136 Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049136: AB_2680648" "unprognostic (2.53e-1)" "unprognostic (2.63e-2)" "unprognostic (9.27e-4)" "unprognostic (6.38e-4)" "unprognostic (4.36e-2)" "unprognostic (3.48e-3)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.19e-2)" "unprognostic (2.00e-1)" "unprognostic (2.46e-2)" "unprognostic (4.53e-3)" "unprognostic (3.32e-1)" "unprognostic (4.24e-1)" "unprognostic (8.32e-3)" "unprognostic (4.60e-2)" 1.1 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 1.4 0.0 0.1 49.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 2.8 0.0 148.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 36.7 2.1 0.0 0.0 1.8 1.7 4.9 1.5 0.9 1.4 0.5 2.1 2.5 0.6 2.3 0.1 0.1 1.5 1.0 0.0 0.1 0.0 7.8 4.2 1.3 1.4 0.0 1.9 2.1 0.2 0.2 0.0 1.0 1.3 0.8 1.7 2.7 0.0 0.5 0.9 0.2 0.3 0.2 0.2 1.5 0.0 1.4 0.8 5.8 0.1 1.3 1.6 1.9 1.3 2.3 5.0 0.7 0.7 1.8 0.3 0.8 3.4 1.0 1.0 2.8 1.2 1.5 1.4 1.1 1.2 1.2 2.9 1.6 0.8 2.5 1.2 1.2 1.7 0.6 0.4 1.6 1.5 1.3 1.4 1.1 0.9 1.4 1.1 1.2 0.5 1.8 1.2 1.4 4.9 0.9 1.0 1.7 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 115.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 1.3 0.4 0.0 0.0 0.0 0.4 RSRC1 "BM-011, MGC12197, SFRS21, SRrp53" ENSG00000174891 "Arginine and serine rich coiled-coil 1" Q96IZ7 3 158105855-158545730 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044792 Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA044792: AB_10794502" "unprognostic (1.06e-2)" "unprognostic (8.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (7.40e-5)" "unprognostic (5.18e-1)" "unprognostic (1.17e-1)" "unprognostic (3.60e-3)" "unprognostic (2.91e-2)" "unprognostic (2.86e-2)" "unprognostic (5.71e-2)" "unprognostic (2.53e-3)" "unprognostic (8.84e-2)" "unprognostic (7.98e-3)" "unprognostic (3.48e-2)" "unprognostic (9.71e-2)" "unprognostic (2.71e-1)" "unprognostic (2.15e-1)" 26.2 24.4 23.8 16.6 25.6 18.7 23.0 43.0 32.3 22.6 17.3 17.7 12.2 12.3 19.4 19.2 18.2 14.6 14.7 20.1 23.8 27.0 22.1 23.1 13.2 17.9 26.5 22.5 18.8 21.5 22.8 28.2 16.5 31.9 19.3 20.7 12.5 16.7 21.5 22.8 15.4 14.3 20.7 33.7 19.5 16.4 14.8 23.2 24.0 24.1 13.3 19.9 19.6 16.2 24.5 33.8 17.6 21.6 9.4 15.7 6.6 31.6 15.2 12.0 15.4 28.5 20.0 15.7 15.9 13.9 18.2 20.2 21.1 24.3 30.4 29.7 19.4 20.2 14.2 22.3 14.3 27.1 46.1 19.0 31.4 13.4 17.2 4.5 26.6 20.3 14.4 13.8 14.2 12.7 19.5 8.5 18.0 18.3 22.9 13.8 25.9 20.7 17.9 10.0 21.5 14.7 24.4 20.5 37.0 13.4 10.5 20.8 23.6 17.6 12.1 19.6 13.5 27.6 23.1 9.4 22.7 13.7 29.4 31.3 19.3 20.6 32.6 23.2 36.3 27.9 17.6 19.8 10.3 14.8 21.6 15.6 24.5 15.7 14.8 11.9 24.1 14.9 15.7 13.7 9.4 19.9 33.8 12.5 6.6 23.8 25.6 43.0 32.3 23.8 27.0 26.5 22.5 31.9 23.2 29.8 20.2 41.2 28.8 33.2 75.7 40.1 53.5 38.8 22.7 78.5 31.4 31.3 63.0 45.2 33.4 29.6 17.7 46.7 52.3 44.9 43.5 26.6 73.0 63.5 34.6 60.4 31.7 32.5 42.4 6.6 42.8 58.5 42.2 45.1 40.3 59.2 39.6 28.1 33.6 44.6 92.1 19.4 39.1 31.6 37.3 24.0 24.7 37.0 28.1 24.0 RTN2 "NSP2, NSPL1, SPG12" ENSG00000125744 "Reticulon 2" O75298 19 45485289-45497061 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "skeletal muscle: 155.7;tongue: 43.2" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 109.9;Extravillous trophoblasts: 125.7;Syncytiotrophoblasts: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 9.1;eosinophil: 3.5;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 11 "dendritic cells: 2.4;granulocytes: 9.1" "Cell line enhanced" "Detected in many" "RH-30: 23.6;RT4: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034941, HPA034948" Approved Approved "Nuclear speckles" NA NA 16000 "Nuclear speckles" "HPA034941: AB_10671358, HPA034948: AB_2674375" "unprognostic (3.08e-1)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (5.07e-3)" "unprognostic (1.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.89e-2)" "unprognostic (3.09e-1)" "unprognostic (6.44e-2)" "unprognostic (5.10e-3)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.58e-6)" "unprognostic (4.34e-1)" "unprognostic (3.23e-1)" "unprognostic (2.21e-1)" "unprognostic (2.03e-1)" 3.4 3.1 6.9 1.9 9.0 1.3 3.4 5.9 10.4 2.5 4.2 1.0 3.7 1.8 3.4 6.7 5.4 2.0 3.5 5.4 7.4 4.8 1.4 1.7 2.6 2.2 4.8 3.7 1.0 2.5 2.2 1.6 11.4 4.6 5.1 1.6 2.6 6.5 4.8 155.7 2.6 1.8 3.3 1.4 2.6 1.9 1.2 1.0 0.0 1.8 43.2 3.5 4.2 1.5 0.1 2.4 9.1 0.5 0.3 0.0 0.5 1.9 2.7 4.6 3.6 7.9 9.8 9.1 4.4 10.7 2.8 5.4 5.4 1.7 1.7 6.2 4.8 2.3 3.7 3.0 2.1 0.8 4.0 4.4 11.8 2.0 4.0 3.4 0.7 13.5 10.7 1.1 1.2 2.2 4.9 5.1 0.4 6.4 3.3 8.3 1.5 0.0 2.2 3.4 8.8 3.5 2.0 23.6 9.4 1.6 23.4 13.0 12.5 0.9 21.7 6.8 4.5 17.1 4.7 4.5 7.9 2.4 0.2 0.9 1.9 4.4 3.9 2.1 2.7 4.0 9.1 0.2 3.5 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.3 0.5 2.4 0.0 0.5 6.9 9.0 5.9 10.4 7.4 4.8 4.8 3.7 4.6 1.0 3.0 7.2 0.0 21.5 5.7 8.9 3.9 5.1 1.4 2.3 3.5 5.9 109.9 0.0 16.6 0.0 10.8 0.3 0.0 6.1 125.7 7.6 19.7 16.1 2.4 23.2 22.3 10.9 20.9 10.0 0.0 5.2 10.6 21.9 10.0 2.0 8.5 9.1 0.0 6.3 0.1 10.6 12.9 10.0 0.4 3.0 3.0 100.5 0.0 0.4 19.5 S100PBP "FLJ12903, S100PBPR" ENSG00000116497 "S100P binding protein" Q96BU1 1 32816767-32858879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 99.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027242, HPA027328" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA027242: AB_2672174, HPA027328: AB_2672221" "unprognostic (4.29e-2)" "unprognostic (8.54e-2)" "unprognostic (3.54e-1)" "unprognostic (2.52e-3)" "unprognostic (2.44e-2)" "prognostic favorable (5.22e-5)" "prognostic unfavorable (1.26e-6)" "unprognostic (1.61e-1)" "unprognostic (2.52e-3)" "unprognostic (3.71e-1)" "unprognostic (6.79e-2)" "unprognostic (1.83e-2)" "prognostic unfavorable (9.03e-4)" "unprognostic (2.87e-1)" "unprognostic (1.06e-1)" "unprognostic (1.14e-1)" "unprognostic (1.48e-1)" 8.5 11.0 9.6 13.2 15.9 13.9 10.5 18.1 12.4 13.0 9.0 18.9 12.2 6.8 19.8 11.9 8.5 11.1 11.4 6.5 9.0 12.0 7.2 7.5 8.7 15.6 14.9 8.7 20.1 6.5 8.7 13.4 12.1 12.0 12.6 8.9 11.0 8.6 10.3 6.3 9.2 10.0 13.7 11.0 14.6 7.7 35.2 16.1 14.2 11.3 6.5 15.9 10.2 12.1 7.7 10.3 5.7 3.5 16.9 8.3 3.4 6.0 7.3 17.6 8.7 8.3 11.9 8.8 12.0 8.3 11.4 12.5 4.6 9.5 18.1 9.3 7.9 11.3 9.6 17.6 7.3 13.9 10.1 4.5 24.2 13.8 6.1 9.9 10.5 9.5 8.4 6.9 11.1 13.4 15.5 11.8 16.0 13.5 14.0 13.6 2.8 16.8 9.1 19.3 4.1 5.7 13.7 18.2 16.1 5.0 3.9 7.1 6.9 11.8 3.4 13.1 28.7 6.7 6.6 5.8 14.2 10.5 12.8 7.3 21.8 19.5 18.6 7.1 11.8 7.2 5.4 3.5 5.7 6.3 1.9 8.3 7.7 5.3 6.9 3.7 4.9 3.6 5.1 3.9 16.9 1.6 10.3 5.1 3.4 9.6 15.9 18.1 12.4 9.0 12.0 14.9 8.7 12.0 16.1 11.9 18.9 15.2 10.0 9.3 20.9 5.3 17.8 5.3 14.8 19.2 33.4 12.4 11.6 9.2 5.4 12.4 6.7 0.0 4.4 13.9 12.4 7.4 13.9 10.4 12.9 17.5 8.1 21.5 19.3 4.9 17.5 9.6 5.0 1.0 6.6 15.2 7.0 2.9 16.6 3.8 23.4 25.8 9.6 99.8 55.3 6.1 5.1 20.8 10.0 4.8 SAP130 FLJ12761 ENSG00000136715 "Sin3A associated protein 130" Q9H0E3 2 127941217-128028120 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.3" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 54.0;Late spermatids: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034664 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA034664: AB_10603238" "unprognostic (2.17e-2)" "unprognostic (1.96e-2)" "unprognostic (1.85e-1)" "unprognostic (1.33e-1)" "unprognostic (5.45e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (7.89e-4)" "unprognostic (2.75e-1)" "unprognostic (1.30e-2)" "unprognostic (1.43e-1)" "unprognostic (3.92e-2)" "unprognostic (6.77e-2)" "unprognostic (3.75e-2)" "unprognostic (5.26e-2)" "unprognostic (4.41e-1)" "unprognostic (2.13e-1)" "unprognostic (1.13e-1)" 9.3 8.7 8.9 10.4 11.3 18.0 7.8 12.2 14.1 9.7 9.3 13.8 6.6 8.2 11.7 9.5 9.9 9.4 8.2 8.0 9.6 8.5 6.8 7.8 7.9 9.1 9.7 9.0 11.6 8.4 16.3 13.8 10.4 9.6 9.1 9.8 8.8 11.3 8.5 10.5 11.6 8.9 10.3 8.9 8.3 9.0 50.3 9.9 17.1 8.8 6.9 11.9 9.9 9.5 5.8 6.8 15.6 8.5 3.5 6.2 3.5 20.5 11.4 21.5 17.3 14.3 9.9 23.6 13.2 12.9 20.5 16.2 27.0 8.6 17.3 11.9 14.8 10.7 14.5 23.7 13.6 21.3 9.6 15.2 17.1 10.3 21.0 17.2 14.8 13.6 9.3 10.2 27.0 17.0 10.8 16.3 14.6 20.7 12.8 17.1 23.0 20.5 11.7 22.2 12.2 12.8 14.2 17.7 11.5 10.9 18.3 11.4 13.7 13.9 13.2 8.2 14.2 9.9 10.2 13.9 19.8 21.6 18.4 13.9 18.0 17.7 20.6 16.3 10.1 12.7 2.4 4.2 4.8 6.2 3.0 4.8 2.4 4.4 4.0 3.7 5.8 3.2 3.5 15.6 3.5 8.5 6.8 3.0 3.5 8.9 11.3 12.2 14.1 9.6 8.5 9.7 9.0 9.6 9.9 0.0 10.4 3.2 1.9 7.0 4.2 11.9 5.1 4.0 1.2 1.8 7.9 9.4 0.0 3.7 54.0 5.3 6.6 0.0 4.1 10.7 4.7 4.4 1.1 5.1 6.6 7.9 6.4 7.4 11.0 34.3 7.8 5.7 5.0 1.0 6.5 4.1 4.3 7.0 7.8 2.9 5.8 6.5 5.0 17.9 16.6 9.2 16.1 5.0 6.6 3.0 SARNP "CIP29, Hcc-1, THO1" ENSG00000205323 "SAP domain containing ribonucleoprotein" P82979 12 55752463-55817756 "Plasma proteins, Predicted intracellular proteins" "mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030902, HPA030903" Supported Supported "Nuclear speckles" NA NA 120000 "Nuclear speckles" "HPA030902: AB_10669872, HPA030903: AB_10964180" "unprognostic (1.83e-2)" "unprognostic (1.58e-2)" "unprognostic (2.22e-1)" "unprognostic (2.50e-1)" "unprognostic (3.01e-2)" "unprognostic (2.10e-1)" "unprognostic (2.36e-4)" "unprognostic (2.02e-2)" "unprognostic (4.29e-3)" "unprognostic (1.21e-2)" "unprognostic (5.03e-2)" "unprognostic (6.48e-2)" "unprognostic (2.31e-6)" "unprognostic (8.50e-2)" "unprognostic (1.31e-1)" "unprognostic (5.29e-3)" "unprognostic (1.19e-1)" 24.3 31.5 32.3 22.8 32.6 40.2 30.8 34.8 29.6 28.8 29.2 22.3 19.9 16.0 26.0 30.8 30.4 22.7 18.2 39.5 27.1 33.5 30.9 25.1 26.3 31.3 35.9 23.6 28.0 31.1 19.4 27.4 28.4 29.4 26.0 28.9 19.8 20.5 26.6 44.4 20.3 25.7 27.9 31.3 30.6 22.1 26.4 28.9 34.6 25.8 20.8 41.8 31.4 23.4 39.7 50.1 68.1 50.2 40.6 53.1 43.7 27.0 23.8 60.1 25.2 27.8 40.1 28.5 38.9 29.5 46.8 39.3 33.3 30.1 44.1 26.2 30.4 18.4 15.4 52.6 36.6 50.6 34.6 30.3 44.5 39.3 28.4 39.8 37.1 33.4 29.5 27.1 30.7 23.1 49.3 49.3 39.8 31.8 32.6 46.7 21.8 46.1 58.4 52.3 24.6 21.2 42.5 31.2 36.1 62.8 30.0 25.5 20.9 32.3 20.8 32.3 35.7 31.5 49.5 34.2 18.9 18.9 24.2 29.4 20.7 27.7 60.5 22.8 37.9 23.7 63.7 46.2 68.1 38.2 50.2 34.7 39.7 40.7 40.7 50.1 34.6 32.6 36.5 35.7 40.6 42.3 48.0 53.1 43.7 32.3 32.6 34.8 29.6 27.1 33.5 35.9 23.6 29.4 28.9 29.8 32.3 14.6 21.9 22.3 10.7 0.3 5.1 72.3 55.7 21.0 15.7 13.7 21.6 23.7 12.9 15.7 10.7 0.0 26.0 17.0 17.1 17.2 25.6 6.8 12.7 7.9 14.3 8.0 20.8 26.8 16.7 25.0 20.3 44.1 11.6 10.6 25.1 10.5 16.3 15.3 10.2 6.5 28.4 36.1 36.2 23.2 14.1 21.9 10.6 14.3 SCAND1 "RAZ1, SDP1" ENSG00000171222 "SCAN domain containing 1" P57086 20 35953617-35959472 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 56.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071335 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA071335: " "unprognostic (3.88e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (1.28e-3)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.83e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-1)" "unprognostic (1.21e-2)" "unprognostic (4.09e-3)" "unprognostic (2.67e-2)" "unprognostic (1.56e-2)" "unprognostic (7.15e-3)" "unprognostic (3.53e-1)" "unprognostic (2.62e-1)" "unprognostic (3.48e-2)" 38.7 31.8 23.5 25.4 22.0 50.3 21.6 13.7 37.7 18.1 30.3 12.3 22.4 45.3 19.3 32.8 21.0 17.0 27.1 19.8 21.6 22.7 30.7 39.6 18.0 26.5 21.0 18.4 19.8 30.7 8.8 21.2 16.9 14.5 26.8 7.2 19.1 36.2 27.8 50.7 19.5 35.4 15.4 16.5 31.9 40.6 23.8 13.4 34.8 26.8 26.2 15.9 14.8 17.3 42.0 60.9 70.6 61.6 30.4 47.2 43.2 13.1 9.8 3.9 7.4 2.0 2.4 24.7 9.2 3.7 4.0 4.7 9.0 9.8 10.2 23.9 1.5 5.0 12.4 0.8 4.3 0.5 3.6 21.9 25.2 5.3 19.3 7.1 7.9 10.4 4.3 3.5 3.3 0.7 2.2 6.5 10.4 10.9 8.2 2.4 13.3 22.1 56.0 13.0 4.9 38.7 16.8 11.9 16.6 3.9 5.2 19.0 28.1 15.2 24.2 20.4 0.5 16.5 15.0 12.9 13.6 12.2 13.1 9.0 24.5 12.0 14.4 15.8 8.5 10.5 70.6 61.6 57.3 35.1 40.9 27.7 36.6 35.0 30.9 45.8 42.0 29.7 29.0 53.3 30.4 39.6 60.9 47.2 43.2 23.5 22.0 13.7 37.7 21.6 22.7 21.0 18.4 14.5 13.4 29.8 61.8 122.1 143.1 53.2 63.9 37.9 122.3 99.0 58.0 157.1 41.2 128.1 263.6 209.3 325.6 135.4 382.5 140.2 293.5 148.6 101.5 133.3 68.1 259.8 180.5 49.3 270.0 173.1 196.2 55.7 109.9 114.4 99.5 165.1 166.0 123.3 251.1 354.2 94.0 414.6 67.4 109.9 81.1 93.9 35.3 65.6 137.0 117.1 137.4 182.1 SETD1A "KIAA0339, KMT2F, Set1" ENSG00000099381 "SET domain containing 1A" O15047 16 30957294-30984664 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020646, HPA058376" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA020646: AB_1856752, HPA058376: AB_2683695" "unprognostic (8.62e-2)" "unprognostic (1.93e-2)" "unprognostic (3.96e-2)" "unprognostic (1.53e-1)" "unprognostic (1.85e-1)" "unprognostic (1.40e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (5.01e-2)" "unprognostic (1.54e-1)" "unprognostic (3.18e-1)" "unprognostic (5.77e-2)" "unprognostic (1.72e-1)" "unprognostic (1.55e-1)" "unprognostic (1.27e-1)" "unprognostic (2.12e-1)" "unprognostic (1.70e-2)" "unprognostic (1.94e-1)" 11.0 10.5 10.0 12.4 10.2 25.6 10.3 23.0 14.5 11.1 12.1 14.1 7.6 10.2 15.3 6.7 9.4 11.2 9.7 7.6 8.8 6.7 9.3 10.5 9.0 12.6 9.3 9.8 15.3 14.8 15.6 12.9 11.3 9.5 10.9 5.7 13.5 12.7 10.5 15.2 12.3 11.4 11.7 8.0 14.5 10.3 22.3 10.0 15.5 12.7 5.4 14.1 10.6 9.9 2.0 2.6 2.5 1.4 1.3 1.6 0.9 6.5 12.6 8.7 10.1 5.0 3.5 9.4 7.4 5.5 6.3 5.4 10.7 6.7 17.5 8.2 6.8 6.6 8.6 7.7 7.5 5.2 9.3 30.4 8.1 21.8 12.0 4.8 13.8 13.9 6.0 5.9 8.9 5.7 5.1 4.8 10.3 16.3 9.9 3.4 13.7 16.3 14.0 12.4 4.7 8.4 24.8 8.6 11.0 4.0 7.2 9.4 9.6 9.9 8.2 5.5 5.0 8.5 11.2 6.6 9.6 9.3 6.1 7.7 15.1 18.2 17.1 7.7 12.0 7.2 0.0 0.8 2.5 1.2 1.4 1.6 0.2 1.0 0.8 0.6 2.0 0.7 1.5 0.5 1.3 0.4 2.6 0.4 0.9 10.0 10.2 23.0 14.5 8.8 6.7 9.3 9.8 9.5 10.0 3.0 8.6 7.6 4.7 14.0 7.7 3.2 10.2 2.7 3.4 7.0 5.9 4.0 0.0 3.5 2.6 9.8 4.6 0.0 3.6 3.1 6.1 4.3 3.5 7.7 5.7 12.7 9.9 9.2 3.5 2.2 9.2 3.2 8.5 2.8 6.9 5.6 4.5 6.2 11.0 2.2 5.3 6.5 5.3 12.9 19.8 11.3 2.4 7.5 5.7 3.9 SETD4 "C21orf18, C21orf27" ENSG00000185917 "SET domain containing 4" Q9NVD3 21 36034541-36079389 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024073, HPA035405" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA024073: AB_1856755, HPA035405: AB_2674612" "unprognostic (4.23e-1)" "unprognostic (5.67e-2)" "unprognostic (6.98e-2)" "unprognostic (5.73e-2)" "unprognostic (1.98e-1)" "unprognostic (8.05e-3)" "unprognostic (7.86e-2)" "unprognostic (2.13e-3)" "unprognostic (2.17e-2)" "unprognostic (5.81e-2)" "unprognostic (1.33e-1)" "unprognostic (4.60e-3)" "unprognostic (1.15e-3)" "unprognostic (1.99e-1)" "unprognostic (8.09e-3)" "unprognostic (3.30e-2)" "unprognostic (1.28e-2)" 10.9 12.1 14.4 10.6 19.4 10.2 12.4 19.8 20.8 11.5 12.9 22.0 13.8 15.1 14.7 15.8 14.1 14.9 10.6 13.4 13.6 13.6 12.6 9.1 11.2 10.6 21.0 14.0 13.8 10.5 18.0 17.2 11.9 18.9 13.2 13.0 14.2 12.7 11.3 11.6 18.0 18.0 15.1 14.5 11.1 13.1 28.9 21.7 10.9 13.5 8.6 16.3 12.3 13.4 17.1 17.4 11.9 14.2 10.9 13.4 8.4 9.4 6.7 10.2 13.0 5.1 6.2 16.6 12.6 11.1 13.0 8.8 14.1 8.7 5.1 8.9 5.7 10.1 7.2 7.6 7.5 11.4 9.1 9.2 13.9 10.7 8.8 12.3 13.1 8.0 6.4 12.8 8.9 11.4 7.4 9.7 7.1 18.0 9.6 8.0 9.9 8.7 19.0 21.3 8.1 8.6 13.1 7.5 12.6 14.3 6.8 8.4 13.5 12.8 14.0 12.8 9.3 12.2 11.1 8.1 11.4 4.3 7.1 11.5 15.2 22.0 8.0 12.0 18.2 9.8 6.7 14.2 11.9 9.8 11.0 10.8 17.1 12.1 10.3 16.2 13.9 8.9 10.3 10.7 10.9 10.5 17.4 13.4 8.4 14.4 19.4 19.8 20.8 13.6 13.6 21.0 14.0 18.9 21.7 8.9 6.5 11.6 9.8 10.8 12.3 8.5 2.5 21.4 10.3 8.7 29.5 13.8 5.0 10.7 28.5 7.0 8.4 0.0 7.2 7.7 9.3 9.5 10.5 4.7 8.9 3.2 3.5 8.6 7.1 5.3 8.9 4.8 10.1 7.2 9.9 8.6 8.5 7.0 9.6 7.4 19.5 6.5 7.2 44.6 18.5 8.0 7.9 5.1 10.0 9.6 SF3B1 "Hsh155, Prp10, PRPF10, SAP155, SF3b155" ENSG00000115524 "Splicing factor 3b subunit 1" O75533 2 197389784-197435091 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050275 Approved Enhanced "Nuclear speckles" NA NA 840000 "Nuclear speckles" "HPA050275: AB_2681071" "unprognostic (6.86e-2)" "unprognostic (2.78e-1)" "unprognostic (2.14e-1)" "unprognostic (3.51e-1)" "unprognostic (4.42e-2)" "unprognostic (1.25e-3)" "unprognostic (2.44e-3)" "unprognostic (3.31e-3)" "unprognostic (1.25e-2)" "unprognostic (2.20e-1)" "unprognostic (6.79e-2)" "unprognostic (1.78e-2)" "unprognostic (2.57e-2)" "unprognostic (9.15e-2)" "unprognostic (1.16e-1)" "unprognostic (1.79e-1)" "unprognostic (3.41e-2)" 53.9 49.9 36.5 54.5 44.9 88.0 57.9 60.8 47.3 72.3 54.2 44.3 45.6 36.8 64.6 72.0 50.5 53.3 43.1 39.6 34.7 26.0 49.7 50.7 53.1 65.3 56.5 27.7 73.6 60.5 66.2 81.4 64.6 46.7 50.0 51.0 37.0 54.4 45.4 49.3 48.5 67.8 41.2 50.2 88.1 48.8 33.3 53.5 113.0 53.3 38.0 65.7 62.4 56.0 32.7 41.9 41.1 37.8 39.6 45.9 29.4 30.2 27.8 62.7 34.2 48.6 49.7 52.6 42.4 43.4 37.0 45.5 53.0 32.7 57.9 28.6 43.1 38.4 29.4 62.6 34.4 58.0 44.3 38.9 61.2 68.0 62.3 36.7 65.0 44.7 51.9 33.7 38.6 47.5 63.1 43.1 38.6 43.8 40.0 41.0 26.6 59.7 62.6 49.3 34.3 44.0 52.7 53.6 38.4 51.5 77.0 35.2 43.6 40.5 24.8 29.0 81.0 24.5 49.8 43.4 29.1 25.0 29.3 30.1 36.4 59.2 83.1 27.9 39.3 32.1 27.7 33.1 39.1 37.5 37.8 40.6 32.7 32.5 35.3 41.9 30.8 33.9 33.9 41.1 39.6 36.1 23.8 45.9 29.4 36.5 44.9 60.8 47.3 34.7 26.0 56.5 27.7 46.7 53.5 166.7 222.4 88.0 131.1 105.8 96.4 104.9 73.9 257.0 221.8 87.2 68.7 93.6 48.0 91.8 6.7 106.2 77.2 46.7 82.1 86.2 104.2 87.4 231.0 63.5 87.0 89.0 106.0 112.3 145.9 14.9 111.4 119.2 72.6 130.8 98.8 119.0 91.7 60.4 98.3 63.2 88.9 116.4 99.9 81.4 93.6 103.8 119.3 119.3 74.2 125.4 SF3B2 "Cus1, SAP145, SF3b1, SF3b145" ENSG00000087365 "Splicing factor 3b subunit 2" Q13435 11 66050729-66069308 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045028 Supported Enhanced "Nuclear speckles" NA NA 57000 "Nuclear speckles" "HPA045028: AB_10965174" "unprognostic (1.48e-1)" "unprognostic (1.51e-1)" "unprognostic (6.45e-2)" "unprognostic (3.29e-1)" "unprognostic (9.86e-2)" "unprognostic (7.10e-2)" "prognostic unfavorable (6.43e-5)" "unprognostic (8.43e-2)" "unprognostic (4.69e-1)" "unprognostic (2.79e-1)" "unprognostic (3.15e-2)" "unprognostic (1.44e-1)" "prognostic favorable (3.51e-5)" "unprognostic (4.03e-2)" "unprognostic (3.56e-1)" "unprognostic (5.14e-2)" "unprognostic (2.60e-2)" 52.4 42.9 50.1 45.8 61.7 75.7 47.3 57.0 75.7 50.6 46.0 61.7 33.0 42.6 53.0 61.8 45.4 65.0 43.5 47.3 51.2 45.5 51.2 56.8 45.2 55.5 54.8 42.4 74.1 60.5 75.2 63.5 58.9 50.5 50.1 49.1 48.8 42.4 51.4 48.8 50.0 46.8 51.9 44.6 56.7 44.2 86.0 52.9 85.9 60.6 34.5 67.7 47.7 47.1 43.8 39.7 63.3 57.8 43.2 57.9 51.5 53.0 42.8 46.3 43.4 48.1 44.4 38.3 40.4 55.0 63.1 47.5 35.0 46.3 50.8 45.8 47.5 63.1 49.3 66.9 46.4 53.0 40.5 34.5 54.7 40.3 57.1 48.7 54.2 41.7 37.8 45.3 63.7 73.8 42.8 45.2 45.2 51.1 84.4 48.0 72.0 61.1 79.9 48.0 40.0 40.0 55.6 39.8 72.0 47.7 43.9 37.0 54.0 40.4 42.7 59.9 35.2 53.8 34.3 37.5 51.9 44.2 57.7 45.5 64.8 75.9 64.5 57.4 35.8 46.8 56.9 39.4 63.3 57.9 46.0 55.7 43.1 51.3 54.0 39.7 43.8 50.3 49.6 52.0 43.2 57.8 30.9 50.0 51.5 50.1 61.7 57.0 75.7 51.2 45.5 54.8 42.4 50.5 52.9 119.1 114.9 136.2 123.3 98.9 85.3 61.3 107.0 198.1 111.5 62.8 84.4 166.5 77.9 136.8 194.5 90.9 93.8 70.0 187.3 151.3 122.2 90.7 114.7 66.0 109.4 101.7 79.2 66.9 93.2 48.0 111.4 109.6 62.4 232.6 79.8 113.3 135.0 91.2 122.4 73.9 100.8 77.6 120.5 169.9 151.2 86.6 156.1 138.4 94.9 111.1 SF3B4 "Hsh49, SAP49, SF3b49" ENSG00000143368 "Splicing factor 3b subunit 4" Q15427 1 149923317-149928344 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028578, HPA064660" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA028578: AB_10601601, HPA064660: AB_2685314" "unprognostic (2.43e-1)" "unprognostic (6.58e-2)" "unprognostic (2.49e-2)" "unprognostic (9.26e-3)" "unprognostic (2.74e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (3.11e-1)" "unprognostic (2.04e-1)" "unprognostic (6.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.74e-7)" "unprognostic (9.63e-2)" "unprognostic (6.54e-2)" "unprognostic (3.15e-2)" "unprognostic (1.91e-1)" 26.7 26.1 14.0 21.1 26.2 32.8 22.2 18.3 33.5 29.1 31.8 28.6 18.3 21.0 36.7 24.6 31.9 29.2 24.3 15.7 13.8 13.3 28.9 26.3 21.4 22.0 16.1 11.3 45.0 23.2 31.1 20.3 41.1 18.1 27.4 28.0 27.6 24.2 27.0 15.2 30.5 27.5 28.3 13.2 30.6 23.5 43.7 14.8 57.7 30.9 24.6 41.5 27.4 23.3 35.7 36.7 53.9 48.7 43.9 41.9 27.3 31.4 26.3 30.5 22.5 17.9 14.3 34.2 29.7 25.9 39.6 31.9 28.6 25.0 31.5 18.9 31.9 24.2 33.5 36.6 31.6 43.1 17.8 20.8 30.1 17.7 22.4 24.9 38.2 36.9 16.1 27.8 38.5 22.1 15.5 21.5 27.0 23.1 26.4 42.3 82.7 42.6 26.8 43.7 41.9 28.5 32.5 28.0 31.7 30.3 30.8 17.0 31.7 26.4 32.2 18.7 39.0 47.3 38.0 17.6 33.8 37.4 27.6 46.5 36.8 55.5 37.7 27.0 28.1 31.0 29.0 35.8 53.9 39.0 46.5 40.1 35.7 37.2 41.9 31.1 31.7 35.2 33.1 48.4 43.9 48.7 36.7 41.2 27.3 14.0 26.2 18.3 33.5 13.8 13.3 16.1 11.3 18.1 14.8 14.9 12.0 26.4 39.1 48.1 20.2 3.1 7.6 46.8 20.5 22.7 3.9 68.7 51.4 55.7 52.0 20.0 32.7 23.3 45.2 64.5 34.9 20.8 38.1 13.9 46.6 7.9 25.0 13.5 21.3 6.6 41.7 30.8 23.6 67.7 33.6 24.6 48.6 31.9 27.6 31.1 14.9 45.3 36.3 52.7 55.6 44.8 79.2 34.8 33.6 41.1 SGK1 SGK ENSG00000118515 "Serum/glucocorticoid regulated kinase 1" O00141 6 134169246-134318112 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 141.3" "Cell type enhanced" "Detected in many" 5 "Ito cells: 455.4;Syncytiotrophoblasts: 484.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 11.7;eosinophil: 45.9;neutrophil: 26.2" "Group enriched" "Detected in many" 7 "granulocytes: 45.9;monocytes: 11.7" "Cell line enhanced" "Detected in many" "HHSteC: 51.2;RPTEC TERT1: 78.5;SK-MEL-30: 50.9;TIME: 61.1;U-266/84: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022085, CAB025148, HPA051251" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB022085: , CAB025148: , HPA051251: AB_2681407" "unprognostic (2.05e-2)" "prognostic favorable (5.26e-4)" "unprognostic (1.12e-1)" "unprognostic (5.09e-3)" "unprognostic (2.76e-1)" "unprognostic (4.20e-2)" "unprognostic (4.53e-2)" "unprognostic (5.62e-2)" "unprognostic (4.03e-1)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (2.55e-1)" "unprognostic (5.82e-3)" "unprognostic (9.10e-2)" "unprognostic (3.81e-2)" "unprognostic (1.79e-1)" "unprognostic (6.59e-2)" 45.6 35.5 16.8 12.8 43.2 15.8 22.9 10.6 25.0 18.4 62.3 51.7 10.8 14.2 14.9 11.2 30.0 16.1 47.8 12.5 22.9 9.6 37.5 51.1 31.2 8.4 48.8 16.6 47.2 47.8 141.3 4.7 19.2 28.3 18.3 11.3 45.8 26.2 18.4 12.4 25.8 131.8 13.6 40.3 7.6 31.1 12.2 50.1 6.2 22.3 24.8 20.4 26.1 31.7 0.6 4.0 45.9 11.7 0.9 0.7 3.1 0.6 1.1 0.7 0.0 8.8 2.2 1.0 12.6 26.3 16.5 13.5 1.9 1.7 2.1 1.9 13.0 8.1 0.4 1.1 2.0 12.2 0.0 0.5 0.1 31.4 1.4 51.2 0.1 1.1 13.2 12.6 16.2 21.0 6.6 27.6 0.3 4.0 32.0 5.9 0.1 0.1 0.4 0.8 3.2 1.3 0.4 1.5 0.2 78.5 0.2 0.3 3.1 39.6 0.1 50.9 7.6 0.1 0.3 61.1 4.8 2.1 29.5 2.7 6.0 56.0 6.5 4.5 1.9 6.5 0.6 11.7 45.9 0.2 6.8 0.5 0.6 0.4 0.2 4.0 0.4 0.5 0.6 26.2 0.9 3.7 0.2 0.7 3.1 16.8 43.2 10.6 25.0 22.9 9.6 48.8 16.6 28.3 50.1 35.7 233.2 40.3 98.2 162.8 10.8 19.4 96.8 24.1 99.0 64.6 33.4 39.9 18.3 60.3 7.2 107.9 230.9 0.0 151.5 27.8 58.7 45.7 257.3 17.5 283.4 0.0 10.2 455.4 148.5 5.6 14.1 322.4 254.8 6.4 46.9 4.3 52.7 129.6 14.9 92.1 28.6 12.9 39.1 48.4 7.5 101.6 484.9 9.6 6.4 68.4 SIM1 bHLHe14 ENSG00000112246 "Single-minded family bHLH transcription factor 1" P81133 6 100385015-100464929 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5" "Group enriched" "Detected in some" 4 "Collecting duct cells: 19.2;Distal tubular cells: 6.6" "Cancer enhanced" "Detected in single" "renal cancer: 1.8" "Region enriched" "Detected in single" 21 "hypothalamus: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.0;BJ: 12.8;BJ hTERT+: 18.7;BJ hTERT+ SV40 Large T+: 5.8;HDLM-2: 5.5;RPTEC TERT1: 14.7" "Region enriched" "Detected in single" 7 "hypothalamus: 6.1" "Group enriched" "Detected in some" 5 "basal ganglia: 2.6;hypothalamus: 5.2" HPA024385 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA024385: AB_1856879" "unprognostic (1.04e-1)" "unprognostic (4.34e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-1)" "unprognostic (4.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "unprognostic (4.64e-2)" "unprognostic (3.76e-2)" "prognostic favorable (5.32e-7)" "unprognostic (1.00e-1)" "unprognostic (1.19e-1)" 5.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 13.2 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.0 2.2 21.6 0.5 0.0 0.0 0.1 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 17.5 4.7 0.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 8.0 0.0 12.8 18.7 5.8 5.4 0.0 0.0 0.0 0.0 4.0 1.2 0.0 0.0 0.0 4.9 5.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 19.2 0.0 0.0 6.6 3.0 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 1.6 0.0 0.4 0.0 0.0 0.0 0.0 SLC2A4RG "GEF, HDBP1, Si-1-2, Si-1-2-19" ENSG00000125520 "SLC2A4 regulator" Q9NR83 20 63739861-63743505 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 90.0;Proximal tubular cells: 114.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in single" 4 "T-cells: 3.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063050 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA063050: AB_2684930" "unprognostic (2.89e-2)" "unprognostic (2.32e-1)" "unprognostic (1.84e-2)" "unprognostic (5.78e-2)" "unprognostic (2.07e-3)" "unprognostic (6.48e-3)" "unprognostic (2.70e-1)" "unprognostic (1.96e-2)" "unprognostic (1.31e-1)" "unprognostic (3.44e-2)" "unprognostic (2.09e-3)" "unprognostic (1.50e-1)" "unprognostic (1.39e-2)" "unprognostic (1.41e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-3)" "unprognostic (3.22e-1)" 30.9 10.5 6.3 7.4 6.1 13.0 16.4 5.4 7.5 19.3 14.2 6.7 18.9 5.2 11.7 17.9 25.1 10.1 19.6 19.3 5.2 4.4 19.3 37.5 10.6 18.6 5.8 4.2 25.1 17.3 5.1 6.9 9.4 6.3 23.4 2.6 16.1 14.7 15.0 71.0 20.2 9.1 29.4 5.0 14.4 11.3 13.2 3.3 6.1 9.3 19.9 16.2 19.3 11.6 0.0 0.7 0.5 0.2 0.6 3.1 0.0 17.8 12.2 5.4 9.1 4.0 10.1 7.3 11.7 9.5 25.6 9.0 22.1 31.3 2.3 19.6 5.8 9.1 18.5 1.8 13.7 2.8 10.8 5.9 2.2 9.3 12.9 11.9 7.7 6.4 10.9 18.3 5.0 5.7 5.8 7.2 3.3 8.6 3.6 8.8 21.6 4.6 16.4 2.7 12.8 34.8 21.5 11.7 8.6 8.5 4.9 7.3 13.6 24.0 14.0 3.1 1.3 32.8 29.1 6.9 33.8 13.9 20.5 9.4 9.8 14.2 5.4 14.9 6.8 8.8 0.0 0.1 0.5 2.0 0.0 0.8 0.0 3.1 1.8 0.3 0.0 3.0 1.9 0.0 0.6 0.2 0.7 1.8 0.0 6.3 6.1 5.4 7.5 5.2 4.4 5.8 4.2 6.3 3.3 8.9 20.5 8.2 28.4 21.8 10.7 18.2 17.8 4.0 9.1 40.1 9.8 26.5 66.3 6.8 5.2 19.2 10.5 23.3 9.2 14.2 34.0 13.4 3.5 90.0 12.4 9.5 2.4 15.4 14.2 3.3 26.7 8.6 3.3 14.4 18.8 22.3 13.9 9.3 32.5 114.1 6.5 32.3 17.6 0.9 5.6 33.1 7.2 22.3 14.5 10.1 SMC5 "KIAA0594, SMC5L1" ENSG00000198887 "Structural maintenance of chromosomes 5" Q8IY18 9 70258962-70354888 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054900 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA054900: AB_2682634" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.24e-2)" "unprognostic (1.40e-1)" "unprognostic (2.72e-1)" "unprognostic (8.04e-3)" "unprognostic (2.15e-2)" "unprognostic (1.20e-1)" "unprognostic (3.80e-2)" "unprognostic (2.23e-1)" "unprognostic (3.36e-2)" "unprognostic (7.30e-2)" "unprognostic (1.71e-2)" "unprognostic (2.73e-2)" "unprognostic (2.54e-1)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" 12.8 9.0 11.5 21.6 13.7 20.8 15.3 34.2 14.7 15.3 14.2 6.9 16.7 12.2 14.4 12.8 14.3 15.5 12.9 13.1 10.7 7.3 10.1 13.3 14.3 15.6 15.0 9.5 33.2 19.9 10.7 30.0 15.9 12.2 15.6 15.9 5.5 17.5 24.3 36.9 11.3 16.9 18.8 13.3 13.9 13.1 11.7 14.6 20.2 13.5 11.1 14.2 14.9 22.9 11.5 11.3 14.7 9.4 9.8 11.9 5.2 22.8 5.7 14.4 8.8 8.4 15.9 11.4 15.9 13.9 8.7 9.5 2.2 12.5 22.9 5.2 11.9 7.6 21.0 15.5 10.5 17.5 10.3 5.5 13.3 9.4 6.8 10.7 21.6 13.8 11.1 7.4 11.7 13.5 13.9 9.0 13.8 9.8 9.3 16.1 3.5 28.4 7.6 11.0 17.6 8.1 16.9 23.8 7.1 8.8 11.3 10.3 7.8 15.7 10.1 4.4 11.0 6.0 9.2 9.9 11.7 12.4 15.9 21.6 11.4 15.2 16.0 9.9 11.4 13.9 14.7 7.7 12.8 11.9 8.4 11.1 10.1 10.2 11.0 5.9 11.5 11.5 10.4 5.1 9.8 9.4 11.3 10.5 5.2 11.5 13.7 34.2 14.7 10.7 7.3 15.0 9.5 12.2 14.6 53.6 61.1 43.6 93.1 40.5 21.7 31.9 22.9 62.9 85.3 19.2 27.5 25.9 8.3 51.5 33.8 35.8 28.5 0.0 48.3 28.4 30.3 90.1 48.7 22.6 14.4 36.5 27.0 11.1 24.3 10.2 49.5 28.0 23.6 72.1 34.7 18.0 48.9 40.3 55.9 10.5 37.9 25.8 53.7 75.1 58.1 36.6 29.7 34.6 40.2 84.3 SMIM19 C8orf40 ENSG00000176209 "Small integral membrane protein 19" Q96E16 8 42541155-42555193 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011145, HPA074830" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA011145: AB_1078360, HPA074830: " "unprognostic (2.12e-2)" "unprognostic (2.33e-3)" "unprognostic (4.01e-2)" "unprognostic (1.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (7.04e-3)" "unprognostic (1.76e-2)" "unprognostic (4.84e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (2.67e-2)" "prognostic favorable (1.74e-6)" "unprognostic (5.10e-2)" "unprognostic (9.70e-3)" "unprognostic (9.64e-2)" "unprognostic (2.93e-3)" 23.7 26.9 20.2 19.2 17.2 12.7 31.2 21.1 23.9 17.5 23.2 12.4 25.2 14.0 16.1 39.3 23.2 27.3 27.9 41.9 18.2 15.6 35.6 61.9 22.1 23.4 17.4 16.5 21.5 40.2 18.0 12.8 16.0 13.6 17.7 16.7 17.7 42.7 20.4 50.6 19.8 31.3 26.6 17.2 18.0 19.5 26.4 9.8 21.4 34.9 30.8 15.8 26.5 13.2 28.1 41.4 25.7 17.0 29.7 29.2 15.2 13.4 10.0 22.0 18.9 13.5 16.1 7.0 10.4 14.4 8.6 10.2 2.4 30.1 14.8 4.4 8.8 20.8 9.7 11.4 6.8 8.9 11.8 9.5 12.6 6.8 5.3 27.6 8.8 3.2 13.2 5.9 7.1 23.0 16.6 7.7 17.6 9.9 34.1 8.5 13.1 6.4 13.4 26.0 31.6 6.9 7.3 15.7 24.9 21.6 10.0 4.6 16.9 10.7 11.6 31.5 12.4 24.5 16.9 9.6 5.4 4.6 14.7 6.8 32.5 17.9 19.5 22.8 14.3 14.2 25.7 17.0 11.5 19.3 12.4 23.2 28.1 24.9 23.5 25.1 27.5 23.9 22.9 6.0 29.7 10.3 41.4 29.2 15.2 20.2 17.2 21.1 23.9 18.2 15.6 17.4 16.5 13.6 9.8 20.8 35.8 32.7 56.6 40.6 24.7 70.6 53.5 119.1 50.0 31.4 5.9 73.7 170.8 60.6 134.0 42.9 36.0 23.3 111.2 54.1 58.6 43.9 39.3 132.8 69.1 22.3 15.6 37.4 37.1 52.2 63.9 47.1 87.7 68.5 72.2 41.5 70.1 73.6 55.9 175.5 10.3 25.8 44.8 48.8 35.6 43.3 39.5 44.9 75.4 48.0 SMURF2 ENSG00000108854 "SMAD specific E3 ubiquitin protein ligase 2" Q9HAU4 17 64542295-64662068 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 55.2;HBF TERT88: 42.4;LHCN-M2: 42.4;TIME: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071508 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA071508: AB_2686406" "unprognostic (1.21e-1)" "unprognostic (2.07e-2)" "unprognostic (1.59e-2)" "unprognostic (3.24e-1)" "unprognostic (6.19e-2)" "unprognostic (7.33e-2)" "unprognostic (2.67e-2)" "unprognostic (1.50e-1)" "unprognostic (7.94e-2)" "unprognostic (1.09e-2)" "unprognostic (5.46e-3)" "unprognostic (2.54e-1)" "unprognostic (5.55e-2)" "unprognostic (1.98e-2)" "unprognostic (7.82e-2)" "unprognostic (2.20e-2)" "unprognostic (1.41e-1)" 12.3 9.2 10.5 9.0 15.0 11.5 10.2 16.7 10.0 9.2 9.1 11.5 8.1 9.3 7.9 6.9 7.6 7.8 10.5 8.2 12.6 4.6 9.4 5.7 19.0 8.6 9.5 4.8 8.5 9.0 8.2 10.7 15.3 10.1 10.6 8.2 9.6 9.9 7.6 7.5 11.0 13.7 8.9 6.6 9.9 9.8 21.6 10.6 8.9 11.4 4.1 9.6 9.4 11.7 3.0 3.0 4.8 2.2 7.3 3.5 1.7 15.9 4.4 3.8 2.8 2.6 10.2 1.8 55.2 25.1 21.6 18.8 2.4 12.2 2.1 3.5 9.4 8.5 3.5 3.6 9.5 42.4 1.1 2.4 2.2 2.7 2.9 2.4 2.9 1.4 2.7 3.7 29.9 11.5 13.1 24.9 2.7 3.3 2.1 42.4 3.5 6.8 1.3 2.2 2.5 5.8 1.6 9.2 1.4 5.9 2.8 3.6 3.2 3.4 1.7 2.5 7.3 2.9 2.4 48.9 24.5 13.3 9.4 36.6 2.4 2.9 3.8 6.0 1.7 7.4 2.8 2.2 4.8 3.3 2.0 2.8 2.0 2.4 3.5 3.0 3.0 2.3 2.6 4.4 7.3 1.0 2.6 1.1 1.7 10.5 15.0 16.7 10.0 12.6 4.6 9.5 4.8 10.1 10.6 29.8 21.3 9.5 27.8 38.9 26.4 9.1 7.6 13.4 19.4 8.7 41.2 10.4 8.3 13.5 18.7 24.0 18.8 0.0 8.4 2.7 21.3 22.7 12.7 4.5 12.6 25.4 17.1 43.6 16.7 7.8 11.5 14.0 20.3 4.6 10.3 20.6 18.4 17.3 11.3 7.4 46.8 0.0 20.3 31.2 24.5 34.8 6.1 20.8 11.5 21.8 SNRNP40 "HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57" ENSG00000060688 "Small nuclear ribonucleoprotein U5 subunit 40" Q96DI7 1 31259568-31296782 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026527, HPA027345" Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA026527: AB_1858814, HPA027345: AB_2239703" "unprognostic (2.31e-3)" "unprognostic (5.63e-2)" "unprognostic (5.24e-3)" "unprognostic (1.36e-1)" "unprognostic (1.14e-3)" "unprognostic (1.28e-2)" "prognostic unfavorable (4.73e-6)" "unprognostic (2.14e-2)" "unprognostic (2.43e-2)" "unprognostic (2.50e-1)" "unprognostic (1.22e-1)" "unprognostic (8.57e-2)" "unprognostic (2.34e-2)" "unprognostic (1.78e-2)" "unprognostic (5.93e-2)" "unprognostic (4.31e-2)" "unprognostic (6.24e-2)" 20.2 23.1 13.2 19.6 20.2 25.2 21.2 24.1 21.8 20.9 20.1 30.0 20.9 16.2 25.6 23.0 23.4 23.0 15.4 17.8 14.3 15.4 18.8 19.1 17.4 31.6 31.5 14.0 26.7 15.8 15.0 20.2 21.9 23.5 20.8 22.8 20.2 17.9 22.4 22.6 20.8 19.9 22.0 22.3 27.3 18.7 31.3 21.3 44.0 24.4 17.0 38.2 20.0 19.4 33.7 32.8 27.5 33.8 36.7 44.3 47.8 20.8 15.7 29.6 24.3 14.8 12.3 20.3 17.6 17.5 32.3 32.1 22.6 21.4 27.3 17.4 13.9 16.6 20.1 44.5 21.1 33.5 29.0 32.8 40.3 22.7 24.7 18.4 44.1 18.4 11.4 16.9 31.5 23.8 10.8 26.1 24.2 37.4 16.3 18.6 15.0 32.5 26.0 52.9 21.2 22.9 25.9 41.7 21.1 13.8 17.3 20.2 19.8 28.0 14.7 33.2 28.7 14.5 28.3 18.0 18.2 26.6 25.1 33.4 13.3 16.3 37.7 14.8 41.5 29.5 26.0 26.7 27.5 37.2 33.8 42.6 33.7 36.4 36.6 32.8 30.9 39.2 44.3 5.9 36.7 30.3 27.9 37.4 47.8 13.2 20.2 24.1 21.8 14.3 15.4 31.5 14.0 23.5 21.3 3.0 6.7 41.0 44.7 47.2 13.7 11.8 20.4 10.7 6.8 15.7 17.7 100.1 36.5 28.8 5.4 33.3 13.5 0.0 31.5 71.3 44.7 26.1 34.5 20.3 49.1 9.5 33.5 29.4 20.6 3.6 24.7 27.9 40.5 47.7 16.9 22.6 27.7 21.0 32.2 34.6 19.3 32.3 34.3 68.7 67.1 47.9 51.3 42.4 31.1 33.6 SNURF ENSG00000273173 "SNRPN upstream reading frame" Q9Y675 15 24954986-24977850 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 140.9" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 6.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 58.4;U-698: 30.9" HPA065733 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA065733: AB_2685548" "unprognostic (2.08e-1)" "unprognostic (2.88e-2)" "unprognostic (6.82e-2)" "unprognostic (4.59e-3)" "unprognostic (4.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.39e-2)" "unprognostic (6.89e-3)" "unprognostic (1.56e-2)" "unprognostic (6.74e-2)" "unprognostic (8.91e-4)" "unprognostic (3.77e-1)" "unprognostic (1.77e-2)" "unprognostic (6.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-2)" 11.9 20.8 47.6 10.9 50.2 16.7 9.7 59.3 140.9 8.1 19.1 16.7 13.7 5.5 13.2 72.6 9.9 8.1 20.4 32.1 47.7 47.8 23.6 20.1 15.5 14.8 45.6 40.9 15.4 19.4 23.9 40.9 6.4 44.4 21.8 6.3 16.0 12.3 13.9 69.6 7.6 10.8 7.9 28.4 23.9 17.8 7.3 18.9 9.5 40.4 6.5 11.3 9.7 6.7 13.4 11.8 6.1 1.4 10.1 22.0 9.5 0.0 3.6 19.5 13.3 0.9 1.2 0.0 11.2 1.0 1.2 0.8 2.0 10.6 0.1 6.1 0.7 1.9 4.2 0.0 2.5 1.0 3.9 0.0 20.1 14.6 0.5 3.4 21.1 7.5 3.0 0.6 2.3 0.0 8.0 1.4 7.4 2.1 0.0 2.1 0.0 15.2 0.1 58.4 0.0 0.5 15.4 24.1 0.2 0.9 24.3 11.3 8.7 0.0 1.0 5.6 27.5 11.4 2.0 20.7 8.5 8.9 0.2 2.4 17.0 20.8 30.9 12.8 9.4 7.0 6.1 0.8 3.0 8.3 0.4 16.2 11.1 17.3 14.9 1.5 13.4 22.0 20.0 0.9 10.1 1.4 11.8 17.1 9.5 47.6 50.2 59.3 65.9 47.7 47.8 45.6 40.9 44.4 18.9 3.0 3.0 3.4 0.6 0.5 1.5 3.2 0.0 6.7 1.2 0.0 0.0 0.0 3.3 2.1 0.3 0.1 0.4 0.0 2.0 0.0 0.2 0.9 1.1 0.8 0.3 3.2 0.0 1.3 1.5 0.0 0.6 0.0 0.0 1.0 2.7 0.3 2.9 2.9 0.4 0.6 1.3 0.0 2.3 0.3 0.9 0.3 0.0 0.7 1.0 0.1 SOHLH1 "bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2" ENSG00000165643 "Spermatogenesis and oogenesis specific basic helix-loop-helix 1" Q5JUK2 9 135693407-135699528 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "brain: 21.1;testis: 21.5" "Cell type enriched" "Detected in some" 10 "Spermatogonia: 82.1" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "CACO-2: 14.8;U-266/84: 22.8" HPA059439 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA059439: AB_2684017" "unprognostic (2.93e-1)" "unprognostic (1.23e-3)" "unprognostic (9.85e-3)" "unprognostic (2.84e-2)" "unprognostic (3.55e-1)" "unprognostic (2.59e-3)" "unprognostic (4.98e-3)" "unprognostic (2.17e-1)" "unprognostic (1.63e-1)" 0.2 0.1 4.4 0.2 3.2 0.1 0.2 1.7 21.1 0.2 0.2 0.2 0.2 0.1 0.2 0.6 0.2 0.1 0.2 0.2 9.4 1.4 0.2 0.2 0.2 0.2 2.0 0.2 0.3 0.2 0.3 1.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.7 0.2 0.2 0.4 0.2 0.2 21.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 3.2 1.7 21.1 9.4 1.4 2.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 8.0 82.1 0.0 0.0 0.0 0.0 0.0 SON "BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP" ENSG00000159140 "SON DNA binding protein" P18583 21 33542618-33577481 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, mRNA processing, mRNA splicing" "DNA-binding, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023535, HPA031755, HPA031756" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030" "unprognostic (1.58e-2)" "unprognostic (2.08e-1)" "unprognostic (4.69e-1)" "unprognostic (2.30e-1)" "unprognostic (5.63e-2)" "unprognostic (2.75e-1)" "unprognostic (4.22e-2)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (2.31e-2)" "unprognostic (2.02e-1)" "unprognostic (1.24e-1)" "unprognostic (9.75e-2)" "unprognostic (4.18e-1)" "unprognostic (9.20e-2)" "unprognostic (1.19e-1)" "unprognostic (2.54e-1)" 40.0 41.1 33.3 32.7 42.8 87.7 40.8 46.2 42.3 38.7 36.1 41.3 34.1 27.8 51.9 41.6 39.3 44.8 27.7 37.5 32.9 25.6 32.0 38.0 41.3 44.8 40.0 32.6 52.9 40.4 92.1 70.3 42.4 41.2 41.3 37.6 37.6 40.7 36.3 64.1 39.2 41.6 34.6 47.6 47.0 41.2 29.6 41.4 59.0 42.1 27.3 46.4 43.0 47.3 20.1 27.1 26.8 15.5 15.2 17.2 9.0 27.8 14.0 36.4 20.5 32.2 29.1 26.2 19.5 26.1 20.7 19.6 23.3 20.2 45.3 11.4 32.5 23.9 20.7 42.2 32.6 33.0 18.7 20.7 58.7 19.2 30.9 23.9 55.2 27.0 30.8 38.0 24.5 37.6 26.5 31.4 24.7 44.2 45.7 29.7 28.1 29.5 31.1 39.7 30.5 16.3 29.0 38.8 33.4 32.0 24.9 20.9 20.6 32.7 28.0 22.6 31.5 25.5 32.5 31.2 22.2 20.7 16.6 21.2 42.9 35.1 54.1 23.8 47.4 21.6 18.6 14.4 18.7 15.4 12.6 15.3 19.9 17.1 16.0 10.9 20.1 17.2 16.7 26.8 15.2 15.5 27.1 14.5 9.0 33.3 42.8 46.2 42.3 32.9 25.6 40.0 32.6 41.2 41.4 381.2 269.8 245.0 287.1 384.7 382.2 339.3 303.2 329.2 315.1 286.1 208.1 195.6 164.2 182.7 62.5 272.4 180.8 256.9 180.4 138.6 293.6 211.2 400.4 301.9 149.2 430.6 179.2 276.8 201.3 39.3 364.7 259.5 207.5 184.0 159.3 365.4 155.4 161.4 369.9 137.2 353.2 375.1 318.2 436.1 320.9 344.7 273.6 278.4 160.2 183.4 SPINDOC "C11orf84, SPIN-DOC" ENSG00000168005 "Spindlin interactor and repressor of chromatin binding" Q9BUA3 11 63813388-63827718 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 3.0;Cytotrophoblasts: 11.7;Hofbauer cells: 4.8;monocytes: 3.6;Syncytiotrophoblasts: 3.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040128, HPA050313" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA040128: AB_10673027, HPA050313: AB_2681083" "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-2)" "unprognostic (2.82e-3)" "unprognostic (1.13e-1)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (2.20e-1)" "unprognostic (3.78e-3)" "unprognostic (1.44e-2)" "unprognostic (1.20e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (5.42e-5)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" 9.2 9.0 9.6 12.3 9.8 5.8 23.3 12.8 15.8 8.8 11.4 6.9 5.8 6.0 13.2 6.0 7.9 8.4 10.1 9.3 9.3 12.2 8.2 3.1 9.9 14.8 9.4 9.1 11.3 8.2 3.3 12.0 28.0 10.8 11.8 4.2 7.8 6.6 12.3 7.7 4.5 6.9 12.9 8.6 10.3 7.4 24.1 6.0 11.8 10.5 3.1 10.5 9.0 39.5 2.0 1.5 2.2 0.1 0.7 1.5 0.2 12.0 16.2 23.7 20.7 4.6 4.5 8.9 9.4 8.1 17.2 12.0 17.0 8.3 20.2 22.0 5.4 22.3 16.0 21.5 4.9 6.3 19.1 9.4 22.3 15.2 14.4 7.4 12.4 19.4 5.2 5.1 13.6 4.9 9.1 10.1 19.5 12.2 10.0 7.3 16.5 25.7 33.8 40.5 3.5 15.1 34.7 16.4 6.9 5.9 7.1 18.1 22.9 14.3 9.2 19.0 15.1 12.7 15.0 11.3 19.4 22.3 23.2 16.4 14.6 20.7 20.1 10.0 11.1 13.6 2.2 0.1 0.4 1.5 0.1 0.2 1.2 0.3 0.9 0.4 2.0 0.7 0.4 0.0 0.7 0.1 1.5 0.6 0.2 9.6 9.8 12.8 15.8 9.3 12.2 9.4 9.1 10.8 6.0 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 11.7 0.0 1.8 0.0 0.0 0.0 0.0 1.5 2.2 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 SPTSSB "ADMP, C3orf57, ssSPTb" ENSG00000196542 "Serine palmitoyltransferase small subunit B" Q8NFR3 3 161344792-161372880 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 68.6;skin 1: 27.5;stomach 1: 42.0" "Cell type enhanced" "Detected in some" 13 "Exocrine glandular cells: 42.0;Glandular cells: 74.2;Melanocytes: 43.9;Suprabasal keratinocytes: 31.9;Urothelial cells: 53.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 24.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 12 "NK-cell: 68.6" "Lineage enriched" "Detected in many" 12 "NK-cells: 68.6" "Group enriched" "Detected in some" 10 "MCF7: 159.0;RT4: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047712 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA047712: AB_2680127" "unprognostic (2.09e-1)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "unprognostic (1.34e-2)" "unprognostic (4.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (5.10e-2)" "unprognostic (6.37e-3)" "unprognostic (2.72e-1)" "unprognostic (4.08e-2)" "unprognostic (5.37e-4)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (9.51e-3)" 1.4 0.4 2.0 0.7 3.4 0.5 6.4 8.9 18.5 4.0 0.9 1.6 0.0 0.5 1.0 0.4 5.1 0.6 1.5 0.4 2.2 2.2 0.7 0.6 0.3 1.0 2.0 6.2 0.4 1.5 0.3 0.3 0.3 12.0 12.4 0.8 0.2 8.0 0.4 0.4 27.5 0.5 1.4 1.1 1.1 42.0 0.3 0.4 0.1 0.4 2.1 1.7 23.5 5.4 0.0 0.0 0.2 0.0 68.6 5.6 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.0 0.0 0.0 0.6 9.7 1.8 0.0 0.0 0.0 0.0 42.2 0.2 1.7 0.0 5.7 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.6 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.2 68.6 0.0 0.0 0.0 0.5 2.0 3.4 8.9 18.5 2.2 2.2 2.0 6.2 12.0 0.4 0.0 0.0 0.0 17.2 3.4 1.5 0.3 2.5 0.0 0.0 3.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 42.0 0.0 0.4 74.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 1.6 0.0 16.3 0.0 0.0 0.0 1.3 0.0 2.7 0.0 0.0 31.9 0.1 0.9 0.0 53.8 SRRM1 "MGC39488, POP101, SRM160" ENSG00000133226 "Serine and arginine repetitive matrix 1" Q8IYB3 1 24631716-24673267 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049941, HPA058612" Supported Enhanced "Nuclear speckles" NA NA 12000 "Nuclear speckles" "HPA049941: AB_2680962, HPA058612: AB_2683778" "unprognostic (3.31e-2)" "unprognostic (3.81e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-1)" "unprognostic (1.49e-1)" "unprognostic (7.71e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (3.83e-2)" "unprognostic (1.80e-3)" "unprognostic (2.38e-1)" "unprognostic (9.27e-2)" "unprognostic (5.08e-3)" "unprognostic (4.52e-2)" "unprognostic (4.50e-2)" "unprognostic (2.77e-2)" "unprognostic (1.88e-1)" "unprognostic (3.46e-1)" 25.0 22.4 16.6 21.8 29.5 44.5 26.9 38.0 30.0 37.1 27.9 39.7 26.3 20.7 35.6 65.6 21.7 31.7 18.6 23.9 19.5 16.6 24.1 27.7 22.8 27.3 27.2 21.1 49.8 20.3 26.7 35.5 35.2 32.6 33.3 20.8 31.8 24.2 25.5 34.4 30.5 28.6 24.2 32.4 29.8 21.5 23.4 29.8 43.4 24.2 20.3 36.4 28.5 29.8 20.3 19.1 23.9 23.7 27.9 26.2 14.8 17.2 13.9 27.6 24.7 15.6 16.1 27.1 20.2 13.4 20.3 23.3 15.3 29.0 38.6 12.8 17.1 13.5 21.7 27.5 19.8 26.7 13.2 19.1 29.6 27.0 18.1 10.9 34.1 19.7 10.9 12.5 16.4 24.2 23.2 17.5 19.0 28.7 21.2 20.8 14.9 30.9 22.9 45.4 14.1 9.5 27.6 22.1 18.8 17.7 18.0 16.8 15.2 21.8 17.7 15.0 21.7 15.9 16.7 19.4 17.8 18.5 24.1 20.2 19.0 14.5 47.7 19.2 40.1 19.7 23.9 17.8 19.2 21.8 21.7 26.2 20.3 20.7 21.2 19.1 19.7 19.2 21.8 23.6 27.9 23.7 16.6 15.4 14.8 16.6 29.5 38.0 30.0 19.5 16.6 27.2 21.1 32.6 29.8 145.9 144.9 171.3 231.9 268.6 176.0 131.8 137.6 180.7 174.0 115.1 111.9 129.0 169.1 144.9 235.5 146.8 116.3 163.5 128.5 137.4 157.1 230.0 229.3 203.4 133.1 117.6 113.6 127.1 162.6 96.6 155.3 180.0 146.8 260.5 126.0 204.1 128.5 135.3 141.8 117.6 174.7 135.8 173.5 224.9 222.2 258.2 201.7 198.3 147.2 308.0 SRRM2 "Cwc21, KIAA0324, SRL300, SRm300" ENSG00000167978 "Serine/arginine repetitive matrix 2" Q9UQ35 16 2752329-2772538 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 36.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041411, HPA066181" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA041411: AB_10796671, HPA066181: AB_2685630" "unprognostic (8.48e-2)" "unprognostic (1.80e-1)" "unprognostic (2.44e-1)" "unprognostic (1.81e-1)" "unprognostic (4.23e-2)" "prognostic favorable (6.77e-4)" "prognostic unfavorable (5.08e-4)" "unprognostic (7.39e-2)" "unprognostic (1.64e-1)" "unprognostic (4.74e-2)" "unprognostic (2.72e-1)" "unprognostic (3.50e-3)" "prognostic unfavorable (4.82e-4)" "unprognostic (1.05e-1)" "unprognostic (5.35e-2)" "unprognostic (1.26e-2)" "unprognostic (7.84e-2)" 41.4 50.2 50.1 73.1 69.8 105.5 48.0 85.3 77.1 53.1 51.7 61.5 57.9 56.1 60.4 44.5 53.1 56.8 60.7 43.7 51.0 28.2 47.2 56.0 48.7 53.3 70.3 38.2 70.8 74.8 88.1 49.1 43.8 48.8 52.5 48.2 45.6 80.8 63.0 91.7 67.4 63.4 46.7 52.9 63.2 61.7 37.8 69.8 48.7 58.9 38.3 46.2 52.0 69.5 9.0 11.6 36.4 8.9 23.9 4.7 0.9 23.1 29.6 47.2 32.5 33.3 32.5 27.9 26.3 14.9 23.6 21.0 24.5 26.9 41.2 20.2 29.1 19.9 33.3 37.6 33.4 25.0 29.9 39.0 35.4 55.1 42.3 15.1 37.0 51.3 33.2 32.4 34.5 41.0 47.0 24.2 29.9 39.6 40.7 21.6 41.2 34.8 59.5 44.3 16.9 16.4 61.3 19.1 32.0 30.3 24.8 31.1 27.5 34.9 35.8 20.4 34.3 32.5 30.4 34.3 33.4 34.3 21.7 32.9 36.1 27.5 89.9 11.6 26.8 22.4 36.4 8.9 4.3 3.2 3.9 3.0 5.2 4.0 3.0 2.0 9.0 3.5 4.7 18.3 23.9 3.5 11.6 2.0 0.9 50.1 69.8 85.3 77.1 51.0 28.2 70.3 38.2 48.8 69.8 131.0 223.1 135.5 295.8 275.8 386.9 120.6 137.6 99.0 127.4 158.7 274.9 154.0 56.3 132.6 66.3 179.8 178.8 70.0 155.2 172.0 158.0 296.9 129.6 159.6 137.3 414.7 182.0 132.6 96.7 50.6 233.0 154.4 114.7 165.1 168.0 254.6 138.2 149.0 180.7 81.9 356.7 194.1 177.2 214.7 238.6 319.2 231.0 133.1 160.7 304.5 SRSF11 "NET2, p54, SFRS11" ENSG00000116754 "Serine and arginine rich splicing factor 11" Q05519 1 70205682-70253052 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008762 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA008762: AB_1856782" "unprognostic (7.82e-3)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (2.85e-1)" "unprognostic (5.32e-3)" "unprognostic (1.30e-3)" "prognostic unfavorable (3.91e-4)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.22e-1)" "unprognostic (6.25e-3)" "prognostic unfavorable (6.53e-6)" "unprognostic (7.79e-2)" "unprognostic (1.63e-1)" "unprognostic (1.90e-1)" "unprognostic (1.43e-2)" 36.1 42.7 38.3 36.9 41.3 80.1 42.2 68.2 43.6 38.6 32.6 34.8 38.4 30.7 41.4 51.2 31.2 39.0 31.6 25.9 33.4 26.6 30.7 42.5 33.9 47.6 47.7 34.4 51.1 42.5 39.0 53.4 38.4 39.9 37.1 32.4 32.3 34.4 41.8 31.3 51.8 40.6 36.8 37.8 45.9 34.5 35.1 41.7 46.6 44.6 25.5 43.3 32.8 36.7 34.7 42.1 45.4 29.7 36.0 36.4 22.2 24.9 12.7 33.4 21.3 17.2 23.2 46.0 30.9 16.0 25.3 23.0 22.3 18.9 42.6 21.2 15.5 16.6 21.4 42.2 17.0 34.6 28.5 33.0 43.1 28.6 26.6 20.6 59.2 17.9 18.6 21.5 23.3 23.9 31.7 22.4 21.9 42.4 27.0 24.8 9.8 35.4 44.0 53.7 19.7 21.5 42.2 37.0 26.9 29.4 18.1 28.2 23.3 26.1 28.4 36.9 32.4 22.7 26.7 26.4 27.9 20.1 20.1 27.8 31.3 25.0 46.8 20.0 44.1 24.4 39.6 29.7 45.4 32.6 23.1 36.4 34.7 32.9 31.4 30.1 34.1 36.1 33.4 15.0 36.0 27.1 42.1 35.5 22.2 38.3 41.3 68.2 43.6 33.4 26.6 47.7 34.4 39.9 41.7 196.5 200.1 139.7 263.5 314.4 155.0 102.3 104.4 147.2 159.3 184.9 111.9 207.5 97.8 131.8 35.2 175.9 101.9 93.5 118.0 224.3 226.0 265.6 185.3 117.5 131.7 151.0 166.7 144.2 126.7 37.3 236.8 155.2 160.3 181.3 121.4 114.0 119.2 94.7 248.6 77.4 151.4 168.1 201.8 223.9 131.7 309.1 254.0 175.7 130.9 285.4 SRSF4 "SFRS4, SRP75" ENSG00000116350 "Serine and arginine rich splicing factor 4" Q08170 1 29147743-29181987 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050975 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA050975: AB_2681296" "unprognostic (3.26e-3)" "unprognostic (8.08e-2)" "unprognostic (1.29e-2)" "unprognostic (1.57e-3)" "unprognostic (1.37e-1)" "unprognostic (5.89e-2)" "unprognostic (1.89e-3)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (2.36e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (4.26e-4)" "prognostic unfavorable (4.30e-4)" "unprognostic (6.25e-3)" "unprognostic (2.80e-1)" "unprognostic (7.75e-3)" "unprognostic (1.60e-2)" 42.5 26.5 26.8 31.7 34.6 46.6 38.7 37.5 28.3 33.9 35.8 27.9 30.7 35.1 39.0 29.1 35.9 30.7 26.3 28.7 26.0 22.3 27.8 40.7 36.7 37.1 35.0 24.1 43.0 30.4 28.5 27.0 40.7 27.9 35.2 26.2 27.8 33.6 34.8 47.0 38.0 34.0 52.6 30.7 38.7 29.9 23.4 33.8 46.9 35.1 23.6 30.0 55.6 70.2 23.8 25.6 44.8 26.1 20.0 35.0 20.7 31.4 18.9 35.3 12.9 25.9 19.7 22.1 26.6 19.6 31.4 27.0 17.2 19.3 36.2 24.9 21.9 20.5 29.6 29.8 24.1 32.0 43.9 35.7 55.3 27.8 26.8 27.1 36.9 35.1 15.8 30.7 26.5 34.2 25.6 25.8 21.0 44.7 28.8 21.2 15.6 47.1 31.9 38.1 18.8 18.0 44.0 38.9 24.4 21.3 32.3 21.7 25.0 32.7 18.6 30.3 32.8 12.3 22.3 25.1 25.4 20.5 27.6 43.2 27.1 20.4 40.0 24.4 47.5 27.6 26.2 20.8 44.8 31.8 24.7 30.9 23.4 29.3 34.0 25.6 23.8 25.6 27.1 41.2 20.0 26.1 19.7 35.0 20.7 26.8 34.6 37.5 28.3 26.0 22.3 35.0 24.1 27.9 33.8 74.5 113.4 61.1 138.0 88.7 64.2 46.2 30.6 103.1 109.2 48.8 80.5 110.3 46.4 56.7 5.5 100.5 64.2 46.7 40.9 106.4 70.9 133.4 86.9 64.4 60.8 54.0 37.5 92.7 69.0 6.8 79.4 75.8 52.3 69.5 66.4 76.0 49.2 66.8 83.8 49.4 95.7 71.1 62.8 58.8 51.7 90.3 119.5 97.5 68.5 198.5 SRSF6 "B52, SFRS6, SRP55" ENSG00000124193 "Serine and arginine rich splicing factor 6" Q13247 20 43457928-43464247 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029005, CAB034889" Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "CAB034889: AB_785899, HPA029005: AB_10610424" "unprognostic (1.51e-1)" "unprognostic (1.26e-1)" "unprognostic (1.98e-1)" "unprognostic (3.25e-2)" "unprognostic (6.41e-2)" "unprognostic (3.91e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "unprognostic (1.27e-3)" "unprognostic (6.03e-3)" "prognostic unfavorable (2.82e-4)" "unprognostic (1.73e-1)" "unprognostic (2.70e-1)" "unprognostic (4.31e-1)" "unprognostic (1.18e-2)" 24.9 35.9 21.7 29.3 31.5 57.0 34.7 30.6 23.0 26.7 21.4 29.5 44.4 20.3 32.1 36.9 23.3 35.6 26.7 18.3 21.4 18.5 30.3 41.4 25.5 26.3 33.9 17.0 41.4 48.3 30.4 47.8 29.0 24.2 30.3 26.7 26.3 32.0 30.2 25.6 27.9 30.0 24.5 17.8 38.8 29.3 27.0 30.5 49.4 36.7 38.6 34.4 21.3 20.7 12.3 17.3 14.7 24.2 15.3 22.1 14.6 15.3 11.0 31.8 20.7 18.3 25.3 23.8 21.6 13.6 19.6 16.5 23.0 19.5 30.4 16.2 25.5 14.9 21.6 32.8 41.1 26.4 8.9 18.1 25.5 21.9 26.1 22.7 30.1 19.7 42.8 22.1 17.4 16.0 30.7 18.2 27.8 18.5 19.2 18.5 18.4 38.7 35.8 18.7 28.8 16.4 22.4 19.8 24.5 22.9 25.8 24.5 31.8 27.0 39.4 35.2 23.3 22.2 35.4 19.1 19.8 14.5 16.9 22.3 25.1 15.3 40.3 24.8 22.8 13.8 14.7 14.5 6.7 15.8 24.2 17.5 12.3 16.6 15.0 17.3 12.2 22.1 20.7 7.2 15.3 19.0 14.8 13.2 14.6 21.7 31.5 30.6 23.0 21.4 18.5 33.9 17.0 24.2 30.5 59.6 67.1 87.4 55.7 83.9 44.9 23.5 45.9 42.8 59.1 43.6 37.3 83.9 74.6 49.5 9.5 51.7 58.0 0.0 38.1 85.0 77.1 57.4 95.7 74.9 49.6 30.2 97.2 59.5 72.4 8.3 50.9 64.2 96.2 44.1 70.8 39.3 44.5 66.6 42.1 48.2 42.7 58.2 64.0 44.7 55.5 85.9 116.4 69.8 73.6 44.3 STK19 "D6S60, G11, RP1" ENSG00000204344 "Serine/threonine kinase 19" P49842 6 31971091-31982821 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 4.9;HEL: 3.6;HL-60: 3.8;REH: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031510, HPA031511, HPA068559" Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA031510: AB_10603119, HPA031511: AB_2673915, HPA068559: AB_2686004" "unprognostic (1.65e-1)" "unprognostic (2.30e-1)" "unprognostic (3.31e-1)" "unprognostic (1.86e-1)" "unprognostic (2.63e-1)" "unprognostic (1.67e-1)" "unprognostic (1.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.95e-2)" "unprognostic (2.76e-3)" "unprognostic (2.25e-2)" "unprognostic (1.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (2.40e-1)" "unprognostic (4.10e-1)" 6.4 8.2 3.8 4.3 6.5 2.9 4.0 9.9 6.3 5.7 6.6 5.5 4.2 2.2 6.0 5.5 5.3 3.5 5.3 3.6 5.0 3.5 3.9 6.6 4.1 2.5 4.3 7.5 5.7 12.4 4.7 4.6 6.3 4.0 6.2 2.7 5.6 2.9 6.7 6.1 6.8 2.6 5.9 3.7 7.0 6.3 7.9 4.2 2.6 4.7 4.1 3.8 4.4 4.2 2.1 2.7 0.4 3.8 0.9 1.1 0.5 0.0 0.3 0.0 1.1 3.0 1.7 0.0 2.4 0.3 0.5 1.1 0.0 2.0 1.5 0.6 1.2 0.0 2.1 0.0 0.6 0.9 4.9 0.9 3.6 1.0 0.2 1.5 3.8 0.0 1.6 0.1 0.9 0.3 1.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.6 0.1 0.0 4.5 2.5 1.2 0.0 0.0 1.0 0.9 0.3 0.6 0.2 0.0 1.7 0.0 0.0 0.0 1.1 1.1 0.0 0.1 2.3 0.1 1.9 0.6 0.1 0.0 3.8 0.1 0.6 1.4 0.7 2.1 0.9 0.1 2.7 1.0 1.1 0.5 0.4 0.9 1.4 1.5 0.1 0.5 3.8 6.5 9.9 6.3 5.0 3.5 4.3 7.5 4.0 4.2 8.9 19.2 8.6 14.6 11.6 11.5 7.5 10.2 33.5 22.7 21.0 19.6 30.1 33.2 22.2 63.7 15.8 13.1 0.0 24.4 16.5 21.1 11.5 9.2 19.6 16.6 9.5 18.6 13.5 11.9 51.4 18.7 8.9 16.9 8.2 15.4 23.5 20.7 14.4 17.3 132.6 19.7 32.3 16.9 29.9 17.8 15.8 41.5 21.8 11.2 9.8 SYF2 "CBPIN, DKFZp564O2082, fSAP29, NTC31, p29" ENSG00000117614 "SYF2 pre-mRNA splicing factor" O95926 1 25222679-25232502 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018265, HPA070710" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA018265: AB_10962002, HPA070710: AB_2686301" "unprognostic (4.19e-3)" "unprognostic (1.58e-2)" "unprognostic (9.98e-2)" "unprognostic (9.29e-2)" "unprognostic (1.21e-1)" "unprognostic (6.76e-2)" "unprognostic (6.76e-3)" "unprognostic (7.40e-3)" "unprognostic (2.36e-2)" "unprognostic (3.26e-1)" "unprognostic (1.33e-2)" "unprognostic (7.58e-2)" "unprognostic (4.89e-2)" "unprognostic (2.27e-2)" "unprognostic (4.80e-2)" "unprognostic (1.45e-3)" "prognostic favorable (5.72e-4)" 37.5 30.4 31.6 30.8 35.4 67.3 34.4 34.7 30.1 38.2 36.0 15.1 29.3 28.7 34.1 37.8 36.3 28.5 24.5 28.6 30.1 22.0 35.5 24.7 27.7 30.1 30.7 25.3 57.8 32.2 29.5 29.8 37.7 32.9 36.6 31.1 16.3 28.2 31.1 69.8 29.9 40.7 46.8 41.0 34.3 31.3 20.7 32.4 37.2 39.3 28.2 37.1 54.5 50.6 31.5 16.9 85.5 26.5 25.8 29.5 20.1 19.0 8.3 19.9 15.9 32.1 39.2 15.4 21.0 31.8 18.6 17.8 5.5 25.6 18.0 27.8 23.1 14.3 17.1 17.0 15.6 26.5 28.7 17.6 21.6 19.8 13.7 31.7 27.4 19.7 29.3 41.2 20.2 26.7 35.4 26.7 21.4 16.3 25.7 25.7 7.8 27.0 35.4 27.0 26.2 13.3 17.7 17.9 27.7 30.2 9.6 17.1 24.9 19.4 15.8 51.4 17.3 13.9 31.6 24.8 16.4 14.6 31.2 16.3 31.1 29.5 17.3 24.5 28.6 15.8 39.4 21.0 51.4 20.9 22.5 24.3 31.5 26.4 25.5 16.9 28.1 28.7 26.3 85.5 25.8 26.5 16.7 29.5 20.1 31.6 35.4 34.7 30.1 30.1 22.0 30.7 25.3 32.9 32.4 119.1 93.4 144.4 112.2 141.5 75.4 95.6 137.6 139.2 99.0 179.7 78.5 161.9 208.9 133.8 64.9 131.3 194.8 23.3 151.2 112.7 120.4 85.3 224.3 104.6 113.4 55.6 106.9 113.0 226.4 24.6 198.8 166.9 102.9 170.5 145.2 79.4 136.7 221.0 154.9 145.7 79.7 161.7 149.7 96.8 113.4 149.7 234.7 205.6 156.6 123.6 TADA2A "ADA2, ADA2A, hADA2, TADA2L" ENSG00000276234 "Transcriptional adaptor 2A" 17 37406874-37479730 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 76.3;Late spermatids: 56.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076497 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA076497: AB_2686801" "unprognostic (3.49e-1)" "unprognostic (5.12e-2)" "unprognostic (7.32e-2)" "unprognostic (7.86e-2)" "unprognostic (4.80e-1)" "unprognostic (1.23e-3)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (6.13e-3)" "unprognostic (8.18e-2)" "unprognostic (1.10e-3)" "unprognostic (7.81e-2)" "prognostic unfavorable (2.25e-5)" "unprognostic (4.38e-2)" "unprognostic (1.06e-1)" "unprognostic (2.56e-2)" "unprognostic (4.41e-2)" 3.9 1.7 2.5 5.1 7.0 3.8 3.2 6.6 11.1 4.8 4.2 5.7 3.0 3.3 5.9 5.5 3.7 4.2 3.5 3.4 4.0 2.7 2.4 4.2 4.2 2.8 5.0 3.8 5.7 4.5 5.7 3.6 6.5 3.9 5.9 6.1 4.4 3.4 7.3 6.7 4.4 6.5 3.0 4.5 3.0 12.4 3.6 5.8 4.6 2.0 5.5 3.4 1.7 10.2 11.4 5.6 7.4 3.9 8.4 3.5 0.8 5.8 6.4 4.4 3.5 3.8 6.2 3.6 3.7 6.5 4.4 7.0 0.0 11.6 5.5 1.9 8.0 8.8 7.8 4.7 8.6 7.6 6.6 6.0 7.1 3.5 4.8 9.0 3.6 3.1 4.4 6.9 3.6 3.5 6.1 14.4 9.3 3.3 7.9 2.8 16.1 7.5 4.3 2.8 3.9 11.2 17.7 8.7 4.0 5.5 7.2 6.4 4.6 2.4 4.2 6.0 7.7 3.3 4.9 7.1 6.0 4.9 5.4 5.2 5.3 13.7 6.9 4.1 5.8 3.2 5.6 5.6 8.4 5.9 5.9 5.9 5.3 6.3 6.3 10.2 8.0 7.3 0.5 3.9 7.4 11.4 4.2 3.5 6.0 5.7 3.7 6.6 2.3 14.5 6.4 7.6 16.0 13.6 8.7 15.7 12.1 1.7 6.0 76.3 8.7 3.8 0.0 5.2 8.5 5.7 4.2 9.3 3.0 7.0 22.3 4.1 4.9 5.3 56.1 7.5 7.2 1.7 11.8 6.3 10.6 5.7 3.5 7.4 4.4 20.9 12.9 3.1 13.5 35.0 2.9 4.2 6.5 6.9 3.3 TADA2B MGC21874 ENSG00000173011 "Transcriptional adaptor 2B" Q86TJ2 4 7041899-7057952 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 38.1;Rod photoreceptor cells: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035770 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035770: AB_10603993" "unprognostic (1.52e-1)" "unprognostic (1.50e-1)" "unprognostic (6.61e-2)" "unprognostic (2.77e-3)" "unprognostic (1.14e-2)" "unprognostic (1.70e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (2.99e-1)" "unprognostic (6.03e-2)" "unprognostic (8.91e-3)" "unprognostic (1.72e-1)" "prognostic favorable (7.17e-11)" "unprognostic (5.00e-2)" "unprognostic (1.58e-1)" "unprognostic (2.59e-2)" "prognostic favorable (1.59e-4)" 8.7 15.0 10.9 12.9 15.3 24.0 13.9 12.5 16.0 10.5 10.6 7.5 12.4 10.2 11.5 8.8 11.4 11.0 11.0 15.6 10.9 7.0 12.9 13.6 8.9 12.4 8.3 9.8 15.8 26.2 10.8 9.0 12.6 9.9 10.2 8.0 17.0 20.5 10.8 42.8 10.6 11.3 10.4 6.6 12.4 11.9 13.0 8.9 9.8 12.8 12.7 10.4 10.6 12.8 3.7 2.1 10.3 3.0 2.1 4.4 1.8 8.6 13.2 9.2 10.9 10.3 11.8 8.9 12.8 13.1 16.5 10.2 12.9 13.0 11.5 7.6 14.1 21.9 7.1 12.7 6.7 10.7 6.8 9.7 11.7 8.2 9.7 12.6 13.4 19.2 8.5 14.4 11.0 12.8 11.4 7.6 10.8 13.0 18.7 12.3 8.2 16.1 11.5 11.0 11.6 20.5 10.6 19.0 6.0 15.2 12.2 15.2 10.9 11.0 9.9 13.0 7.8 14.9 20.2 11.8 10.5 8.1 12.7 17.3 17.0 14.2 15.1 8.6 7.3 10.6 1.1 2.2 10.3 4.4 2.6 3.2 3.7 2.9 4.4 1.9 2.7 3.9 2.9 7.1 2.1 3.0 2.1 3.0 1.8 10.9 15.3 12.5 16.0 10.9 7.0 8.3 9.8 9.9 8.9 8.9 15.9 2.2 2.7 4.0 27.8 10.5 5.1 6.7 12.5 7.0 29.5 3.2 5.0 3.9 2.1 3.8 6.6 0.0 8.0 2.5 6.1 4.8 9.2 14.7 4.9 38.1 6.9 2.5 7.9 3.4 15.5 6.0 6.8 3.6 8.7 8.3 6.6 7.0 12.0 6.9 35.0 0.0 2.8 5.9 4.2 5.1 3.7 6.9 5.8 4.7 TARBP1 "TRM3, TRMT3, TRP-185" ENSG00000059588 "TAR (HIV-1) RNA binding protein 1" Q13395 1 234391313-234479103 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020810, HPA024632" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "CAB020810: , HPA024632: AB_1857770" "unprognostic (3.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.75e-1)" "unprognostic (3.47e-1)" "unprognostic (8.26e-2)" "unprognostic (2.44e-3)" "unprognostic (8.45e-3)" "unprognostic (5.22e-3)" "unprognostic (3.72e-2)" "unprognostic (5.52e-2)" "unprognostic (2.56e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (5.14e-10)" "unprognostic (5.72e-2)" "unprognostic (1.82e-1)" "unprognostic (4.38e-2)" "unprognostic (4.27e-2)" 7.2 6.7 10.3 10.5 19.4 12.0 11.4 22.5 22.9 6.5 7.3 10.5 3.0 7.8 7.2 9.8 10.7 10.0 11.3 6.6 7.1 6.8 7.0 4.7 7.6 11.9 6.6 18.2 5.7 12.7 12.9 12.1 10.1 13.0 9.5 11.4 8.7 12.8 5.8 11.0 10.1 8.9 5.7 8.0 8.7 10.2 5.6 6.4 8.7 10.1 6.2 13.6 5.5 7.7 1.2 4.0 0.0 0.3 0.9 1.9 0.2 11.5 8.1 5.4 6.2 8.9 12.3 11.1 4.9 3.8 6.5 4.8 3.8 7.6 10.0 5.3 3.7 5.6 7.6 6.1 6.2 6.3 9.8 9.4 5.5 8.5 5.6 2.8 24.2 4.9 5.1 5.7 4.7 2.6 5.1 6.6 13.6 6.9 6.5 4.5 2.4 10.0 11.9 11.3 12.5 3.3 17.6 3.1 9.9 4.4 6.8 5.7 6.8 6.8 8.9 7.5 3.7 5.7 24.8 4.4 6.0 0.7 6.6 9.9 17.4 11.4 4.4 3.9 11.4 8.9 0.0 0.3 0.0 0.6 0.3 0.9 1.2 0.4 0.4 0.4 0.3 1.9 1.1 0.0 0.9 0.1 4.0 0.0 0.2 10.3 19.4 22.5 22.9 7.1 6.8 6.6 18.2 13.0 6.4 38.7 17.7 11.9 3.5 5.6 29.8 5.2 10.2 30.8 14.8 7.0 35.3 16.9 1.7 4.3 12.6 9.2 4.2 0.0 5.0 12.3 8.0 4.6 3.5 7.6 7.8 54.0 11.1 11.1 5.3 1.5 5.2 9.1 10.1 2.8 11.2 8.2 7.1 3.5 5.6 3.3 17.9 0.0 7.6 3.5 5.1 7.2 10.0 11.8 17.6 4.6 TATDN2 KIAA0218 ENSG00000157014 "TatD DNase domain containing 2" Q93075 3 10248023-10281218 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA036822 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036822: AB_10671972" "unprognostic (4.51e-2)" "unprognostic (2.66e-3)" "unprognostic (2.75e-1)" "unprognostic (4.23e-2)" "unprognostic (9.88e-2)" "unprognostic (1.58e-2)" "unprognostic (2.57e-3)" "unprognostic (8.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.63e-1)" "prognostic favorable (4.66e-4)" "unprognostic (3.25e-1)" "unprognostic (1.87e-1)" "unprognostic (2.55e-2)" "unprognostic (1.70e-1)" "unprognostic (3.33e-1)" "unprognostic (2.48e-2)" 12.0 13.1 20.4 16.2 22.8 32.8 14.3 17.5 31.6 15.5 13.8 15.8 17.5 14.2 17.2 17.9 16.4 12.6 14.5 13.8 18.3 14.0 14.3 12.2 14.3 21.6 13.7 19.2 22.4 20.8 25.8 16.9 11.1 13.8 17.6 17.2 16.2 20.4 15.3 12.0 19.5 15.2 15.8 13.0 20.6 13.7 10.1 13.5 37.5 18.8 8.6 25.2 12.5 15.2 3.3 3.5 2.5 2.5 2.2 6.0 2.3 9.5 16.1 9.0 7.6 11.6 12.8 38.2 11.5 12.1 15.4 10.1 11.7 8.6 23.3 8.8 17.1 16.2 7.0 15.6 11.0 12.4 14.7 17.8 12.3 15.7 12.4 7.7 17.1 12.9 9.7 12.4 21.7 7.2 10.1 12.5 14.4 13.6 21.2 14.1 18.4 22.6 14.3 12.3 12.8 16.1 12.3 9.6 13.3 9.7 13.9 9.9 11.7 9.8 11.7 5.3 8.9 11.4 16.1 10.1 18.0 11.5 14.6 20.7 13.0 21.2 41.5 15.7 17.5 12.1 2.5 1.6 1.2 4.6 2.5 4.5 2.5 3.9 3.7 1.5 3.3 4.0 6.0 1.3 2.2 1.3 3.5 4.4 2.3 20.4 22.8 17.5 31.6 18.3 14.0 13.7 19.2 13.8 13.5 6.0 14.1 6.5 3.7 11.2 4.4 5.0 12.7 1.4 4.5 10.4 5.9 3.0 1.7 4.8 1.3 7.1 6.2 0.0 7.8 3.4 7.2 8.4 4.7 10.2 8.7 4.8 16.1 9.2 12.3 1.5 6.6 7.7 13.5 1.8 8.9 4.1 6.7 0.0 7.1 4.4 2.7 6.5 4.1 1.7 5.1 10.8 2.1 14.9 9.3 6.4 TBX19 "dj747L4.1, TPIT" ENSG00000143178 "T-box 19" O60806 1 168281040-168314426 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "pituitary gland: 50.4" "Cell type enhanced" "Detected in many" 5 "granulocytes: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 9.4;HDLM-2: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005800, HPA072686" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA005800: AB_1080219, HPA072686: AB_2732209" "unprognostic (2.47e-1)" "unprognostic (1.20e-2)" "unprognostic (8.76e-4)" "unprognostic (1.43e-2)" "unprognostic (3.09e-2)" "unprognostic (8.36e-2)" "unprognostic (7.14e-7)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (5.58e-2)" "unprognostic (9.78e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (4.55e-9)" "unprognostic (8.57e-2)" "unprognostic (6.63e-2)" "unprognostic (9.06e-2)" "unprognostic (1.05e-2)" 1.0 0.4 1.0 1.0 1.0 0.5 2.5 1.0 1.0 1.5 1.3 1.0 1.0 0.8 5.3 1.0 1.1 2.0 1.4 1.0 1.0 0.8 1.0 1.0 2.2 2.1 1.0 1.0 2.9 1.0 0.2 50.4 1.0 1.0 1.2 1.1 1.0 2.2 1.4 1.0 1.9 1.0 3.6 1.0 2.1 0.6 1.0 1.0 1.0 1.0 1.0 1.3 1.3 1.2 1.6 6.3 2.7 2.4 2.6 3.1 1.3 1.6 0.1 1.4 5.3 2.5 1.2 1.7 2.9 1.5 1.0 1.6 2.4 1.7 1.5 2.9 1.1 1.5 9.4 0.8 0.7 1.4 8.1 1.4 0.3 1.7 0.7 2.9 2.6 3.6 2.2 2.6 0.3 1.5 2.6 1.2 0.6 1.8 2.4 1.3 0.3 1.4 2.4 0.4 5.6 1.0 2.2 0.7 0.5 2.3 0.7 1.9 2.8 1.6 1.2 1.6 2.4 0.4 2.2 2.1 1.0 2.4 2.0 2.9 1.6 1.3 1.2 0.2 0.8 2.8 0.5 1.8 0.8 3.1 1.3 1.4 1.2 2.2 2.0 1.8 1.6 1.5 1.3 2.7 2.6 2.4 6.3 2.0 1.3 1.0 1.0 1.0 1.0 1.0 0.8 1.0 1.0 1.0 1.0 0.0 0.3 0.0 1.1 2.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.5 2.7 0.9 0.0 0.3 0.2 2.3 3.4 4.6 0.5 1.1 0.0 1.2 0.0 2.1 0.4 3.1 2.8 0.0 2.8 0.7 0.8 1.4 0.0 2.5 0.3 0.0 0.0 0.8 0.5 0.7 2.9 0.1 1.8 0.8 2.0 TCEANC MGC17403 ENSG00000176896 "Transcription elongation factor A N-terminal and central domain containing" Q8N8B7 X 13653189-13681964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000337, HPA001013" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA000337: , HPA001013: AB_1079371" "unprognostic (1.44e-1)" "unprognostic (2.21e-3)" "unprognostic (1.74e-2)" "unprognostic (4.45e-2)" "unprognostic (2.21e-3)" "unprognostic (2.29e-3)" "unprognostic (4.03e-2)" "unprognostic (4.29e-6)" "unprognostic (3.82e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-5)" "unprognostic (1.68e-1)" "unprognostic (1.25e-3)" "unprognostic (1.19e-1)" "unprognostic (1.38e-1)" "unprognostic (5.10e-3)" "unprognostic (1.11e-4)" 2.2 2.4 2.1 1.1 2.1 6.3 3.9 3.3 1.8 2.1 1.6 1.3 2.3 5.0 1.1 2.8 1.2 2.0 1.9 2.3 2.1 2.8 2.5 3.6 2.1 4.1 2.7 1.6 2.3 1.5 2.1 2.1 2.3 1.7 2.6 2.0 2.5 2.1 2.4 4.4 1.9 1.0 3.1 2.8 1.9 1.6 5.6 3.7 9.9 2.7 2.4 6.1 3.1 0.7 2.2 2.4 4.2 5.2 6.1 0.9 0.7 1.9 2.0 0.9 0.8 1.7 2.5 2.3 1.6 1.2 1.2 2.1 1.2 0.5 2.6 3.1 1.4 1.3 1.1 2.8 2.0 2.5 5.2 2.0 1.1 8.5 2.9 0.6 2.6 2.5 4.3 2.8 1.8 3.3 2.0 3.2 1.2 0.6 2.6 2.2 5.2 1.1 1.3 2.5 2.3 2.2 2.3 3.0 3.1 2.4 1.9 1.1 1.7 0.9 1.7 0.3 3.5 2.0 1.7 2.5 1.2 0.9 9.9 2.7 6.8 4.7 2.2 5.1 5.6 5.1 6.1 2.2 5.2 6.1 5.6 3.4 2.4 2.4 3.7 5.8 3.1 0.0 1.4 1.4 0.9 0.2 3.3 2.4 2.5 1.4 2.3 3.5 2.0 1.6 3.3 1.2 0.0 1.6 1.3 0.0 0.8 0.9 1.4 1.7 4.7 3.4 1.7 1.6 2.4 1.3 2.1 0.0 3.1 2.5 0.0 2.8 1.5 4.8 0.4 1.5 2.1 2.5 2.4 0.0 1.2 1.1 0.4 0.3 2.7 3.5 1.3 0.7 TCF15 "bHLHa40, EC2, PARAXIS" ENSG00000125878 "Transcription factor 15" Q12870 20 603797-610398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 11.4;heart muscle: 19.4;skeletal muscle: 18.0" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 8.5;Endothelial cells: 4.3;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 10.9;HMC-1: 17.9;SuSa: 3.3;U-2 OS: 3.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050998, HPA060221" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA050998: AB_2681302, HPA060221: AB_2684225" "unprognostic (2.12e-2)" "unprognostic (1.96e-2)" "unprognostic (1.58e-2)" "unprognostic (3.55e-2)" "unprognostic (1.29e-1)" "unprognostic (4.62e-2)" "unprognostic (5.57e-2)" "unprognostic (2.33e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.52e-1)" "unprognostic (9.43e-2)" "unprognostic (1.27e-3)" "unprognostic (7.21e-2)" "unprognostic (8.56e-2)" "unprognostic (5.11e-1)" "unprognostic (6.99e-2)" 8.4 0.3 0.9 0.4 1.0 0.2 11.4 0.1 1.1 0.6 1.3 0.1 0.0 0.4 0.8 0.3 1.7 0.4 0.7 19.4 1.2 0.7 0.5 0.3 0.9 0.3 1.0 0.0 0.2 0.1 0.4 0.3 8.2 0.7 1.0 0.3 0.3 0.8 0.3 18.0 0.2 0.4 1.3 1.1 0.2 0.4 1.6 0.6 0.2 1.3 6.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.1 10.9 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 1.6 0.0 1.4 0.0 3.3 0.0 1.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.1 1.1 1.2 0.7 1.0 0.0 0.7 0.6 0.0 0.0 0.0 0.1 0.1 0.4 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.6 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 12.9 1.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 TCF23 "bHLHa24, OUT" ENSG00000163792 "Transcription factor 23" Q7RTU1 2 27149004-27156974 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 28.0;endometrium 1: 56.4;ovary: 49.9" "Group enriched" "Detected in some" 4 "Peritubular cells: 27.3;Sertoli cells: 51.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in single" 10 "THP-1: 8.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044596 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA044596: AB_10797258" "unprognostic (1.04e-1)" "unprognostic (2.47e-3)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (3.65e-2)" "unprognostic (2.68e-2)" "unprognostic (1.70e-2)" "unprognostic (4.07e-2)" "unprognostic (3.21e-1)" "unprognostic (1.74e-2)" "unprognostic (4.08e-2)" "unprognostic (8.58e-2)" "unprognostic (2.41e-5)" "unprognostic (7.58e-3)" "unprognostic (3.01e-1)" "unprognostic (8.58e-4)" "unprognostic (2.64e-2)" 0.3 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.1 28.0 0.5 0.0 0.5 0.0 56.4 7.2 0.1 14.0 0.4 0.6 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 49.9 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 16.7 0.1 6.2 0.1 7.5 0.0 0.0 0.1 0.0 0.0 0.7 1.5 1.8 1.4 4.4 1.0 1.3 1.2 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.4 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.5 0.1 0.6 0.3 0.0 0.1 0.9 0.1 0.7 0.0 0.3 0.2 0.1 0.2 0.3 0.1 0.3 0.3 8.8 0.0 0.2 0.2 0.3 0.2 0.1 0.0 0.2 0.1 0.3 0.0 4.4 1.0 0.9 1.0 0.5 0.8 1.1 1.1 0.8 0.2 1.8 1.2 1.0 3.9 1.3 0.5 1.4 0.6 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 2.1 0.0 0.5 0.0 0.1 0.6 0.0 0.0 1.2 0.0 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 1.8 0.3 0.7 9.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 27.3 0.0 0.5 51.8 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.5 TCP11L2 MGC40368 ENSG00000166046 "T-complex 11 like 2" Q8N4U5 12 106301929-106347015 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 21.6;Horizontal cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 32.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 32.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039483, HPA042188" Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA039483: AB_10795291, HPA042188: AB_10794415" "unprognostic (1.41e-1)" "unprognostic (3.17e-1)" "unprognostic (1.24e-1)" "unprognostic (8.15e-2)" "unprognostic (1.97e-1)" "prognostic favorable (9.52e-4)" "unprognostic (3.87e-3)" "unprognostic (2.43e-1)" "unprognostic (2.11e-1)" "unprognostic (9.05e-3)" "unprognostic (5.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-2)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (5.02e-2)" "unprognostic (3.67e-1)" 9.1 12.0 8.1 6.2 18.2 22.3 9.0 10.4 13.0 9.7 8.6 31.5 3.3 6.2 10.3 7.1 20.1 11.6 8.1 18.9 8.3 5.8 6.1 5.6 14.4 12.9 22.2 9.4 9.7 8.6 11.1 7.2 12.3 16.2 7.5 7.9 9.5 15.9 5.9 18.0 14.0 10.3 10.2 14.6 10.2 10.2 8.7 18.4 16.4 12.2 6.3 14.0 11.3 11.8 6.2 0.8 32.1 3.2 1.9 6.3 1.7 2.5 6.2 0.9 1.8 8.6 10.0 3.9 1.6 8.0 1.0 2.6 1.0 3.3 0.8 2.5 6.2 2.4 11.7 0.8 3.5 1.9 1.3 2.6 0.5 2.4 3.8 8.4 0.2 1.7 12.5 8.1 1.2 6.1 20.0 5.8 4.6 1.5 1.2 1.4 1.8 1.5 1.3 1.1 3.3 3.9 0.7 0.2 2.8 8.1 11.6 3.9 2.8 4.2 1.3 4.8 6.9 3.6 0.3 4.4 1.5 1.3 2.2 0.4 7.8 0.6 3.0 4.2 0.2 0.7 10.8 3.2 4.9 2.4 1.4 1.8 6.2 4.9 2.7 0.8 5.7 6.3 4.1 32.1 1.9 2.2 0.6 5.6 1.7 8.1 18.2 10.4 13.0 8.3 5.8 22.2 9.4 16.2 18.4 11.9 11.8 9.3 3.0 1.0 7.0 8.5 0.0 16.0 10.3 3.5 21.6 1.2 1.7 2.6 4.2 7.7 3.3 0.0 2.2 0.6 2.9 3.7 2.3 1.3 1.2 20.6 4.1 3.1 1.5 3.3 5.5 3.3 3.3 3.6 3.1 3.1 2.9 3.5 2.5 0.8 13.8 12.9 2.8 1.5 2.1 2.3 12.6 4.3 1.5 2.6 THOC1 "HPR1, P84" ENSG00000079134 "THO complex 1" Q96FV9 18 214520-268050 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019096, HPA019687" Enhanced Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA019096: AB_1857979, HPA019687: AB_1857980" "prognostic favorable (8.43e-4)" "unprognostic (2.06e-3)" "unprognostic (1.84e-1)" "unprognostic (3.69e-2)" "unprognostic (8.75e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.83e-5)" "unprognostic (6.74e-3)" "unprognostic (2.49e-3)" "prognostic favorable (2.89e-5)" "unprognostic (3.60e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (1.80e-6)" "unprognostic (2.03e-1)" "unprognostic (2.24e-1)" "unprognostic (3.42e-1)" "prognostic favorable (9.62e-4)" 11.9 9.1 11.8 12.5 14.5 10.7 7.7 19.0 12.5 10.5 10.7 12.3 10.9 10.4 15.5 8.1 13.4 8.2 7.7 8.5 10.9 9.9 11.6 16.5 7.1 17.6 18.1 7.6 9.9 8.1 11.1 23.3 9.6 11.5 8.4 8.7 8.9 10.4 7.6 12.1 9.1 9.4 10.8 14.2 12.8 9.6 26.3 17.7 16.2 9.2 7.8 17.8 14.6 7.8 11.7 11.0 9.1 9.7 9.7 14.2 6.4 12.7 6.9 16.1 13.5 10.2 7.4 20.0 7.0 7.0 15.3 16.0 14.2 8.3 18.2 5.9 9.8 23.0 8.4 20.8 11.7 18.9 5.8 9.0 11.0 9.1 9.5 8.1 25.0 10.2 4.9 7.2 16.3 10.6 6.6 16.3 16.0 24.9 8.7 13.2 9.6 18.2 14.2 15.9 16.5 10.2 25.6 15.5 16.6 8.4 12.5 10.9 8.2 19.7 10.2 11.7 19.2 6.9 17.8 8.2 13.7 14.7 10.9 23.2 7.1 12.2 26.7 11.6 17.3 11.7 9.1 6.7 5.7 9.5 9.7 14.2 11.7 11.6 12.0 11.0 9.5 13.6 13.3 0.7 9.7 7.8 6.5 11.4 6.4 11.8 14.5 19.0 12.5 10.9 9.9 18.1 7.6 11.5 17.7 17.9 9.4 6.2 13.1 11.4 30.6 7.8 2.5 9.4 18.2 10.4 19.6 20.5 13.3 14.2 47.4 13.4 4.5 0.0 7.0 13.3 10.4 10.2 26.5 10.5 13.7 27.0 9.1 7.4 6.3 5.6 17.8 13.1 3.3 10.8 7.1 13.8 10.7 8.7 15.9 6.8 25.5 6.5 11.3 57.7 26.8 8.0 15.7 17.9 13.2 10.8 THRAP3 "BCLAF2, TRAP150" ENSG00000054118 "Thyroid hormone receptor associated protein 3" Q9Y2W1 1 36224416-36305357 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012041, CAB017472, HPA063765" Supported Enhanced "Nuclear speckles" NA NA 22000 "Nuclear speckles" "CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: AB_2685117" "unprognostic (8.53e-2)" "unprognostic (1.68e-1)" "unprognostic (9.29e-2)" "unprognostic (2.11e-1)" "unprognostic (1.71e-2)" "unprognostic (4.70e-2)" "unprognostic (2.65e-3)" "unprognostic (1.67e-1)" "unprognostic (9.30e-2)" "unprognostic (1.16e-1)" "unprognostic (5.08e-2)" "unprognostic (4.82e-2)" "unprognostic (3.34e-2)" "prognostic favorable (5.36e-4)" "unprognostic (7.56e-2)" "unprognostic (7.52e-2)" "unprognostic (1.23e-1)" 33.9 30.5 19.8 27.2 28.5 26.8 27.0 30.7 33.7 25.5 26.6 28.4 24.8 20.2 30.2 23.6 29.7 25.1 21.5 28.1 19.7 20.2 25.2 37.1 24.6 32.4 21.2 20.1 29.6 24.8 38.6 32.6 35.6 28.5 32.1 24.1 26.3 27.4 23.7 79.1 27.0 29.3 27.6 20.7 32.6 26.5 23.8 22.2 57.4 29.0 28.6 38.8 27.4 26.1 36.2 23.1 49.3 24.0 25.2 29.8 22.2 31.3 20.3 35.0 29.8 28.0 22.8 29.3 33.8 34.1 34.1 35.2 23.8 28.9 58.5 12.8 34.8 24.1 29.1 39.0 32.8 42.7 30.1 21.9 48.5 31.4 25.1 30.5 49.2 32.7 34.9 20.7 34.6 29.4 23.5 37.4 35.5 40.1 30.4 24.4 17.8 52.9 27.3 41.4 19.5 16.0 50.7 41.5 31.2 24.4 44.5 22.2 26.5 38.6 25.0 28.0 35.4 23.1 21.1 39.4 28.4 33.0 26.4 35.4 18.2 32.0 53.2 26.7 33.7 29.5 36.6 20.1 36.7 29.8 24.0 25.2 32.2 25.3 26.0 22.7 36.2 26.8 23.3 49.3 25.2 23.8 23.1 21.3 22.2 19.8 28.5 30.7 33.7 19.7 20.2 21.2 20.1 28.5 22.2 107.2 81.4 114.8 82.1 50.5 89.2 98.7 56.0 99.0 85.3 45.4 29.5 126.9 82.9 123.3 5.3 83.5 50.1 46.7 91.4 130.0 82.0 97.4 88.1 63.2 88.9 82.6 69.5 65.1 67.8 7.8 74.2 78.2 69.2 174.1 63.3 132.3 90.9 52.6 78.5 58.7 85.1 90.5 82.4 132.9 116.0 59.8 120.5 106.5 79.1 64.3 TMEM179B ENSG00000185475 "Transmembrane protein 179B" Q7Z7N9 11 62787415-62790405 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016585, HPA062068" Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA016585: AB_1844357, HPA062068: AB_2684676" "unprognostic (1.18e-2)" "unprognostic (2.83e-1)" "unprognostic (2.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.68e-1)" "unprognostic (6.11e-3)" "unprognostic (1.96e-2)" "unprognostic (2.35e-1)" "unprognostic (2.44e-1)" "unprognostic (1.25e-2)" "unprognostic (4.61e-3)" "unprognostic (2.76e-2)" "unprognostic (4.56e-1)" "unprognostic (1.64e-1)" "unprognostic (2.16e-1)" "unprognostic (5.74e-3)" "unprognostic (3.60e-2)" 26.1 34.6 13.2 19.5 15.7 13.4 36.0 6.3 15.4 24.9 31.3 23.7 37.7 24.5 27.8 53.6 24.9 28.9 35.0 21.8 12.9 11.1 43.1 55.4 39.0 43.2 17.1 9.8 27.4 47.1 15.5 17.5 39.8 20.9 28.8 29.3 28.0 55.1 54.2 16.7 29.7 44.2 20.4 19.9 30.4 26.5 29.4 14.8 25.5 44.9 21.2 28.2 24.1 24.0 35.5 80.6 70.4 67.6 28.3 35.4 53.5 12.6 25.8 6.4 12.7 50.4 12.8 7.9 13.9 17.1 11.0 12.6 14.7 29.4 5.8 19.9 27.4 15.9 23.2 11.8 12.5 8.5 17.2 16.8 8.4 11.7 13.4 34.0 10.6 11.8 24.6 20.3 20.7 25.6 21.9 11.0 17.3 11.6 16.6 12.4 28.8 13.6 20.6 9.6 26.6 28.5 9.3 10.3 30.2 20.5 15.6 8.8 9.7 17.9 23.2 23.7 13.4 27.1 13.1 14.2 14.4 10.8 26.4 11.4 19.0 11.2 7.5 20.8 6.5 16.7 52.6 67.6 70.4 35.4 64.9 34.8 35.5 32.5 33.9 43.2 31.5 28.9 28.5 49.9 28.3 61.8 80.6 31.3 53.5 13.2 15.7 6.3 15.4 12.9 11.1 17.1 9.8 20.9 14.8 56.6 43.3 42.5 61.1 61.0 12.3 1.1 63.7 73.6 54.6 57.6 0.0 154.6 31.5 119.9 4.5 76.8 91.9 23.3 131.2 131.6 80.8 88.4 54.2 69.2 120.1 7.9 62.6 65.1 70.8 7.8 70.2 79.2 101.3 101.0 82.1 70.3 107.6 133.3 43.2 73.2 12.7 64.7 35.0 93.4 90.3 66.5 154.8 55.4 88.9 75.9 TMEM56 FLJ31842 ENSG00000152078 "Transmembrane protein 56" Q96MV1 1 95117338-95197607 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.2" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 68.8;Erythroid cells: 186.9;Hepatocytes: 246.3" "Cancer enhanced" "Detected in many" "liver cancer: 13.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 3.3;naive B-cell: 1.6;neutrophil: 1.0" "Group enriched" "Detected in many" 6 "B-cells: 3.3;granulocytes: 1.0" "Cell line enhanced" "Detected in many" "A-431: 13.9;GAMG: 13.1;RH-30: 23.2" HPA046762 Approved "Nuclear speckles" No No "Nuclear speckles" "HPA046762: AB_2679792" "unprognostic (1.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.98e-3)" "unprognostic (2.79e-1)" "unprognostic (3.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.82e-3)" "unprognostic (3.63e-2)" "unprognostic (4.42e-3)" "unprognostic (2.69e-2)" "unprognostic (4.99e-2)" "unprognostic (4.40e-2)" "unprognostic (1.16e-3)" "unprognostic (1.10e-1)" "unprognostic (9.46e-2)" "unprognostic (1.59e-1)" "unprognostic (3.15e-2)" 3.3 6.6 6.1 1.6 6.5 10.4 2.0 10.9 10.6 2.0 8.2 3.8 2.8 3.6 2.5 2.1 1.9 2.2 4.5 15.1 4.2 3.2 3.9 74.2 2.6 0.7 3.5 5.7 1.5 6.5 5.4 6.8 3.1 4.7 3.8 6.6 28.1 4.8 2.7 7.2 1.7 6.6 8.1 4.1 1.0 3.9 3.2 3.2 0.0 4.8 1.7 0.8 4.8 3.1 3.3 0.1 1.0 0.1 0.0 0.3 0.1 13.9 8.0 1.1 1.7 0.5 0.0 1.9 0.5 0.3 1.8 4.3 5.8 6.7 0.0 7.0 0.2 13.1 0.1 4.7 0.7 3.2 9.7 2.6 0.3 6.8 1.2 0.5 0.2 0.4 0.8 0.2 1.4 0.0 2.9 0.0 0.8 12.2 0.7 0.4 1.1 0.8 0.0 1.1 0.4 4.4 0.0 23.2 0.3 7.8 9.1 2.9 2.3 9.9 7.0 4.1 1.2 7.6 0.2 0.1 0.2 6.0 0.7 4.9 2.5 4.8 0.0 1.0 0.0 1.4 0.3 0.1 0.1 0.1 0.0 0.0 3.3 0.2 0.2 0.0 1.6 0.3 0.1 1.0 0.0 0.0 0.1 0.1 0.1 6.1 6.5 10.9 10.6 4.2 3.2 3.5 5.7 4.7 3.2 6.0 22.6 10.7 4.2 1.0 3.2 68.8 25.5 4.0 3.4 14.0 0.0 6.6 1.7 13.6 13.9 1.0 39.2 186.9 21.0 1.3 5.1 21.2 0.0 246.3 0.5 0.0 15.6 17.2 5.0 36.7 2.6 0.0 1.7 0.0 18.7 37.5 10.3 13.6 2.1 12.4 1.0 6.5 4.2 3.3 6.0 0.4 3.8 1.0 13.3 4.2 TRIP12 KIAA0045 ENSG00000153827 "Thyroid hormone receptor interactor 12" Q14669 2 229763838-229923239 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036835, HPA045893" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036835: AB_2675340, HPA045893: AB_2679486" "unprognostic (1.22e-1)" "unprognostic (4.87e-2)" "unprognostic (2.61e-1)" "unprognostic (3.33e-2)" "unprognostic (6.81e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.37e-3)" "unprognostic (3.49e-3)" "unprognostic (4.87e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (1.62e-1)" "unprognostic (6.83e-2)" "unprognostic (8.80e-2)" "unprognostic (2.01e-2)" 29.6 28.1 23.6 25.4 26.9 26.9 23.1 20.5 26.2 24.0 23.1 26.2 24.3 14.3 25.3 26.3 30.6 19.9 20.7 35.9 19.0 19.3 26.2 24.9 26.2 26.5 23.1 20.5 24.3 18.8 32.4 33.1 27.2 24.8 25.8 21.3 22.3 25.5 22.0 62.7 23.6 22.0 26.2 23.3 32.5 23.4 77.1 24.0 42.2 28.0 21.5 31.5 26.5 27.4 7.0 9.1 25.8 12.0 9.1 12.7 6.1 24.1 27.3 25.1 21.0 23.9 29.1 23.3 37.4 25.3 27.1 30.2 21.9 19.4 9.4 27.4 33.3 34.8 18.9 36.5 26.6 39.7 38.7 13.3 65.8 22.9 19.3 20.7 49.4 43.0 25.2 20.5 45.0 28.9 21.1 35.3 23.8 48.6 10.2 30.9 18.4 27.6 17.1 19.6 12.3 12.5 25.1 49.5 8.3 20.1 41.6 25.5 18.2 0.5 12.5 25.7 22.8 12.7 30.3 49.0 35.2 25.0 22.8 28.8 17.7 20.2 30.9 26.8 19.5 29.4 18.8 9.9 15.7 9.5 11.3 9.7 7.0 8.8 9.2 9.1 6.8 7.3 7.0 25.8 9.1 12.0 9.0 12.7 6.1 23.6 26.9 20.5 26.2 19.0 19.3 23.1 20.5 24.8 24.0 83.4 49.3 17.2 24.2 27.5 29.6 80.3 38.2 65.6 51.2 29.6 49.1 23.6 13.3 31.9 89.6 47.2 37.6 0.0 38.7 20.9 28.2 43.4 37.1 48.3 30.9 39.7 17.9 58.3 81.5 79.5 32.2 36.5 25.3 26.2 30.2 28.2 45.3 32.3 42.8 26.2 32.5 19.4 30.1 113.9 53.0 31.7 35.5 27.7 25.5 54.5 UBE4A "E4, KIAA0126, UBOX2, UFD2" ENSG00000110344 "Ubiquitination factor E4A" Q14139 11 118359585-118399211 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055035, HPA064010" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA055035: AB_2682679, HPA064010: AB_2685174" "unprognostic (1.32e-2)" "unprognostic (8.15e-2)" "unprognostic (5.23e-3)" "unprognostic (3.34e-1)" "unprognostic (2.80e-2)" "unprognostic (1.97e-1)" "unprognostic (7.67e-3)" "unprognostic (3.31e-1)" "unprognostic (1.30e-1)" "unprognostic (4.67e-2)" "unprognostic (6.01e-2)" "unprognostic (5.83e-2)" "unprognostic (7.73e-3)" "unprognostic (4.74e-2)" "unprognostic (5.94e-2)" "unprognostic (2.72e-1)" "unprognostic (8.86e-2)" 19.3 18.5 17.7 20.5 30.1 16.6 19.7 49.4 36.6 19.0 18.5 33.0 16.1 20.3 23.2 21.2 21.2 19.8 17.0 20.3 17.7 18.8 20.3 29.5 18.4 22.2 25.7 25.7 24.2 26.7 31.1 24.2 18.6 35.5 21.5 23.1 21.2 20.3 17.2 32.5 25.6 23.7 19.9 25.5 24.0 25.5 21.8 27.5 22.1 22.1 15.1 22.6 21.6 20.4 5.7 11.0 14.6 13.2 7.1 9.0 5.2 9.3 9.1 11.7 11.6 20.3 18.8 11.6 13.9 14.5 10.3 12.6 25.1 23.0 19.7 26.8 17.4 13.9 20.7 16.4 13.1 17.2 11.1 7.6 32.3 8.1 12.8 17.5 18.2 24.8 18.9 9.5 21.1 20.7 13.8 17.1 17.4 18.3 18.6 14.8 17.6 15.5 18.2 10.8 18.9 11.7 9.9 16.9 20.1 11.3 21.9 10.6 11.1 20.0 17.4 6.1 13.3 23.2 8.3 17.6 15.3 10.1 13.0 11.5 5.5 6.7 18.8 8.5 21.1 15.7 14.6 10.9 10.5 9.0 12.0 6.9 5.7 6.9 6.4 11.0 4.3 7.4 6.6 11.0 7.1 13.2 6.5 7.7 5.2 17.7 30.1 49.4 36.6 17.7 18.8 25.7 25.7 35.5 27.5 11.9 26.4 13.7 19.3 23.8 18.0 14.9 15.3 37.5 22.7 14.0 17.7 16.7 5.0 16.7 12.4 18.0 17.7 23.3 24.6 14.8 17.7 22.8 10.4 40.3 19.1 15.9 17.9 20.3 28.8 11.0 15.8 24.1 23.6 16.2 19.6 21.4 21.8 17.5 20.1 10.2 16.0 19.4 18.4 31.7 19.8 34.4 20.7 21.8 19.8 23.0 USP22 "KIAA1063, USP3L" ENSG00000124422 "Ubiquitin specific peptidase 22" Q9UPT9 17 20999593-21043760 "Enzymes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044980 Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA044980: AB_10794503" "unprognostic (7.24e-2)" "unprognostic (5.38e-2)" "unprognostic (7.67e-2)" "unprognostic (6.19e-2)" "unprognostic (4.72e-1)" "unprognostic (1.11e-2)" "prognostic unfavorable (9.66e-4)" "unprognostic (2.17e-2)" "unprognostic (7.81e-2)" "unprognostic (6.37e-2)" "unprognostic (1.07e-3)" "unprognostic (5.68e-2)" "prognostic favorable (1.53e-7)" "unprognostic (8.95e-2)" "unprognostic (1.93e-1)" "unprognostic (2.91e-1)" "unprognostic (1.79e-2)" 22.5 33.0 40.7 21.5 49.5 25.9 24.6 66.1 66.4 26.8 23.6 31.9 25.1 18.9 36.7 29.3 21.9 33.9 23.0 44.1 38.7 47.6 27.7 22.9 26.1 25.1 31.0 40.7 45.6 24.5 47.4 32.2 22.4 35.1 27.5 20.5 28.7 20.0 29.5 47.6 22.1 21.1 31.2 24.8 23.7 22.7 20.2 23.7 41.2 32.8 24.8 27.3 25.1 23.2 13.7 12.1 13.4 13.3 8.9 15.5 6.9 19.6 35.6 34.6 29.7 20.2 21.0 16.5 22.6 17.4 20.4 17.4 41.0 8.9 26.9 21.8 34.7 13.8 21.1 33.5 27.0 30.6 12.8 23.2 22.3 23.7 19.9 24.0 24.5 19.5 23.1 16.2 23.1 24.3 23.3 25.4 17.7 25.3 9.8 28.8 20.2 34.3 11.7 17.8 23.3 11.7 38.0 54.8 18.3 18.8 28.9 16.7 34.4 29.2 12.1 23.7 99.0 20.3 14.5 32.2 20.9 27.8 21.4 30.5 10.5 14.1 89.5 21.2 13.1 32.2 6.8 13.3 12.6 11.0 9.8 11.1 10.9 11.7 10.9 12.1 13.7 15.5 14.6 13.4 8.9 12.2 10.2 7.8 6.9 40.7 49.5 66.1 66.4 38.7 47.6 31.0 40.7 35.1 23.7 38.7 45.6 40.4 39.5 29.3 90.6 20.9 58.6 29.4 35.2 57.6 88.4 42.1 19.9 47.1 31.0 40.9 35.1 0.0 50.6 33.9 44.7 49.2 29.0 55.2 34.1 111.2 84.7 78.0 53.0 39.2 47.2 23.7 33.7 24.4 42.7 58.7 59.0 38.6 67.5 45.1 54.5 12.9 38.8 14.2 16.6 25.5 55.0 23.0 46.6 38.9 VAX2 DRES93 ENSG00000116035 "Ventral anterior homeobox 2" Q9UIW0 2 70900590-70965373 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.4;retina: 21.2" "Group enriched" "Detected in some" 7 "Bipolar cells: 8.7;Cone photoreceptor cells: 15.7;Horizontal cells: 11.1;monocytes: 7.2;Muller glia cells: 7.2;Rod photoreceptor cells: 17.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 6.6;MCF7: 7.5;RH-30: 6.5;SCLC-21H: 6.6;SH-SY5Y: 7.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "basal ganglia: 2.1;hypothalamus: 4.7" HPA009708 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA009708: AB_2668261" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.96e-2)" "unprognostic (3.16e-2)" "unprognostic (1.63e-2)" "unprognostic (2.17e-1)" "unprognostic (3.52e-2)" "unprognostic (7.23e-3)" "unprognostic (2.42e-1)" "unprognostic (1.98e-1)" "unprognostic (3.81e-1)" "unprognostic (2.16e-1)" "unprognostic (7.74e-3)" "unprognostic (6.63e-3)" "unprognostic (4.65e-1)" "unprognostic (6.67e-3)" "unprognostic (2.18e-2)" 2.7 2.6 4.4 1.4 1.9 0.4 2.1 16.4 7.9 1.9 0.8 1.1 0.0 0.5 3.6 0.8 1.8 1.1 0.6 1.5 2.5 4.1 0.6 0.3 0.9 0.6 1.4 1.1 2.3 6.9 0.9 2.2 1.2 0.8 2.3 0.6 21.2 4.5 0.6 2.0 1.5 0.5 1.9 1.6 0.4 0.4 0.8 1.0 0.0 0.7 1.2 0.4 1.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.0 1.2 6.6 1.8 1.0 3.7 1.2 0.5 0.1 0.0 0.1 0.0 0.0 0.0 2.9 2.2 0.3 2.5 0.0 0.2 0.0 4.1 0.0 0.1 2.8 0.8 0.0 0.0 1.8 0.0 0.3 0.0 1.9 0.6 0.3 0.0 0.0 2.4 7.5 0.0 0.1 2.9 0.0 0.1 0.0 6.5 0.0 2.0 1.6 6.6 7.9 5.1 0.0 2.7 0.2 2.9 0.2 1.2 3.1 0.7 1.5 1.3 0.0 0.0 0.0 1.5 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.9 16.4 2.7 2.5 4.1 1.4 1.1 0.8 1.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 15.7 0.1 1.7 1.4 0.0 0.4 0.0 0.0 0.6 0.2 0.8 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.2 0.0 7.2 0.6 0.0 0.0 0.0 17.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 VPS72 "Swc2, TCFL1, YL-1, YL1" ENSG00000163159 "Vacuolar protein sorting 72 homolog" Q15906 1 151169987-151195321 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065709 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA065709: AB_2685540" "unprognostic (2.55e-1)" "unprognostic (3.79e-1)" "unprognostic (3.10e-1)" "unprognostic (4.50e-2)" "unprognostic (2.16e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (4.41e-6)" "unprognostic (4.10e-2)" "unprognostic (2.25e-1)" "unprognostic (1.10e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (7.92e-2)" "unprognostic (4.52e-2)" "unprognostic (4.92e-2)" "unprognostic (4.49e-2)" "unprognostic (1.30e-1)" 23.7 19.7 28.2 20.9 26.3 11.8 19.2 30.2 30.2 21.0 19.2 20.6 20.5 17.8 26.1 21.6 24.6 26.5 19.2 22.0 25.7 26.2 20.1 14.9 18.2 19.6 26.5 25.1 27.3 18.5 19.8 16.4 23.7 21.8 23.8 17.7 19.2 23.8 24.6 66.6 22.5 16.3 32.8 27.0 19.3 19.6 17.3 21.9 21.4 22.2 20.2 26.4 29.0 21.3 35.4 28.8 41.4 25.8 38.2 33.8 27.9 20.1 13.8 32.4 23.3 14.3 12.6 27.8 22.0 11.7 17.7 12.9 14.8 17.0 20.4 27.1 16.5 12.3 19.0 23.9 14.2 13.4 24.1 25.2 17.4 10.9 10.1 20.0 25.6 15.7 10.1 19.7 20.1 16.8 18.5 23.1 25.3 33.1 15.2 13.9 33.8 22.0 17.4 37.7 36.2 23.0 24.3 18.6 31.9 16.4 10.3 22.9 40.9 15.1 23.5 26.4 31.9 26.4 38.1 21.7 9.3 15.6 14.7 27.8 28.6 40.2 32.8 15.3 17.8 17.0 25.9 25.8 41.4 32.1 24.5 31.0 35.4 28.9 27.2 28.8 27.4 28.9 26.2 18.9 38.2 19.6 18.3 33.8 27.9 28.2 26.3 30.2 27.3 25.7 26.2 26.5 25.1 21.8 21.9 6.0 7.8 16.6 24.1 25.2 13.8 11.3 25.5 10.7 12.5 22.7 3.9 48.9 54.7 44.6 9.5 27.5 20.1 23.3 40.3 44.6 28.0 21.9 31.1 16.2 28.2 14.3 19.4 22.7 20.8 9.5 23.3 19.8 40.5 40.5 28.1 22.4 46.9 27.9 23.3 25.9 11.5 51.8 32.2 34.2 33.8 27.7 52.7 20.8 25.4 31.0 WDR17 ENSG00000150627 "WD repeat domain 17" Q8IZU2 4 176065834-176182818 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9;parathyroid gland: 19.0;pituitary gland: 22.5" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 15.7;Cone photoreceptor cells: 60.9;Horizontal cells: 20.6;Rod photoreceptor cells: 35.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.9;SCLC-21H: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042766, HPA054501" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA042766: AB_10806372, HPA054501: AB_2732586" "unprognostic (3.41e-4)" "unprognostic (1.72e-1)" "unprognostic (1.20e-1)" "unprognostic (6.43e-7)" "unprognostic (3.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (8.62e-2)" "unprognostic (1.42e-1)" "unprognostic (1.39e-3)" "unprognostic (6.04e-4)" "unprognostic (3.66e-4)" "unprognostic (9.25e-3)" "unprognostic (4.63e-2)" "unprognostic (7.32e-3)" "unprognostic (8.24e-3)" 2.1 5.8 12.4 2.2 22.1 1.5 3.3 12.2 23.9 2.0 2.9 3.4 0.0 1.6 4.5 6.2 1.9 3.5 3.0 1.3 9.7 7.1 6.2 1.0 3.6 1.8 4.4 16.3 4.0 3.0 19.0 22.5 0.7 7.9 2.3 3.1 6.0 1.7 2.2 0.7 1.2 1.8 2.8 4.0 2.9 3.1 4.1 6.9 0.1 10.2 0.0 1.6 1.9 1.5 1.1 0.7 2.6 1.6 1.3 0.8 0.2 0.0 3.7 8.9 0.1 0.2 0.6 0.3 0.2 0.0 0.8 3.1 0.2 0.1 6.1 0.0 0.1 4.8 0.1 3.9 2.0 0.8 0.0 3.1 0.0 0.7 0.0 0.3 3.3 4.8 1.4 1.2 0.1 0.5 1.3 0.0 7.1 0.0 0.3 0.6 1.6 3.4 0.1 2.0 0.0 1.9 0.0 3.8 0.0 0.5 0.0 10.2 7.4 0.0 2.4 6.2 1.4 0.4 0.0 0.0 1.2 1.7 0.1 5.7 4.4 2.9 3.5 7.0 0.0 2.4 2.6 0.6 0.3 0.6 1.6 0.3 1.1 0.6 0.4 0.2 0.8 0.7 0.8 1.7 1.3 0.3 0.7 0.3 0.2 12.4 22.1 12.2 21.8 9.7 7.1 4.4 16.3 7.9 6.9 0.0 4.3 0.0 0.4 0.1 15.7 0.8 2.5 12.0 2.3 0.0 60.9 0.0 1.7 0.3 1.2 0.5 0.0 0.0 0.5 0.0 0.5 0.2 3.5 0.0 0.2 20.6 4.6 1.8 0.3 0.8 0.9 0.2 1.7 0.0 0.0 9.5 0.3 0.0 1.4 4.4 35.8 0.0 1.0 2.6 4.5 0.0 0.0 0.0 0.0 0.3 WDR90 "C16orf15, C16orf16, C16orf17, C16orf18, C16orf19, FLJ36483, KIAA1924" ENSG00000161996 "WD repeat domain 90" Q96KV7 16 649311-667833 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 38.8;Rod photoreceptor cells: 35.4;Spermatocytes: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 28.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA049362, HPA061785" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049362: AB_2680728, HPA061785: AB_2684606" "unprognostic (1.97e-2)" "unprognostic (1.50e-2)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.89e-2)" "prognostic favorable (2.70e-4)" "unprognostic (2.67e-2)" "unprognostic (8.28e-2)" "unprognostic (5.23e-2)" "unprognostic (1.02e-1)" "unprognostic (9.55e-2)" "unprognostic (9.96e-3)" "unprognostic (2.84e-3)" "unprognostic (8.26e-2)" "unprognostic (3.08e-1)" "unprognostic (4.25e-2)" "unprognostic (4.48e-2)" 4.5 10.5 5.9 8.7 8.0 14.2 6.5 11.1 6.6 11.2 6.5 7.7 11.5 8.5 15.6 12.5 5.9 13.8 10.3 4.2 5.1 4.1 8.9 5.5 6.1 5.4 4.3 3.8 13.4 10.3 7.0 16.7 6.9 6.8 8.5 3.5 11.4 7.9 8.9 3.2 13.5 7.4 6.8 4.6 4.3 8.4 34.3 6.2 9.8 13.4 9.1 7.9 5.0 6.1 3.3 1.9 0.0 0.8 0.0 1.7 0.8 5.6 7.9 4.5 10.8 1.7 1.1 0.3 4.2 1.6 3.1 3.7 10.3 8.0 4.9 3.3 1.3 0.1 12.5 2.2 3.4 0.7 8.3 7.8 1.6 28.3 9.3 0.5 8.8 7.8 2.3 2.8 6.3 1.4 1.1 2.2 7.8 0.5 12.6 1.3 4.1 6.8 8.3 4.4 4.7 2.6 19.3 1.7 8.1 3.4 5.3 8.5 8.9 3.9 8.0 0.8 0.3 16.5 7.2 2.4 7.7 7.7 8.3 5.4 12.8 5.5 5.2 2.2 4.7 4.9 0.0 0.1 0.0 0.3 0.8 0.0 3.3 0.5 1.7 0.2 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.8 5.9 8.0 11.1 6.6 5.1 4.1 4.3 3.8 6.8 6.2 0.0 7.8 0.0 2.9 3.1 8.1 2.8 22.9 38.8 7.9 8.7 13.7 2.5 0.0 4.5 4.4 4.2 2.9 0.0 3.2 2.2 3.3 2.6 0.0 4.7 2.3 11.1 1.2 1.8 1.2 3.6 5.8 1.7 3.3 0.0 6.7 7.6 3.7 2.9 4.2 1.1 35.4 6.5 3.1 37.0 21.3 1.9 2.1 0.7 7.2 1.6 WRN "RECQ3, RECQL2" ENSG00000165392 "Werner syndrome RecQ like helicase" Q14191 8 31033801-31173769 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028661 Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA028661: AB_10602255" "unprognostic (8.73e-2)" "unprognostic (9.33e-2)" "unprognostic (1.51e-3)" "unprognostic (3.85e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-2)" "unprognostic (2.21e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "unprognostic (1.16e-2)" "unprognostic (1.27e-2)" "unprognostic (6.63e-2)" "unprognostic (1.53e-2)" "unprognostic (6.51e-2)" "unprognostic (2.49e-1)" "unprognostic (1.00e-2)" "unprognostic (2.66e-1)" 10.1 9.2 5.6 8.5 6.6 15.6 11.1 10.7 7.3 14.2 8.0 7.7 7.7 5.5 24.4 8.8 7.6 9.7 6.9 7.0 5.9 4.0 5.1 7.7 7.2 6.7 8.2 5.3 12.0 9.9 7.8 28.1 8.5 7.0 8.6 7.8 8.3 10.8 7.8 7.7 10.2 7.0 12.1 14.9 8.9 8.3 10.4 7.3 11.8 7.9 6.3 9.3 10.8 8.7 3.9 2.7 1.3 1.9 2.9 6.2 1.6 6.5 6.4 13.3 8.4 8.0 12.8 8.4 7.4 7.3 9.1 9.5 4.1 4.0 15.4 6.8 7.5 6.9 3.4 8.2 5.3 13.6 4.3 7.0 15.7 6.1 3.4 10.0 9.3 5.8 9.3 5.9 8.6 10.4 4.5 8.7 10.8 24.8 9.7 8.3 4.2 19.3 4.5 11.4 7.1 4.6 11.1 10.1 6.2 3.8 7.2 2.9 7.7 9.0 5.1 7.0 7.8 3.5 4.6 13.9 9.9 6.1 5.0 6.2 2.6 2.8 19.3 7.3 7.3 6.8 1.2 1.9 1.3 3.3 1.9 6.2 3.9 3.8 3.3 2.7 3.5 2.5 3.2 0.5 2.9 0.8 2.0 2.8 1.6 5.6 6.6 10.7 7.3 5.9 4.0 8.2 5.3 7.0 7.3 8.9 8.8 10.8 8.0 11.9 14.2 6.5 12.7 9.4 11.4 15.7 21.6 5.9 1.7 5.1 37.8 8.5 3.2 23.3 8.4 4.7 10.8 8.1 2.3 8.9 4.5 14.3 2.4 6.2 5.1 8.1 17.5 4.9 10.1 5.4 12.1 21.9 7.1 2.9 13.4 2.1 22.1 6.5 9.5 8.7 18.6 8.9 4.7 5.1 7.6 9.8 WTAP "KIAA0105, MGC3925, Mum2" ENSG00000146457 "WT1 associated protein" Q15007 6 159725585-159756319 "Predicted intracellular proteins" "Cell cycle, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Basal keratinocytes: 372.2;Suprabasal keratinocytes: 398.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010550 Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA010550: AB_1858866" "unprognostic (9.57e-2)" "unprognostic (1.58e-2)" "unprognostic (5.10e-2)" "unprognostic (2.32e-1)" "unprognostic (7.19e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.57e-6)" "unprognostic (8.65e-2)" "unprognostic (3.75e-1)" "prognostic unfavorable (7.51e-4)" "unprognostic (7.72e-2)" "unprognostic (4.92e-2)" "prognostic unfavorable (3.01e-5)" "unprognostic (7.92e-2)" "unprognostic (2.62e-1)" "unprognostic (4.00e-2)" "unprognostic (1.32e-2)" 37.6 31.0 21.5 38.7 24.7 106.0 37.5 30.1 22.3 29.7 28.2 19.4 25.1 19.1 33.8 34.6 30.3 28.8 27.3 28.9 22.0 22.1 28.5 28.8 29.7 36.1 20.9 21.2 37.1 30.1 23.1 31.2 35.0 22.1 33.0 28.7 23.7 30.3 27.2 81.2 29.3 28.6 30.9 22.6 36.5 27.1 20.4 21.6 53.2 36.3 26.2 39.3 33.4 34.6 26.6 22.3 33.4 27.1 23.9 30.5 14.7 13.8 13.3 30.0 27.4 35.2 39.0 19.6 21.7 73.7 27.8 37.2 25.7 13.2 34.4 13.1 23.8 61.2 18.9 29.1 25.4 36.2 17.9 19.5 34.3 14.5 36.2 29.5 31.0 20.8 46.3 24.7 31.0 41.1 21.3 21.1 33.8 36.8 32.3 29.3 13.9 42.7 41.7 25.4 21.6 11.2 28.5 19.4 24.6 29.9 17.1 28.7 20.9 40.8 23.2 10.7 21.2 10.7 38.5 18.8 19.7 21.4 28.5 31.5 23.4 26.0 53.0 18.1 31.1 19.6 27.2 19.2 22.6 23.4 24.3 26.4 26.6 28.3 27.8 22.3 23.8 25.6 25.8 33.4 23.9 27.1 18.9 30.5 14.7 21.5 24.7 30.1 22.3 22.0 22.1 20.9 21.2 22.1 21.6 32.8 59.0 84.2 176.7 372.2 29.5 46.6 84.1 36.1 35.2 57.6 33.4 93.4 72.9 99.7 34.1 64.1 45.2 46.7 70.5 105.3 82.6 229.3 39.3 81.8 67.3 35.0 59.1 50.3 77.6 39.5 60.4 106.3 231.2 127.2 57.7 39.0 73.8 54.5 47.7 75.7 31.8 71.1 169.7 61.3 74.5 398.0 124.8 111.7 56.9 130.8 XYLB "FLJ10343, FLJ12539" ENSG00000093217 Xylulokinase O75191 3 38346760-38421348 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Xylose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 34.0" "Group enriched" "Detected in many" 5 "Hepatocytes: 42.9;Proximal tubular cells: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 6.4;monocytes: 3.6;T-cells: 3.9" "Cell line enhanced" "Detected in many" "Hep G2: 21.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037863, HPA038415" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA037863: AB_10672729, HPA038415: AB_10672592" "unprognostic (2.48e-1)" "unprognostic (9.72e-2)" "unprognostic (3.42e-2)" "unprognostic (6.25e-2)" "unprognostic (7.52e-2)" "unprognostic (5.19e-2)" "unprognostic (5.82e-2)" "unprognostic (1.26e-3)" "unprognostic (6.55e-2)" "unprognostic (2.22e-1)" "unprognostic (6.91e-3)" "unprognostic (4.63e-2)" "prognostic favorable (8.57e-4)" "unprognostic (3.26e-1)" "unprognostic (2.06e-1)" "unprognostic (5.78e-2)" "unprognostic (3.37e-2)" 2.3 3.2 2.7 1.9 3.4 2.5 3.0 10.3 4.7 2.7 5.9 2.3 1.6 5.8 3.7 3.6 3.1 1.9 2.5 1.5 1.8 1.8 11.3 34.0 1.8 1.3 1.9 3.3 2.8 6.1 1.2 3.1 1.4 4.1 2.1 5.1 3.0 7.1 1.8 1.3 1.9 9.8 3.6 2.0 1.6 3.7 2.1 1.6 2.3 1.5 1.8 1.3 2.7 2.9 0.4 6.4 1.1 3.6 0.9 3.9 1.1 3.0 5.8 2.1 4.7 2.9 3.3 5.2 4.3 1.6 3.9 3.8 7.8 3.3 2.7 1.1 5.5 5.0 2.1 6.3 2.6 4.3 3.8 4.9 5.3 4.5 21.3 1.8 7.6 5.8 2.1 4.4 5.3 2.1 1.2 3.5 7.2 14.6 5.3 3.7 1.6 6.5 1.0 3.1 6.4 7.0 3.2 4.2 3.9 0.4 4.8 2.6 2.5 2.5 11.6 9.4 1.9 5.6 4.4 1.4 7.4 5.8 11.2 1.9 2.8 4.6 7.4 4.0 6.3 5.4 0.5 2.2 0.7 1.5 3.6 1.0 0.3 1.2 0.8 6.4 0.4 1.5 1.5 1.1 0.9 2.9 1.3 3.9 1.1 2.7 3.4 10.3 4.7 1.8 1.8 1.9 3.3 4.1 1.6 0.0 2.2 0.0 1.6 0.8 3.1 0.8 0.0 1.4 2.3 0.0 0.0 3.2 1.7 0.9 0.2 1.0 4.9 0.0 2.6 3.0 1.3 0.9 0.0 42.9 3.4 0.0 0.0 1.8 1.2 0.0 1.4 2.3 0.0 1.0 4.7 0.4 1.3 6.6 1.8 19.9 5.0 0.0 0.9 0.3 2.7 0.6 1.1 0.5 4.5 1.8 ZBTB18 "C2H2-171, RP58, TAZ-1, ZNF238" ENSG00000179456 "Zinc finger and BTB domain containing 18" Q99592 1 244048939-244057476 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 114.4;skeletal muscle: 40.3" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 48.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 114.4" "Cell type enhanced" "Detected in many" "neutrophil: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024656, HPA074019" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA024656: , HPA074019: " "unprognostic (3.48e-3)" "unprognostic (9.17e-3)" "unprognostic (3.69e-3)" "prognostic favorable (1.34e-4)" "unprognostic (6.83e-2)" "unprognostic (4.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.15e-2)" "unprognostic (1.15e-2)" "unprognostic (8.43e-2)" "unprognostic (1.01e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.54e-3)" "prognostic favorable (6.78e-6)" 4.1 3.4 20.1 7.3 14.7 13.4 4.7 114.4 26.0 4.1 4.7 5.4 8.1 6.9 3.5 10.3 3.0 4.6 3.8 7.4 24.8 6.3 6.4 10.0 5.1 8.8 7.1 19.1 4.0 13.0 3.1 2.7 4.9 11.7 5.5 5.8 4.6 5.2 6.7 40.3 4.1 6.2 5.9 7.5 10.0 5.8 11.4 4.6 16.4 4.4 2.8 8.1 6.5 9.3 2.4 2.2 5.8 1.5 0.3 1.4 0.2 11.7 4.2 16.2 0.6 2.1 2.2 11.3 6.6 4.9 10.7 6.5 3.2 9.5 8.9 0.6 12.7 3.4 1.2 10.3 3.3 13.4 3.1 9.1 1.5 1.4 1.5 3.3 1.8 4.7 1.8 2.8 6.4 4.0 12.9 11.5 9.9 1.1 3.8 12.6 0.1 15.3 7.5 8.3 3.6 1.9 4.5 11.0 2.5 6.7 4.1 23.9 23.3 2.7 0.1 7.3 7.1 0.2 13.6 17.1 5.5 6.7 3.4 13.9 1.6 0.2 3.5 5.5 5.8 11.1 0.2 0.7 2.9 0.3 0.7 0.4 1.6 0.7 0.5 0.9 2.4 1.4 0.9 5.8 0.3 1.5 2.2 0.5 0.2 20.1 14.7 114.4 24.1 24.8 6.3 7.1 19.1 11.7 4.6 8.9 21.0 6.4 3.0 10.0 5.1 19.9 12.7 10.7 11.4 17.4 11.8 1.2 0.0 4.0 2.6 13.2 6.2 0.0 4.5 1.7 2.8 5.0 5.8 37.6 5.2 6.4 18.6 13.5 24.1 2.2 2.0 13.3 3.3 2.8 18.3 48.1 7.3 7.0 4.6 10.1 24.2 12.9 8.1 10.0 6.6 17.2 0.8 3.2 12.8 3.1 ZC3H11A "KIAA0663, ZC3HDC11A" ENSG00000058673 "Zinc finger CCCH-type containing 11A" O75152 1 203795654-203854999 "Predicted intracellular proteins" "mRNA transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA026439, HPA028490, HPA028526" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533" "unprognostic (8.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.45e-2)" "unprognostic (3.35e-1)" "unprognostic (1.51e-1)" "unprognostic (3.67e-2)" "unprognostic (2.87e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-2)" "unprognostic (2.38e-1)" "unprognostic (1.13e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-2)" "unprognostic (1.41e-1)" 21.7 18.1 19.0 17.7 15.9 23.2 49.0 27.7 17.9 16.8 20.4 16.9 15.7 18.4 21.9 12.5 18.8 15.2 13.7 15.5 20.7 12.8 16.2 23.9 20.8 22.4 22.9 11.0 19.0 17.2 23.0 42.7 30.8 18.8 16.9 16.8 11.0 19.5 15.6 23.0 23.4 25.4 15.5 20.5 23.9 18.5 42.1 18.7 23.1 21.0 14.1 22.8 21.5 44.7 6.7 5.1 15.1 6.3 5.9 9.5 4.9 13.8 11.2 22.0 14.4 13.6 10.5 24.1 16.1 11.1 13.2 14.8 15.6 17.6 17.8 9.9 16.3 10.6 19.9 17.3 9.4 18.0 25.9 12.5 17.1 18.4 7.7 7.5 23.7 30.8 9.0 11.6 13.9 13.7 16.4 11.7 19.4 33.8 24.4 10.7 11.4 26.1 9.6 21.2 9.9 9.3 19.2 25.8 11.7 9.5 24.3 16.4 15.4 16.0 13.1 14.6 26.2 14.2 17.8 18.6 19.3 17.2 16.5 15.0 18.1 17.0 28.4 12.3 13.8 14.6 15.1 4.4 6.5 6.9 4.3 9.5 6.7 6.3 6.2 5.1 5.0 8.0 5.8 9.2 5.9 6.3 2.8 5.8 4.9 19.0 15.9 27.7 17.9 20.7 12.8 22.9 11.0 18.8 18.7 11.9 25.6 37.1 51.4 90.1 41.6 53.6 56.0 20.1 22.7 0.0 43.2 26.1 0.0 0.2 31.1 62.7 40.4 46.7 0.2 22.8 64.8 79.2 24.3 53.9 28.2 79.4 44.9 55.3 49.7 7.6 55.8 34.3 45.5 0.0 60.1 40.3 0.4 38.4 63.3 0.0 47.2 77.6 59.5 48.9 36.6 97.5 42.7 34.6 45.7 81.4 ZC3H11B ZC3HDC11B ENSG00000215817 "Zinc finger CCCH-type containing 11B" 1 219608347-219613145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 8.9" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.4;Collecting duct cells: 1.8;monocytes: 1.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "HPA026439, HPA028490, HPA028526" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533" "unprognostic (1.75e-1)" "unprognostic (5.54e-2)" "unprognostic (2.21e-1)" "unprognostic (2.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.92e-1)" "unprognostic (5.07e-1)" "unprognostic (1.15e-1)" "unprognostic (1.02e-1)" "unprognostic (2.44e-1)" "unprognostic (1.30e-1)" "unprognostic (8.19e-2)" "unprognostic (2.28e-2)" "unprognostic (7.87e-2)" "unprognostic (9.15e-2)" "unprognostic (2.56e-2)" "unprognostic (1.87e-2)" 0.1 0.1 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.8 0.1 0.0 0.1 0.0 8.9 0.0 0.0 0.0 0.5 0.7 2.1 0.9 0.6 0.9 0.6 1.0 0.8 2.2 1.3 0.4 0.3 1.9 1.9 0.3 0.3 0.4 0.9 0.9 0.7 0.5 0.3 1.0 1.5 0.2 0.2 0.3 3.1 0.8 0.5 1.1 0.8 0.1 0.8 1.8 0.2 0.1 0.4 0.5 0.8 0.0 1.9 2.2 2.3 0.2 0.4 1.6 1.1 1.2 0.2 0.6 0.7 1.5 0.7 0.2 0.9 0.9 1.4 1.1 1.7 1.3 1.0 1.4 3.2 1.1 1.0 1.3 1.0 2.0 1.4 1.2 1.1 2.3 1.4 2.0 1.0 0.9 0.7 0.7 0.4 0.8 0.5 0.6 0.7 0.7 0.5 0.7 0.6 2.1 0.6 0.3 0.3 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZC3H18 NHN1 ENSG00000158545 "Zinc finger CCCH-type containing 18" Q86VM9 16 88570381-88631966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040847, HPA041327" Enhanced Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA040847: AB_10794865, HPA041327: AB_10795005" "unprognostic (3.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.88e-1)" "unprognostic (2.90e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.06e-4)" "unprognostic (1.10e-2)" "unprognostic (7.37e-2)" "unprognostic (2.89e-2)" "unprognostic (2.79e-1)" "unprognostic (2.07e-3)" "prognostic favorable (3.68e-4)" "unprognostic (5.83e-2)" "unprognostic (1.40e-1)" "unprognostic (4.29e-2)" "unprognostic (4.01e-1)" 17.5 13.5 15.5 28.1 19.0 30.9 15.3 28.3 21.4 15.1 17.1 20.7 17.4 20.3 20.5 12.2 16.5 15.5 21.8 13.9 15.6 12.6 11.5 13.6 14.7 23.1 17.1 10.5 18.2 19.7 18.8 17.7 18.7 15.0 13.2 11.8 13.4 18.4 13.0 27.6 16.3 20.2 14.6 14.3 22.4 16.9 31.4 18.4 27.0 15.3 10.7 18.6 17.2 21.3 4.5 5.8 7.6 9.9 6.4 6.8 4.1 15.4 20.8 15.2 15.2 7.5 6.5 24.5 15.6 8.5 14.6 6.7 20.4 13.5 19.0 13.3 7.3 9.8 18.6 14.3 11.8 9.3 11.1 18.1 12.6 10.3 17.3 9.6 9.7 11.0 5.9 9.0 15.5 7.5 6.1 9.0 13.3 34.2 6.3 7.2 29.9 30.9 17.2 23.8 12.1 12.6 38.1 10.5 13.9 6.6 9.9 16.1 13.9 29.9 8.3 8.7 9.3 18.9 13.2 12.2 15.8 16.4 11.4 15.7 14.2 22.3 45.5 14.0 22.7 16.6 4.5 4.5 4.3 6.0 5.2 6.7 4.4 5.5 6.1 4.0 4.5 5.0 3.9 7.6 6.4 9.9 5.8 6.8 4.1 15.5 19.0 28.3 21.4 15.6 12.6 17.1 10.5 15.0 18.4 26.8 21.6 22.5 15.2 14.9 26.0 8.4 17.8 14.7 33.0 15.7 33.4 19.5 6.6 13.7 54.6 14.7 19.7 46.7 14.3 18.3 11.6 15.0 19.7 12.9 15.7 27.0 24.0 15.4 18.7 5.8 20.1 22.5 13.5 22.6 16.2 24.7 14.3 20.1 15.9 6.3 42.6 6.5 12.7 30.5 34.6 19.4 21.1 30.5 19.3 14.2 ZCWPW2 ZCW2 ENSG00000206559 "Zinc finger CW-type and PWWP domain containing 2" Q504Y3 3 28349146-28538122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 46.6;Spermatocytes: 62.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035035, HPA039839" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035035: AB_10602256, HPA039839: AB_2676708" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (4.59e-3)" "unprognostic (6.53e-2)" "unprognostic (6.09e-4)" "unprognostic (3.21e-1)" "unprognostic (2.70e-2)" "unprognostic (1.73e-3)" "unprognostic (1.12e-1)" "unprognostic (1.10e-4)" "unprognostic (1.06e-2)" "unprognostic (7.88e-2)" "unprognostic (1.40e-2)" "unprognostic (2.38e-2)" 2.6 3.1 3.9 2.8 5.3 1.3 3.4 4.8 4.2 3.3 2.9 3.1 5.2 2.1 6.2 4.1 2.8 2.6 4.1 5.1 3.5 2.7 3.2 2.7 4.4 1.9 3.9 2.3 5.0 3.5 3.7 10.5 2.5 3.9 4.2 2.0 2.9 4.8 2.6 9.6 3.6 2.4 5.7 5.4 2.4 2.8 16.1 5.1 2.8 5.2 0.4 2.6 2.7 2.6 0.9 1.4 3.6 2.4 0.6 2.4 0.7 0.7 0.4 1.8 0.8 2.5 5.9 3.0 2.4 2.0 0.9 0.8 0.6 1.9 1.8 1.2 1.4 1.7 1.1 0.5 0.6 1.1 0.9 0.8 0.6 2.2 0.6 1.8 0.7 1.2 3.5 1.6 0.7 1.1 3.2 2.0 3.7 0.8 2.2 3.8 1.0 0.5 1.4 0.8 0.3 2.5 0.6 0.7 1.3 2.8 0.3 0.9 2.8 0.2 1.2 1.6 2.1 1.0 5.6 1.9 2.3 1.1 1.6 1.4 0.9 0.6 0.5 6.6 1.1 2.4 2.7 2.4 3.1 0.8 2.1 0.5 0.4 0.8 0.6 1.0 0.9 1.8 2.4 3.6 0.6 0.5 1.4 0.8 0.7 3.9 5.3 4.8 4.2 3.5 2.7 3.9 2.3 3.9 5.1 0.0 1.3 0.0 2.7 0.6 2.3 10.1 0.0 1.4 4.5 0.0 0.0 1.8 5.0 0.5 46.6 0.1 0.1 0.0 0.7 1.2 1.9 1.5 2.3 0.4 1.2 3.2 1.2 1.3 1.2 9.4 4.4 0.8 0.0 1.0 1.6 3.1 0.8 0.0 4.6 2.1 1.7 0.0 2.0 62.1 5.7 1.4 1.0 0.5 0.5 1.3 ZFP14 "KIAA1559, ZNF531" ENSG00000142065 "ZFP14 zinc finger protein" Q9HCL3 19 36334453-36379199 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 58.6;Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 95.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030637 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA030637: AB_10602353" "unprognostic (1.89e-1)" "unprognostic (3.80e-2)" "unprognostic (9.61e-2)" "unprognostic (3.53e-1)" "unprognostic (2.20e-2)" "unprognostic (3.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.23e-2)" "unprognostic (1.96e-2)" "unprognostic (1.17e-1)" "unprognostic (3.18e-3)" "unprognostic (1.91e-1)" "unprognostic (5.51e-2)" "unprognostic (1.86e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "prognostic favorable (2.75e-5)" 4.8 6.7 9.1 6.0 11.7 2.7 10.0 13.8 11.5 7.5 5.1 10.3 5.6 6.7 11.4 13.1 5.6 8.0 4.8 4.6 9.6 7.8 8.2 5.0 5.0 8.3 14.6 9.8 10.7 5.1 12.9 14.9 5.1 10.6 7.8 5.2 6.5 6.0 8.0 3.5 7.9 6.5 7.6 11.6 8.3 6.1 2.8 12.8 9.2 10.9 3.1 8.3 6.2 7.0 10.4 5.7 5.7 4.4 5.8 9.5 1.7 2.1 3.8 7.7 7.1 6.7 3.4 1.8 1.0 3.3 2.1 3.3 2.5 1.7 6.1 2.8 1.5 1.7 0.8 3.2 0.5 2.3 2.3 2.4 5.4 3.8 2.1 2.2 4.4 5.8 1.5 1.4 0.9 0.2 4.0 2.9 7.2 1.6 0.1 3.3 1.5 6.8 1.8 5.8 3.2 1.7 5.7 4.4 1.8 2.2 4.2 4.3 6.5 3.8 1.2 2.2 4.2 2.4 3.5 2.0 2.2 4.9 2.3 1.1 1.7 2.8 3.2 0.4 0.6 3.8 5.7 4.0 5.3 6.2 4.4 6.3 10.4 6.8 7.8 3.8 9.4 9.5 9.5 2.5 5.8 3.9 5.7 6.3 1.7 9.1 11.7 13.8 11.5 9.6 7.8 14.6 9.8 10.6 12.8 0.0 4.0 26.2 5.8 2.9 58.6 4.9 12.7 12.0 4.5 12.2 49.1 6.7 6.6 6.4 1.5 9.2 8.7 0.0 3.9 2.0 5.8 5.7 12.7 3.4 7.2 44.5 12.7 7.4 6.7 0.4 14.4 8.5 3.3 7.2 9.5 21.4 4.4 12.7 18.4 7.9 95.4 32.3 4.1 4.7 7.7 2.3 2.1 11.5 8.0 4.8 ZNF217 ZABC1 ENSG00000171940 "Zinc finger protein 217" O75362 20 53567065-53609907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.5" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 114.7;Suprabasal keratinocytes: 93.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 50.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051857 Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA051857: AB_2681641" "unprognostic (4.17e-2)" "unprognostic (4.05e-1)" "unprognostic (2.41e-1)" "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (2.49e-3)" "unprognostic (1.19e-1)" "unprognostic (1.47e-2)" "unprognostic (7.17e-2)" "unprognostic (4.13e-3)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.33e-1)" "unprognostic (2.90e-1)" "unprognostic (2.67e-1)" "unprognostic (2.52e-2)" 9.9 3.0 3.6 9.3 2.9 10.9 15.0 2.2 3.1 7.6 6.7 3.1 6.1 4.5 6.2 2.9 10.0 5.7 5.7 5.4 3.4 1.6 6.3 10.3 8.8 20.9 3.0 2.3 6.1 7.1 8.3 3.9 65.5 4.8 7.1 6.8 5.7 11.0 8.6 5.2 11.9 8.9 6.6 3.4 16.8 6.7 9.9 2.4 16.7 6.9 4.9 9.5 10.6 8.6 4.3 4.1 19.4 11.5 5.8 3.6 2.2 9.2 11.0 9.3 13.5 8.7 10.0 20.4 10.4 10.7 11.8 5.9 7.1 10.4 9.0 11.2 12.6 15.3 9.1 7.4 10.9 13.7 6.4 2.1 2.9 4.8 12.3 6.8 4.6 12.5 5.4 10.6 6.3 17.6 9.3 6.7 9.4 6.3 42.8 8.8 36.9 16.0 10.3 9.8 5.3 11.0 12.6 7.8 10.4 6.8 20.7 0.9 2.6 9.6 50.0 10.1 12.3 14.9 19.8 4.7 23.9 8.9 12.2 12.7 17.8 19.7 7.6 8.7 5.3 7.6 5.9 4.9 8.4 2.8 6.3 3.6 4.3 3.0 3.5 3.9 3.9 3.4 3.3 19.4 5.8 11.5 4.1 2.9 2.2 3.6 2.9 2.2 3.1 3.4 1.6 3.0 2.3 4.8 2.4 0.0 10.1 12.3 36.1 114.7 0.6 7.5 15.3 22.7 14.8 17.4 0.0 11.9 8.3 23.0 36.2 14.6 32.6 23.3 14.3 14.2 18.3 61.3 11.5 24.3 13.3 0.0 5.8 16.0 38.2 20.0 6.4 34.4 20.3 6.4 27.1 2.0 19.8 28.1 4.9 9.6 0.5 0.0 8.6 5.4 24.0 93.3 37.8 20.8 21.0 72.7 ZNF382 "FLJ14686, KS1" ENSG00000161298 "Zinc finger protein 382" Q96SR6 19 36604817-36634113 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.6" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 22.7;Early spermatids: 21.4;Horizontal cells: 47.7;Late spermatids: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049259 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049259: AB_2680694" "unprognostic (5.43e-3)" "unprognostic (5.16e-2)" "unprognostic (1.17e-1)" "unprognostic (2.68e-3)" "unprognostic (6.13e-2)" "unprognostic (1.85e-3)" "unprognostic (5.63e-2)" "unprognostic (6.64e-2)" "unprognostic (1.12e-2)" "unprognostic (5.76e-2)" "unprognostic (4.43e-3)" "unprognostic (3.07e-3)" "unprognostic (1.76e-5)" "unprognostic (8.71e-2)" "unprognostic (2.06e-2)" "unprognostic (2.53e-1)" "unprognostic (6.22e-2)" 3.3 5.9 6.7 3.5 10.5 1.9 3.3 27.6 13.8 4.2 3.9 4.9 2.3 1.3 4.8 4.2 3.1 5.8 3.0 7.5 6.2 6.2 3.8 1.5 2.7 5.1 5.6 11.2 4.7 2.6 4.8 11.0 4.6 9.4 3.6 1.9 4.4 3.3 3.1 1.7 1.4 2.8 4.3 5.5 5.5 2.2 6.7 5.3 3.6 5.7 2.0 6.3 4.0 2.0 9.0 2.4 3.5 0.7 4.5 9.0 2.7 0.2 0.1 4.5 6.4 1.9 2.6 1.5 2.0 0.6 5.9 6.1 0.1 0.4 3.9 4.3 2.4 2.6 0.1 5.8 0.1 3.8 10.9 2.6 6.3 0.3 1.6 5.2 0.9 7.6 3.5 0.2 3.3 0.2 6.0 0.7 7.7 0.1 0.2 3.8 0.6 8.8 2.1 3.0 0.0 2.2 0.4 1.9 1.7 1.6 0.2 0.6 8.7 0.3 0.3 3.5 6.8 2.7 0.7 0.2 1.4 0.3 0.3 5.7 10.0 0.7 0.4 0.1 0.1 3.5 2.1 0.6 3.5 5.6 0.7 9.0 9.0 8.8 6.2 2.3 6.6 7.6 8.4 1.2 4.5 0.7 2.4 5.0 2.7 6.7 10.5 27.6 13.8 6.2 6.2 5.6 11.2 9.4 5.3 3.0 0.0 0.0 0.6 0.1 22.7 9.8 0.0 2.7 1.2 3.5 9.8 1.8 5.0 2.4 21.4 2.1 0.0 0.0 0.4 0.8 2.0 0.4 0.0 0.4 2.4 47.7 0.0 1.3 0.6 15.0 0.6 1.1 1.7 1.0 0.1 4.0 0.2 0.0 1.1 1.3 12.7 0.0 1.2 4.4 2.8 0.0 0.1 2.1 0.0 0.4 ZNF441 FLJ38637 ENSG00000197044 "Zinc finger protein 441" Q8N8Z8 19 11767000-11784078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 14.9;Rod photoreceptor cells: 19.1;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA063338 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA063338: AB_2684989" "unprognostic (1.97e-1)" "unprognostic (1.96e-1)" "unprognostic (2.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (6.42e-4)" "unprognostic (2.60e-2)" "unprognostic (1.92e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-2)" "unprognostic (1.33e-3)" "unprognostic (1.80e-1)" "unprognostic (1.75e-1)" "unprognostic (1.68e-2)" "unprognostic (2.70e-3)" 7.6 5.7 7.5 10.6 15.5 1.6 11.3 18.4 11.1 9.6 6.0 4.4 9.4 4.4 8.9 12.1 5.4 7.7 6.9 7.0 7.0 6.7 12.4 8.1 6.6 9.5 5.4 7.1 16.4 6.6 12.1 13.3 8.1 11.6 11.1 6.3 6.6 6.7 9.9 13.9 6.1 7.9 10.8 4.9 8.2 5.9 5.0 5.5 7.2 13.5 3.8 8.1 11.1 7.0 4.5 1.5 2.1 3.6 2.1 4.2 1.7 2.6 0.0 3.3 2.8 4.1 4.4 3.5 6.5 3.6 4.8 4.6 2.9 0.9 5.5 3.4 4.3 2.4 2.0 2.1 4.0 5.7 0.0 2.3 2.6 2.2 4.7 3.6 0.1 4.7 5.3 4.4 3.4 2.7 3.3 2.7 2.3 4.1 0.1 7.5 0.0 5.8 1.6 0.6 1.1 4.6 2.2 6.6 1.7 4.0 4.4 2.5 4.0 4.3 1.5 2.4 3.4 4.3 5.8 1.3 10.6 2.5 9.2 4.3 5.8 8.4 2.4 0.7 0.1 4.2 0.0 1.0 2.1 2.9 0.9 2.2 3.6 2.9 3.9 1.5 4.5 3.8 4.2 1.3 2.1 3.6 1.0 2.1 1.7 7.5 15.5 18.4 11.1 7.0 6.7 5.4 7.1 11.6 5.5 14.9 5.4 0.8 0.7 0.3 11.3 7.1 0.0 0.0 6.8 10.4 13.7 1.6 3.3 1.3 0.1 4.5 1.4 0.0 1.0 0.6 1.3 0.6 2.3 1.9 0.7 6.4 0.0 4.9 0.3 0.0 2.3 2.3 3.3 0.0 0.7 7.2 0.9 0.8 6.7 2.7 19.1 19.4 3.1 2.9 2.3 0.0 0.7 1.8 0.8 0.4 ZNF446 "FLJ20626, ZKSCAN20, ZSCAN52" ENSG00000083838 "Zinc finger protein 446" Q9NWS9 19 58474017-58481230 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 22.8" "Low region specificity" "Detected in all" "HPA052786, HPA078262" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA052786: , HPA078262: " "unprognostic (1.52e-2)" "unprognostic (8.71e-3)" "unprognostic (2.72e-1)" "unprognostic (5.04e-3)" "unprognostic (3.28e-2)" "unprognostic (1.78e-2)" "unprognostic (5.15e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-1)" "unprognostic (3.94e-1)" "prognostic favorable (1.32e-4)" "unprognostic (3.94e-1)" "unprognostic (9.24e-2)" "unprognostic (2.43e-1)" "unprognostic (9.96e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-3)" 3.6 4.6 5.2 5.1 6.7 4.0 5.0 8.9 8.8 6.7 4.9 5.3 15.1 3.7 7.2 6.2 3.4 11.0 10.0 5.5 5.3 4.8 6.2 6.5 4.3 8.6 5.5 5.9 11.9 13.6 9.7 8.8 2.9 6.7 7.2 3.0 4.4 9.4 7.5 3.5 5.6 4.2 8.5 4.9 4.3 4.8 7.8 3.7 17.1 6.8 3.2 6.4 5.7 10.1 6.8 6.0 5.6 9.8 3.0 7.5 3.6 3.5 7.5 5.2 4.7 5.2 9.7 5.0 2.2 6.8 1.8 2.6 3.6 3.1 3.5 3.1 2.9 8.3 5.6 2.0 2.8 0.9 5.1 22.8 4.4 5.6 3.0 7.7 2.2 6.5 8.0 5.3 3.1 3.3 8.8 4.5 6.4 2.5 2.4 2.8 4.3 5.9 2.6 1.7 3.3 4.6 5.2 3.6 4.6 3.8 6.6 6.1 5.8 4.3 5.8 3.7 3.0 4.1 2.8 3.4 9.0 3.2 2.1 4.9 8.1 10.8 2.2 4.7 1.3 3.2 5.2 4.4 4.6 6.4 5.9 3.9 4.9 7.5 4.1 6.0 6.8 5.1 6.3 5.6 3.0 9.8 3.9 6.0 3.6 5.2 6.7 8.9 8.8 5.3 4.8 5.5 5.9 6.7 3.7 3.0 2.7 1.7 1.8 1.8 8.5 0.8 15.3 5.3 4.5 5.2 7.9 4.6 3.3 6.5 4.6 2.9 6.7 0.0 4.5 3.2 4.0 1.9 8.1 2.9 3.8 7.9 10.3 1.8 4.0 4.4 6.6 2.1 3.3 1.8 5.6 10.1 4.2 3.7 4.9 4.4 8.2 0.0 3.3 20.6 8.5 3.1 2.9 2.5 5.4 1.1 ZNF572 FLJ38002 ENSG00000180938 "Zinc finger protein 572" Q7Z3I7 8 124973298-124979389 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 6 "Distal tubular cells: 1.7;Muller glia cells: 2.0;Spermatocytes: 2.2;Spermatogonia: 1.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066838 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA066838: AB_2685734" "unprognostic (8.65e-2)" "unprognostic (3.11e-1)" "unprognostic (5.59e-2)" "unprognostic (2.33e-2)" "unprognostic (1.49e-3)" "unprognostic (8.37e-2)" "unprognostic (4.11e-2)" "unprognostic (1.81e-2)" "unprognostic (3.36e-1)" "unprognostic (8.88e-2)" "unprognostic (8.67e-2)" "unprognostic (2.42e-2)" "unprognostic (1.43e-1)" "unprognostic (8.95e-3)" "unprognostic (2.89e-1)" "unprognostic (2.82e-1)" "unprognostic (6.17e-2)" 2.7 1.6 4.5 5.1 4.5 0.5 6.1 2.7 3.5 3.8 3.2 6.4 3.1 2.6 4.6 6.7 2.6 4.6 2.1 2.8 4.0 2.7 5.1 3.5 3.0 7.1 6.0 2.7 6.8 4.4 2.3 2.3 4.3 3.9 4.4 3.9 4.7 3.7 4.9 1.2 2.5 3.6 2.8 4.4 4.4 4.0 9.8 4.6 11.0 5.4 0.7 5.3 5.1 5.3 2.4 0.6 1.1 1.0 2.3 3.3 0.6 1.7 0.8 1.9 0.0 2.7 3.1 0.0 0.6 0.2 2.3 1.3 2.5 1.2 4.3 2.9 0.7 0.5 3.4 1.1 0.1 2.1 0.0 0.9 0.0 1.2 2.9 2.2 0.0 2.3 2.3 2.9 2.4 0.0 0.6 1.4 0.0 2.5 0.0 3.0 7.0 0.0 0.0 0.0 4.1 0.0 2.8 5.0 0.5 1.3 1.2 4.4 4.3 2.7 4.3 4.5 3.9 1.9 2.9 1.0 2.7 3.2 0.8 0.0 0.0 2.4 1.9 0.6 0.0 0.3 0.0 0.4 1.1 1.0 1.0 1.4 2.4 1.0 0.5 0.6 2.4 3.3 2.0 0.0 2.3 0.7 0.2 0.0 0.6 4.5 4.5 2.7 3.5 4.0 2.7 6.0 2.7 3.9 4.6 0.0 0.0 0.0 0.2 0.1 0.8 0.7 0.0 1.4 1.2 0.0 0.0 0.7 1.7 0.3 0.2 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 2.0 0.0 0.0 1.1 0.7 0.3 0.0 0.3 2.2 1.9 0.0 0.2 0.0 0.7 0.1 ZNF584 FLJ39899 ENSG00000171574 "Zinc finger protein 584" Q8IVC4 19 58401504-58418327 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 31.4" "Low region specificity" "Detected in all" "HPA043408, HPA048075" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA043408: AB_2678466, HPA048075: AB_2680251" "unprognostic (6.06e-2)" "unprognostic (3.27e-3)" "unprognostic (3.76e-3)" "unprognostic (8.15e-3)" "unprognostic (5.50e-2)" "unprognostic (1.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.04e-2)" "unprognostic (6.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.01e-3)" "unprognostic (1.90e-3)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.80e-1)" "unprognostic (3.27e-1)" "unprognostic (1.36e-2)" 10.4 9.3 7.3 7.4 11.7 3.3 11.7 16.6 12.1 10.6 8.6 9.5 6.4 7.4 10.5 8.2 9.2 13.8 10.5 13.3 7.6 9.6 10.4 13.4 7.9 6.7 7.2 5.0 11.9 13.1 13.6 11.6 5.8 7.9 8.6 5.5 10.8 7.6 13.0 13.3 11.7 4.6 10.9 6.2 6.4 8.1 6.3 7.8 6.6 11.5 10.3 6.7 8.7 16.6 4.4 5.0 1.2 4.5 4.1 8.4 3.9 7.0 10.3 7.1 9.2 6.9 7.0 2.9 5.6 9.9 3.4 4.2 1.7 2.0 3.4 4.5 9.0 9.1 4.0 7.6 9.1 3.9 4.6 31.4 9.5 5.9 2.0 11.9 10.4 2.6 7.1 6.6 10.5 14.7 7.6 6.8 5.9 9.4 3.2 5.6 5.0 8.6 3.2 1.7 4.6 14.6 6.3 5.3 5.4 4.8 8.3 5.7 6.0 12.1 3.4 4.7 1.9 2.2 5.2 4.2 13.6 4.1 5.6 8.7 3.2 5.6 0.7 9.8 3.6 4.4 0.0 3.2 1.2 5.0 3.1 8.4 3.3 6.8 7.2 5.0 4.4 3.8 5.7 1.0 4.1 4.5 4.4 7.2 3.9 7.3 11.7 16.6 12.1 7.6 9.6 7.2 5.0 7.9 7.8 3.0 3.8 0.5 2.3 10.0 3.9 11.7 2.5 6.7 1.2 8.7 3.9 0.9 11.6 4.4 8.2 3.6 1.4 0.0 4.4 1.2 4.3 2.3 2.3 4.9 2.4 3.2 6.4 5.5 3.1 4.6 4.9 1.4 1.7 1.0 1.7 5.8 3.9 2.9 6.0 5.0 8.9 6.5 6.2 7.2 3.9 13.9 0.3 4.9 3.0 1.1 ZNF621 FLJ45246 ENSG00000172888 "Zinc finger protein 621" Q6ZSS3 3 40524878-40574685 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065518, HPA071440" Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA065518: AB_2685501, HPA071440: AB_2686395" "unprognostic (1.09e-1)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (9.50e-3)" "unprognostic (3.06e-2)" "unprognostic (3.14e-2)" "unprognostic (2.62e-1)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.19e-1)" "unprognostic (5.33e-2)" "unprognostic (8.76e-2)" "unprognostic (2.50e-2)" "unprognostic (2.01e-3)" 12.3 11.3 14.6 10.6 27.1 11.6 16.6 20.4 17.3 14.2 11.1 26.2 15.5 9.6 16.4 18.3 9.1 10.9 11.3 9.3 17.3 14.1 11.8 10.0 12.5 11.1 26.7 12.1 14.1 15.0 18.4 15.6 10.6 17.6 13.3 11.4 12.1 12.6 14.8 10.5 16.2 10.4 15.9 22.7 11.6 11.2 8.6 24.7 4.8 13.9 8.1 11.5 10.4 10.6 7.4 4.3 5.5 3.4 4.9 4.8 1.8 9.2 4.9 13.0 12.8 9.5 14.1 7.0 9.6 11.8 12.7 12.2 10.4 5.0 3.7 7.2 12.9 8.6 3.1 12.4 7.1 14.9 13.0 13.7 12.4 18.4 9.6 15.1 11.7 12.1 11.2 16.3 12.8 20.7 14.1 9.9 4.5 12.7 10.9 10.5 5.0 2.9 13.7 7.6 3.3 10.1 1.3 8.4 3.9 6.7 11.2 4.3 11.4 9.0 7.2 11.4 13.5 10.9 9.7 12.2 21.4 10.6 10.1 13.8 16.5 15.4 7.9 10.1 8.7 13.2 5.5 3.0 2.5 3.9 3.4 2.7 6.1 3.8 4.8 2.4 7.4 4.4 3.9 4.4 4.9 1.9 4.3 3.1 1.8 14.6 27.1 20.4 17.3 17.3 14.1 26.7 12.1 17.6 24.7 8.9 10.5 7.5 4.2 1.3 12.5 10.1 10.2 4.0 11.4 10.4 11.8 4.5 5.0 6.0 6.0 8.7 5.0 0.0 4.9 2.9 5.1 4.9 3.5 4.0 3.3 14.3 9.8 5.5 6.7 5.7 6.9 4.4 3.3 10.0 5.6 9.4 5.5 3.5 11.3 2.9 15.0 0.0 4.9 9.4 7.0 1.6 4.6 5.7 5.8 4.2 ZNF695 SBZF3 ENSG00000197472 "Zinc finger protein 695" Q8IW36 1 246945547-247008093 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 8.3;testis: 8.3" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 2.0;Extravillous trophoblasts: 3.7;Mucus-secreting cells: 2.0;Spermatocytes: 3.1;Spermatogonia: 2.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 5.1" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.2" "Low cell line specificity" "Detected in many" HPA024743 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA024743: AB_1859419" "unprognostic (8.46e-3)" "unprognostic (6.28e-2)" "unprognostic (1.82e-1)" "unprognostic (2.57e-4)" "unprognostic (4.51e-2)" "unprognostic (1.72e-1)" "unprognostic (1.10e-2)" "unprognostic (1.16e-1)" "unprognostic (5.71e-5)" "unprognostic (7.42e-4)" "unprognostic (2.81e-3)" "unprognostic (2.21e-2)" "unprognostic (1.05e-9)" "unprognostic (2.22e-1)" "unprognostic (2.07e-1)" "unprognostic (2.72e-1)" "unprognostic (3.87e-1)" 0.3 0.3 0.6 3.2 2.1 3.3 1.5 1.6 1.0 0.6 1.0 0.0 0.0 0.4 0.6 0.0 1.3 0.3 0.2 0.3 5.1 0.4 0.7 0.2 0.9 1.1 0.5 0.9 0.6 1.7 0.0 0.6 2.5 0.3 0.4 1.5 0.1 1.1 0.1 0.2 0.5 2.3 1.4 0.7 0.4 0.6 8.3 0.0 8.3 0.3 0.0 2.2 0.4 0.7 0.1 0.1 3.2 0.2 0.2 0.2 0.0 6.6 0.8 4.1 10.3 0.1 0.1 10.8 2.2 0.1 3.1 4.3 6.9 0.4 5.5 4.4 1.2 3.8 2.0 11.6 0.6 3.6 0.0 4.0 3.5 1.5 4.2 0.0 0.0 1.4 0.2 0.0 3.6 2.9 0.9 1.2 7.0 4.7 0.0 3.3 2.6 7.4 3.9 7.7 6.7 4.3 4.1 9.5 0.0 0.7 3.7 3.7 6.3 3.4 2.7 1.2 4.2 2.9 4.9 0.5 0.5 6.0 3.1 0.0 0.7 1.8 0.1 0.0 0.0 2.2 0.7 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 3.2 0.2 0.1 0.1 0.0 0.0 0.6 2.1 1.6 1.0 5.1 0.4 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 3.7 0.4 0.1 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.1 2.7 0.1 0.9 0.0 1.4 0.1 ZSCAN5A "MGC4161, ZNF495, ZSCAN5" ENSG00000131848 "Zinc finger and SCAN domain containing 5A" Q9BUG6 19 56219670-56368383 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.9" "Group enriched" "Detected in many" 6 "Early spermatids: 101.0;Late spermatids: 64.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041263, HPA043123, HPA046836, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: " "unprognostic (1.72e-1)" "unprognostic (3.19e-3)" "unprognostic (8.22e-4)" "unprognostic (1.65e-2)" "unprognostic (2.05e-3)" "unprognostic (6.99e-2)" "unprognostic (1.39e-3)" "unprognostic (3.10e-3)" "unprognostic (1.17e-1)" "unprognostic (2.42e-1)" "unprognostic (8.67e-4)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.10e-2)" "unprognostic (4.70e-2)" "unprognostic (6.15e-3)" "unprognostic (3.99e-3)" 4.0 4.9 5.2 5.4 9.9 3.8 4.3 5.9 8.0 6.0 6.0 6.5 4.9 6.1 6.6 5.0 4.7 11.3 4.3 8.1 5.2 4.8 5.6 5.8 5.0 4.3 4.9 3.9 6.3 5.9 6.4 14.3 4.9 6.9 4.6 7.4 9.9 5.7 7.8 5.9 6.1 5.6 6.3 3.4 4.6 4.1 29.9 5.5 7.6 5.4 5.9 5.3 4.6 4.7 4.2 10.8 4.7 8.9 1.4 8.0 4.1 4.8 4.2 6.1 7.4 5.0 3.2 8.9 2.9 6.2 8.8 5.3 8.4 2.9 8.7 2.3 5.0 5.3 6.0 7.8 6.2 8.0 2.5 16.5 10.7 2.8 8.3 4.0 11.8 12.1 2.5 9.4 8.7 4.0 1.7 6.3 6.9 4.2 4.0 2.7 5.9 2.8 6.7 10.9 4.3 11.1 4.5 9.2 5.1 3.6 9.1 5.9 6.0 7.6 5.9 3.1 3.6 2.6 10.9 3.4 7.7 7.7 4.1 9.4 6.6 16.7 6.1 10.0 11.8 2.9 4.4 7.7 4.7 5.3 8.9 8.0 4.2 5.5 4.0 8.7 2.5 7.2 3.8 0.6 1.4 5.0 10.8 1.4 4.1 5.2 9.9 5.9 8.0 5.2 4.8 4.9 3.9 6.9 5.5 0.0 3.4 5.4 4.3 4.2 3.9 14.8 0.0 12.0 4.5 0.0 7.9 2.7 10.0 4.2 101.0 4.6 3.2 0.0 4.5 3.0 3.1 4.0 2.3 5.9 5.9 3.2 7.5 4.9 6.3 64.2 2.3 4.3 0.0 1.0 3.6 4.8 4.0 0.0 2.5 4.5 9.6 0.0 3.9 11.9 13.8 3.1 5.8 2.5 4.9 2.7 ZSCAN5B "ZNF371, ZNF495B" ENSG00000197213 "Zinc finger and SCAN domain containing 5B" A6NJL1 19 56189570-56197920 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.5;testis: 6.1" "Cell type enriched" "Detected in single" 11 "Spermatogonia: 5.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 1.5;plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 1.7;hTCEpi: 1.3" "HPA043123, HPA046836, HPA059494, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA043123: AB_2678328, HPA046836: AB_2679832, HPA059494: AB_2684038, HPA060667: " "unprognostic (4.73e-2)" "unprognostic (9.73e-2)" "unprognostic (3.43e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (5.79e-2)" "unprognostic (2.88e-2)" "unprognostic (2.44e-1)" "unprognostic (5.15e-1)" "unprognostic (1.98e-1)" "unprognostic (7.01e-2)" "unprognostic (2.90e-1)" "unprognostic (2.55e-1)" "unprognostic (3.52e-2)" "unprognostic (2.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.83e-2)" 0.0 0.0 0.7 0.0 1.2 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.0 0.2 0.1 0.0 0.0 0.8 0.3 0.4 0.3 0.2 0.5 0.5 0.0 0.6 0.0 0.0 1.0 0.1 0.9 0.1 0.1 0.2 0.0 0.0 0.0 1.7 0.9 0.0 0.3 0.0 0.6 0.3 0.4 1.3 0.0 0.0 0.1 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.9 0.0 0.3 0.0 0.4 0.0 1.0 0.0 0.4 0.0 0.3 0.0 0.6 0.8 0.3 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.7 0.0 0.0 0.0 0.0 0.0 ZSCAN5C "ZNF495C, ZSCAN5CP" ENSG00000204532 "Zinc finger and SCAN domain containing 5C" A6NGD5 19 56202301-56209452 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.7" "HPA041263, HPA043123, HPA046836, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: " "unprognostic (3.74e-1)" "unprognostic (1.54e-1)" "unprognostic (3.29e-2)" "unprognostic (2.56e-2)" "unprognostic (9.17e-3)" "unprognostic (1.53e-1)" "unprognostic (1.47e-1)" "unprognostic (3.68e-2)" "unprognostic (4.01e-2)" "unprognostic (2.13e-2)" "unprognostic (7.45e-2)" "unprognostic (1.35e-1)" "unprognostic (8.51e-2)" "unprognostic (1.55e-1)" "unprognostic (7.89e-2)" "unprognostic (2.53e-1)" "unprognostic (9.53e-3)" 0.4 0.0 0.1 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 1.0 0.3 0.0 0.7 0.0 0.9 0.3 0.0 0.3 0.0 0.7 0.2 0.2 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.9 0.0 0.4 0.7 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.4 0.9 0.2 1.7 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.8 0.0 0.0 0.2 0.4 0.7 0.7 0.3 0.0 0.3 0.4 0.4 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.6 0.3 0.7 0.7 0.7 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZSWIM5 KIAA1511 ENSG00000162415 "Zinc finger SWIM-type containing 5" Q9P217 1 45016399-45306209 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 7.6;Cone photoreceptor cells: 9.8;Horizontal cells: 7.9;Intestinal endocrine cells: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 7.0;Hep G2: 7.9;SCLC-21H: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018211 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA018211: AB_1859502" "unprognostic (1.86e-1)" "unprognostic (2.58e-1)" "unprognostic (3.06e-1)" "unprognostic (1.49e-3)" "unprognostic (3.19e-1)" "unprognostic (3.72e-2)" "unprognostic (1.72e-3)" "unprognostic (2.65e-2)" "unprognostic (1.57e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-3)" "unprognostic (2.55e-1)" "unprognostic (4.12e-3)" "unprognostic (7.12e-2)" "unprognostic (3.09e-2)" "unprognostic (2.88e-2)" "unprognostic (1.16e-1)" 1.8 18.5 5.9 4.4 6.5 0.7 3.2 17.3 6.6 3.8 7.2 6.6 3.8 7.5 5.2 4.5 2.2 4.5 5.4 2.5 6.4 4.6 5.2 1.3 3.8 2.0 4.9 4.0 14.0 5.4 16.9 16.0 1.8 6.1 5.6 8.5 6.2 6.3 4.4 2.0 2.7 11.7 5.4 3.2 2.9 3.2 6.6 7.1 0.0 7.1 1.3 1.9 4.4 3.7 0.1 0.5 0.0 0.0 0.7 2.4 0.3 0.6 1.8 4.2 7.0 0.6 0.2 1.0 0.2 5.6 1.0 0.9 0.5 0.7 0.4 0.1 0.1 3.2 0.2 2.9 0.1 1.3 2.9 5.3 0.3 5.8 7.9 0.0 0.8 0.9 0.1 0.2 0.3 0.0 0.6 1.2 1.4 0.3 0.3 0.1 2.3 0.5 0.3 3.8 4.8 2.1 1.9 0.1 0.2 0.1 1.3 9.9 5.1 2.7 1.0 0.5 1.2 2.0 0.2 0.3 1.0 0.6 0.3 1.1 1.9 0.3 0.1 3.9 0.2 0.8 0.0 0.0 0.0 0.9 0.0 0.5 0.1 0.5 0.8 0.0 0.0 2.4 0.3 0.0 0.7 0.0 0.5 0.9 0.3 5.9 6.5 17.3 6.6 6.4 4.6 4.9 4.0 6.1 7.1 0.0 1.9 0.0 0.5 0.5 7.6 1.1 2.5 1.4 2.3 0.0 9.8 0.1 1.7 0.2 1.1 1.0 3.8 0.0 1.2 0.0 0.4 0.3 0.0 0.2 0.1 7.9 6.4 1.8 0.0 0.8 0.3 0.0 0.0 1.0 2.3 2.0 1.0 3.5 1.4 1.4 4.7 0.0 0.4 0.9 2.3 0.6 0.1 0.0 3.7 0.1